Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2018
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article New paradigm construction - education, clinical duties, study ... for sustained evolution of the clinical pharmacy
千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2018.
Japanese Article Innovation of the lung transplantation
大藤剛宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2018.
English Article Integration of clinical pharmacy services : implementation, research, outcomes, sustainability
Sandra Leal1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-145, 2018.
Japanese Article Septicemic pathologic new understanding and therapy development
西堀正洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2018.
Japanese Article Medical communication: Significance in the curative medicine
中野重行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2018.
Japanese Article From the position of pharmacist residency specialized in a family practice and pharmacist education - family doctor in the primary care domain -
松下明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2018.
Japanese Article Study of the clinical pharmaceutics on oral preparation, parenteral injection
内田享弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2018.
Japanese Article Study on pharmaceutical factor to give it to outcome of the rehabilitation in the convalescent rehabilitation ward
小瀬英司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2018.
Japanese Article For improvement in usefulness of eye drops: The applied nature of the eye drops evaluation based on pharmaceutics properties and nanopharmaceutical products
長井紀章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2018.
Japanese Article Study on theoretical dose design for the patients with acute renal failure, hemocatharsis therapy introduction patients
山本武人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2018.
Japanese Article Study of the clinical pharmacy on improvement in treatment management in the cancer medical therapy
北澤文章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2018.
Japanese Article Elucidation of cisplatin origin-related nephropathic protective efficacy with the magnesium administration and the mechanism
齋藤佳敬1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2018.
Japanese Article Exploring therapeutic strategy and prognostic biomarker of malignant breast cancer
相良篤信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2018.
Japanese Article Development of the optimal antiemesis therapy in the highly emetic chemotherapy including the cisplatin
鈴木賢一1, 辻大樹2, 伊藤邦彦2, 山本信之3, 濱敏弘1, 加藤裕久4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2018.
Japanese Article Clinical outcome of the treatment with multi-type of job team support in patients with bacteremia and study on prognosis-related factor
前田真之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2018.
Japanese Article 23-3-SP-1. Directionality and problems of the AI utilization in the DI room
若林進1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-159, 2018.
Japanese Article 23-3-SP-2. Request of suggestion and the participation in planning made with structure about the AI utilization to be useful for the field of future pharmacy
木村隆夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2018.
Japanese Article 23-3-SP-3. Research and development about the pharmacist support system utilizing the artificial intelligence (AI)
湯本哲郎1, 亀井淳三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2018.
Japanese Article 23-3-SP-4. Introduce "a type drug information offer support system mounted with AI" into hospital DI room inquiry duties; and from an example of - Okayama University hospital pharmacy -
神崎浩孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2018.
Japanese Article 23-3-SP-5. Expectation to the artificial intelligence utilization in pharmacist duties
望月伸夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2018.
English Article CJK-1. Immunotherapeutic Agents for the Treatment of Refractory Pediatric Acute Lymphoblastic Leukemia
Jennifer Thackray1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2018.
English Article CJK-2. Nutrition Support Pharmacists in Cancer Patients
Bo Yu1,2, Qing Zhai1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2018.
English Article CJK-3. The role of pharmacists in nutrition therapy - As a chef of parenteral nutrition -
Keiichiro Higashi1, Kiyoshi Sasayama1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2018.
English Article CJK-4. Management and Use of Opioid Analgesics and Pathway Sharing of Cancer Pain Homecare
Li Ran1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2018.
English Article CJK-5. Efforts to cooperate with community pharmacists and hospital pharmacists
Yasuko Kurata1, Yoshihisa Kitamura1, Toshiaki Sendo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2018.
English Article 23-10-IS1-1. Facilitating collaboration between pharmacy schools and hospitals to foster future pharmacist-clinical scientists
Makiko Iwasawa1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-170, 2018.
English Article 23-10-IS1-2. Pharmacy Practice Model in Thailand
Surakit Nathisuwan1,2, Amnouy Preukpakpoom1, Thida Ninsananda1, Pranee Pinyowattayakorn1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2018.
English Article 23-10-IS1-3. Brief Introduction of Pharmaceutical Services in China
Sun Lulu1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2018.
English Article 23-10-IS1-4. Specialty Pharmacy Residency : The Importance of Training and Advancing Next Generation of Specialized Pharmacists
Jennifer Thackray1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2018.
English Article 23-10-IS2-1. Overseas clinical rotation and exchange program of pharmacy students in Keio University
Takeshi Akiyoshi1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-175, 2018.
English Article 23-10-IS2-2. Future Perspectives of Clinical Pharmacists in Oncology Care
Masami Tsuchiya1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2018.
English Article 23-10-IS2-3. Establishing individualized cancer therapy based on clinical molecular pathogenesis - Clinical significance of tumor suppressor CYLD downregulation in malignant tumors -
Hirofumi Jono1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2018.
English Article 23-10-IS2-4. Approach Made by Pharmacy Pharmacists to Increase the Generic Use
Hiromi Shinohara1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2018.
English Article 23-10-IS2-5. Labeling in Asia : What are the labeling regulations for Healthcare Professionals (HCPs) & Patients, and how the labeling information is delivered in Asia?
Rie Matsui1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2018.
Japanese Article 23-1-S1-1. Expectation to the pharmacist in the AST activity
三鴨廣繁1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-181, 2018.
Japanese Article 23-1-S1-2. Role of the pharmacist in AST of the university hospital
浦上宗治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2018.
Japanese Article 23-1-S1-3. Role of the pharmacist in AST of the large-scale hospital
梅村拓巳1,2, 武藤義和2,3, 位田陽史2,4, 大竹有里2, 石原誉志美2,4, 小崎耕自1, 須川真規子2, 鷹見繁宏1, 市原利彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2018.
Japanese Article 23-1-S1-4. Role of the pharmacist in AST of the small and medium size hospital
片山歳也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2018.
Japanese Article 23-1-S1-5. Role of the pharmacist in AST which we saw from the university pharmacy school
村木優一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2018.
Japanese Article 23-1-S2-1. We attack AMR from the situation of hospital pharmacist and AST!
前田真之1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2018.
Japanese Article 23-1-S2-2. We attack AMR measures from the position of the drugstore pharmacist!
宮崎長一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2018.
Japanese Article 23-1-S2-3. We attack AMR measures from the situation of the pharmacy education!
松元一明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2018.
Japanese Article 23-1-S2-4. We attack AMR measures from the situation of the fundamental researches of medicine-based university!
小田真隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2018.
Japanese Article 23-1-S2-5. We attack AMR measures from the situation of the pharmaceutical company!
野村伸彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2018.
Japanese Article 23-1-S2-6. What do you seek in a pharmacy for AMR measures?
松永展明1, 具芳明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2018.
Japanese Article 23-2-S3-2. How to catch and evaluation of the adverse event of the anticancer medicine to expect of a pharmacist
田村和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2018.
Japanese Article 23-2-S3-3. The management of the adverse event with the cancer medical therapy
池末裕明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2018.
Japanese Article 23-2-S3-4. High blood pressure that a pharmacist evaluates it and manages
藤堂真紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2018.
Japanese Article 23-2-S3-5. Diarrhea that a pharmacist evaluates it and manages
大橋養賢1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2018.
Japanese Article 23-2-S3-6. Hypothyroidism that a pharmacist evaluates it and manages
土手賢史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2018.
Japanese Article 23-2-S4-1. From "adverse drug reaction assessment" to securing of safety of medicine
宇野勝次1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-199, 2018.
Japanese Article 23-2-S4-2. Interview point - not to worry - patients how you hear a side effect symptom
小茂田昌代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2018.
Japanese Article 23-2-S4-3. Circulatory organ disorder assessment
佐藤光利1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2018.
Japanese Article 23-2-S4-4. Main point - of the medication counseling of mind, neuropathy assessment - psychiatry analogous drug
三輪高市1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2018.
Japanese Article 23-2-S4-5. Dermatopathy assessment
蒲原毅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2018.
Japanese Article 23-2-S5-1. ... which sends rearward clinical record research - results of research to learn as evidence from zero
河添仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-205, 2018.
Japanese Article 23-2-S5-2. Statistical analysis utilizing the tendency score in clinical studies
魚住龍史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2018.
Japanese Article 23-2-S5-3. It is ... through a multicenter double-blind randomized phase II study of dispatch - olanzapine of the evidence by the prospective clinical study
矢内貴子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2018.
Japanese Article 23-2-S5-4. Introduction of the study support of the pharmacist with the Japanese cancer supportive care study group
橋本浩伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2018.
Japanese Article 23-3-S7-1. We expect it of a pharmacist from ... administration to the activation of the adverse event report
太田美紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2018.
Japanese Article 23-3-S7-2. Efforts of the adverse event report by the Hiratsuka Naka-gun pharmacist society method
飯塚敏美1,3, 鈴木優司2, 平本要3, 今井裕久3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2018.
Japanese Article 23-3-S7-3. Efforts - as - pharmaceutical company contributing to the risk management of pharmaceutical products
大箸義章1,2, 田中慎一3, 野村誠3, 富澤志帆3, 田端秀日朗3, 吉田真3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2018.
Japanese Article 23-3-S7-4. Role - of activated - hospital pharmacist of the adverse event report by the medicine medicine cooperation
鈴木優司1,2,3, 奥村伊代1, 矢野裕士1, 江川裕之1, 吉澤美香1, 飯塚敏美2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2018.
Japanese Article 23-4-S8-1. Is the pharmacist used to the pivot from disaster occurrence to revival?
渡邉暁洋1, 高田洋介1, 山田太平2, 中尾博之1, 中尾篤典2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-220, 2018.
Japanese Article 23-4-S8-3. Problem of the cooperation in the disaster medical care
若井聡智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2018.
Japanese Article 23-5-S9-1. Picture of HIV-related nerve cognitive impairment (HAND) in Japanese: From J-HAND results report
木内英1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-225, 2018.
Japanese Article 23-5-S9-2. Development situation of the Residual medicine and "we intended to take medicine case"
大石裕樹1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2018.
Japanese Article 23-5-S9-3. Efforts of the improvement in medication adherence to patients with HIV infection that caused the cognitive dysfunction in the health insurance pharmacy
小川和彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2018.
Japanese Article 23-5-S9-4. Art - psychological tests inflection technique ... of the medication management success
辻麻理子1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2018.
Japanese Article 23-5-S10-1. The effectiveness and stability of the indometacin gargle for the pain control of oral mucositis with the cancer chemotherapy
安武夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2018.
Japanese Article 23-5-S10-2. It is ... from study - theme setting of the clinical pharmacy by the cooperation with ethical pharmacy and university to an article contribution
山本佳久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2018.
Japanese Article 23-5-S10-3. Efforts - that university cooperated with clinical studies - municipal hospital of the diabetes domain using receipt data
堀井剛史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2018.
Japanese Article 23-5-S10-4. The need of data in the medication counseling at the drugstore
福田春香1, 山本佳久2, 鈴木豊史3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2018.
Japanese Article 23-5-S10-5. Fact-finding of the polypharmacy in the Tokyo suburbs
百賢二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2018.
Japanese Article 23-5-S11-1. Development and problem of IPE in Chiba University
石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2018.
Japanese Article 23-5-S11-2. Approach in the current situation and the Gifu University faculty of medicine of the multi-type of job cooperation education in the medical education
藤崎和彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2018.
Japanese Article 23-5-S11-3. Clinical IPE of student nurse and the pharmacy student by the Miyagi IPE project
大塚眞理子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2018.
Japanese Article 23-5-S11-4. Efforts of multi-type of job cooperation education (IPE) in the specialty college
渡部一宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2018.
Japanese Article 23-6-S12-1. Associated - of eating deglutition, the nourishment particularly correspondence - to eating dysphagia in being at home
戸原玄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2018.
Japanese Article 23-6-S12-2. All associated <fruits of nourishment, the pressure sore are> together with oneself
塚田邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2018.
Japanese Article 23-6-S12-3. The effect that food for the use actual situation of the food for the thickness adjustment at medication and the general-purpose thickness adjustment gives to the collapse of the tablet
富田隆1, 幸田幸直2, 工藤賢三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2018.
Japanese Article 23-6-S12-4. Because a pharmacist becomes a specialist of the community medical care
小原道子1,2, 林秀樹2,3, 生木庸寛1,2, 福田英二4, 杉山正2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2018.
Japanese Article 23-6-S13-1. Usefulness of the balun strike scorecard in the non profit organization
赤瀬朋秀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-244, 2018.
Japanese Article 23-6-S13-2. ... which makes the practice - hard drug agent part of the drug section management utilizing BSC
井口恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2018.
Japanese Article 23-6-S13-3. Tochigi Prefectural cancer center pharmacy BSC and in-hospital BSC meeting
小林尚加1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2018.
Japanese Article 23-6-S13-4. Growth strategy using the balun strike scorecard in the middle scale hospital
佐藤大輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2018.
Japanese Article 23-6-S14-1. Importance of the heart failure team approach in medical care
佐藤幸人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2018.
Japanese Article 23-6-S14-2. From the position of importance - nurse of "tying it" that support patients with heart failure -
辻井由紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2018.
Japanese Article 23-6-S14-3. Medical treatment of the heart failure to bring up in the multi-type of job and patients
野崎歩1, 奥川寛1, 馬橋美由季1, 堀内望1, 深見智子2, 小林由佳1, 中村茂3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2018.
Japanese Article 23-6-S14-4. We think about the relation pharmacist in the local inclusion care that fixed its eyes on a heart failure pandemic
西村知晃1, 大山亜梨沙1, 坂田美紀1, 田上治美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2018.
Japanese Article 23-6-S14-5. We prevent rehospitalization of the heart failure in an area! ... which suggests the new role of ... health insurance pharmacy
土岐真路1, 磯崎弘恵2,4, 八田重雄3,4, 前田幹広1, 坂上逸孝1, 田中恒明1, 木田圭亮5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2018.
Japanese Article 23-7-S15-1. Children in this country, the current situation and problem of the fecundity preservation for patients with puberty, juvenile generation cancer
鈴木直1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2018.
Japanese Article 23-7-S15-2. It is ... from the team cooperation with practice - pharmacist of construction and the fecundity preservation therapy of a cancer, the reproductive medicine network of Mie to the cooperation with the cancer practice hospital
前沢忠志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2018.
Japanese Article 23-7-S15-3. It is the efforts as the pharmacist for fecundity preservation
赤阪未来1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2018.
Japanese Article 23-7-S15-4. Approach about the gestation period cancer medical therapy and the example
土屋雅美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2018.
Japanese Article 23-7-S16-1. We think about the role of the pharmacist from the position of the manager in the hospitalization and release support section
鬼塚伸也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2018.
Japanese Article 23-7-S16-2. We think about the role of the pharmacist from the position of the nurse of the central role in the management of the hospitalization and release support section
足羽孝子1,2, 猪田宏美2, 井川祐輔2, 錦織淳美2, 名和秀起2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2018.
Japanese Article 23-7-S16-3. Efforts ... of the pharmacist in the usefulness - hospitalization preconditioning center of the early intervention by the pharmacist before the hospitalization
奥貞智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2018.
Japanese Article 23-7-S16-4. We regard pharmaceutical intervention as confirmation of common use medicine in perioperative care
山口洪樹1, 中村貴子1, 柴田みづほ1, 鈴木貴明1, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2018.
Japanese Article 23-7-S17-1. The basics, flow of acute intoxication treatment, the point that the pharmacist is associated with
堀寧1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2018.
Japanese Article 23-7-S17-2. A role and usage of the Japanese poison control center
遠藤容子1, 波多野弥生1, 高野博徳1, 三瀬雅史1, 飯田薫1, 黒木由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2018.
Japanese Article 23-7-S17-3. Charm of analysis and the case report
芳澤朋大1,2, 鈴木善樹1,2, 栗原弘紀1,2, 上條吉人2, 岸野亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2018.
Japanese Article 23-7-S17-4. An outline and example of the caffeinism
安藤基純1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2018.
Japanese Article 23-7-S17-5. Authorized clinical toxicologist and pharmacist
峯村純子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2018.
Japanese Article 23-8-S18-1. Prevention and treatment - overview - of the delirium
和田健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-267, 2018.
Japanese Article 23-8-S18-2. Prophylactic intervention for the delirium by the liaison team pharmacist leadership
進健司1,2, 小林大介2, 川尻雄大2, 金澤康範1, 島添隆雄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2018.
Japanese Article 23-8-S18-3. Delirium measures to work on from the outpatient department
河野佐代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2018.
Japanese Article 23-8-S18-4. It is delirium inhibitory effect after the relation and the operation of the pharmacist in the Okayama University Hospital delirium measures team
江角悟1, 村川公央1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2018.
English Article 23-8-S19-1. Introduction to DDIs : Guidelines and Guidance in Western Countries
David Back1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2018.
Japanese Article 23-8-S19-2. About drug interactions guidelines for pharmaceutical products development and appropriate reporting
石黒昭博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2018.
Japanese Article 23-8-S19-3. Risk assessment of the drug interactions in the healthcare setting utilizing PISCS
大野能之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2018.
Japanese Article 23-8-S19-4. Way of thinking of drug interactions from position of the hospital pharmacist
増田純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2018.
Japanese Article 23-8-S20-1. The point that hesitates about the clinical judgment in patients in CKD
吉田拓弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-276, 2018.
Japanese Article 23-8-S20-2. The point that hesitates about a clinical judgment in renal disease treatment
林八恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2018.
Japanese Article 23-8-S20-3. Gap ... to feel to be ... settings hearing the voice of the kidney in the emergency care
門口直仁1, 河村真歩1, 田中聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2018.
Japanese Article 23-8-S20-4. Viewpoint ... which leads to ... clinical practice for kidney and remote organ protection
成田勇樹1, 門脇大介2, 平田純生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2018.
Japanese Article 23-8-S20-5. We hear the voice of the kidney in the antimicrobial therapy
高根浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2018.
Japanese Article 23-16-S21-2. Of the clinical utilization of "the IPCD method", actually
井上幸枝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2018.
Japanese Article 23-16-S21-4. Risk and prevention ... in patients with hypokalemia - cardiovascular disease with the Glycyrrhiza
高井靖1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2018.
Japanese Article 23-16-S22-1. A case conference aim and request for clinical reasoning
川口崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-286, 2018.
Japanese Article 23-16-S22-2. The 80s woman that presented dehydration, disturbance of consciousness during hospitalization for pneumonia
梶原洋文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2018.
Japanese Article 23-16-S22-3. The men whom purulent spondylitis, bacteremia due to the MRSA was treated, and a rash appeared in 70s
西海一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2018.
Japanese Article 23-16-S22-4. The women who were urgently taken by disturbance of consciousness with the fever in 90s
今井徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2018.
Japanese Article 23-16-S22-5. With a viewpoint of way - medical education of the effective education conference to change to learn experience -
岸田直樹1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2018.
Japanese Article 23-16-S23-1. For essence and multi-type of job cooperation - anyone of the treatment at home, what do you do for what?
川添哲嗣1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-292, 2018.
Japanese Article 23-16-S23-2. Role of treatment at home and the team
小原道子1,2, 生木庸寛1,2, 林秀樹1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2018.
Japanese Article 23-16-S23-3. As one method to learn program construction - treatment at home of the multi-type of job cooperation education in pro-medical care university ...
川上ちひろ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2018.
Japanese Article 23-16-S23-4. Construction of the local leader authorization pharmacist system in the drugstore attached to Gifu Pharmaceutical University
寺町ひとみ1,3, 伊野陽子2,4, 野口義紘1,2, 堺千紘2,4, 山下修司2,5, 玉木啓史2,4, 舘知也1,2, 井口和弘2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2018.
Japanese Article 23-16-S23-5. With the at-home pharmacist sought from the settings of the treatment at home
船戸崇史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2018.
Japanese Article 24-1-S24-1. Advance care planning and continuous pharmaceutical support to patients with cancer in the pharmacist outpatient department
祝千佳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-298, 2018.
Japanese Article 24-1-S24-2. Message to the comprehensive patients support in blood-forming organ tumor and a next-generation pharmacist
内田まやこ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2018.
Japanese Article 24-1-S24-3. The patients support that problems and the pharmacist whom patients with cancer of the AYA generation have should work on
後藤愛実1, 上田育子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2018.
Japanese Article 24-1-S24-4. Practice and the prospects of the advance care planning in the university hospital by the cancer nursing clinical nurse specialist
角裕子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2018.
Japanese Article 24-1-S24-5. Expect it of the current situation and a pharmacist of the at-home palliative care
渡辺剛1, 八杉まゆみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2018.
Japanese Article 24-1-S25-1. Authorized examination results and trends such as pharmacists, and the like specialized in a 2017 cancer
濱敏弘1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2018.
Japanese Article 24-1-S25-2. Summary (1) of the case summary: Colon cancer
亀岡春菜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2018.
Japanese Article 24-1-S25-3. Summary (2) of the case summary: Malignant lymphoma
栗林未帆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2018.
Japanese Article 24-1-S25-4. Summary (3) of the case summary: Pancreatic cancer
高橋新次1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2018.
Japanese Article 24-1-S25-5. Summary (4) of the case summary: Multiple myeloma
村上仁志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2018.
Japanese Article 24-1-S25-6. Summary (5) of the case summary: Unknown primary cancer
葉山達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2018.
Japanese Article 24-1-S26-1. For the personalized medicine of antibody pharmaceutical products
米澤淳1,2, 松原和夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2018.
Japanese Article 24-1-S26-2. The blood level measurement of antibody pharmaceutical products and clinical significance
内藤隆文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2018.
Japanese Article 24-1-S26-3. The measurement of the antidrug antibody and clinical significance
石井明子1, 柴田寛子1, 西村和子1, 中村亮介2, 斎藤嘉朗2, 川合眞一3, 山田壮一4, 南木敏宏4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2018.
Japanese Article 24-1-S26-4. An evaluation of the Biosimilar: About safety, the effectiveness
早狩誠1,2, 増井翔2, 佐野信介2, 米澤淳2, 松原和夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2018.
Japanese Article 24-2-S27-1. To show "a pharmacist power" by clinical duties
吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2018.
Japanese Article 24-2-S27-2. Theory and practice - about the personnel training in behavior properties - medical care of the pharmacist who can do it
赤瀬朋秀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2018.
Japanese Article 24-2-S27-3. Drug information utilization technique of the pharmacist who can do it
林昌洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2018.
Japanese Article 24-2-S27-4. Power to examine the patients of the pharmacist who can do it
川口崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2018.
Japanese Article 24-2-S27-5. Postgraduate education for possible pharmacist upbringing
佐々木忠徳1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2018.
Japanese Article 24-2-S28-1. It is ... from ... cancer genomic medicine to think about from this now of the personalized medicine to primary care: Purpose explanation
山本和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2018.
Japanese Article 24-2-S28-2. An examination for gene panel and drug choice in the cancer genomic medicine
玉谷卓也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2018.
Japanese Article 24-2-S28-3. The future of personalized medicine and the community medical care by the medical healthy big data and AI
内野詠一郎1, 奥野恭史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2018.
Japanese Article 24-2-S28-4. Attempt - in the genetic information referral - Tohoku medical megabank plan for the realization of personalized medicine, the individualization prevention
福島明宗1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2018.
Japanese Article 24-2-S28-5. The health, specimen measurement business to connect with medical individual optimization service to watch at a drugstore
岡崎光洋1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2018.
Japanese Article 24-2-S29-1. Improvement of the clinical business by the clinical pharmacy that a pharmacist takes
吉山友二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2018.
Japanese Article 24-2-S29-2. Mainly on point - research of data count and the analysis -
波多江崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2018.
Japanese Article 24-2-S29-3. Precaution of clinical studies and the article making that business of the community pharmacy becomes the theme
渡邉文之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2018.
Japanese Article 24-2-S29-4. The Japanese alphabet of the article making not to readily listen to
大谷壽一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2018.
Japanese Article 24-3-S30-1. The preparation and approach for the onset extension risk reduction of diabetic complications
藤井博之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2018.
Japanese Article 24-3-S30-2. Practice of the medicine for external application therapy in the diabetes foot lesion
西村博之1, 吉田陽1, 塩山由紀1, 守田彩文1, 高田雅文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2018.
Japanese Article 24-3-S30-3. Practice of the medical therapy in elderly people diabetes indicating delicate health characteristics
深野光司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2018.
Japanese Article 24-3-S30-4. For inhibition of the onset, the extension of practice - nephropathy, cardiovascular disease of the medical therapy in diabetic kidney disease (DKD) -
竹内裕紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2018.
Japanese Article 24-3-S31-1. The actual situation of quality information and the offer of the generic drug which a pharmacist buys
恩田光子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-333, 2018.
Japanese Article 24-3-S31-2. Feedback for confirmation and the improvement of the quality in the public testing institution
伊豆津健一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2018.
Japanese Article 24-3-S31-3. The pharmaceutical products quality information that a generic drug company provides to a pharmacist
立木秀尚1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2018.
Japanese Article 24-3-S31-4. When we change it to a generic drug
寺川伸江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2018.
Japanese Article 24-3-S32-1. With the side effect spontaneous report found by the pharmaceutical person concerned?
沼生智晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2018.
Japanese Article 24-3-S32-2. Collection of information on adverse drug reactions in foreign countries
原梓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2018.
Japanese Article 24-3-S32-3. For the uniform management of the side effect report in the community medical care cooperation
舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2018.
Japanese Article 24-3-S32-4. We think about standards such as the information on adverse drug reactions, and the like that you should report based on safe information report systems such as pharmaceutical products, medical equipment, and the like
佐藤倫広1, 小原拓2,3, 目時弘仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2018.
Japanese Article 24-3-S32-5. Creation of the pharmaceutical products safety information by the pharmacist
小原拓1, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2018.
Japanese Article 24-4-S33-1. It is ... from ... custom to reconsider fluid therapy to evidence
井上真1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2018.
Japanese Article 24-4-S33-2. History and problems - so strange fluid therapy - of the fluid therapy for children
鶴知光1, 高瀬麻以2, 阿部浩子2, 上坂英二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2018.
Japanese Article 24-4-S33-3. Infusion management of change ... perioperative period of the fluid therapy
石橋生哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2018.
Japanese Article 24-4-S33-4. With the fluid therapy to revise the balance of the seriously ill patients
野崎歩1, 奥川寛1, 堀内望1, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2018.
Japanese Article 24-4-S33-5. Efforts of the fluid therapy of patients with end-stage cancer in our hospital
今井一輝1, 東口高志2, 二村昭彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2018.
Japanese Article 24-4-S34-1. The current situation of the medical treatment for intractable amyloidosis and the future prospects
城野博史1,2, 安東由喜雄3, 齋藤秀之1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2018.
Japanese Article 24-4-S34-2. Approach to a mechanism elucidation and resistance conquest of the anticancer medicine resistance
奥村学1,4, 岩切智美1, 長友隆雄1, 吉川直樹1, 綾部貴典2,4, 関屋裕史1, 平原康寿1, 中村都英3,4, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2018.
Japanese Article 24-4-S34-3. Challenge to a diagnosis, the treatment of the Niemann-Pick disease C type which assumed clinical chemistry a base
前川正充1, 成田綾2, 崎山快夫3, 山口浩明1, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2018.
Japanese Article 24-4-S34-4. Reverse translational research aiming at conquest of schizophrenia
永井拓1, 尾崎紀夫2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2018.
Japanese Article 24-4-S34-5. Molecular mechanism and therapeutic drug front of Alzheimer's dementia
武田泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2018.
Japanese Article 24-4-S35-1. Interaction of the oral molecular target anticancer medicine through the transporter
山口浩明1, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-353, 2018.
Japanese Article 24-4-S35-2. Pharmacokinetic interaction of the antitumor agents which macrolide derivative antimicrobial and an azole-based antifungal agent participate in
新岡丈典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2018.
Japanese Article 24-4-S35-3. Interaction with an antihistamine and the luxury goods at eruption measures
赤嶺由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2018.
Japanese Article 24-4-S35-4. Drug interactions of the tyrosine kinase inhibitor
大神正宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2018.
Japanese Article 24-4-S35-5. Interaction of antiemetic drug aprepitant
大野能之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2018.
Japanese Article 24-5-S36-1. - that problems - neonates medical care of the medical therapy peculiar to children is history of the adverse event
河田興1,2, 小西麗子1, 眞島崇1, 向井啓1, 小森浩二1, 小村純子1, 日下隆2, 伊藤進2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-359, 2018.
Japanese Article 24-5-S36-2. Problems of the use to codeine phosphate and the children such as antibiotics, and the like
冨家俊弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2018.
Japanese Article 24-5-S36-3. The current situation and measures of the mis-deglutition of the medicine
石川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2018.
Japanese Article 24-5-S36-4. Problems (mainly on fecundity) of the cancer chemotherapy to children
米村雅人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2018.
Japanese Article 24-5-S37-1. What happens? With the experience-based training demanded at a middle scale hospital
段林正明1, 高橋一栄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-364, 2018.
Japanese Article 24-5-S37-2. Do you show drug intoxication - anything to learn on the site? How do you charm him? ...
田村亮1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2018.
Japanese Article 24-5-S37-3. Basic form of the multi-type of job cooperation to learn in an intensive care unit and an infection control area
澤田真嗣1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2018.
Japanese Article 24-5-S37-4. With the balance of a theory and the practice of the nutrition therapy with high education effect
神谷貴樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2018.
Japanese Article 24-5-S37-5. To bring up medical therapy of the heart failure; learn
野崎歩1, 奥川寛1, 馬橋美由季1, 堀内望1, 深見智子3, 小林由佳1, 中村茂2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2018.
Japanese Article 24-5-S37-6. Think with a pharmacy student; a role of the hospital pharmacist to "a cancer, palliative care"
辻井聡容1,2, 松原一磨1, 加茂由比子1, 上坂君子1, 中嶋正博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2018.
Japanese Article 24-5-S37-7. About the future of a revision model core curriculum and the pharmacy education
平田收正1, 村岡未彩1, 西野隆雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2018.
Japanese Article 24-5-S38-2. Efforts to the problem solving utilized the logical thought in drugstore duties
斉藤美月1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2018.
Japanese Article 24-5-S38-3. Leader ship education in the medical person
島久美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2018.
Japanese Article 24-5-S38-4. We make use of wisdom of MBA in the tissue management
山田正実1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2018.
Japanese Article 24-5-S38-5. Fusion of drugstore administration and MBA
田宮謙三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2018.
Japanese Article 24-6-S39-1. Pharmaceutical products safety assessment utilizing MID-NET and the significance
佐藤大作1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-378, 2018.
Japanese Article 24-6-S39-2. Relation to study using the medical information database and MID-NET of the hospital pharmacy
堀雄史1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2018.
Japanese Article 24-6-S39-3. As a pharmacist of relation ... cooperation medical institution to MID-NET
江本晶子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2018.
Japanese Article 24-6-S39-4. Relation to inflection of real world data and MID-NET in the municipal hospital
野村浩子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2018.
Japanese Article 24-6-S39-5. Governance to maintain administrative data-based quality about pharmaceutical products: Quality control activity in MID-NET
高田敦史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2018.
Japanese Article 24-6-S40-1. From the viewpoint of importance - critical care center working full time pharmacist of the evidence to create from the clinical question in clinical drug duties -
今井徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-384, 2018.
Japanese Article 24-6-S40-2. Basic examination for the clinical question of first aid, the intensive care domain
榎屋友幸1,4, 今井寛2, 丸山一男3, 奥田真弘4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2018.
Japanese Article 24-6-S40-3. Knowledge - obtained from study - TDM duties for the optimal administration of antimicrobial method establishment for sepsis
中馬真幸1, 今井徹2, 栃倉尚広2, 鈴木慎一郎2, 岩渕聡2, 関本真雄2, 中山貴裕2, 座間味義人3,4, 武智研志1, 今西正樹3, 岡田直人3, 合田光寛3, 近藤正輝3, 菊池憲和5, 吉田善一2, 石澤啓介3,4, 楊河宏章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2018.
Japanese Article 24-6-S40-4. Problem to the individual administration plan of the drug in the sustained kidney alternative therapy
尾田一貴1, 城野博史1, 齋藤秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2018.
Japanese Article 24-6-S40-5. How does the onset of pharmacokinetics, efficacy, adverse effect change in the seriously ill patients? - Through a study of the sedative sedative, antimicrobial -
八木達也1, 田中紀章1, 三浦基靖1, 内藤隆文1, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2018.
Japanese Article 24-6-S40-6. Translational research utilizing the medical information database large-scale in the first aid, the intensive care domain
座間味義人1,2, 石澤有紀3, 新村貴博1, 今西正樹2, 武智研志4, 中馬真幸4, 堀ノ内裕也3, 池田康将3, 桐野靖2, 中村敏己2, 寺岡和彦2, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2018.
Japanese Article 24-6-S41-1. Efforts in relation Hokkaido from the ER to intensive care
齋藤靖弘1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-391, 2018.
Japanese Article 24-6-S41-2. Efforts in the ICU bridging JA Hiroshima General Hospital in the sedative painkilling
吉廣尚大1, 櫻谷正明2, 小野塚和人1, 無漏田香穂1, 加藤之紀2, 河村夏生2, 高場章宏2, 稲田淑江1, 吉田研一2, 橋本佳浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2018.
Japanese Article 24-6-S41-3. Activity of a fact of the in-hospital medicine medicine cooperation by Medication Reconciliation and the pharmacist in Kyushu
甲斐光1, 柴田啓智1, 田上治美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2018.
Japanese Article 24-6-S41-4. Clinic of the pharmacist resident who assumed intensive care a base
田村亮1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2018.
Japanese Article 24-6-S41-5. Fix the eyes on PICS (Post Intensive Care Syndrome) and after pharmacist - discharge; and ...
前田幹広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2018.
Japanese Article 24-8-S42-1. The clinical pharmacy study that clinical pharmacy arts and sciences Committee leads
山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2018.
Japanese Article 24-8-S42-2. Relation to the drug interactions in the healthcare setting (the academic first subcommittee)
伊藤清美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2018.
Japanese Article 24-8-S42-3. Research for domestic base construction of the precision medicine based on a pharmaceutical viewpoint: About a summary and progress
寺田智祐1, 斎藤嘉朗2, 莚田泰誠3, 三浦昌朋4, 辻大樹5, 平大樹6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2018.
Japanese Article 24-8-S42-4. Clinical studies support platform architectural efforts - by the pharmacist in activity - cancer domain of the Japanese cure association academic third subcommittee
宮崎雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2018.
Japanese Article 24-8-S43-1. Feedback to taking childhood preparation-related quantification and clinical practice
内田享弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-401, 2018.
Japanese Article 24-8-S43-2. The pharmaceutical products dosage form which children seek is the world in - Japan; -
石川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2018.
Japanese Article 24-8-S43-3. A world tide in the pediatric preparation development and problem of this country
原田努1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2018.
Japanese Article 24-8-S44-1. Relation for heart failure treatment as the pharmacist
安部敏生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2018.
Japanese Article 24-8-S44-2. Cardiovascular side effect of anticancer medicine
倉橋基尚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2018.
Japanese Article 24-8-S44-3. Relation of the pharmacist for the cardiotoxicity with the chemotherapy
上田浩貴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2018.
Japanese Article 24-8-S44-4. Role of the tumor circulatory organ team (Onco-Cardiology Team) in the cancer practice
向井幹夫1, 岡亨1, 清水克次2, 迫田由佳梨2, 南美穂2, 坂上嘉浩2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2018.
Japanese Article 24-16-S45-1. Individualization therapy in antipsychotics
赤嶺由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-409, 2018.
Japanese Article 24-16-S45-2. Individualization treatment of the dementia therapeutic drug
山本吉章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2018.
Japanese Article 24-16-S45-3. Efforts to the proper use of the sleeping drug for the individualization therapy
高橋結花1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2018.
Japanese Article 24-16-S45-4. Individualization therapy in the antidepressant
猿渡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2018.
Japanese Article 24-16-S45-5. For personalized medicine in the psychiatry: Viewpoint from a clinician
古郡規雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2018.
Japanese Article 24-16-S46-1. Do you not have trouble with problems - these thing of the case conference? -
上塚朋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2018.
Japanese Article 24-16-S46-2. What you should know for preparations for the case conference
矢野良一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2018.
Japanese Article 24-16-S46-3. To deepen case conference public performance - discussion
内田まやこ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2018.
Japanese Article 24-16-S46-4. The instruction method to look back, and to connect with - improvement of the case conference
湊川紘子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2018.
Japanese Article 24-16-S47-1. It is ... through a relation ... own omen case in the nervous disease domain
宮津大輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2018.
Japanese Article 24-16-S47-2. Relation circulatory organ domain to medical therapy
馬場安里1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2018.
Japanese Article 24-16-S47-3. Intervention example as the pharmacist for the medical therapy of the chylopoietic disease
北原裕子1, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2018.
Japanese Article 24-16-S47-4. The condition of a patient grasp and the problem solving type thought that are demanded from a pharmacist specialized in medical therapy
北原加奈之1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2018.
Japanese Article 24-16-S47-5. How to use right case summary to a form and medical therapy by the PAPO method
河原昌美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2018.
Japanese Article 25-1-S48-1. Make the evidence of the change factor in the pharmacokinetics, tell, use
内田信也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2018.
Japanese Article 25-1-S48-2. The interaction between drug - drink which was due to a change change for gastrointestinal inland waters and the quantitative prediction
白坂善之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2018.
Japanese Article 25-1-S48-3. It is timely and conveys the evidence of the change factor in the pharmacokinetics obtaining in a pharmaceutical company in various forms clearly in the healthcare setting
田島武志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2018.
Japanese Article 25-1-S48-4. We use the pharmacokinetic evidence by clinical practice and make evidence from clinical data
木村丈司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2018.
Japanese Article 25-1-S48-5. Medicine to think of from the settings of lifesaving first aid, the intensive care
宮川幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2018.
Japanese Article 25-2-S49-1. About a guideline (the general remarks edition) of the pharmaceutical products proper use of elderly people
溝神文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-429, 2018.
Japanese Article 25-2-S49-2. Polypharmacy measures in the neurology domain
林祐一1, 西田承平2, 鈴木昭夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2018.
Japanese Article 25-2-S49-3. Polypharmacy measures in the department education
水野智博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2018.
Japanese Article 25-2-S49-4. Polypharmacy and pharmacoepidemiology
浜田将太1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2018.
Japanese Article 25-2-S49-5. ... which thinks about polypharmacy measures ... patients to develop-centered polypharmacy measures
樋口恵子1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2018.
Japanese Article 25-2-S50-1. "It is underlying", "is hard to write it"? To the thing which is more imminent by an evaluation and a record of the fluid therapy!
黒沢秀夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2018.
Japanese Article 25-2-S50-2. The intervention to patients with renal failure is not difficult and puts it on ... evaluation pattern and will think about an instruction record to reach it
浦嶋和也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2018.
Japanese Article 25-2-S50-3. Can we take this medicine during the pregnancy, the nursing? The trouble of ... mom and the trouble of the pharmacist. ... that a team thinks about a plain record
木村初1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2018.
Japanese Article 25-2-S50-4. As for thing - way of thinking that a physician would like to read the most necessary information in a short time, same as presentation; is three report method ...
辻川正彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2018.
Japanese Article 25-3-S51-1. What happens in immune response with cancer microenvironment?
西川博嘉1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-439, 2018.
Japanese Article 25-3-S51-2. What is irAE?
各務博1, 山口央1, 毛利篤人1, 塩野文子1, 内田貴裕1, 三浦雄1, 橋本康佑1, 西原冬実1, 村山芳武1, 小林国彦1, 解良恭一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2018.
Japanese Article 25-3-S51-3. Reactions of drugs and effect, side effect, interaction of the immune checkpoint inhibitor
牧野好倫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2018.
Japanese Article 25-3-S51-4. Are the relations of the immune checkpoint inhibitor and antitumor agents additive? Is it synergistic?
鈴木賢一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2018.
Japanese Article 25-3-S52-2. RMP in the anticancer agent (immune checkpoint inhibitor)
竹本信也1, 千葉俊1, 村木輝2, 田中邦彦2, 山田華那2, 渡部さやか2, 石原由美2, 吉田真1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2018.
Japanese Article 25-3-S52-3. We think about use and application of RMP from the experience of the anticancer medicine trial
坂口裕美1, 渡邊裕之1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2018.
Japanese Article 25-3-S52-4. Use and application of RMP after the marketing of the anticancer medicine
幸田恭治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2018.
Japanese Article 25-3-S52-5. The thing which RMP aims at in clinical settings
米村雅人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2018.
Japanese Article 25-4-S53-1. Inevitability - knowledge of knowing the kidney is ... across a domain
平田純生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-449, 2018.
Japanese Article 25-4-S53-2. Way of thinking about the kidney to keep alive in a cancer domain
山本和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2018.
Japanese Article 25-4-S53-3. Approach of the specialized pharmacist in infection treatment of patients in CKD
三星知1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2018.
Japanese Article 25-4-S53-4. Way of thinking about the kidney to make use of in drug information
大野能之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2018.
Japanese Article 25-4-S53-5. Way of thinking about the kidney to keep alive in a pediatric domain
諏訪淳一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2018.
Japanese Article 25-4-S53-6. Way of thinking about the kidney to keep alive in first aid, an intensive care domain
柴田啓智1, 田上治美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2018.
Japanese Article 25-4-S54-1. Need - of - team approach in medical care to examine heart failure
川村一太1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2018.
Japanese Article 25-4-S54-2. Relation ... to patients with ward duties - heart failure in HCU
八代佳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2018.
Japanese Article 25-4-S54-3. Individualization and systematization of the heart failure medical treatment to think about by a heart team
土岐真路1, 高木瑛美1, 大矢小百合1, 倉田浩2, 石阪光央2, 矢島裕徳2, 嶋田巧2, 前田幹広1, 木田圭亮3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2018.
Japanese Article 25-4-S54-4. Is this a diuretic-resistant? How will the pharmacist intervene then?
芦川直也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2018.
Japanese Article 25-4-S54-5. Approach ... for patients with heart rehabilitation - heart failure of the pharmacist viewpoint
吉国健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2018.
Japanese Article 25-4-S54-6. About palliative care of the terminal heart failure
寺崎展幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2018.
Japanese Article 25-6-S55-1. Clinical studies of the drugstore pharmacist
中山健夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2018.
Japanese Article 25-6-S55-2. Epidemiologic studies of the drugstore pharmacist
横井正之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2018.
Japanese Article 25-6-S55-3. A question born through a support task of the inhalation therapy is one step of the beginning
腰山節子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2018.
Japanese Article 25-6-S55-4. Research in the Nagasaki pharmacist society and experience of the idea culture
宮崎長一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2018.
Japanese Article 25-6-S55-5. A drugstore is university and university hospital pharmacy and the merit of collaborating it
野田敏宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2018.
Japanese Article 25-6-S56-1. About the background of the foreign patients who should be careful in medication counseling and the measures
池浦恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-467, 2018.
Japanese Article 25-6-S56-2. Efforts to foreign correspondence in the community pharmacy
雨宮淑子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2018.
Japanese Article 25-6-S56-3. Role of the pharmacist whom we saw from residence foreigner medical care
入野真規子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2018.
Japanese Article 25-6-S56-4. From an experience of the interpreter of the foreign patients in our hospital
上田彩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2018.
Japanese Article 25-6-S56-5. To train the pharmacist who can play an active part in the global viewpoint
黒澤菜穂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2018.
Japanese Article 25-7-S57-1. The academic D tailor ascertains evidence and inflects and makes the evidence
小茂田昌代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2018.
Japanese Article 25-7-S57-2. To wear a literature evaluation skill
小川竜一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2018.
Japanese Article 25-7-S57-3. Practice: We ascertain evidence of the medical treatment of dyslipidemia
花井雄貴1,2, 松尾和廣2, 吉尾隆2, 西澤健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2018.
Japanese Article 25-7-S57-4. Practice: We ascertain evidence of the medical treatment of type 2 diabetes
佐村優1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2018.
Japanese Article 25-7-S57-5. The examination of pharmaceutical products adoption and the off-label use: Shake in evidence and the interval of the clinical ethic
寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2018.
Japanese Article 25-8-S58-1. Mainly on basic knowledge - allergic property side effect of the adverse drug reaction -
継田雅美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-478, 2018.
Japanese Article 25-8-S58-2. One consideration ... about prescription real ... allergic check using a drug information database of a check
宮崎美香1, 岩田一史1, 秋吉明子1, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2018.
Japanese Article 25-8-S58-3. Allergic management judging from medical security
町谷安紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2018.
Japanese Article 25-8-S58-4. Patients information management for the drug allergy (side effect) recurrent prevention
冨岡謙二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2018.
Japanese Article 25-8-S58-5. A system and the problem to manage an allergy and the side effect
野村浩子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2018.
Japanese Article 25-8-S58-6. Pharmaceutical products allergy measures to work on by a team
木下元一1, 岸真司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2018.
Japanese Article 25-13-S59-1. Role, responsibility of team approach in medical care and the pharmacist in the cancer medical care
大野真司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-485, 2018.
Japanese Article 25-13-S59-2. The training of the study mind-oriented pharmacist in the advanced business training
高取真吾1, 田中亮裕2, 飛鷹範明2, 田中守2, 秋山伸二1, 坂本宜俊1, 野元裕1, 荒木博陽2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2018.
Japanese Article 25-13-S59-3. Effect - that disseminating information to process of the knob medicine bag motion and further development - Residual medicine adjustment and a physician results
島添隆雄1, 小林大介1, 窪田敏夫2, 川浪望恵1, 小柳香織3, 加崎哲夫4, 國武雅弘5, 竹下文明6, 安東恵津子7, 中芝高彦8, 永富茂8, 郡司清志3, 金子絵里奈3, 林田諭3, 吉井瞳3, 三井所尊正3, 高木淳一3, 木原太郎3, 瀬尾隆3, 田中泰三3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2018.
Japanese Article 25-13-S59-4. Efforts to polypharmacy by the cooperation with the physician in the psychiatry domain
亀井浩行1, 岩田仲生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2018.
Japanese Article 25-13-S59-5. The multi-type of job cooperation in the field of disaster medical care utilized the pharmacist professional ability
江川孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2018.
Japanese Article 25-13-S60-1. Pregnancy and diabetes - commentary ...
和栗雅子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-491, 2018.
Japanese Article 25-13-S60-2. Use of metformin during pregnancy
中島研1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2018.
Japanese Article 25-13-S60-3. Recent trend ... of medical therapy - diabetes therapeutic drug of diabetes in the gestation period
西村あや子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2018.
Japanese Article 25-13-S60-4. Of the medication counseling of the pharmacist for the carbohydrate metabolism abnormality merger pregnant woman actually arrive
中川友恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2018.
Japanese Article 25-14-S61-1. The thing which treatment with specific drug management charges 2 aims at that TERMS, RevMate aims
遠藤一司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-496, 2018.
Japanese Article 25-14-S61-2. Patients program (the video screening) including the contents which are sensitive (contraception, sexual intercourse)
伊藤忠明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2018.
Japanese Article 25-14-S61-3. Having been understood from sensitive communication education scenario making
柏村友一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2018.
Japanese Article 25-14-S61-4. Of the patients communication in TERMS, RevMate, actually
小室雅人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2018.
Japanese Article 25-14-S62-1. Is it a side effect of medicine? We aim at the pharmacist who grasps the state of patients, and reasons in a side effect
今井徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2018.
Japanese Article 25-14-S62-2. Practice of the side effect management by the clinical practice
石川寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2018.
Japanese Article 25-14-S62-3. Development of the clinical pharmacy study for the construction of the side effect management mainly composed of the expression prevention
岡田直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2018.
Japanese Article 25-14-S62-4. Study aiming at countermeasure establishment of peripheral neuropathy with the anticancer medicine
川尻雄大1, 小林大介1, 宮城杏奈1, 清水栞1, 重松奈央1, 座間味義人2,3, 牛尾聡一郎4, 新村貴博3, 北村佳久4, 千堂年昭4, 石澤啓介2,3, 島添隆雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2018.
Japanese Article 25-14-S62-5. Search of the preventive preparation for the drug-related myocarditis utilizing a large-scale medical information database and the gene expression database
新村貴博1, 座間味義人1,2, 石澤有紀3, 齊藤広海1, 西牟田剛広1, 今西正樹2, 武智研志4, 中馬真幸4, 福島圭穣5, 堀ノ内裕也3, 池田康将3, 藤野裕道5, 土屋浩一郎6, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2018.
Japanese Article 25-14-S62-6. Risk assessment and risk management by medical treatment and the renal failure pharmacist
矢野貴久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2018.
Japanese Article 25-15-S63-1. Offer - of the latest safe information depending on the reporting system (1) - characteristic of the patient from the pharmaceutical company
竹本信也1, 吉田由以子1, 千葉俊1, 富谷聡学1, 田端秀日朗1, 富澤志帆1, 梅津恒星1, 若井真人2, 加藤弘之2, 大寺昭雄2, 梶山達也2, 石部竜大2, 山口岳裕3, 小田育子4, 金澤恵美4, 中島美保5, 内海奈穂子5, 近藤育絵5, 田中里和5, 結城陽二郎5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2018.
Japanese Article 25-15-S63-2. About an effective drug information offer system using ICT
慶徳一浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2018.
Japanese Article 25-15-S63-3. How is a pharmacist one of "making" information for the artificial intelligence era?
幸田恭治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2018.
Japanese Article 25-15-S63-4. With "medical information system that is necessary to save it to make" information?
池田和之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2018.
Japanese Article 25-15-S64-1. Guess, evaluation, correspondence of the pain accompanied with the energy intake
菅幸生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2018.
Japanese Article 25-15-S64-2. Perioperative care and diet
柴田ゆうか1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2018.
Japanese Article 25-15-S64-3. Inappetence and electrolyte abnormality in patients with cancer
菅原英輝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2018.
Japanese Article 25-15-S64-4. Appetite decreased of the patients who developed unexpected glaucomatous attack during chemotherapy
池田博昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2018.
Japanese Article 25-15-S64-5. A change and invention of "the meal" to support hope to the death
萬谷摩美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2018.
Japanese Article 25-15-S64-6. The seamless patients care that a pharmacist works on
内田まやこ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2018.
Japanese Article 25-16-S65-1. A perioperative care team and anesthesiologist
齋藤繁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-517, 2018.
Japanese Article 25-16-S65-2. Reporting ... to the medical institution through efforts report ... patients to patients undergoing the surgery in the health insurance pharmacy
柄澤忍1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2018.
Japanese Article 25-16-S65-3. We think about the multi-type of job cooperation, regional alliances in perioperative care
猪田宏美1, 井川祐輔1, 錦織淳美1, 名和秀起1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2018.
Japanese Article 25-16-S65-4. The prospects to usefulness and medicine - medicine cooperation of the pharmacist preoperation patients interview in the perioperative medical security
宮田祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2018.
Japanese Article 25-16-S65-5. Seamless relation of the pharmacist for the perioperative patients in the university hospital
柴田みづほ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2018.
Japanese Article 25-16-S66-1. Pharmacist activity by the ASEAN disaster medical care cooperation reinforcement project
江川孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-523, 2018.
Japanese Article 25-16-S66-2. If a pharmacist continues searching international health, in a global health department store
奥村順子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2018.
Japanese Article 25-16-S66-3. One pharmacist person fulfils the responsibility as the professional for the world. Role ... which is sought by the pharmacist in ... NGO
青山寿美香1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2018.
Japanese Article 25-16-S66-4. The change and the current situation of the Japan Team for Disaster Relief medical care team in the international community
渡邉暁洋1, 高田洋介1, 山田太平2, 中尾博之1, 中尾篤典2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2018.
Japanese Article 25-16-S66-5. Role of the pharmacist in the Red Cross
雪本江里子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2018.
Japanese Article The diet, exercise method for the dementia prevention that Oriental medicine and Western medicine recommend
菱川望1, 高橋依子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2018.
Japanese Article Academic F1-1. The participation of the pharmacist starting polypharmacy measures and research of the usefulness
武藤浩司1, 小田慎2, 佐藤康一3, 澁田憲一4, 樋島学5, 別所千枝6, 吉岡睦展7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2018.
Japanese Article Academic F1-2. "Research about the handling of the medical information of the pharmacist accompanied with the revision of the Personal Information Protection Law" (final report)
池田和之1, 岡橋孝侍2, 小枝伸行3, 高田敦史4, 関谷泰明5, 青柳吉博6, 黒田知宏7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2018.
Japanese Article Academic F2-1. Participation of the hospital pharmacist in medical therapy in the convalescence in the local inclusion care system and research of the usefulness
岸本真1, 荒川隆之2, 宮川哲也3, 溝神文博4, 藤原久登5,6, 酒向幸7, 川崎美紀8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2018.
Japanese Article Academic F2-2. The construction of the pharmaceutical products safety management system for the proper use of an unlicensed drug, the medicine out of the adaptation and role of the pharmacist
近藤直樹1, 濃沼政美2, 阿部直樹3, 中澤寛仁4, 米村雅人5, 山口拓洋6,7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2018.
Japanese Article Academic F2-4. We conduct research for becoming it the marketing of the drug necessary for the healthcare setting
渡辺享平1, 大津史子2, 後藤伸之1, 佐々木忠徳3, 原田幸子4, 山川雅之5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2018.
Japanese Article MS1-1. About systems construction and the possibility and problems to be useful for the medicine industry using the artificial intelligence (AI)
木村隆夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2018.
Japanese Article MS1-2. Research and development of the new pharmaceutical products inquiry system utilizing the artificial intelligence (AI)
里香世子1, 亀井淳三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2018.
Japanese Article MS1-3. Research and development of the new DI reporting system about herbal medicinal products utilizing the artificial intelligence (AI)
南絢子1,2, 亀井淳三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2018.
Japanese Article MS2. Collaboration ... of a physician, the pharmacist to realize the proper use of physician, pharmacist cooperation guide - drug for multiple drug prescription reviews of elderly people
竹屋泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-545, 2018.
Japanese Article MS3. We think about the traceability of pharmaceutical products
芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2018.
Japanese Article MS4. Team approach in medical care in the immune checkpoint inhibitor
田端雅弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2018.
Japanese Article MS5. It is ... from revision breast cancer practice guidelines for treatment strategy - 2,018 years of metastasis, the recurrent breast cancer
土井原博義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2018.
Japanese Article MS6. Heart failure to examine in an area: Importance of the body fluid management
伊藤浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2018.
Japanese Article MS7. Future discussion for Biosimilar latest knowledge and the use promotion
坂巻弘之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2018.
English Article MS8. Management of DDIs by a Clinical Pharmacist in Patients Prescribed Hepatitis C Virus Treatment.
David J Back1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2018.
Japanese Article MS9. The medical security that a pharmacist needs now
長田理1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2018.
Japanese Article MS10. Prescription support ... by the scientific viewpoint to join ... basics that an academic D tailing turns prescription behavior into together for clinical practice
小茂田昌代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2018.
Japanese Article MS11. Proper use of the latest treatment and drug for the hormone acceptor-positive HER2-negative progress recurrent breast cancer
徳永えり子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2018.
Japanese Article MS12. Epilepsy, antiepileptic drug, neurologic manifestation
山田了士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2018.
Japanese Article MS13. With the optimal antiemesis therapy made in the viewpoint of patients?
村上通康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2018.
Japanese Article MS15-1. It is ... for optimization of impact ... treatment of the immune checkpoint inhibitor
田中洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2018.
Japanese Article MS15-2. To confront immune therapy; will be ... ... "from now on" "until now"
吉野真樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2018.
Japanese Article MS16. Practice of biomedicine Quality Assurance for pharmacists
舟越亮寛1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2018.
Japanese Article MS17-1. Introduction of the call center support system which used Watson possibility of the AI utilization to spread
朝生祐介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2018.
Japanese Article MS17-2. About the expandability by the combination of usefulness and speech recognition of the AI question-answering system by the natural language recognition
橋爪康知1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2018.
Japanese Article MS18. Understanding of gastric cancer treatment guidelines sought by the multi-type of job
山口研成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2018.
Japanese Article MS19-1. It is ... mainly on medical therapy - FOLFOXIRI + BV therapy in unresectable progress recurrence colon cancer
仁科智裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2018.
Japanese Article MS19-2. Chemotherapy management and pharmacist in the Shikoku cancer center
小暮友毅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2018.
Japanese Article MS20. Economic evaluation - of the Chinese medicine utilizing medical economy and Chinese medicine - medical care big data
赤瀬朋秀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2018.
Japanese Article MS22. Resistant bacteria infection treatment up to date
松元一明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2018.
Japanese Article MS23. The current situation and the point at issue of the biomedicine
益山光一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2018.
Japanese Article MS24. With the significance of oral mucositis measures in the cancer chemotherapy, actually
曽我賢彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2018.
Japanese Article MS25. Cancer-related thrombosis treatment - strange with tumor angiocardiology - medicine
吉田賢司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2018.
Japanese Article MS26. Simple; is duties reduction, management improvement by the management of the adoption medicine! It is ... for ... proper use promotion
小池博文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2018.
Japanese Article MS27. It is Hazardous Drug in healthcare Settings Road to Compliance to USP 800
Fred Massomi1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2018.
Japanese Article MS29. Because menopausal women shine; clinical correspondence ... to complaints peculiar to ... woman characteristics
後山尚久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2018.
Japanese Article MS30. - to think from guidelines on art - new chronic constipation of constipation treatment not to listen to now
中島淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2018.
Japanese Article MS31-1. Pharmaceutical care - dysfunction thyroid and diabetes, hyperglycemia ... to patients receiving immune checkpoint inhibitor done from tomorrow
土手賢史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2018.
Japanese Article MS31-2. With the risk assumed by the treatment of the immune checkpoint inhibitor in patients with collagenosis?
鈴木賢一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2018.
Japanese Article MS32-2. A medical lawsuit and medical security
三村まり子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2018.
Japanese Article MS33. Virus safety measures - past, present, future - of the plasma derivative
柚木幹弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2018.
Japanese Article MS34. Want to tell you; is an ad usum externum therapy city legend!
安部正敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2018.
Japanese Article MS35. One or ... that regulation of the Biosimilar and the Biosimilar of current situation - monoclonal antibody are approved how
荒戸照世1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2018.
Japanese Article MS36. Alleviation of fever, analgesic ABC
鈴木聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2018.
Japanese Article MS37. It is ... from the current situation of the medication support of patients with role - HIV infection of the pharmacist for the chronic disease in the ambulatory practice
矢倉裕輝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2018.
Japanese Article MS38. Basic knowledge of the biomedicine that we want to know only this
若林進1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2018.
Japanese Article MS40. Pharmaceutical management of CKD-MBD utilized the pharmacist power
木村健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2018.
Japanese Article MS41. High blood pressure treatment that fixed its eyes on a heart failure pandemic
土肥薫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2018.
Japanese Article MS42. Search - of the new index of bowel control - pharmacist duties of home care patients
荒井國三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2018.
Japanese Article MS43. Progress of the breast cancer molecules target treatment
田口哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2018.
Japanese Article 23-9-O1-1. Research about the regulations item of the medication guide for patients for the safe examination matter in the pharmaceutical products risk management plan of the antineoplastic
市江敏和1,2, 浅川博翔2, 鈴木大介1,2, 寺崎嘉正1, 林秀樹2, 畔柳敏弥1, 杉山正2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2018.
Japanese Article 23-9-O1-2. Safe investigation by the PCSK9 inhibitor continuation
大宮寛子1, 内藤成美1, 吉田夕貴1, 川井悦嗣1, 三輪耕次1, 田中伸享2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2018.
Japanese Article 23-9-O1-3. The effectiveness of the acetaminophen IV infusion liquid appointed hour administration in the colon cancer post-operative pain
堀田栄治1, 高橋裕治1, 高嶋孝次郎1, 斎藤健一郎2, 高嶋吉浩2, 宗本義則2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2018.
Japanese Article 23-9-O1-4. The off-label use situation of DOAC and safe fact-finding
福井里佳1, 平大樹1,2, 國津侑貴1, 磯野哲一郎1, 田淵陽平1, 生野芳博1,3, 伊藤英樹3,4, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2018.
Japanese Article 23-9-O1-5. Usefulness of the efforts of the pharmacy for the appropriate administration of dry concentration person prothrombin complex preparation (Kay Saint lah)
中西裕明1, 大山翔1, 西崎恵利1, 澤田真嗣1, 小森玉緒1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2018.
Japanese Article 23-9-O2-1. Use experience of the SGLT2 inhibitor for the decreased renal function patients during Hiroshima City Hiroshima Municipal Hospital circulatory organ internal medicine hospitalization
菅原隆文1, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2018.
Japanese Article 23-9-O2-2. The effect that a dialysis period gives to the effectiveness of the levocarnitine preparation on anemia in renal disease
植田徹1, 井上敬之1, 辻川正彦1, 国府孝敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2018.
Japanese Article 23-9-O2-3. Effect on anemia in renal disease with the long-term levocarnitine intravenous administration for haemodialysis patients
長谷川裕矢1, 青木真矢2, 矢島隆宏3, 荒尾舞子3, 松本利恵1, 野田孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2018.
Japanese Article 23-9-O2-4. Examination of the efficacy titer of Etelcalcetide Hydrochloride and the cinacalcet by our hospital case
安部真一1, 相原瞳1, 中村江理1, 鈴木英則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2018.
Japanese Article 23-9-O2-5. We look at the rear about a conventional dose of DOAC and the initial dose setting and search for a mark
馬替仁1, 白承婀1, 西脇龍広1, 原田光枝1, 實川東洋1, 宮内靖史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2018.
Japanese Article 23-9-O3-1. The need and problem of the patients with diabetes pharmacist outpatient department in the non-diabetes special hospital
大西順子1, 坪井仁美1, 石松義人2, 湯本英一朗2, 渡辺佑介2, 冨岡憲明2, 渡辺伸一郎2, 渡辺哲夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2018.
Japanese Article 23-9-O3-2. Efforts and results of the diabetes rounds team in the convalescent hospital
ソディ保子1, 富山正俊2, 早苗広人3, 小杉正4, 松田光栄5, 永山友美5, 和田達也5, 武田千賀子1, 畔立子6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2018.
Japanese Article 23-9-O3-3. Patient factors and cancellation drug to consider in the case of the cancellation of the hypoglycemic agent for patients with type 2 diabetes by the diabetologist
金井紀仁1,2, 櫛山暁史3, 庄野あい子2, 宮下紗季2, 小泉聖人2, 米川拓渡2, 仙石悠紀子2, 沖村悠希2, 梶山里奈2, 森田修司2, 菊池貴子3, 山崎広貴4, 谷口洸亮2, 末永みどり2, 赤沢学2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2018.
Japanese Article 23-9-O3-4. The diabetes medical treatment that is optimal for an individual
富岡節子1, 山崎勝弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2018.
Japanese Article 23-9-O3-5. Instillator in the type 2 diabetes self injection introduction and investigation - instruction time, erroneous operation about the instruction time required and post hoc analysis of usability, the use satisfaction
朝倉俊成1, 荒西利彦2, 鈴木秀一2, 蔡志紅2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2018.
Japanese Article 23-9-O4-1. Effect (examination using Fib4-index) that SGLT-2 inhibitor gives for the liver function of patients with type 2 diabetes
西垣賢1, 米田勝晃2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2018.
Japanese Article 23-9-O4-2. Evaluation of the hypoglycemia risk by the combination of repaglinide and clopidogrel
赤木祐貴1, 池滝晶子1, 木村晴奈1, 松平有希1, 捧敬子1, 小澤孝美1, 西村富啓2, 高橋省三1, 重松絵理奈3,4, 宇治原誠3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2018.
Japanese Article 23-9-O4-3. Examination of the diet endurance test using the FreeStyle livret
野口景子1, 葛葉守1, 久嶋真紀子1, 中野玲子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2018.
Japanese Article 23-9-O4-4. Effect of Hb1Ac by the Residual medicine of the oral antidiabetic drug
平井利幸1, 寺門祐介1, 関利一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2018.
Japanese Article 23-9-O4-5. Association with effect on liver function after the liraglutide administration in patients with type 2 diabetes and the body-mass index
塩見めぐみ1,2, 田中庸一1,2, 高田哲秀3, 尾鳥勝也1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2018.
Japanese Article 23-9-O5-1. The regional alliances reinforcement that made full use of multiple drug adjustment system development and a system
杉生雅和1, 吉岡睦展1, 高子優子1, 石津智司1, 長尾彰太1, 若松雄太1, 山本真由美1, 根上朋子1, 波多野友美1, 西山祐美1, 小川佳美1, 馬淵英一郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2018.
Japanese Article 23-9-O5-2. One case that an at-home visit by the hospital pharmacist was able to contribute to extension during a home care period of the cancer-carrying patient
徳永奈都子1, 生川晃子1, 米田勝晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2018.
Japanese Article 23-9-O5-3. Correspondence in the discharge conference for treatment at home to be provided smoothly and the problem that it seemed
松下智侑1, 藤岡記代子1, 尾崎麻理1, 松尾早穂1, 四方奏1, 海野憲郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2018.
Japanese Article 23-9-O5-4. Future prospects ... of the result of Residual medicine cancellation effect - two years by the Residual medicine cancellation PBPM introduction of the regional alliances base Hospital that assumed ICT a base
寺門祐介1, 平井利幸1, 関利一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2018.
Japanese Article 23-9-O5-5. About the effect that clinical test value indication gives to a doubt inquiry on outside Parliament prescription
小牟田豊1, 齋藤玲奈1, 衛藤広士1, 中井優作1, 八代哲也1, 東海秀吉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2018.
Japanese Article 23-9-O6-1. Study on medicine medicine cooperation and patients outcome
高井靖1, 前田雄太郎1, 木本珠美1, 松岡佳子1, 伊藤涼子1, 梶間勇樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2018.
Japanese Article 23-9-O6-2. Efforts of the medicine medicine cooperation in the Yachiyo medical center attached to Tokyo Women's Medical University
鈴木駿介1, 高柳論也1, 大場ちはる1, 小林恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2018.
Japanese Article 23-9-O6-3. Approach from approach - hospital pharmacist to medicine medicine cooperation
丸岡由貴1, 見元尚1, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2018.
Japanese Article 23-9-O6-4. Efforts of the medicine medicine cooperation that we collaborated with NST in the short bowel syndrome case and joined together to treatment at home
宗村雅男1, 土肥麻貴子1, 久保理美2, 中川素子2, 藤原智美1, 鶴谷茂1, 伊藤次郎3, 水本素子4, 室井延之1, 橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2018.
Japanese Article 23-9-O6-5. Consideration of the fact-finding of the illness medicine cooperation inhalation instruction system and the inhalational error contributing factor
天谷拓也1, 正木克宜2, 大野凜太朗1, 仲地一郎2, 稲見正幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2018.
Japanese Article 23-13-O7-1. Fact-finding of the prescription suggestion by the pharmacist at physician rounds company and the order support to a physician
木本絵理華1, 近藤麻衣1, 荒川隆之1, 坪井俊之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2018.
Japanese Article 23-13-O7-2. Usefulness and problem of the holiday ward duties by the pharmacist
真志田絵美子1, 柴田ゆうか1, 土井舞子1, 佐伯康之1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2018.
Japanese Article 23-13-O7-4. We look back on a physician, the conference with the nurse and information sharing-related importance than a pharmaceutical intervention case
坂井孝行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2018.
Japanese Article 23-13-O7-5. Efforts in our hospital in the regimen management including the nonrecognition anticancer agent
安藤洋介1, 西部星来1, 加藤さや香1, 河田健司2, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2018.
Japanese Article 23-13-O8-1. The application support system of the Relief System for Sufferers from Adverse Drug Reactions that linked ward drug duties
中川義浩1, 浮池聡子1, 中村愛2, 中山洋輔3, 鶴崎泰史1, 花田聖典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2018.
Japanese Article 23-13-O8-2. The use investigation of the immune checkpoint inhibitor and construction of the drug control system for irAE
早坂州生1, 岩本浩史1, 出町拓也1, 北山秀則1, 田中宏尚1, 芦崎雅之1, 平田力1, 竹内公美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2018.
Japanese Article 23-13-O8-3. Intervention to the inappropriate prescription that combined the safe medical therapy guidelines on elderly people 2015 with STOPP criteria version 2
藤田弥佐1, 木村丈司1, 清水倫子1, 久保萌子1, 住吉霞美1, 番匠咲帆1, 三島唯1, 戸田飛鳥1, 松本久美子1, 大本暢子1, 西岡達也1, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2018.
Japanese Article 23-13-O8-4. Investigation about the pharmacist intervention at perioperative medical treatment and discharge in the catheter ablation
寺島純一1,2, 石山由香1, 山田哲也1, 中村直人1, 鷹見繁宏1, 長内宏之2, 浅野博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2018.
Japanese Article 23-13-O8-5. Medical treatment intervention to the steroid therapy for patients with acute renal failure due to the cholesterol embolisation
小野田稔久1, 増田雅行1, 真坂亙2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2018.
Japanese Article 23-13-O9-1. Enforcement and performance evaluation of the in-hospital blood level measurement with the new HPLC fixed-quantity system which is applicable to medicine targeted for the TDM of the multi-item
森川剛1, 深海和人2, 反町美穂3, 土屋達寛3, 田村和季3, 守岩友紀子3, 東海林敦3, 半田幸雄2, 岡澤香津子1, 柳田顕郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2018.
Japanese Article 23-13-O9-2. Quantitative evaluation of blood behavior of an endogenous marker of the CYP3A activity in puerperium women and amlodipine
田口怜奈1, 内藤隆文1, 久保野尚子1, 小川法良2, 伊東宏晃3, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2018.
Japanese Article 23-13-O9-3. It is ... based on relationship - part-specific PK-PD analysis with blood level and the fascial tissue density of cefazolin in the total hip replacement
小松敏彰1, 夏目祐衣2, 坂之上和実2, 川村充史2, 友田吉則2, 池田信介2, 内山勝文3, 高山陽子1, 厚田幸一郎2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2018.
Japanese Article 23-13-O9-4. Change over time of the tacrolimus body change in the lung transplantation patients who used itraconazole together
川本雄士1, 片田佳希1, 中川俊作1, 杉本充弘1, 糸原光太郎1, 山本由貴1, 福井彩香1, 松田裕也1, 松村勝之1, 大村友博1, 米澤淳1,2, 中川貴之1, 長尾美紀3, 陳豊史4, 伊達洋至4, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2018.
Japanese Article 23-13-O9-5. Study on development change model and covariates of the anticoagulant effect in the childhood warfarin therapy
田村理香1, 渡辺直1, 中村早稀1, 芳村直樹2, 小澤綾佳3, 廣野恵一3, 市田蕗子3, 田口雅登1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2018.
Japanese Article 23-13-O10-1. Relations of blood level and the treatment result of the gefitinib in patients with non-small cell lung cancer
横田隼人1, 小林裕幸1, 佐藤一洋2, 坂本祥2, 中山勝敏2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2018.
Japanese Article 23-13-O10-2. About an association between weight loss, cancellation and pharmacokinetics of the Erlotinib of the Erlotinib in patients with progress non-small cell lung cancer
長谷川一将1, 山本達郎1, 渡部裕紀1, 武田賢一2, 田中那津美2, 清水英治2, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2018.
Japanese Article 23-13-O10-3. Effect of the drug transportation transporter genetic polymorphism giving it to a pathological complete response after the nedaplatin +5-FU therapy in the cancer of the esophagus
藤田一馬1, 本山悟2,3, 佐藤雄亮2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2018.
Japanese Article 23-13-O10-4. The establishment of the optical isomer simultaneous measurement method of human blood tramadol and the demethyl metabolite and stereoselective evaluation in the CYPs metabolism
鈴木光路1,2, 内藤隆文1, 田中達也1, 山田康秀3, 伊藤邦彦2, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2018.
Japanese Article 23-13-O10-5. Calculation of the cutoff value of the adrenal cortical steroid dose to affect eGFRcys/eGFRcreat
津下遥香1, 田中遼大1, 鈴木陽介1, 佐藤雄己1, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2018.
Japanese Article 23-13-O11-1. Examination about the dose setting of irinotecan based on the UGT1A1 genetic polymorphism in patients with colon cancer
山田友奈美1, 藤井宏典1, 渡辺大地1, 松橋延壽2, 高橋孝夫2, 吉田和弘2, 鈴木昭夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2018.
Japanese Article 23-13-O11-2. A search of the new preventive preparation for the cisplatin-induced renal failure and inspection of the effectiveness
合田光寛1, 斉家和仁2, 伊勢諒3, 新村貴博2, 石澤有紀3, 座間味義人1,2, 中馬真幸4, 濱野裕章1, 岡田直人1, 武智研志4, 今西正樹1,2, 堀ノ内裕也3, 池田康将3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2018.
Japanese Article 23-13-O11-3. Effect on renal function by cisplatin and the antihypertensive medications combination in patients with cancer of the esophagus
熊谷優1, 赤嶺由美子1, 安倍明2, 和田優貴2, 戸沢智樹2, 笹嶋素子2, 熊谷聡2, 橋本学2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2018.
Japanese Article 23-13-O11-4. Examination about onset of vascular pain and the effect of treatment by the dissolution liquid increase in quantity of bendamustine
森川花絵1, 石田茂1, 杉尾健志2, 森康雄2, 渡邊裕之1, 江頭伸昭1, 宮本敏浩2, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2018.
Japanese Article 23-13-O11-5. Effect of the serotonin receptor blocker on retching, vomiting of the temozolomide combination radiotherapy
熊倉康郎1, 亀川弥那1, 渡邉美菜子1, 石井沙也加1, 井上理香子1, 高木麻衣1, 大岡史治2, 本村和也2, 夏目敦至2, 藤井正純2, 若林俊彦2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2018.
Japanese Article 23-13-O12-1. Examination about the exposure risk at use of anticancer agent division
中山季昭1, 内田礼人1, 片山明香1, 嶋崎幸也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2018.
Japanese Article 23-13-O12-2. The exposure investigation of the anticancer medicine disposal container and examination of the storage management method
橋本昂介1, 入佐俊弘1, 石田茂1, 秦晃二郎1, 中嶋一惠1, 渡邊裕之1, 辻敏和1, 江頭伸昭1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2018.
Japanese Article 23-13-O12-3. The anticancer medicine scattering situation investigation to the preparation environment outside and evaluation of the usefulness of preventive measures against exposure
後藤優理1, 鈴木貴明1, 中村貴子1, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2018.
Japanese Article 23-13-O12-4. Multicenter study on fact-finding of the quantity of nivolumab disposal in Hokkaido and cancellation policy (NEWHOPE STUDY) - final report -
福土将秀1, 石川良太1, 相馬亮太1, 吉田光一1, 木村周古1, 新田悠一朗1, 小枝正吉1, 三嶋一登1, 小野尚志1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2018.
Japanese Article 23-14-O13-1. We see the rear of the factor to reduce response rate of tazobactam/piperacillin and the effect on elderly people pneumonia treatment and examine a mark
宗村盛1, 尾田一貴2, 太田景子1, 坂本直治3, 鈴木豊史4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2018.
Japanese Article 23-14-O13-2. Clarithromycin-resistant H. The effect that a choice of the antimicrobial gives to a sanitization rate on pylori infection
深津昌弘1, 水野貴仁1, 梅村拓巳1, 岩津慎次郎1, 河邊智久2, 新家卓郎2, 竹中宏之2, 黒岩正憲2, 鷹見繁宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2018.
Japanese Article 23-14-O13-3. An initial therapeutic drug for the MRSA bacteremia and prognostic relations
吉田三矢1, 川上智久1, 南翔大1, 三浦菜々子1, 山口崇臣1, 畝佳子1, 政道修二1, 志馬伸朗2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2018.
Japanese Article 23-14-O13-4. Sensitivity analysis of the oral antimicrobial including the cefaclor for cefazolin-resistant Escherichia coli
片野田朋美1,2, 尾田一貴1,2, 山本景一2,3, 福嶋理香2,3, 野坂生郷2, 齋藤秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2018.
Japanese Article 23-14-O13-5. Effect of Antifungal Stewardship (AFS) on surgical system, Candida blood symptom in the intensive care domain
伊藤亮太1, 渡邊卓嗣1, 星野祐太1, 菊地未由1, 菅野和彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2018.
Japanese Article 23-14-O14-1. Intervention for the oral third generation cephalosporin medicine consumption reduction in the antimicrobial proper use
久保田健1, 宮澤衣鶴1, 小池恵理1, 森川剛1, 岡澤香津子1, 千秋智重2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2018.
Japanese Article 23-14-O14-2. Clinical outcome evaluation by the expansion targeted for the surveillance from report antimicrobial to the use of all injectable antimicrobial patients
大橋健吾1, 松岡知子1, 篠田康孝1,2, 新井かおり1, 森卓之1, 吉田真也1, 林秀樹2,3, 杉山正2,3, 吉村知哲1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2018.
Japanese Article 23-14-O14-3. Should we assume consumption as of the past when an index in the antimicrobial-sensitive monitoring?
岡村祐嗣1,3, 東野優花1, 津山博匡1,3, 木村正彦2,3, 齋藤紀先2,3, 萱場広之2,3, 新岡丈典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2018.
Japanese Article 23-14-O14-4. Intervention effect of Antimicrobial Stewardship Team based on process index and outcome index
平山晴奈1, 倉本恵里子1, 藤田拓俊1, 平畠正樹1, 安藤基純5, 小倉明子2, 奈須聖子3, 土井朝子4, 池末裕明1, 室井延之1, 橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2018.
Japanese Article 23-14-O14-5. Use trend ... by the proper use ... oral third generation cephem permission system of the childhood SSI prevention antimicrobial
渡邉稜子1, 野田有貴子1, 山田真人1, 三輪祐太朗1, 石田達彦1, 上田理恵1, 福井由美子1, 伊藤雄介2, 笠井正志2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2018.
Japanese Article 23-14-O15-1. The proper use support effect to a carbapenem-based antimicrobial chronic administration case in our hospital and role of the pharmacist
赤沢翼1, 茂野絢子1, 原量平1, 大橋裕丈1, 守山祐樹2,3, 太田雅之2, 高谷紗帆2, 山元佳2, 日馬由貴3, 増田純一1, 目崎和久4, 早川佳代子2,3, 忽那賢志2, 寺門浩之1, 大曲貴夫2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2018.
Japanese Article 23-14-O15-2. Examination about the acute renal failure risk by vancomycin and the tazobactam piperacillin combination drug combination
稲毛俊介1, 中村翔太郎1, 礒江雄人1, 岡本早織1, 植竹将1, 村上美聖1, 山口礼華1, 森島雅世2, 根井貴仁2, 伊勢雄也1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2018.
Japanese Article 23-14-O15-3. Examination about the usefulness of the initial loading dose of vancomycin for the renal function normalcy case
植田貴史1, 竹末芳生1, 中嶋一彦1, 一木薫1, 石川かおり1, 和田恭直1, 山田久美子1, 土田敏恵1, 高橋佳子2, 石原美佳2, 木村健2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2018.
Japanese Article 23-14-O15-4. Search of the index to sort patients requiring administration of high-dose vancomycin
可児紘子1, 田中雄大1, 山口諒1, 山本武人1,2, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2018.
Japanese Article 23-14-O15-5. Result analysis of Antimicrobial Stewardship by the cooperation of a pharmacist and the medical technologist in the municipal hospital
小島さおり1, 片山歳也1, 井上靖浩2, 町田祐子3, 野田晋司1, 三好美穂4, 三宅真人4, 伊藤佐知子5, 木枝秀人6, 松田浩明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2018.
Japanese Article 23-14-O16-1. From hospital preparation to clinical experimental medicine production role - of the hospital pharmacist by the - sirolimus gel preparation development
中村歩1,2, 前田真一郎3, 大石雅子5, 三輪芳弘1, 斎藤勝久2, 金田眞理4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2018.
Japanese Article 23-14-O16-2. Examination of the new quality docimasy in the hospital preparation selenium injection
鈴木英二1, 吾妻貴司2, 熊谷静香1, 牧内里衣3, 堀勝幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2018.
Japanese Article 23-14-O16-3. Basic study of the pregabalin bougie which was hard to take medicine, and aimed at the pain control of the patients
矢島領1,2, 松元一明2, 横野加那子2, 渡部佑樹2, 榎木裕紀2, 田口和明2, 伊勢雄也1, 片山志郎1, 木津純子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2018.
Japanese Article 23-14-O16-4. For improvement in convenience of the Mohs ointment: Fluid improvement effect with usefulness and the shear stress of the cryopreservation
岡本広世1, 吉川知宏1, 竹内健太1, 松岡寛1, 出口粧央里2, 畠中優斗2, 川畑篤史2, 長井紀章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2018.
Japanese Article 23-14-O16-5. Sustained ... of elution of development - amphotericin B of the amphotericin B-containing gum preparation and the effect
小田原瑛理1, 大川杏果1, 村山信浩1, 原田努1, 中村明弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2018.
Japanese Article 23-14-O17-1. Construction of the rating system that considered the sex differences of the drug induced hepatic injury onset risk by the tazobactam piperacillin in the ward for acute phase
雨宮貴洋1, 本間雅1, 長瀬幸恵1, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2018.
Japanese Article 23-14-O17-2. The onset of liver damage during Eltrombopag administration attenuates an increased number of platelets effect
柳町直哉1,2, 小原直3, 錦井秀和3, 坂田麻実子3, 長谷川雄一3, 千葉滋3, 土岐浩介1,2, 本間真人1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2018.
Japanese Article 23-14-O17-3. Examination of the risk factor of the effectiveness and retching of the prophylactic antiemetic drug for retching, vomiting at oxycodone introduction
市川洋一1, 守田和憲1, 徳永晃己1, 佐々扶美1, 山下愛子1, 田上治美1, 坂本慎弥2, 大山高廣2, 中村和美2, 政賢悟2, 齋藤秀之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2018.
Japanese Article 23-14-O17-4. The construction of the safe information management system of the immune checkpoint inhibitor and search of the clinical factor associated with the immune-mediated adverse event expression
板井進悟1, 川岸篤史1, 川上貴裕1, 速水良恵1, 菅幸生2, 原祐輔1, 嶋田努1, 崔吉道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2018.
Japanese Article 23-14-O17-5. Analysis of an appearance ratio and the risk factor of the steroid-induced mental disorder in patients with children, young adults blood-forming organ tumor
スタッブ由紀子1,2, 菅幸生2, 伊川泰広3, 坪内清貴4, 橋本美紀恵4, 川岸篤史4, 嶋田努4, 崔吉道4, 松下良2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2018.
Japanese Article 23-14-O18-1. Construction of side effect monitoring duties utilizing pharmaceutical products risk management plan (RMP)
高田裕介1, 和田陽子2, 中村美代子1, 秋山伸二2, 難波弘行2, 飛鷹範明1, 田中守1, 田中亮裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2018.
Japanese Article 23-14-O18-2. It is prospective study about the association with the protein urine creatinine ratio with protein urine fixed-quantity in urine collection for 24 hours in patients with antiVEGF antibody-related protein urine appearance at any time
阪田安彦1, 北本真一2, 水上皓喜1, 阿部圭輔1, 妹尾啓司1, 岩本康男3, 松尾宏一4, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2018.
Japanese Article 23-14-O18-3. Relation of the pharmacist before the non-fixed form sustained-release parenteral injection (LAI) introduction using Shared Decision Making (SDM)
小林真美1,2, 庄司優2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2018.
Japanese Article 23-14-O18-4. Construction of the onset of impaired renal function ratio estimate model with vancomycin using the data mining technique
今井俊吾1, 山田武宏1, 笠師久美子1, 新沼悠介1, 小林正紀1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2018.
Japanese Article 23-14-O18-5. Cover suspicion medicine by effect - database analysis that treatment with anticancer agent gives to a male sexual function pharmacologic examination - using the rat
片岡智哉1, 真川明将2, 鈴木純3, 武藤樹也4, 堀田祐志3, 前田康博3, 川出義浩3, 頭金正博4, 木村和哲1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2018.
Japanese Article 23-15-O19-1. The effectiveness and safety of the olanzapine combination for the standard antiemesis therapy of breast cancer chemotherapy-induced retching, vomiting: Tendency score analysis
河添仁1, 魚住龍史2, 村上朱里3, 山下美智子3, 田口加奈3, 日下恵梨菜3, 山澤令菜3, 薬師神芳洋4, 亀井義明3, 中村智徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2018.
Japanese Article 23-15-O19-2. Effect to give blood glucose level of Olanzapine to use for an antiemesis purpose by chemotherapy for the breast cancer perioperative period
友松拓哉1, 平出誠1, 青山剛1, 鈴木賢一1, 伊藤良則2, 濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2018.
Japanese Article 23-15-O19-3. It is evaluated the antiemesis therapy using three drugs of palonosetron, aprepitant, the dexamethasone for the CapOX therapy after the stomach cancer technique
萩野茜1, 青山剛1, 横川貴志1, 中野泰寛1, 樋口秀太郎1, 柴田直樹1, 鈴木賢一1, 若槻尊2, 山口研成2, 濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2018.
Japanese Article 23-15-O19-4. Examination ... about the need of retching, anorectic expression situation investigation - antiemesis therapy reinforcement due to platinum-containing cancer chemotherapy
杉山弘樹1, 中田淳也1, 市村菜穂2, 原田晴司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2018.
Japanese Article 23-15-O19-5. The effectiveness of the peg filgrastim second prophylactic administration in the small cell lung cancer chemotherapy and safe examination
櫻下弘志1, 佐伯康之1, 泉谷悟1, 畝井浩子1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2018.
Japanese Article 23-15-O20-1. Establishment of the proper use of the expression situation according to the CINV risk factor with the breast cancer anthracycline regimen and olanzapine
小暮俊明1, 佐々木俊則1, 水谷三浩2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2018.
Japanese Article 23-15-O20-2. Examination of the olanzapine relief dosage effect to retching with the chemotherapy including the anthracycline anticancer agent on patients with breast cancer
渡邉大毅1, 高田慎也2, 橋下浩紀2, 鶴山辰1, 遠藤雅之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2018.
Japanese Article 23-15-O20-3. Extra effect of aprepitant on delayed-action retching, vomiting at the CBDCA initial administration in the lung cancer
細川祐岐1, 新谷拓也1, 斎藤由佳1, 村地康1, 山本智也1, 門脇裕子1, 勝浦正人1, 平田陽彦2, 長友泉2, 木田博2, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2018.
Japanese Article 23-15-O20-4. Appropriate mild cathartic choice for the intractable constipation in blood cancer chemotherapy patients
川田敬1, 太田剛史2, 小笠原瑞穂1, 津野文香1, 山崎好恵1, 藤澤康代1, 段松雅弘1, 今井利2, 田中聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2018.
Japanese Article 23-15-O20-5. An oral Mg agent and effect of the antacid administration to give to onset of low Mg blood symptom due to the antiEGFR antibody
佐藤淳也1, 石川寛1, 田中怜1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2018.
Japanese Article 23-15-O21-1. Investigation of the expression situation of edema at the docetaxel administration to patients with breast cancer and the associated factor
宇野健一1,2, 高田慎也2, 橋下浩紀2, 遠藤雅之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2018.
Japanese Article 23-15-O21-2. Elucidation of the onset of phlebitis mechanism by Fosaprepitant and the epirubicin combination
山崎美保1, 木村竜司1, 馬屋原慈理1, 前田頼伸1, 西田俊博2, 小田啓祐3, 森信博3, 村上照夫3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2018.
Japanese Article 23-15-O21-3. The onset of vascular pain situation investigation accompanied with the gemcitabine solution change
中田淳也1, 杉山弘樹1, 市村菜穂2, 原田晴司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2018.
Japanese Article 23-15-O21-4. The onset of oral mucosa disorder situation with the immune checkpoint inhibitor in the single institution
金子忍1, 塩飽英二1, 土手賢史1, 古田祐美子1, 野崎歩1, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2018.
Japanese Article 23-15-O21-5. Risk factor analysis of the febrile neutropenia in nedaplatin, the 5-FU combination therapy
橋詰淳哉1, 松丸由美1, 金澤絵莉2, 樋口則英3, 黄智剛1, 神田絋介1, 山崎拓也4, 本田琢也5,6, 日高重和7, 佐々木均1, 室高広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2018.
Japanese Article 23-15-O22-1. One case of acute hepatitis B that caused the HBV reactivation that occurred five years after malignant lymphoma completion of treatment
上ノ段友里1, 大森薫2, 富田珠美1, 福山康朗3, 横田昌樹2, 縄田好一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2018.
Japanese Article 23-15-O22-2. It is randomized controlled trial (AEOLUS) about the improvement in adjuvant chemotherapy successful execution after the S-1 gastric cancer technique by the adverse event reduction of the lafutidine
木村仁1,2, 寺島雅典3, 多久佳成4, 大門貴志5, 安井博史3, 野崎功雄6, 福島紀雅7, 高金明典8, 金容壱9, 滝口伸浩10, 高木正和4, 三澤一成11, 木村泰生12, 前田賢人13, 金井俊和14, 太田光彦15, 横山日出太郎16
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2018.
Japanese Article 23-15-O22-3. Examination about the effectiveness of the polaprezinc for the cancer chemotherapy-induced taste disturbance
廣瀬智恵美1, 藤井宏典1, 石原正志1, 飯原大稔1, 今井寿2, 松橋延壽2, 高橋孝夫2, 山口和也2, 吉田和弘2, 鈴木昭夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2018.
Japanese Article 23-15-O22-4. Study on search of a clinical course and the risk factor of the case that paclitaxel caused eye disorders
野口裕介1, 川島悠吾1, 丸山恵未1, 瓦比呂子1, 徳山洋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2018.
Japanese Article 23-15-O22-5. The combination of irinotecan hydrochloride and killer cells-related anticancer medicine is a risk factor of the cholinergic syndrome
坪谷綾子1,2, 藤田健一3, 久保田祐太郎4, 石田博雄4, 滝伊織1, 亀井大輔1, 岩井信市1, 佐々木康綱3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2018.
Japanese Article 23-15-O23-1. Search of new urinary biomarker to detect onset of acute rejection of renal-transplant recipients
田島壮一郎1, 付饒2, 末次王卓1,2, 土本晃裕3, 岡部安博4, 増田智先1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2018.
Japanese Article 23-15-O23-2. Examination of the blood pressure independence-like kidney protection effect by PDE5 inhibitor Tadalafil
冨田なつみ1, 堀田祐志1, 内木綾2, 片岡智哉3, 前田康博1, 高橋智2, 木村和哲1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2018.
Japanese Article 23-15-O23-3. It is ... for investigation - effect-like Rincon trawl about the inorganic phosphorus content in oral medicine, the supplement which haemodialysis patients take
下石和樹1, 安楽誠2, 庵原大輔2, 平山文俊2, 小田切優樹2, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2018.
Japanese Article 23-15-O23-4. Search of the new liver function improvement medicine by the choler phosphatide discharge promotion effect
池田義人1, 森田真也1, 波多野亮2, 辻徳治1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2018.
Japanese Article 23-15-O23-5. Examination of the risk factor becoming poor in pain control after opioid switching from oxycodone tablets to fentanyl patch
森川記道1, 笠原庸子2, 高橋裕子1, 西原昌幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2018.
Japanese Article 23-15-O24-1. The study on factor to give it to malpractice: About powders formulations
大嶋耐之1, 水野まい1, 宮地佑佳1, 仲山千佳1, 廣嶋尚美2, 舟橋智美2, 長芝計代2, 木下功2, 大西正文2, 斎藤寛子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2018.
Japanese Article 23-15-O24-2. A risk factor about the administration of non-fixed form antipsychotics in the Parkinson's disease patients and relative evaluation with the length of stay
池谷怜1,2, 今井志乃ぶ2, 堀口裕正2, 古島大資1, 伏見清秀2, 山田浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2018.
Japanese Article 23-15-O24-3. Clinical background associated with under dose of the direct action type oral anticoagulant drug for the atrial fibrillation
宮崎元康1, 坂元佑哉1, 三崎桃子1, 松尾宏一1, 内山将伸1, 浦田秀則2, 仲村佳彦3, 今給黎修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2018.
Japanese Article 23-15-O24-4. Examination of the onset risk of dyslipidemia with the antiepileptic drug using the large-scale cohort
鈴木亮平1, 近藤芳皓2, 柴田晋弥3, 深見和宏3, 石嶋麗4, 中出恵里奈4, 山本吉章5, 林誠2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2018.
Japanese Article 23-15-O24-5. Case report about the safety assessment to transitivity out of the mother's milk of antibody preparation Tocilizumab and an infant at breast
齊藤順平1, 八鍬奈穂2, 高井千夏2, 中島研2, 金子佳代子3, 後藤美賀子2,3, 山谷明正1, 石川洋一4, 村島温子2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2018.
Japanese Article 24-9-O25-1. The current situation of establishment and duties of the pharmacist outpatient department
大窪典子1, 津曲恭一1, 尾之江剛樹2, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2018.
Japanese Article 24-9-O25-2. Pharmacist outpatient department establishment in our hospital and evaluation of prescription suggestion contents
村地康1, 細川祐岐1, 堀野沙耶1, 山本智也1, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2018.
Japanese Article 24-9-O25-3. Examination of proper use and the medication counseling to psychotropic drug polypharmacy, the long-term prescription patients by the pharmacist of the circulatory organ internal medicine outpatient department
上野良夫1, 玉木真紀子2, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1,2, 石川真也3, 村尾敏4, 高木雄一郎5, 前田剛6, 森由弘6, 厚井文一6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2018.
Japanese Article 24-9-O25-4. Evaluation of efforts and the usefulness of the pharmacist outpatient department in the idiopathic pulmonary fibrosis therapeutic drug
薩摩由香里1, 楠田かおり1, 池末裕明1, 室井延之1, 森令法2, 古郷摩利子2, 富井啓介2, 橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2018.
Japanese Article 24-9-O25-5. Examination of intervention contents in the chemotherapy center permanent residence type pharmacist outpatient department
後藤由起子1,2, 鶴崎泰史2, 眞弓健介2, 丸田基史3, 大橋邦夫2, 藤田強記2, 横田千明2, 山室蕗子1, 末吉栄志1, 中川義浩2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2018.
Japanese Article 24-9-O26-1. Evaluation of efforts for improvement in methotrexate medication adherence for outpatients and the usefulness
雪矢良輔1, 奥田佳子1, 松岡里枝1, 梶田貴司1, 中島亜梨沙1, 石丸裕康2, 八田和大2, 上田睦明1, 奥野智之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2018.
Japanese Article 24-9-O26-2. Discontinuation instruction duties before operation of the antithrombotic drug by the outpatient department pharmacist and fact-finding of the instruction observance situation
森亜沙美1, 赤嶺聡彦1, 冨澤淳1, 椎崇1, 近藤留美子1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2018.
Japanese Article 24-9-O26-3. About dose setting and adherence of the bringing medicine in the anticoagulation patients
鳥谷部翔1, 清藤一輝1, 岩崎友美1, 石田瑞穂1, 花田和大1, 高瀬公子1, 倉内寿孝1, 萩井譲士2, 清野聡2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2018.
Japanese Article 24-9-O26-4. Analysis - of economic effect - Pharmaceutical Intervention Record (pharmaceutical intervention report) of a test value check, the bringing medicine check
味澤香苗1, 鈴木学1,2, 林由依1, 國府田真綾1, 金地夏実1, 林秀樹1,3, 小原道子3, 棚瀬友啓2, 土屋照雄2, 杉山正1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2018.
Japanese Article 24-9-O26-5. Future problem about the inflection of the prescription notebook found from the bringing medicine for patients with direct hospital admission of emergency confirmation
松本乃里子1, 加藤隆寛1, 竹内正幸1, 山之内博明1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2018.
Japanese Article 24-9-O27-1. Internal change of the lamotrigine when we supplemented with valproic acid
山本吉章1, 石川哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2018.
Japanese Article 24-9-O27-2. Pharmacokinetics of apixaban, dabigatran, the edoxaban of elderly patients in our hospital and the rivaroxaban
西岡美穂1,2, 小菊実2, 岸博久2, 野田昌幸2, 遠藤純男2, 竹川充2, 太田美樹1, 野津祐貴1, 清水万紀子1, 山崎浩史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2018.
Japanese Article 24-9-O27-3. The establishment of the simultaneous assay of aprepitant out of the human plasma and the metabolite and evaluation of the CYP3A subfamily in the metabolic process
鈴木祐介1, 内藤隆文1, 柴田海斗1, 土屋未来広1, 岡村純2, 細川誠二2, 峯田周幸2, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2018.
Japanese Article 24-9-O27-4. Evaluation of the OATP1B activity after the living renal transplantation that assumed Coproporphyrin-I an index
小野寛之1, 鈴木陽介1,2, 田中遼大1, 佐藤文憲3, 佐藤雄己1, 三股浩光3, 大野恵子2, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2018.
Japanese Article 24-9-O27-5. Association between serum paraoxonase 3 levels and lactone type drug hydrolysis activity in normal adults
尾形浩1, 三坂眞元1, 鎌村美歩1, 阿部理1, 小野委成1, 色摩弥生2, 下村健寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2018.
Japanese Article 24-9-O28-1. Association between Everolimus blood level and adverse event investigation in renal carcinoma treatment
高崎新也1, 川崎芳英2, 菊地正史1, 田中雅樹1, 山口浩明1, 伊藤明宏2, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2018.
Japanese Article 24-9-O28-2. It is 3 ingredients simultaneous assay establishment of 5-FU, the uracil Tegafur in the UFT/LV combination therapy and clinical application after the hepatectomy for colon cancer liver metastases
白岩健1, 鈴木陽介1, 岩男元志1, 田中遼大1, 佐藤雄己1, 岩下幸雄2, 内田博喜2, 多田和裕2, 猪股雅史2, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2018.
Japanese Article 24-9-O28-3. The rate of use of the blood level measurement and the renal function analyses in the digoxin user
千手綾香1, 大場延浩1, 安部恵1, 渡邉文之1, 西銘千絵1, 萩原紫乃1, 福岡憲泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2018.
Japanese Article 24-9-O28-4. The effect that PTH gives to the tacrolimus doses in renal-transplant recipients and blood level
平田憲史郎1, 渡邊博志2, 杉本龍星2, 丸山徹2, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2018.
Japanese Article 24-9-O28-5. 1 case of the children who succeeded in blood tacrolimus levels control by using cimetidine together
楠川侑吾1, 村田龍宣1, 村岡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2018.
Japanese Article 24-10-O29-1. Fact-finding about knowledge for the hemorrhoids in the dweller and the remedial behavior and the consciousness
小堀宅郎1, 仲田博貴1, 榎本恭子1, 沖津孝幸1, 今井康平1, 八木誠次2, 荻野勇人2, 若林修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2018.
Japanese Article 24-10-O29-2. The effect that cerebral infarction disease severity and the arteriosclerosis risk management in patients in CKD give
安泰成1, 松永佳誉子1, 浦田大樹1, 近藤佑紀1, 入岡隆2, 吉川明彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2018.
Japanese Article 24-10-O29-3. Use fact-finding of the oral antimicrobial in the Kitasato University Hospital
小泉朱乃1, 小松敏彰2, 瀬戸良教1, 大川原裕樹1, 和田達彦2, 高山陽子2, 厚田幸一郎1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2018.
Japanese Article 24-10-O29-4. Efforts aiming at proper use of the ad usum externum local anesthesia preparation used for patients on dialysis
亀山直哉1, 玉木真紀子1, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1, 川原勁介2, 笠井雅実2, 松原啓介3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2018.
Japanese Article 24-10-O29-5. Investigation of anxiety and the depression by the treatment cancellation of patients with chronic myelogenous leukemia
祖川倫太郎1,2, 木村早希子1, 矢ヶ部良太1, 溝上泰仁1, 田崎正信1, 荒金尚子1,2, 成澤寛1,3, 木村晋也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2018.
Japanese Article 24-10-O30-1. Contribution of the pharmacist in the urgent medical support team
仲里泰太郎1, 佐藤尚子2, 井上陽平3, 山地優依子1, 雪本江里子1, 中出雅治4, 小林政彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2018.
Japanese Article 24-10-O30-2. The current situation of the common use medicine storage situation for the large-scale disaster that it showed from patients questionary survey
原田大1, 中込早苗1, 影山明1, 加藤潤一郎1, 川久保孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2018.
Japanese Article 24-10-O30-5. Enforcement of the training correspondence at the system failure in the electronic medical chart and examination of problems
南目祐希1, 富山直敏1, 渡辺美恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2018.
Japanese Article 24-10-O31-1. Study on input method and indication of the discharge drug control instruction information to electronic edition prescription notebook
中村貴子1, 横山威一郎1, 渡辺健太1, 山口洪樹1, 鈴木貴明1, 田中政吉2, 野本禎3, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2018.
Japanese Article 24-10-O31-2. Automation of the inventory control by an electronic medical chart system and the management of material distribution system cooperation
阿部剛1, 竹野孝慶1, 左迫間昭一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2018.
Japanese Article 24-10-O31-3. [by the ward drug duties enforcement addition acquisition] The need of the pharmaceutical products material by the ward pharmacist improves.
塚口真穂登1, 多川洋史1, 北峯あづみ1, 伊藤晶子1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2018.
Japanese Article 24-10-O31-4. Efforts of the case conference which a drug information management room conducts by leadership
横山香保1, 加藤亜紀1, 鈴木晴久1, 吉野宗宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2018.
Japanese Article 24-10-O31-5. Construction and evaluation of the anticancer agent regimen check system having pharmaceutical products risk management plan (risk management plan: RMP) information
尾崎正和1, 田中翔子1, 清永智子1, 幸田恭治1, 北原隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2018.
Japanese Article 24-10-O32-1. The difference in elution, crush properties between a zolpidem innovator drug, the generic drug: Function of additive macrogol
稲葉一訓1, 大家才治2, 大竹裕子2, 井上知美2, 小竹武2, 長井紀章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2018.
Japanese Article 24-10-O32-2. Investigation ... which paid its attention to contents of quality information comparison between starting pharmaceutical products and generic drug - pharmaceutical products interview form
松井友希1, 浅山美穂1, 大谷智也1, 恩田光子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2018.
Japanese Article 24-10-O32-3. Medical expenses reduction effect of the outside Parliament prescription which wrote clinical test value
保ヶ辺雄也1, 横山威一郎1, 石川雅之1, 齊藤美聡1, 山口洪樹1, 山崎香織1, 新井さやか1, 中村貴子1, 鈴木貴明1, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2018.
Japanese Article 24-10-O32-4. Cost effect analysis of the neuraminidase inhibitor in the influenza virus infection
中川直人1, Leanne Lai2, 金澤幸訓3, 森川昭正3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2018.
Japanese Article 24-10-O32-5. Coping - from a point of view of running it in the hospital targeted for DPC to the adoption item choice second report - generic medicine amount base new calculation method
脇田真之1, 岡村吏華1, 人見智香子1, 吉井千菊1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2018.
Japanese Article 24-10-O33-1. Safe examination of the direct action type oral anticoagulant drug (DOAC) administration for elderly people
川根誉代1, 渡邉操1, 土井崇1, 岡祐介1, 佐合裕子1, 芦川直也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2018.
Japanese Article 24-10-O33-2. Associated factor of pharmaco-frailty in the elderly inpatient
松井瑛子1, 大山茜2, 竹屋泰2, 中嶋恒男2, 竹屋美幸2, 武田朱公3, 鷹見洋一2, 立入頌子1, 渡邊梓1, 山本智也1, 杉本研2, 山本浩一2, 三輪芳弘1, 樂木宏実2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2018.
Japanese Article 24-10-O33-3. Examination - using use experience - G8 score of the immune checkpoint inhibitor in elderly people
山本泰大1, 宇都宮純平1, 福岡智宏1, 高木真由美2, 溝口真巨2, 戸田康裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2018.
Japanese Article 24-10-O33-4. Association between actual situation and fall, fall accident of the polypharmacy in the care health center for the elderly
竹村有美1, 塚原邦浩1, 居塚しのぶ1, 久保田厚子1, 小倉秀美1, 山下智省2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2018.
Japanese Article 24-10-O33-5. Efforts for the prescription adequacy of elderly people in the JCHO Kyushu Hospital
阿部名月1, 吉国健司1, 末松文博1, 折口秀樹2, 中村哲郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2018.
Japanese Article 24-10-O34-1. Construction of the infusion formulation study software in our hospital adoption medicine
博田舞子1, 大橋啓子1, 平岩知子1, 後藤亨2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2018.
Japanese Article 24-10-O34-2. The effect that cerebral damage gives to an internal change of zinc
冨澤淳1, 片岡祐一2, 近藤留美子1, 厚田幸一郎1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2018.
Japanese Article 24-10-O34-3. One case of short bowel syndrome that resulted in hyperferremia by chronic administration of the commercial trace element preparation
石井康世1,2, 中島康裕1,2, 畠中英理子1,2, 城村なる乃2, 角田すみ代2, 福原真美2, 辻井悟2,3, 池西政幸1, 雪矢良輔1, 梶田貴司1, 上田睦明1, 生島繁樹1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2018.
Japanese Article 24-10-O34-4. Effect of indometacin giving it to the volume of urine of the patent ductus arteriosus premature infant and serum electrolyte
大久保翔1, 赤嶺由美子1, 安達裕行2, 高橋勉2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2018.
Japanese Article 24-10-O34-5. One case that protein doses adjustment by the NST intervention contributed to improvement of the overall status for hepatic portal region cholangiocarcinoma postoperative AKI
巽道代1, 渡辺祐子1, 笠師久美子1, 片山真育1, 平井志明1, 本田愛子1, 熊谷聡美2, 村上壮一3, 七戸俊明3, 武田宏司4, 井関健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2018.
Japanese Article 24-11-O35-1. About development of the bar code authentication system to support "the internal use Distribution of medicine management" of the nurse in the pharmaceutical products proper use cycle and the usefulness
内海敦志1, 田辺友也1, 原田靖子1, 尾崎仁美2, 西原昌幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2018.
Japanese Article 24-11-O35-2. It is analyzed the source of information associated with inquiry contents and pharmaceutical products in doubt inquiry
金子絵里奈1, 高木博子2, 石橋久1, 園田正信1, 家入一郎2, 山野徹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2018.
Japanese Article 24-11-O35-3. Safe evaluation with the injection drug inspection support system which we introduced newly in the JCHO Kyushu Hospital
居塚しのぶ1, 藤村弥生2, 小倉秀美1, 末松文博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2018.
Japanese Article 24-11-O35-4. Efforts of the ban on use medicine administration prevention utilizing the electronic medical chart tag function
佐々木弘好1, 松村みどり1, 大塚さとみ2, 阿部佳史2, 福島美由紀1, 関沢祐一2, 松浦弘司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2018.
Japanese Article 24-11-O35-5. Examination of the intervention to the perioperative care by the health insurance pharmacy
笹原侑祐1, 鈴木裕司2, 村上恵一3, 井田美香子4, 板垣幸太郎5, 村田勇人6, 武田郁子7, 田島亮8, 小橋斉彬9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2018.
Japanese Article 24-11-O36-2. The reinforcement of the medical safety management system and the evaluation
木全司1, 吉田弘樹1, 三輪奈津貴1, 高木祥子1, 三輪めぐみ1, 今井視保子1, 鬼頭克暢1, 加藤康子1, 木下元一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2018.
Japanese Article 24-11-O36-3. Efforts to proper use of the benzodiazepine system medicine
伊東健一1, 川崎伸子2, 渡辺朋子2, 松尾剛志3, 白尾一定4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2018.
Japanese Article 24-11-O36-4. The sleeping drug remedy in the non-surgery elderly patients by the case cross-over study and allied evaluation of the fall
鳥井栄貴1, 冨田秀明2, 安藤基純3, 田中茉歩子1, 藤本一秀1, 小原智子1, 清水るみ子1, 池末裕明2, 奥貞智2, 橋田亨2, 久米典昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2018.
Japanese Article 24-11-O36-5. Adequacy of the use of sleep agent by the collaboration with the dementia support team
平田備子1,7,8, 岡本奈美2,8, 中島昌二3,8, 大西聖子3,8, 藤原彩音4,8, 松葉薫里5,8, 木南佐織6,7, 大西尚6,7, 吉田俊一6,8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2018.
Japanese Article 24-11-O37-1. Fact-finding of polypharmacy in patients with heart failure of our hospital
太田友樹1, 衣笠良治2, 山本達郎1, 加藤雅彦2, 小川勝弘1, 秦英司1, 山本一博2, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2018.
Japanese Article 24-11-O37-2. Examination about the bleeding risk of the direct action type oral anticoagulant drug in patients with non-valvular atrial fibrillation
渡辺圭1, 林太祐1, 矢島領1, 飯田謙司1, 伊勢雄也1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2018.
Japanese Article 24-11-O37-3. Effect of treatment judgment of the diuretics using the BIA method in patients with chronic cardiac insufficiency
黒岩亮平1, 井口恵美子1, 倉林学2, 猪股克彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2018.
Japanese Article 24-11-O37-4. The case that was treated effectively with sodium valproate, topiramate, a triple-drug therapy of stiripentol to patients with Dravet syndrome
森本真仁1, 島川清司1, 橋本俊顕1, 浜田茂明1, 北岡泰介2, 京谷庄二郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2018.
Japanese Article 24-11-O37-5. Decision of the optimal inhalational method that paid its attention to particle diameter between the preparation in the fixed-quantity aerosol-type inhalant
平大樹1,2, 水谷彩乃2, 冨田奈央2, 水野愛2, 角本幹夫1, 岡野友信1, 奥田知将2, 岡本浩一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2018.
Japanese Article 24-11-O38-1. Fact-finding about the quantity of conversion from oral medicine of the levodopa-containing preparation in the Parkinson's disease treatment to an injection drug
和久津稔1, 三浦由貴1, 田中敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2018.
Japanese Article 24-11-O38-2. One patient who responded to Tadalafil for the diffuse scleroderma with the skin ulcer
佐藤伸輔1, 櫻井淳二1, 山川香織2, 佐々木美織1, 岡田優1, 野上佳奈子1, 渡辺昌子1, 宮内康夫1, 阿部順1, 高橋知子2, 石澤文章1, 佐々木毅3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2018.
Japanese Article 24-11-O38-3. 1 case that ileus developed during hepatitis C treatment, and was able to continue treatment by the simple suspension method
細川宜嗣1, 原田恭江1, 和田望2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2018.
Japanese Article 24-11-O38-4. One patient who was able to continuously administer tolvaptan in the elderly people safely
内藤成美1, 大宮寛子1, 吉田夕貴1, 川井悦嗣1, 三輪耕次1, 田中伸享2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2018.
Japanese Article 24-11-O38-5. It is an enforcement report for an efforts first stage of the improvement in quality of the inhalation therapy by the instruction to the inhalational instruction video using the QR cord with letter
倉田香織1, 小林豊2, 上路彩芽3, 鈴木高弘3, 伊丹一海4, 渡邊剛彦5, 橋爪敦弘3, 土橋朗1, 北村修2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2018.
Japanese Article 24-11-O39-1. Examination in examination II isosorbide dinitrate of the interaction with the commercial denture adhesive and ethical drug and the nt roll spray
梅村雅之1, 福谷勇真1, 池上雄貴1, 吉田彩乃2, 柳原保3, 脇屋義文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2018.
Japanese Article 24-11-O39-2. Quantitative mechanism analysis of the interaction between drug - drink which was due to environment for gastrointestinal inland waters
竹村美由記1, 白坂善之1, 鮒井悠汰1, 石原麻梨華1, 一條一貴1, 岸本久直1, 井上勝央1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2018.
Japanese Article 24-11-O39-3. Examination about the elution durability of the minocycline-containing medical cement
丸尾陽成1, 牛尾聡一郎1, 江角悟1, 小川敦1, 沖田駿治2, 村川公央1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2018.
Japanese Article 24-11-O39-4. Basic examination about the amyloidogenesis of the insulin analog
大野由依1, 江川祐哉1, 三木涼太郎1, 細谷治1, 関俊暢1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2018.
Japanese Article 24-11-O39-5. Safety assessment of the caffeine administration for premature birth, the premature baby
田口雅登1, 勝眞愛梨沙1, 川崎裕香子2, 足立雄一2, 吉田丈俊2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2018.
Japanese Article 24-11-O40-1. Examination of the effect that a lot of thickness agents give to an elution rate in the collapse time for tablet for the internal use
江畠麗1, 藤田吉明1, 原田努1, 中村明弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2018.
Japanese Article 24-11-O40-2. Press through pack with the mount in consideration of convenience
神田修子1, 山之内崇紘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2018.
Japanese Article 24-11-O40-3. Development of the new mount press through pack that is superior in opening characteristics
山之内崇紘1, 神田修子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2018.
Japanese Article 24-11-O40-4. Study on optimization of a preparation, the preservation condition of the hospital preparation L- thyroxine sodium injection
益田佑輔1, 蛭子小春2, 山崎由夏2, 長井紀章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2018.
Japanese Article 24-11-O40-5. Bioequivalent study about the quetiapine inside the hospital bougie
落合秀1, 行成美1, 神原諒2, 早川太郎2, 河渕真治1, 伊藤由佳子1, 栄田敏之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2018.
Japanese Article 24-12-O41-1. Precision investigation of the formulations technical aid to use at tablet division formulations
山脇優輝1, 佐藤淳也1, 遠藤恵1, 土屋貴之1, 賀茂佳子1, 石川寛1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2018.
Japanese Article 24-12-O41-2. Effect on duties by the automation of formulations
福本勝政1, 平田龍司1, 井上真理1, 横田淳子1, 宅間大祐1, 岩崎裕昭3, 京谷庄二郎2, 濱田篤秀1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2018.
Japanese Article 24-12-O41-3. Examination of an effect prospective for oral medicine 1st by formulations and the change of the duties time
松井友里恵1, 五十嵐敏明1, 松嶋あづさ1, 高橋翠1, 山本大1, 重森美奈1, 林咲希1, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2018.
Japanese Article 24-12-O41-4. Examination about the usefulness of the simple suspension method using the method to agitate to be ground with the rotation, the revolution mixer
中尾元紀1, 田邨保之1, 永井聡子1, 覺野律1, 竹本晃佑2, 高塚隆之2, 橋本直文2, 大竹裕子3, 長井紀章3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2018.
Japanese Article 24-12-O41-5. Examination about the usefulness of the simple suspension method that used ultrasonically vibrating it
中尾元紀1, 松尾世為子1, 田邨保之1, 永井聡子1, 覺野律1, 大竹裕子2, 長井紀章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2018.
Japanese Article 24-12-O42-1. Inspection of the usefulness using a medication stand scan hi-vision camera for patients
遠藤瑠里1, 湧井宣行1,2, 町田昌明1, 吉澤有紀子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2018.
Japanese Article 24-12-O42-2. Relation of the pharmacist for the red blood cell hematopoietic stimulation preparation (ESA) use proper use for the anemia in renal disease
永江寛子1, 舌間清晃1, 谷田繁夫1, 林聡子1, 山本瞳1, 中島有里子1, 田村明子1, 長岡麻由1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2018.
Japanese Article 24-12-O42-3. Overlap administration prevention, a side effect and onset of allergic reaction prediction of the Chinese medicine that we consider a constitution crude drug
古澤正司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2018.
Japanese Article 24-12-O42-4. Analysis of doubt inquiry one-year after the prescription issuance with the test value
上津沙織1, 釘原瑶子1, 山澤結季1, 吉国健司1, 桑村恒夫1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2018.
Japanese Article 24-12-O42-5. Approach of PBPM where it is assumed that doubt inquiry to a specialist in prescription in the general Tokyo Hospital is not necessary
守屋瑞穂1, 外石昇1, 田籠美保子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2018.
Japanese Article 24-12-O43-1. Classification evaluation ... about "nursing and analysis (the second report) - nursing of consultation contents in the medicine" outpatient department
小西久美1, 前島多絵1, 梅澤理恵子1, 小畠真奈2, 濱田洋実2, 本間真人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2018.
Japanese Article 24-12-O43-2. Analysis of the inquiry example about the pregnancy, the nursing and the use of drug
深谷さおり1, 宇野英理子1, 野々垣知行1, 黒瀬優輔1, 大西正文1, 山之内博明1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2018.
Japanese Article 24-12-O43-3. Examination about the possibility of the allergic conditions control by the exosome derived from milk
太田知沙1, 田中祥子1, 油谷遥1, 遠藤美緒2, 櫻井基一郎2, 水野克己2, 恩田健二1, 杉山健太郎1, 平野俊彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2018.
Japanese Article 24-12-O43-5. Example that suffered from the digoxin administration plan to a pregnant woman
楠美克紀1, 久米央子1, 奥ヶ谷教1, 佐藤陽1, 松岡佳吾1, 細井智弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2018.
Japanese Article 24-12-O44-1. Medication support for improvement in adherence for the low vision patients
柴谷直樹1,2, 藤田和美1,2, 田中郁壮1,2, 別府あかね3, 室井延之1,2, 栗本康夫4, 橋田亨2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2018.
Japanese Article 24-12-O44-2. Development of the method "OMOTENASHI" which aimed at the foreign patients using medicine appropriately prototype model and evaluation in the ethical pharmacy
鈴木渉太1,2, 佐藤恵子2, 譽田真子2, 加藤恵理2, 劉金梁2, 小林学司2, 桑原佳宏2, 保野慎治2, 桝田出3, 山川紘希4, 笠原正登1, 上嶋健治2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2018.
Japanese Article 24-12-O44-3. The talks instruction by the patients-based medical practice to hear causes sick-role behavior transformation and realizes 100 million total achievement society
杉原真理1, 中島佳子2, 石垣洋次郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2018.
Japanese Article 24-12-O44-4. Effect on drugstore pharmacist - by the difference by change - prescription meeting a demand frequency of the consciousness by the patients with psychiatry consultation communication workshop enforcement
成井繁1,2, 野澤玲子2, 三田充男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2018.
Japanese Article 24-12-O44-5. Examination - from the inspection of strategic construction - United States Houston medical center aiming at the edition academic D tailing spread in Japan
尾関理恵1,2, 和田猛1,2, 西川元也1,2, 後藤惠子1,2, 青山隆夫1,2, 真野泰成1,2, 根岸健一1,2, 宮崎智1,2, 嶋田修治1,2, 吉澤一巳1,2, 高澤涼子1,2, 河野洋平1,2, 江角浩安2,3, 寺下真人2,4, 宮崎美子2,5, 山本美智子1,2, 小茂田昌代1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2018.
Japanese Article 24-12-O45-1. Response to 8 representative diseases in the trial drugstore business training
松下隼士1, 高木淳一1, 松村千晶2, 小林大介2, 川尻雄大2, 岸田義博1, 小柳香織1, 勢島充1, 吉田理1, 山野徹1, 園田正信1, 吉川学1, 島添隆雄2, 田中泰三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2018.
Japanese Article 24-12-O45-2. Examination about the evaluation method of the prescription analysis program for business trainees
阿登大次郎1, 齋藤玲奈1, 小竹武2, 小森浩二3, 森山博由4, 井上知美2, 三田村しのぶ3, 清水忠5, 日高眞理6, 廣瀬隆7, 吉田彰彦8, 小牟田豊1, 東海秀吉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2018.
Japanese Article 24-12-O45-3. From the questionary survey by relation - trainee of the pharmacist CRC in the trial business training -
西田佳苗1, 谷大輔1, 辻井佳代1, 小林政彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2018.
Japanese Article 24-12-O45-4. Attitude survey about understanding and the medication counseling of the hearing loss for rational consideration to the hearing person with a disability for pharmacy school fifth graders
俵口奈穂美1, 窪田敏夫2, 大光正男2, 芦原美咲2, 大津屋美咲2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2018.
Japanese Article 24-12-O45-5. Participation in planning - of the medicine trainee to "training program of the pharmacist taking local team approach in medical care" medicine pharmacy cooperation community medical care business training (Yao model) - Epinephrine autoinjector classroom
竹村美穂1, 篠原裕子2, 奥村隆司2, 中野道雄2, 小川充恵3, 小枝伸行3, 山崎肇3, 大里恭章4, 小竹武5, 村岡未彩1, 西野隆雄1, 平田收正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2018.
Japanese Article 24-12-O46-1. Specialist job cooperation education with the School of Nursing student that we conducted through a true case during pharmacy school Hospital training period
薄井健介1,2, 岡田浩司1,2, 紫桃裕造2, 上岡泰弘2, 渡辺善照1,2, 瀬戸初江3, 大塚眞理子4, 高橋知子1, 小嶋文良1, 吉村祐一1, 柴田信之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2018.
Japanese Article 24-12-O46-2. Significance - second report ... of the continuous new face training to conduct one year after accession
新井亘1, 増田裕一1, 矢嶋美樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2018.
Japanese Article 24-12-O46-3. Introduction - making and evaluation of the education material of the parenteral injection domain for new face pharmacists
亀田悠1, 稲秀士1, 山口紗緒里1, 荒畑和博1, 宮本拓也1, 鈴木智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2018.
Japanese Article 24-12-O46-4. Development of the standard education model for pharmacist upbringing to take mild medical care on
山田真裕1, 内田まやこ2, 葉田昌生3, 因間大悟4, 有吉俊二4, 青木和子4, 井上章治4, 島添隆雄4,5, 満生清士4, 原口亨4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2018.
Japanese Article 24-12-O46-5. Attempt ... for the purpose of practice of the 2-day hospital practice training for health insurance pharmacy pharmacists and the promotion of evaluation - community medical care cooperation
炭昌樹1, 長谷川千晶1, 森井博朗1, 星野伸夫1, 奥貫裕美1, 金本賢枝1, 堀江美弥1, 岡本陽香1, 藪田直希1, 松田雅史1, 神谷貴樹1, 須藤正朝1, 増田恭子1, 宮口美由紀1, 岩下由梨2, 松田佳織2, 本岡芳子2, 平大樹1,3, 森田真也1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2018.
Japanese Article 24-13-O47-1. Effect of the taking Abiraterone timing in the onset of liver damage
守田和憲1, 徳永晃己1, 北岡朋子1, 山下愛子1, 田上治美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2018.
Japanese Article 24-13-O47-2. Examination about proteinuria in the progress recurrent gastric cancer ramucirumab treatment
藤井千賀1, 柳下祐貴子1, 鶴島克将1, 小川直希1, 木村豊2, 間狩洋一3, 三上城太3, 安井友佳子1, 石坂敏彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2018.
Japanese Article 24-13-O47-3. Examination of the onset factor of the venous thromboembolism in patients with ovarian cancer given adjuvant chemotherapy after the operation
佐藤雄己1, 鈴木芳1, 中原良介1, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2018.
Japanese Article 24-13-O47-4. Multicenter observational, prospective study about retching, vomiting in the non-extensive emetic antitumor agents combination therapy
杉浦央1, 有賀久晃2, 斎藤由起子1, 鎌田恵子3, 瀬川満3, 辻俊輔4, 松岡佳吾5, 石井裕人6, 辻康秀3, 坂田幸雄2, 小林道也7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2018.
Japanese Article 24-13-O47-5. Examination about blood poison characteristics of the Carboplatin + etoposide combination therapy in the decreased renal function patients and the tolerability
高木淳平1, 奈良克彦1, 大野能之1, 永徳孝介1, 鹿毛秀宣2, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2018.
Japanese Article 24-13-O48-1. Examination about the oxaliplatin readministration using the high-dose dexamethasone regimen for oxaliplatin hypersensitivity in patients with colon cancer
金子明日美1,2, 洞澤智至2, 小谷大輔2, 坂東英明2, 中嶌明香1, 吉野孝之2, 川崎敏克1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2018.
Japanese Article 24-13-O48-2. About the allergic expression situation with the oxaliplatin-containing regimen and the usefulness of the measures regimen
原田桂作1,2,3, 鴨志田武4, 山内健太郎1, 末吉宏成1,2, 福永聡5, 野口純也2,6, 上原智仁2,6, 山吉隆友2,6, 村本眞由美1, 篠道弘4, 木戸川秀生2,6, 名倉弘哲3, 岡本好司2,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2018.
Japanese Article 24-13-O48-3. Association between decreased renal function and side effect expression in patients with colon cancer received oxaliplatin
渡辺大地1, 藤井宏典1, 山田友奈美1, 松橋延壽2, 高橋孝夫2, 吉田和弘2, 鈴木昭夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2018.
Japanese Article 24-13-O48-4. Inspection of the pyrogenic neutropenic prediction by the AUC estimate of the docetaxel
槙原克也1, 内山ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2018.
Japanese Article 24-13-O48-5. Examination of the predictor of myelosuppression of S-1
平井利典1, 山賀亮佑1, 伊東俊雅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2018.
Japanese Article 24-13-O49-1. Examination of the onset of eruption predictor by various test value before the checkpoint inhibitor administration of immunity
井上誠二1, 大澤友裕1, 梅田道1, 甲田明英1, 堀晃代1, 田中和秀1, 安田昌宏1, 水井貴詞1, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2018.
Japanese Article 24-13-O49-2. Relative examination of dry skin and the horny cell layer ceramide level by the Erlotinib remedy
冨士野ひより1, 内野智信1, 宮嵜靖則1, 神谷大地1, 鈴木誠規1, 水野初2, 轟木堅一郎2, 白井敏博3, 朝田和博3, 八木宏明4, 佐野悠子4, 森木睦4, 木村緑5, 賀川義之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2018.
Japanese Article 24-13-O49-3. Comparison according to the radiation field of thrombocytopenia frequencies after the G-CSF preparation administration in patients who received chemoradiotherapy
尾関智子1, 今井一博2, 南谷佳弘2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2018.
Japanese Article 24-13-O49-4. Study on association of a side effect of wPTX + Rmab therapy and total bilirubin levels
奈良克彦1, 山本武人1,2, 高田龍平1, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2018.
Japanese Article 24-13-O49-5. Study about the usefulness of the patients treatment diary in the side effect evaluation of the treatment with anticancer agent
實川東洋1, 中田千博1, 下川陽子1, 澤山絢子1, 廣永和也1, 三上麻衣2, 高市直子2, 瀬谷知子3, 横瀬紀夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2018.
Japanese Article 24-13-O50-1. The effectiveness and safety of the EGFR tyrosine kinase inhibitor
濱武清範1, 小西史子1, 美和孝之1, 松本弘誠1, 中西輝1, 酒井ちひろ1, 野間敏也1, 足立那々緒1, 後藤仁美1, 仲忠士1, 小島一晃1, 北英夫2, 菅理晴3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2018.
Japanese Article 24-13-O50-2. Safe examination of the cisplatin weight loss method for the decreased renal function patients
河野光1, 龍島靖明1, 荒井将至2, 内田康光2, 金井邦光2, 門間哲雄2, 高橋邦雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2018.
Japanese Article 24-13-O50-3. How do you choose new anticancer agent + lenalidomide dexamethasone combination regimen for the multiple myeloma?
小島一晃1, 濱武清範1, 小西史子1, 中西輝1, 松本弘誠1, 奥村優介1, 山村裕佳子1, 梶美里1, 酒井ちひろ1, 野間敏也1, 仲忠士1, 美和孝之1, 安斎尚之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2018.
Japanese Article 24-13-O50-4. Use fact-finding of Talaporfin sodium in the primary malignant brain tumor
外賀真佑美1, 浜田幸宏1, 丸山隆志2, 寺島華江2, 都築俊介2, 齋藤太一2, 新田雅之2, 村垣善浩2, 川俣貴一2, 木村利美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2018.
Japanese Article 24-13-O50-5. Examination about the factor that CD34-positive cells of the number of the aims cannot gather in the peripheral blood stem cell transplantation
大畑紘一1,2, 加藤寛子1, 山内智世1, 小林亮1, 松本拓郎2, 中村信彦2, 北川順一2, 兼村信宏2, 清水雅仁2, 鈴木昭夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2018.
Japanese Article 24-13-O51-1. Unresectable progress, examination about the effect that an event of the bevacizumab-induced elevated blood pressure gives the prognostic difference of right and left of the primary tumor in recurrent colon cancer
梅原健吾1, 高田慎也2, 高田寛奈1, 若本あずさ1, 佐川保3, 橋下浩紀2, 遠藤雅之2, 初山多恵1, 佐藤秀紀4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2018.
Japanese Article 24-13-O51-2. Examination (multicenter fact-finding) second report for the commonization of the confirmation item of the pharmacist in the cancer medical therapy regimen
小沼大祐1, 太田貴洋2, 鈴木真也2, 篠原旭2, 植木大介3, 大橋養賢4, 龍島靖明5, 宇田川涼子6, 吉野名穂子2, 川崎敏克2, 山口正和6, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2018.
Japanese Article 24-13-O51-3. Usefulness of CARG SCORE in the adjuvant chemotherapy of the elderly people breast cancer
佐々木俊則1, 小暮俊明1, 水谷三浩2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2018.
Japanese Article 24-13-O51-4. Investigation of the use situation of the Lenvatinib for the unresectable hepatocellular carcinoma
佐久間大樹1, 若月淳一郎1, 松本香織1, 花輪和己1, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2018.
Japanese Article 24-13-O51-5. Effect of the mTOR genetic polymorphism giving it to maintenance doses and a quantity of internal exposure of the Everolimus
加賀谷英彰1, 井上高光2, 齋藤満2, 沼倉一幸2, 羽渕友則2, 佐藤滋3, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2018.
Japanese Article 24-13-O52-1. Evaluation after the anticancer agent preparation robot introduction in the Matsue Municipal Hospital
今井孝1, 佐伯由美子1, 酒井牧子1, 河野通盛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2018.
Japanese Article 24-13-O52-2. Efforts to the anticancer agent exposure measures introduction in the angiography room
佐々木紀彰1, 唯間和博2, 安部奈央1, 古岡真菜1, 古元俊徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2018.
Japanese Article 24-13-O52-3. Safety cabinet in the anticancer agent preparation using the chemosafe, personal protector, infusion solution bag, exposure investigation about the coinfusion Exit cap
渡邊裕之1, 宮本拓2, 梅田瞳1, 三上知佳1, 木村錦子1, 松本公佑1, 藤金永美1, 治田匡平1, 神野正敏3, 杉山幸正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2018.
Japanese Article 24-13-O52-4. Examination of the introduction of the closed system anesthesia connection appliance in the request for consumption of the bevacizumab preparation
中村暢彦1, 楠本正明1, 中嶋江美2, 木下里紗2, 岡田知子2, 森田直2, 谷本祐子2, 小林政彦2, 矢野義孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2018.
Japanese Article 24-14-O53-1. Efforts to dentistry internal use antimicrobial proper use in the Sapporo Tokushukai Hospital
星貴薫1, 宮越貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2018.
Japanese Article 24-14-O53-2. The examination of the risk factor of epidemiology and the 30th death of the bloodstream infection: University hospital single institution retrospective study
服部はるか1,2, 前田真之1, 長友安弘3, 詫間隆博3, 二木芳人3, 内藤結花2, 佐々木忠徳2, 石野敬子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2018.
Japanese Article 24-14-O53-3. Change of the Antimicrobial Stewardship activity of the Hiroshima City Funairi municipal hospital and the oral antimicrobial prescription in pediatric outpatients
田中和行1, 綾部ゆか1, 政本伸二2, 渡辺美和1, 松原啓太3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2018.
Japanese Article 24-14-O53-4. About AST activity by the cooperation with an ICT pharmacist and the microorganism test engineer
宮崎浩光1,2, 小池祐史2, 櫻田玲子2, 長谷川功1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2018.
Japanese Article 24-14-O53-5. 1 case that experienced false extension of the APTT with aminoglycoside drugs in the ECMO management patients
長原新太郎1, 坂野博之1, 平井瑞希1, 三浦義彦1, 伊勢雄也1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2018.
Japanese Article 24-14-O54-1. Effect of the carbapenem-based antimicrobial proper use patients support intervention round that ICT conducted
小林謙一1, 丸山智幸1, 西堀武明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2018.
Japanese Article 24-14-O54-2. AS activity ... which adult oral third generation cephem adoption cancellation - green hospital (99 beds) started
酒向聡子1,4, 亀山聡美1,4, 今西正人1,4, 太田淳2,4, 森逸治3,4, 岩井雄司2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2018.
Japanese Article 24-14-O54-3. A problem and the future prospects that we were able to see in 1 year after AST setup
石塚友一1, 本田勝亮1, 武地大維2, 渥美位知子1, 釋悦子3, 石原冬馬3, 安間有希4, 齊藤一仁2, 渡邊卓哉2, 矢部勝茂1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2018.
Japanese Article 24-14-O54-4. Examination about antimicrobial proper use support team (AST) and the activity contents
池谷修1, 上蓑義典1,2, 高野八百子1, 石川春樹1,3, 宇野俊介1, 新庄正宜1,4, 荒美幸1,2, 長谷川直樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2018.
Japanese Article 24-14-O54-5. Efforts of Shizuoka drug resistant bacterium control team - Antibiotic Awareness, Shizuoka -
望月敬浩1,12, 倉井華子2,12, 荘司貴代3,12, 本康宗信4,12, 田中敏博5,12, 日馬由貴6,12, 神戸宏憲7,12, 更谷和真8,12, 滝久司9,12, 土屋憲10,12, 後藤幹生11,12, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2018.
Japanese Article 24-14-O55-1. Individual differences factor of blood behavior of the isolation form daptomycin that paid its attention to a bond change of the serum albumin in patients with MRSA infection
宮寺友香里1, 内藤隆文1, 山田尚広1, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2018.
Japanese Article 24-14-O55-2. Clinical analysis of PK/PD parameter target value about the effectiveness, the safety of vancomycin
伊地知由樹1, 佐古兼一1, 伊賀正典2, 高野温志2, 町田充2, 猪川和朗1, 千代谷大志1, 藤掛佳男1, 松田佳和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2018.
Japanese Article 24-14-O55-3. Examination of the optimal vancomycin initial blood level in patients with blood disorder in consideration of the effectiveness and safety
岡田直人1, 中馬真幸2, 座間味義人1,3, 今西正樹1, 武智研志2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2018.
Japanese Article 24-14-O55-4. It is a 1 case receiving vancomycin for patients with sepsis during the sustained resistance haemodialysis (SLED) enforcement
安達昂一郎1, 吉水浩史1, 白井祐也1, 小田亮介1, 中野一也1, 池上洋平1, 山下大輔1, 粉川俊則1, 本田芳久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2018.
Japanese Article 24-14-O55-5. Intervention effect on loading dose of the Teicoplanin by the ward permanent residence pharmacist
水岡大策1, 山口佳津騎1, 元木貴大1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2018.
Japanese Article 24-14-O56-1. Usefulness of the vancomycin nomogram in the Augmented renal clearance expression patients
杉山恭平1, 石井英俊1,2, 平井啓太2, 中谷英仁3,4, 伊藤邦彦2, 木村緑1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2018.
Japanese Article 24-14-O56-2. Examination of the search of the population pharmacokinetics model of the meropenem in Augmented renal clearance and the optimal administration plan
玉造竜郎1, 大林真幸1, 佐々木杏理1, 神山紀子1, 小林靖奈2, 山元俊憲3, 福田賢一郎4, 中村俊介5, 三宅康史6, 土肥謙二4, 向後麻里1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2018.
Japanese Article 24-14-O56-3. Factor about initial blood level after the Teicoplanin loading dose enforcement
檜山洋子1, 片岡達夫1, 冨田隆志1, 宮本佳奈1, 垰越崇範1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2018.
Japanese Article 24-14-O56-4. Examination about the combination reversibility after the vancomycin tissue cells combination
岩崎也奈1, 山田智之2, 大畑彩也香1, 山田整司1, 椋木菫1, 浦嶋庸子1, 廣谷芳彦1, 池田賢二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2018.
Japanese Article 24-14-O56-5. It is the difference in cefotaxime cerebral fluid shift by the indwelling drain part after the subarachnoid hemorrhage technique
近藤匡慶1, 高島勇基2, 長野槙彦1, 柴田あみ4, 工藤小織3, 金子純也3, 佐藤慎3, 北原章子3, 田上隆3, 久野将宗3, 畝本恭子3, 菅谷量俊1, 花田和彦2, 高瀬久光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2018.
Japanese Article 24-14-O57-1. The doubt inquiry rate of use investigation about the clinical test value from the health insurance pharmacy
山崎香織1, 横山威一郎1, 山口洪樹1, 齊藤美聡1, 新井さやか1, 中村貴子1, 鈴木貴明1, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2018.
Japanese Article 24-14-O57-2. Efforts to outside Parliament prescription doubt inquiry simplification
富施哲也1, 須賀宏之1, 麻生一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2018.
Japanese Article 24-14-O57-3. Questionary survey about the efforts about the information sharing of impaired renal function and the glaucoma using a prescription notebook cover
尾崎誠一1,2, 廣子真大2, 中村嘉孝2, 河田尚己2, 渡辺宗男2, 松久哲章2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2018.
Japanese Article 24-14-O57-4. Analysis ... of the prescription suggestion by effect - pharmacist whom the medication reporting book to the physician by the drugstore pharmacist gives to drug proper use
郡司清志1, 木原太郎1, 小柳香織1, 金子絵里奈1, 林田諭1, 吉井瞳1, 鶴田達也1, 朝原寛子1, 川浪望恵2, 都築加奈2, 高山浩太郎2, 高木淳一1, 小林大介2, 窪田敏夫3, 島添隆雄2, 田中泰三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2018.
Japanese Article 24-14-O57-5. Approach for the qualitative improvement of the interactive tracing report in the treatment with oral anticancer agent
川勝勇樹1, 長谷川晃司1, 関奈緒子1, 春名康裕1, 東碧1, 武田智子1, 和田淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2018.
Japanese Article 24-14-O58-1. Efforts of the medicine decreasing by it to the NSAIDs chronic administration patients by the drugstore pharmacist who collaborated with a physician
高橋祐介1, 水野千里1, 笠原のぞみ1, 金澤香里1, 駒形美結1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2018.
Japanese Article 24-14-O58-2. Practice inspection of the continuous locomotive syndrome prophylactic activity to be carried out at a drugstore
山口京子1, 鈴木匡2, 小嶋雅代3, 浅井治行4, 大竹芳房5, 中尾理香6, 永田隼也7, 堀場亜佐子8, 松波晋平9, 菊池千草2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2018.
Japanese Article 24-14-O58-3. Collection and analysis of the information on adverse drug reactions in the health insurance pharmacy
矢野脩一朗1,2, 山本巌1, 新雪乃1, 青木淳子2, 佐藤弘希3, 岡山善郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2018.
Japanese Article 24-14-O58-4. It is ... around Residual medicine fact-finding - psychiatry domain by four person (pharmacist society, medical association, university, administration) cooperation
加藤剛1,2,5,6, 大塚正征2,5, 斉藤祐次2,5, 安達秀夫2,5, 赤津拓彦3,5, 酒見文人3,5, 三浦省吾3,5, 菅野敦之4,5, 赤沢学4,5, 鈴木順子6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2018.
Japanese Article 24-15-O59-1. How can you increase the prescription suggestion number?
西川隆一1, 荒木寛也1, 坂柳悦章1, 澤柳直樹1, 藤井友和1, 永田治1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2018.
Japanese Article 24-15-O59-2. It is investigated the bone fracture risk using the patients information in the initial interview at hospitalization
江藤祥子1, 久保みさき1, 戸邊隆夫1,2, 戸田貴洋1, 林高弘1,2, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2018.
Japanese Article 24-15-O59-3. The effect that the intervention by the pharmacist gives to the incidence of nausea post-operative vomiting and the prophylaxis decision of the anesthesiologist
猪狩賢蔵1, 鈴木信也1, 外園弥生1, 関博志2, 志熊亜美1, 野村嘉奈子1, 吉田蘭子1, 伊藤智一1, 荒瀬透3, 林誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2018.
Japanese Article 24-15-O59-4. Approach - to improvement in medication adherence by effect - pharmacist whom the medication self-care in the psychopathic ward gives in medication adherence
坂東寛1, 武智研志3, 今西正樹1, 中馬真幸3, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2018.
Japanese Article 24-15-O59-5. Examination of the usefulness of the pharmacist-led psychiatry measures team in the convalescent rehabilitation ward
加藤豊範1, 吉田章悟1, 鈴木絢子1, 町田祐実子1, 小田高司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2018.
Japanese Article 24-15-O60-1. Role of the pharmacist for the pharmaceutical products management in the Aichi Medical University Hospital operating room
野村知世1, 野々垣知行1, 前仲亮宏1, 林良亮1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2018.
Japanese Article 24-15-O60-2. We look at the rear of the treatment with extensive critical care center charge pharmacist intervention effect and examine a mark
三浦義彦1, 礒江雄人1, 坂野博之1, 長原新太郎1, 久保村優1, 平井瑞希1, 岡本早織1, 植竹将1, 風間彩1, 伊勢雄也1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2018.
Japanese Article 24-15-O60-3. Risk of developing hypophosphatemia associated with Refeeding Syndrome in the intensive care domain and search of the effect factor
中川貴弘1, 泉野浩生2, 小野恵2, 北庄司敦久1, 西井拓人1, 若林里絵1, 森朝紀文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2018.
Japanese Article 24-15-O60-4. An example of the collaboration serious case cellulitis with the ER doc in the initial treatment room
佐野邦明1, 高木雄一1, 松本富夫1, 杉木大輔2, 松島久雄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2018.
Japanese Article 24-15-O60-5. The analysis of the risk factor of the delirium generating after the cardiovascular surgery surgery and evaluation of the usefulness of the delirium check sheet
西村文宏1, 牛島智子1, 梅田景子2, 三嶋あかね2, 杉野由起子2, 宮村重幸3, 工藤未来4, 鬼木健太郎4, 猿渡淳二4, 柳茂樹5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2018.
Japanese Article 24-15-O61-1. Examination of the risk factor of the onset of acute renal failure by the levetiracetam
西田麻以1, 長尾由佳1, 大熊沙代子1, 奥田敏勝1, 赤木晋介1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2018.
Japanese Article 24-15-O61-2. One case that there were no allergic symptoms in vancomycin during treatment, but resulted in an anaphylactoid symptom just after a change to Teicoplanin
中山裕一1, 山口寛和2, 檜山紀子2, 松本順2, 竹島英之3, 田中昌代1, 加藤敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2018.
Japanese Article 24-15-O61-3. The adult cirrhosis case that hyperammonemia improved by pivoxil group-containing antimicrobial cancellation
吉野走1, 山根理恵子1, 佐道紳一1, 本吉康英2, 市川辰樹2, 樋口則英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2018.
Japanese Article 24-15-O61-4. Investigation about the onset of eruption in patients receiving lenalidomide
松尾彩音1, 田久保慎吾2, 飯田洋子2, 鈴木健太2, 田中邦佳2, 柳井美奈2, 吉原哲3, 吉原享子3, 木村健2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2018.
Japanese Article 24-15-O61-5. Examination ... from a bleeding case during use of ... heparin Ca for choosing wisely of the DVT prevention in the internal medicine domain
榎本貴一1,4, 舘林和樹1, 小坂鎮太郎2,4, 木村泰3,4, 福永貴志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2018.
Japanese Article 24-15-O62-1. Rearward investigation about the dermatopathy risk reduction effect by the low-dose introduction of the lamotrigine
森田陽介1, 渡邉享平1,2, 斎木明子1, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2018.
Japanese Article 24-15-O62-2. Efforts for a change and the adverse event evasion of the sleeplessness indicator in the orthopedics ward
江草徳幸1, 丸谷佳代1, 安原昌子1, 堀川俊二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2018.
Japanese Article 24-15-O62-3. Search of hypoglycemic frequency by Sulfamethoxazole - Trimethoprim and the risk factor
森田直1, 岡本賢一2, 吉野秀紀1, 松平有加2, 木下理紗1, 井上知美2, 石渡俊二2, 北小路学2, 大鳥徹2, 小竹武2, 小林政彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2018.
Japanese Article 24-15-O62-4. One case that seemed to present hyponatremia by lansoprazole remedy
光崎亜弥1, 川井悦嗣1, 三輪耕次1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2018.
Japanese Article 24-15-O62-5. Investigation about the hypokalemia due to beta 2 receptor stimulation inhalant
山崎彬史1, 濱宏仁1, 中浴伸二1, 森本茂文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2018.
Japanese Article 24-15-O63-1. The use trend of the new antiepileptic drug and examination about side effect expression
真鍋健一1, 西田初博1, 甲斐真理子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2018.
Japanese Article 24-15-O63-2. Questionary survey about BRONJ for a dentist and the pharmacist
佐藤一求1, 江草徳幸1, 安原昌子1, 堀川俊二1, 伊藤翼2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2018.
Japanese Article 24-15-O63-3. An example of patients with sickle cell disease that showed withdrawal symptoms of the opioid
新江裕貴1, 生駒忠史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2018.
Japanese Article 24-15-O63-5. Examination of the inhibitory effect for opioid-induced retching of the naldemedine
志田敏宏1,3, 田中総一郎1, 細谷順1, 山川真由美2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2018.
Japanese Article 24-15-O64-2. Examination ... of the usefulness in efforts ... multi-type of job cooperation of the oral anticancer agent at-home medication management system introduction utilizing the ICT and the foreign cancer instruction to patient
久田真規子1, 桑田直樹1, 河野葵1, 村田充弘1, 秦真由美2, 広田将司3, 長瀬博次3, 川瀬朋乃3,4, 今村博司3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2018.
Japanese Article 24-15-O64-3. The example that we intervened in the examination of the prescription menu for a discharge from all over the hospitalization, and we used it, and a visit pharmacist enabled home medical treatment three pumps
中村薫1, 川崎博行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2018.
Japanese Article 24-15-O64-4. Efforts to questionary survey and education about the effect on fecundity with the anticancer agent
日野亜莉沙1, 土屋裕伴1, 国吉央城1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2018.
Japanese Article 24-15-O64-5. Examination about the proper use of the renal excretion type anticancer agent by the making of in-hospital standard criteria
中島誠1,2, 新上香奈子1, 三浦ひとみ3, 大迫政彦4, 林秀樹2,5, 杉山正2,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2018.
Japanese Article 25-5-O65-1. About usefulness of the pharmacist intervention in the on admission interview with the palliative care unit
長谷部千夏1, 兼松友紀1, 宮部芳之1, 塚原民夫1, 堀内正1, 伊藤浩明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2018.
Japanese Article 25-5-O65-2. The opioid analgesic gradual decrease situation investigation after the head and neck cancer RT-CDDP therapy
前勇太郎1, 竹野伸洋1, 三木真梨杏1, 長谷川聡子1, 鈴木亘1, 根本真記1, 鈴木賢一1, 渡邉大至1, 利安隆史2, 高橋俊二3, 濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2018.
Japanese Article 25-5-O65-3. Fact-finding of the patients that rescue is a high dose for an oxycodone daily dose
岩崎愛里1, 竹野伸洋1, 古谷良太1, 中山博文2, 鈴木賢一1, 濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2018.
Japanese Article 25-5-O65-4. Result of the improvement in mild medical knowledge of the pharmacist by the mild medical regional pharmacist training workshop (2017)
松本高広1,2, 金子健2, 熱海幸恵2, 上島健太郎2, 柏原由佳2, 岸田悦子2, 塚川麻利子2, 鳥越一宏2, 藤掛沙織2, 森理保2, 宮里明芽2, 山内由美子2, 和田紀子2, 片山志郎2, 鈴木勉2, 伊東俊雅2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2018.
Japanese Article 25-5-O65-5. Intervention effect by the medicine medicine cooperation using the mutual reporting book in the use of drug patients for the ambulatory care
山口文子1,2, 鈴木澪1,2, 佐々木美理1,2, 佐藤透1, 土井千春2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2018.
Japanese Article 25-5-O66-1. Making and evaluation of cancer chemotherapy support tool "gastrointestinal carcinoma Reference book" which can conjugate for normal business routine
伊藤文香1,2, 神谷幸江2, 兼子詩布2, 北川佳奈子2, 切畑麻那2, 嶋洋将2, 鈴木大介2, 竹内美緒2, 玉置彩奈2, 冨田庸介2, 丹村亜梨朱2, 丹羽侑理奈2, 伊藤夕貴2, 平松久典2, 鵜飼麻由2, 川合甲祐2, 岩田智樹2, 遠山幸男2, 山口智江2, 中根茂喜2, 山田清文1, 板倉由縁3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2018.
Japanese Article 25-5-O66-2. The current situation of the drug control in the chic day during the cancer chemotherapy enforcement and the future prospects
重田和也1, 奈良由里絵1, 花村菜月1, 後藤博1, 松本利恵1, 野田孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2018.
Japanese Article 25-5-O66-3. A relation and effect as the pharmacist to the safe treatment of the immune checkpoint inhibitor
内山将伸1, 井上貴文1, 松尾宏一1, 平野公一2, 前川隆文2, 宮崎元康1, 今給黎修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2018.
Japanese Article 25-5-O66-4. Rearward controlled trial of the intervention effect by Oncology Pharmacist and non-Oncology Pharmacist in the foreign cancer chemotherapy
嘉屋道裕1, 中村和代1, 永峰槙子1, 須山由佳子1, 中條倫成1, 内田亮1, 萩倉翔1, 神田藍1, 杉山恭平1, 杉山理奈1, 中垣繁1, 木村緑1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2018.
Japanese Article 25-5-O66-5. Relation ... to proteinuria in the medical treatment management (PBPM) - VEGF inhibitor based on the protocol in the foreign chemotherapy center
佐分利美帆子1, 本多信二1, 内藤舞1, 三松史野1, 目黒裕史1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2018.
Japanese Article 25-9-O67-1. The construction of the doubt inquiry information sharing system and the utilization report
古野孝明1, 万徳真子1, 吉國淑子1, 平田直奈1, 中川和成1, 田中皓正1, 太田絵莉1, 山平和博1, 黒飛謙次1, 藤川亜衣1, 川根良太1, 富田哲夫1, 川原邦仁1, 川口健1, 出口明日香1, 半田寛1, 今井圭介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2018.
Japanese Article 25-9-O67-2. Examination about the association between use and glaucoma development of statin using receipt data
岩橋麗羅1, 野上暁子1, 田代結女1, 寺田柚花1, 木内智美1, 福岡憲泰1, 大場延浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2018.
Japanese Article 25-9-O67-3. Usefulness evaluation of the side effect of pharmaceutical products uniform management system which we built in the middle scale hospital
安島秀友1, 松崎貴志1, 澤藤園子2, 有木宏宗2, 田中恒明2, 横山美恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2018.
Japanese Article 25-9-O67-4. 80% of drugstore pharmacists have trouble with acquisition, an evaluation, inflection of the drug information
惠谷誠司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2018.
Japanese Article 25-9-O67-5. Fact-finding of the patients drug allergy registration in the electronic medical chart system
瀬戸良教1, 坂倉智子1, 菅原充広1, 近藤留美子1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2018.
Japanese Article 25-9-O68-1. Examination of the side effect expression of Shakuyakukanzoto situation using adverse event spontaneous report database (JADER)
野々垣知行1, 宇野英理子1, 深谷さおり1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2018.
Japanese Article 25-9-O68-2. Study on onset of progressive multifocal leukoencephalopathy situation using FDA Adverse Event Reporting System
鈴木剛史1, 矢島功1, 相澤雄介1, 南真進1, 井上博章1, 小杉隆祥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2018.
Japanese Article 25-9-O68-3. Search of the new kidney protective utilizing real world big data
堀ノ内裕也1, 池田康将1, 福島圭穣2, 濱野裕章3, 今西正樹3, 石澤有紀1, 座間味義人3,4, 武智研志5, 藤野裕道2, 石澤啓介3,4, 土屋浩一郎6, 玉置俊晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2018.
Japanese Article 25-9-O68-5. As for the receipt information, specific medical examination, and the like, it is epidemiologic studies about the domestic use situation of the palonosetron hydrochloride using information database (NDB) opening data
岡田浩司1,2, 薄井健介1,2, 菊池大輔2, 高橋将典2, 渡辺善照1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2018.
Japanese Article 25-10-O69-1. Work-style reform of the pharmacist using quantity of duties investigation
和泉早智子1, 加藤遥平1, 千崎可奈子1, 中脇誠一1, 長谷川美栄子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2018.
Japanese Article 25-10-O69-2. Efforts for the drug global assessment adjustment addition calculation
西迫多重1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2018.
Japanese Article 25-10-O69-3. Efforts to the polypharmacy by the ward pharmacist
村上翔梧1, 境泰樹1, 佐古守人1, 黒沢秀夫1, 芳竹美帆1, 東珠美1, 板並優里1, 吉田綾子1, 野村剛久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2018.
Japanese Article 25-10-O69-4. Before and after handling study session of a drug, the psychotropic drug and three months later, a correct answer rate change of the issue of knowledge confirmation of the nurse six months later and inspection of the difference by the years of experience
菊地寛隆1, 鈴木真也1, 太田貴洋1, 久松大祐1, 竹野美沙樹1, 鎌田隼1, 上本剛1, 小室亜由美1, 五十嵐隆志1, 中嶌明香1, 松山千容1, 奥中真白1, 石黒太造1, 森下滉己1, 仁熊久美1, 原田まなみ1, 末永亘1, 石原淑子1, 瀬戸裕美子1, 金子明日美1, 岩本義弘1, 山口正和2, 川崎敏克1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2018.
Japanese Article 25-10-O69-5. Management of the oral medicine with the administration cart in the ward which the bringing medicine included and the evaluation
加藤遥平1, 和泉早智子1, 中脇誠一1, 二井矢ひとみ2, 高橋都3, 長谷川美栄子4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2018.
Japanese Article 25-10-O70-1. Consideration to connect with pharmacist duties foreign than the examination of the SGLT2 inhibitor remedy cancellation patients
久保田厚子1, 塚原邦浩1, 居塚しのぶ1, 竹村有美1, 小倉秀美1, 野田薫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2018.
Japanese Article 25-10-O70-2. Examination about the medication situation's confirmation and cancellation, continuation instruction before hospitalization of the pharmacist in the perioperative care team
森泰子1, 野村直幸1, 平見明浩1, 小山朋子1, 中村孝佑1, 山本淳平1, 板野亨1, 相良義弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2018.
Japanese Article 25-10-O70-4. The case that there was a request for outpatient oneself decrease medicine, and suggested drug adjustment
若松雄太1, 杉生雅和1, 高子優子1, 長尾彰太1, 石津智司1, 吉岡睦展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2018.
Japanese Article 25-10-O70-5. New efforts of the pharmacist duties in the foreign general support center
上嶋和代1, 北原加奈之1,2, 金正興1, 杉田栄樹1,2, 鈴木康介1,2, 玉造竜郎1,2, 若林仁美1,2, 清水久範1,2, 白井敦1, 佐々木忠徳1,2, 桑原靖子3, 樋口比登実4, 小田原良子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2018.
Japanese Article 25-12-O71-1. Establishment and clinical application of the assay of cefotaxime plasma and in cerebrospinal fluid and the active metabolite
高島勇基1, 近藤匡慶2, 長野槙彦2, 柴田あみ4, 工藤小織3, 金子純也3, 佐藤慎3, 北橋章子3, 田上隆3, 畝本恭子3, 高瀬久光2, 花田和彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2018.
Japanese Article 25-12-O71-2. Drug population pharmacokinetics analysis of the Teicoplanin in neonates, infants and comparison between actual value and estimate
宮川泰宏1, 岸里奈1, 永井拓1, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2018.
Japanese Article 25-12-O71-3. About vancomycin initial administration plan and the intervention effect of the pharmacist on examination of blood culture-positive patients
町田聖治1, 宮崎博章2, 大井慈文3, 山下恵美2, 戸根智和2, 福島将友1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2018.
Japanese Article 25-12-O71-4. Examination about the dose setting in consideration of renal function of vancomycin in the NICU
西條純1, 鈴木英二1, 藤原香織1, 堀勝幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2018.
Japanese Article 25-12-O71-5. Examination of optimum doses of vancomycin in continuous hemodialysis enforcement children
小林翼1, 佐々木剛1, 高辻未来1, 福島優美1, 山崎直樹1, 森宏幸1, 笠松悠2, 白野倫徳2, 後藤哲志2, 村田みどり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2018.
Japanese Article 25-12-O72-1. About the effect that obesity-related genetic screening brings a citizen
池田佳代1, 細井徹1, 三浦常代2, 春日真由3, 高畑真由子3, 龍春花2, 幾田美紀2, 谷口智昭2, 天崎あゆみ2, 吉井美智子1, 杉山政則4, 大谷純一2, 若生あき3, 小澤光一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2018.
Japanese Article 25-12-O72-2. Making and evaluation of the information sheet to alert for pharmaceutical products proper use by the analysis of administrative data
永田健一郎1, 村岡香代子1, 石田茂1, 齊藤麻美1, 辻敏和1, 渡邊裕之1, 金谷朗子1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2018.
Japanese Article 25-12-O72-3. Comparison between analysis and true clinical practice ... that is robust of "The Paper Surgeon" - clinical article
鳥居良太1, 内藤雅人1, 下雅意彩1, 竹村敏也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2018.
Japanese Article 25-12-O72-4. Relations with the Residual medicine generating situation of the antiHIV medicine and the cognitive function
合原嘉寿1,2,3, 大石裕樹1,2,3, 辻麻理子2,3, 西脇香4, 福田雪絵4, 古田加菜恵4, 三浦真貴子4, 浦上秀刀4, 加留部信介5, 山本政弘2,3,6, 西野隆1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2018.
Japanese Article 25-12-O72-5. Pharmacy clinical studies to experience the course of the development of the medicine
中谷友香1, 金岩未紗1, 西村美和1, 杉澤湖希1, 恒岡麗華1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2018.
Japanese Article P0001-23-PM. Effect on water content by the illegally parked condition of the ketoprofen poultice
山本佳久1, 星加織1, 神原澪奈1, 山内理恵2, 大野修司2, 浅井和範2, 深水啓朗3, 小出達夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2018.
Japanese Article P0003-23-PM. The study on eye irritation-related prediction of commercial eye drops: The in vitro eye irritation study that assumed a pH change an index
長井紀章1, 本多公貴1, 大竹裕子1, 岡本紀夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2018.
Japanese Article P0005-23-PM. Making of in-hospital guidelines about an infusion filter in our hospital and the administration route
二村哲未1, 岡崎敬之介1,2, 中山泰葉1,2, 嶋崎真耶1,2, 中野裕佳子1,2, 阿部誠治1,4, 城所扶美子3, 佐々木忠徳1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2018.
Japanese Article P0007-23-PM. The effect that mixed formulations give to the skin permeability of a characteristic of the salicylic acid vaseline ointment and the principal ingredient
宍戸康剛1, 湯谷玲子1, 寺岡麗子1,2, 坂根稔康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2018.
Japanese Article P0009-23-PM. Photodegradation ... of color change - bromocriptine of Parlodel tablets by the difference in lighting
山下修司1,2, 井口和弘2,3, 野口義紘2,4, 堺千紘2,3, 玉木啓文2,3, 伊野陽子2,3, 林秀樹1, 寺町ひとみ2,4, 酒向孫市5, 杉山正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2018.
Japanese Article P0011-23-PM. Quality fact-finding of the do-it-yourself importing metformin preparation
Shu Zhu1, 吉田直子1, 松下良2, 木村和子3, 坪井宏仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2018.
Japanese Article P0002-24-AM. About the stability comparison for the one for TERAL vicine injection and the Pinorubin injection
岩根裕紀1,2, 小林由佳1,2, 成橋和正2, 杉浦伸一2, 中西弘和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2018.
Japanese Article P0004-24-AM. Factorial experiments about the filter obstruction at the liquid antibody preparation administration
矢田部恵1, 小川千晶1,3, 井上元基2, 長山佳之1, 五味緩子1, 中舘和彦2, 足立茂2, 伊藤智夫3, 谷地豊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2018.
Japanese Article P0006-24-AM. Stability of the dexamethasone in the hyperalimentation
久保儀忠1, 大森仁2, 戸口拓弥1, 柴山良彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2018.
Japanese Article P0008-24-AM. Effect of the storage temperature to give it to the rheology properties of the hydrozincite ointment and the mixed nature
加藤薫1, 湯谷玲子1, 寺岡麗子1,2, 坂根稔康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2018.
Japanese Article P0010-24-AM. A viscosity properties of matter change by the high temperature preservation of the tacrolimus ointment and effect on preparation uniformity
浜口雅史1, 藤井美佳2, 山本佳久3, 小出達夫4, 深見啓朗2, 林祥弘1, 大貫義則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2018.
Japanese Article P0016-24-AM. Duties improvement example by the analysis of a drug incident, the dispensing error
森田淳介1, 新木美枝1, 鈴木達宙1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2018.
Japanese Article P0018-24-AM. About the efforts of the inspection potentially serious medical errors example report and the measures
山田宜和1, 岩田真子1, 青柳和代2, 貝瀬眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2018.
Japanese Article P0020-24-AM. Efforts ... for safety management of construction, introduction - pharmaceutical products of the operational system of the system contraindicated to the name of disease
中川碧1, 上西幸治1, 炭昌樹1, 國津侑貴1, 星野伸夫1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2018.
Japanese Article P0022-24-AM. The sleeping drug remedy in the elderly people at the acute phase hospital by the case cross-over study and allied evaluation with the fall
小原智子1, 鳥井栄貴1, 安藤基純2, 冨田秀明3, 田中茉歩子1, 藤本一秀1, 清水るみ子1, 池末裕明3, 奥貞智3, 橋田亨3, 久米典昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2018.
Japanese Article P0024-24-AM. Fall rate investigation of the sleeping drug in the inpatient
磯崎僚1, 栗島彬1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2018.
Japanese Article P0026-24-AM. About the association with risk score and the use drug of the fall fall of the inpatient
藤盛真衣1, 藤松美希1, 高垣志保1, 室岡邦彦1, 中里祐二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2018.
Japanese Article P0028-24-AM. Examination about the number of the fall, the falls decrease in S zopiclone in the sleeplessness indicator
稲田佑亮1, 原青穂1, 津田尚始1, 夏目義明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2018.
Japanese Article P0030-24-AM. Relation of the pharmacist about the use drug at cardiac catheter ablation
井岡瑞樹子1, 福田裕子1, 道下佳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2018.
Japanese Article P0032-24-AM. Attempt ... of the improvement in understanding degree by the designation of understanding degree investigation second report - emphasis high risk medicine about the high-risk medicine
岡村吏華1, 吉井千菊1, 人見智香子1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1, 脇田真之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2018.
Japanese Article P0034-24-AM. Construction of the information management system of a specialist in nonrecognition newcomer medicine in our hospital and the contraindicated use patients out of the adaptation
丘龍祥1, 金野昇2, 富永綾2, 高橋信明2, 細谷順2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2018.
Japanese Article P0036-24-AM. Examination of the tool which is available for the foreign patients having difficulty in Japanese correspondence
掛札聡美1, 阿多郁子2, 池浦恵3, 入野真規子4, 森田直美5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2018.
Japanese Article P0017-23-PM. The evaluation of the administration management system from an incident report and improvement and measures
折戸融1, 沼田諒1, 梶原彩香1, 小野歩1, 阿部和恵1, 比毛有理子1, 石井勇太1, 片山潤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2018.
Japanese Article P0019-23-PM. It is reduced the number of formulations potentially serious medical errors by the use of calculation electronic calculator because we were suitable for calculation compounding of medicines
土屋貴之1, 佐藤淳也1, 川岸佐和子1, 鈴木恵子1, 望月敬浩1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2018.
Japanese Article P0021-23-PM. Examination of the effect that a background color gives to the discrimination of the tablet in formulations one package
岩佐昌広1, 横田秀一1, 矢野忠1, 八木圭太2, 市川訓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2018.
Japanese Article P0023-23-PM. A fall, the fall in the hospital inpatient basic for acute phase and relations of the drug
西村健二1, 亀井健人1, 赤木晋介1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2018.
Japanese Article P0025-23-PM. A fall fall is examined by remedy medicine
田中善子1, 木下宏美1, 兼島恭子1, 寺田さやか1, 松濱志保里1, 谷崎百合子1, 西崎翔太1, 西海理絵1, 丁子江利1, 山下ゆみ2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2018.
Japanese Article P0027-23-PM. Effect on fall, fall with the sleeping drug
角田健1, 小室治孝1, 喜古康博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2018.
Japanese Article P0029-23-PM. Efforts ... to adequacy of the efforts - benzodiazepine drugs prescription to a fall, the fall prevention
金古成美1, 茂木秀敏1, 橋場弘武1, 酒井秀二1, 高玉真光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2018.
Japanese Article P0031-23-PM. Efforts for injectable potassium preparation administration wrong prevention
角井碧1, 中島恵子1, 村中好美2, 徳毛宏則2, 橋本佳浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2018.
Japanese Article P0033-23-PM. Quantification of the analogous change by the examination cutting apart of the appearance similarity of the PTP sheet
向井淳治1, 面谷幸子1, 初田泰敏1, 名徳倫明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2018.
Japanese Article P0035-23-PM. Contraindications use classification of medicine and efforts to management in inside the hospital
北山知里1, 上田彩1, 有木宏宗1, 坂上逸孝1, 井上莊一郎2, 長谷川泰弘3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2018.
Japanese Article P0037-23-PM. Relation to the allergic information of the pharmacist
鈴木拓磨1, 關基成1, 堀場圭1, 尾崎昌大1, 添田真司1, 渡邊昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2018.
Japanese Article P0038-24-AM. The effect that one package of carved seal tablets and both sides printing tablets gives to inspection duties efficiency
松元一明1, 大森栄2, 石井伊都子2,3, 川久保孝4, 神田博仁2, 鈴木貴明3, 横山威一郎3, 中澤一純5, 木津純子6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2018.
Japanese Article P0040-24-AM. A rose lock by the inspection system introduction at tablet automatic packeted plane filling pre-; the establishment of the inspection system to produce
山田倭花1, 内山乃映1, 中島のぞみ1, 上田奈緒美1, 大窪真理絵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2018.
Japanese Article P0042-24-AM. Pharmacist attitude survey ... for way - package formulations of the formulations which are new from anti-thing duties to interpersonal duties
近藤澄子1, 豊田彬1, 田中直哉2, 加藤誠一2, 寺戸靖2, 矢島毅彦3, 田中秀和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2018.
Japanese Article P0044-24-AM. About the current situation evaluation after efforts and the introduction for the simple suspension method introduction in our hospital
馬見新ちとせ2, 山内浩子1, 八木秀明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2018.
Japanese Article P0046-24-AM. Taste bitter inhibition evaluation of the drug with the γ-polyglutamate high mud gel using the taste sensor
小島穂菜美1, 市川聽奈1, 井上由梨1, 原口珠実1, 吉田都1, 内田享弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2018.
Japanese Article P0048-24-AM. Investigation of doubt inquiry accompanied with renal function test value mention to an injection prescription
関綾香1, 長岡匠1, 恩田寿美子1, 臼井悟1, 本田雅巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2018.
Japanese Article P0050-24-AM. Analysis of the doubt inquiry contents by test value mention to in the hospital and outside Parliament prescription
森河内彩1, 國津侑貴1, 平大樹1,2, 十亀裕子3, 増田恭子1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2018.
Japanese Article P0052-24-AM. Attitude survey (the second report) about the occupational exposure of the pharmacist at pharmaceutical products formulations
前田志津子1, 杉原数美1, 田山剛崇1, 三宅勝志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2018.
Japanese Article P0039-23-PM. Examination about the change of the injection drug withdrawal method (from a medicine bag division into four of trays) in our hospital
桶谷純子1, 佐々木利佳1, 畠山いずみ1, 堀田瑞絵1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2018.
Japanese Article P0041-23-PM. Construction of the formulations inspection system avoiding an amount mistake and pharmaceutical products mistake
後藤千寿1, 土田陽子1, 大野佑城1, 甲田明英1, 梅田道1, 水井貴詞1, 小林健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2018.
Japanese Article P0043-23-PM. Prospects ... of package formulations to see from way - data analysis of new formulations from anti-thing duties to interpersonal duties
田中直哉1, 豊田彬2, 町田匡俊2, 加藤誠一2, 寺戸靖2, 近藤澄子2, 矢島毅彦3, 田中秀和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2018.
Japanese Article P0045-23-PM. It is examined the drug indicating the alkalinity at simple suspension
中田一孝1, 冨田有香1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2018.
Japanese Article P0047-23-PM. Drug elution behavior when we suspended an unstable drug with magnesium oxide preparation for alkali temporarily
森雅俊1, 下山哲哉1, 伊藤邦彦1, 小林道也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2018.
Japanese Article P0049-23-PM. Effective evaluation of the alert indication to evade the mug Koror P administration to patients with severe impaired renal function
山本恭平1, 鶴田昌吾1, 岩瀬由枝1, 中村和行1, 伊藤友恵1, 大野愛1, 久保田敏行1, 杉浦洋二1, 勝見章男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2018.
Japanese Article P0051-23-PM. Construction and evaluation of the protocol according to the physician of doubt inquiry in the outside Parliament prescription
村井宗正1, 新妻由花1, 西村恵里子1, 阿藤友美2, 吉田遥香1, 林由紀子1, 本多秀俊1, 並木路広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2018.
Japanese Article P0053-23-PM. It is improved the drug loss rate by forming it the pulse eat of the levetiracetam crush
菅寛史1, 矢嶋隆宏1, 山本吉章1, 杉山尭紀1, 加藤浩充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2018.
Japanese Article P0054-24-AM. The manufacture of the hospital preparation "tacrolimus bougie" in our hospital and the evaluation
辻和美1, 濱野有里1, 小山朋子1, 相良義弘1, 佐藤英治2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2018.
Japanese Article P0056-24-AM. Design of the intraoral gelation solution using methylcellulose
石屋和浩1, 磯貝純1, 三上龍生1, 下山哲哉1, 伊藤邦彦1, 小林道也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2018.
Japanese Article P0058-24-AM. It is ... for the TPN adjustment that is clean for bioclean - 365 days in the culture 72 hours after the TPN no bacteria adjustment
外間健吾1, 奥野靖隆1, 妻鹿宏美1, 永田文恵1, 小西愛1, 近藤幸男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2018.
Japanese Article P0060-24-AM. Examination of new herbal medicinal products aiming at Chinese medicine remedy improvement
亀田愛華1, 杉山育美1, 佐塚泰之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2018.
Japanese Article P0055-23-PM. Safe examination of the 20% serum eye drops hospital preparation
前田知穂1, 藤後恭二2, 大神隆行1, 後藤正道3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2018.
Japanese Article P0057-23-PM. Development of the leuprorelin percutaneous absorption type preparation
小幡誉子1, 新井裕子1, 表萌々1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2018.
Japanese Article P0059-23-PM. Design of the oral jelly agent using xyloglucan
金子寧々1, 下山哲哉1, 伊藤邦彦1, 小林道也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2018.
Japanese Article P0061-23-PM. Inspection of the need of the ward drug duties in the medical treatment ward
町田裕実子1, 加藤豊範1, 吉田章悟1, 鈴木絢子1, 小田高司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2018.
Japanese Article P0063-23-PM. Rebuilding and management of the pharmaceutical products safety management system as ward drug duties
高木祥子1, 三輪奈津貴1, 木全司1, 荒木憲昭1, 木下元一1, 小笠原智彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2018.
Japanese Article P0065-23-PM. Having been able to see it than a ward drug duties intervention example
渡邉悦子1, 佐野邦明1, 高木雄一1, 松本富夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2018.
Japanese Article P0067-23-PM. Establishment of the quantity of duties rating system for the appropriate staff placement in ward drug duties
只見智恵子1, 佐藤美絵1, 宮崎雅子1, 金田純子1, 木村桂子1, 藤本裕子1, 浜田幸宏1, 木村利美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2018.
Japanese Article P0069-23-PM. Usefulness of ward drug duties judging from a pharmaceutical correspondence example (DI record)
小野元久1, 中田吉則1, 安田早織1, 山口智江1, 宮原兼二1, 佐藤美砂1, 万塩倫子1, 永田和裕1, 渡久川敦子1, 平松久典1, 片野貴大1, 上田知靖1, 佐藤江莉1, 伊藤彰洋1, 荒川正悟1, 竹内美緒1, 兼子詩布1, 丹村亜梨朱1, 藤井哲也1, 徳田富妃子1, 旭将来1, 鵜飼麻由1, 重共孝一1, 伊藤功治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2018.
Japanese Article P0071-23-PM. Examination about the factor to disturb the remedy observance in being at home in the circulatory organ internal medicine inpatient
菅直恵1, 西村健二1, 亀井健人1, 赤木晋介1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2018.
Japanese Article P0073-23-PM. About the current situation of the palliative care in the terminal phase of the heart failure in our hospital
伊藤和幸1, 平嶋由貴1, 中村くみこ1, 植村太志1, 浦崎圭太1, 河井和子1, 磯谷聡1, 青木満子2, 石黒久美子3, 加藤美紀3, 杉本隆一3, 三好美奈4, 加藤寛之4, 村上央4, 加田賢治4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2018.
Japanese Article P0075-23-PM. The effect that a pharmacist interview before hospitalization gives in an initial interview at hospitalization
五十嵐文1, 市田千佳1, 山本郁生1, 高橋賢成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2018.
Japanese Article P0077-23-PM. The analysis results of the prescription suggestion example for the person of decreased renal function in ward duties and future problem
和田朋海1, 鈴木光幸1, 小野田佳子1, 小竹泰子1, 中村愛1, 須佐充1, 上村賢介1, 高橋成博1, 茂木武1, 間宵聖太1, 肥田野綾1, 内坪誉歳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2018.
Japanese Article P0079-23-PM. The current situation and problem of the in-hospital manual operation to face each other at delirium, unrest in the dementia night
辻依利1, 若林厚史1, 里見彩1, 田畑寛明1, 猿谷淳1, 向一美1, 地野幹子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2018.
Japanese Article P0081-23-PM. Efforts about the patients autoregulation pain relief (patient controlled analgesia: PCA) instruction
垣本光未1, 宮本那央1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2018.
Japanese Article P0083-23-PM. Enforcement of the active drug control instruction for patients during high-risk medicine remedy
鈴田浩孝1, 則松郁香1, 吉田翔平1, 小坂隆介1, 古川和弘1, 桑原貴美子1, 河野大希2, 中島浩太郎3, 岩尾卓朗4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2018.
Japanese Article P0085-23-PM. Relation to the oral cyclophosphamide therapy introduction and drug control to children
前原美桜1, 綾部ゆか1, 佐古有紀1, 河瀬志保1, 松本俊治2, 渡辺美和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2018.
Japanese Article P0087-23-PM. About intervention to the clinical department crossing-like polypharmacy by the pharmacist
入江優美1, 藤本倫正1, 南のどか1, 玉置尚1, 中須賀基1, 田畑佳祐1, 籾井佳奈1, 瀬川和子1, 垣尾尚美1, 辻本純子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2018.
Japanese Article P0091-23-PM. A circulatory organ, the intervention to the Distribution of medicine set duties of the pharmacist in the thoracic surgery ward and the evaluation
奥村蕗子1, 山口高雅1, 浜口真徳1, 酌井敏伸1, 世古口拓也1, 夏目尚子1, 竹上愛1, 三宅知宏1, 谷村学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2018.
Japanese Article P0093-23-PM. A role and intervention case of the pharmacist in the urination care team
川地雄基1, 宇佐美英績1, 藤本佳則2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2018.
Japanese Article P0095-23-PM. The current situation of the correspondence to the foreign patients in the obstetrics and gynecology department ward
加藤結1, 後藤祥子1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2018.
Japanese Article P0062-24-AM. Investigation about the intervention effect of the local inclusion care system, hospital pharmacist in the convalescence
岸本真1, 荒川隆之1, 川崎美紀1, 酒向幸1, 藤原久登1, 溝神文博1, 宮川哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2018.
Japanese Article P0064-24-AM. It is efforts ... in ... circulatory organ ward about the efficiency of medication management instruction duties in the understaffing of the pharmacist, ward drug control duties
杉本吉春1, 池田佳子2, 浅原慶徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2018.
Japanese Article P0066-24-AM. The current situation and future problem judging from the number of the drug control instruction of our hospital
井上真緒1, 安福平1, 松山哲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2018.
Japanese Article P0068-24-AM. Efforts to ward drug duties efficiency in the University of Occupational and Environmental Health Hospital
川道直子1, 稲村由香1, 竹中美紗1, 花沢直子1, 井手健太1, 篠原義剛1, 植木哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2018.
Japanese Article P0070-24-AM. Examination for intervention investigation and the duties improvement of the pharmacist to medical treatment depending on renal function in our hospital
望月丈裕1, 山本美智子1, 平松健人1, 加藤淳美1, 遠藤さゆり1, 村山奈千1, 深澤努1, 上原君男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2018.
Japanese Article P0072-24-AM. Relation of the pharmacist to the heart failure team in our hospital
大石晶子1, 米田奈美2, 筒井景子1, 山内浩子1, 八木秀明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2018.
Japanese Article P0074-24-AM. Significance (the first report) of the drug control instruction duties for the taking antithrombocytic agent patients
益田玲1, 北英士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2018.
Japanese Article P0076-24-AM. Analysis and evaluation of the intervention example of problems about the drug control before operation and the ward pharmacist
吉岡紗由1, 小久江伸介1, 大野能之1, 長瀬幸恵1, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2018.
Japanese Article P0078-24-AM. Clinical manifestations of patients with cerebrospinal fluid reducing symptom that we examined from a ward pharmacist
中里直美1, 鈴木高広2,3, 北條祥子4,5, 菅野洋6, 篠永正道6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2018.
Japanese Article P0080-24-AM. Questionary survey ... to practice - enforcement situation investigation and a cooperation institution of the reporting utilizing the drug control summary for the hospital transfer patients
藤井美紀1, 満田正樹1, 石川裕大1, 本郷志帆1, 稲葉静香1, 中谷亮介1, 奥下梨賀1, 野際俊希1, 瀧浪靖子1, 松本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2018.
Japanese Article P0082-24-AM. Examination about the osteoporosis therapeutic drug remedy continuation support in ward drug duties
土屋貴1, 倉田賢生1, 荒木弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2018.
Japanese Article P0084-24-AM. Introduction of the inhalational check list which we made by a review for ward duties
寺山和利1, 岡田侑子1, 加藤菊郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2018.
Japanese Article P0086-24-AM. Efforts of the pharmacist in the childhood cancer ward
岩崎剛士1, 丸山紗緒里1, 三枝美和1, 平野桂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2018.
Japanese Article P0088-24-AM. Efforts and the current situation to polypharmacy measures in our hospital comprehensive medical care medical service
鈴木善樹1, 芳澤朋大1, 栗原弘紀1, 伊藤護之1, 永野浩之1, 林良行1, 岸野亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2018.
Japanese Article P0090-24-AM. Relation of our hospital pharmacy in "the disease severity, medical care, nursing necessary degree" for the medical service fees revision
安福平1, 松山哲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2018.
Japanese Article P0092-24-AM. Team approach in medical care in short bowel syndrome and pharmaceutical example that intervened
山本真由美1, 西山祐美1, 森田聡子1, 細見真世1, 有延早弥香1, 杉生雅和1, 橋口具世2, 宇多優吾3, 今中秀光4, 吉岡睦展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2018.
Japanese Article P0094-24-AM. An activity and result of the pharmacist in the urination care team
脇田恵里1,2, 梅村拓巳1,2, 浅野真美2, 中村直人1, 鷹見繁宏1, 武田宗万2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2018.
Japanese Article P0096-24-AM. Suit from the patients in the drugstore, the effect that an interview gives in change of prescription on patients
林由依1, 鈴木学1,2, 味澤香苗1, 金地夏実1, 國府田真綾1, 林秀樹1,3, 小原道子3, 棚瀬友啓2, 土屋照雄2, 杉山正1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2018.
Japanese Article P0097-23-PM. About the evaluation for the pharmacist duties of the operating room in our hospital
濱浦弘光1, 高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2018.
Japanese Article P0099-23-PM. Efforts and problem of the ward drug duties in the NICU ward
渡邊清人1, 近江令司1, 高柳昌宏1, 千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2018.
Japanese Article P0101-23-PM. Evaluation of the pharmacist leadership multi-type of job team rounds in the intensive care unit
立石裕樹1, 宮津大輔1, 後藤貴央1, 平川雅章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2018.
Japanese Article P0105-23-PM. About the making of the in-hospital general use manual of non-active form 4 factor-containing prothrombin complex preparation (4F-PCC) and the observance situation
長谷悠紀1, 清水誉志1, 藤野真理子1, 福島将友1, 丸子浩1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2018.
Japanese Article P0107-23-PM. Efforts evaluation for the early intervention of the working full time pharmacist in the ER type first aid system (North American type ER)
須賀明輝1, 宮田祐一1, 上野栞1, 岩崎睦1, 大村史1, 鬼村紀子1, 吉田萌絵1, 和田健太郎1, 仲鉢英夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2018.
Japanese Article P0109-23-PM. The current situation of the pharmaceutical intervention in our hospital critical care center Initial doctor's office
小守陽介1, 中村亜由美1, 鈴木正論1, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2018.
Japanese Article P0111-23-PM. The use of herbal medicinal products situation investigation in the critical care center
佐藤史織1, 河村聡志1, 佐脇久美1, 末延道太1, 原尻学志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2018.
Japanese Article P0098-24-AM. Efforts of the drug fixed number placement in the operating room
大橋洵1, 福田聖啓1, 早見知浩1, 渡辺繭子1, 長谷川直美2, 水井貴詞1, 飯沼宏和3, 大畠博人3, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2018.
Japanese Article P0100-24-AM. The angiopathic fact-finding with the nicardipine injection in the pediatric intensive care unit and examination of the risk factor
三浦寄子1, 大穂祐介1, 三大寺紀子1, 宇野千晶1, 赤羽三貴1, 壷井伯彦2, 奥田裕美3, 持丸奈央子4, 吉田和恵4, 山谷明正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2018.
Japanese Article P0102-24-AM. The making of the parenteral injection incompatibility chart in ICU and HCU and evaluation of the usefulness
高野温志1, 道場勇真1, 齋藤彩子1, 亀井陽子1, 伊賀正典1, 町田充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2018.
Japanese Article P0104-24-AM. The use situation of the sedative drug sustained after the operation that aimed at the comprehensive pain control
野村亜衣1, 山本智也1, 原伸輔1, 武本梨沙1, 山上聡子1, 勝浦正人1, 門脇裕子1, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2018.
Japanese Article P0106-24-AM. Relation of making and the pharmacist of the alteplase (rt-PA) administration flowchart in super acute phase cerebral infarction treatment
木元健寛1, 齊藤伸1, 水沢重則1, 篠田和人1, 仙葉悠紀1, 工藤和彦1, 吹谷真紀子1, 金美紀1, 佐藤恵葉1, 鈴木ひとみ1, 八代佳子1, 後藤敏晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2018.
Japanese Article P0108-24-AM. Evaluation of the type of the side effect in the patients who received an emergency visit for the side effect of pharmaceutical products and the severity
松山卓矢1, 舘知也1,2, 青山智2, 大澤友裕2, 勝野隼人1, 古山愛紗1, 杉岡まゆ子1, 村山あずさ1, 大坪愛実1, 上野杏莉1, 野口義紘1, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2018.
Japanese Article P0110-24-AM. Effect of the pharmacist intervention in emergency/intensive care domain
小林洋平1, 山岡怜央1, 山崎浩二郎1, 熊井正貴1, 笠師久美子1, 山田武宏1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2018.
Japanese Article P0112-24-AM. The current situation report (the third report) of the foreign inhalational instruction in the Komaki Municipal Hospital
水谷貴樹1, 山本将司1, 櫻井美来1, 戸田康裕1, 小島英嗣2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2018.
Japanese Article P0114-24-AM. Efforts to the prescription adequacy for foreign polypharmacy patients by the cooperation with the physician and the evaluation
加賀富貴枝1, 細野真吾1, 近藤裕樹2, 山崎崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2018.
Japanese Article P0116-24-AM. The efforts about the hospitalization support task in the hospitalization and release support center and the evaluation
井戸田麻由1, 石川ゆり1, 竹内正幸1, 山之内博明1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2018.
Japanese Article P0118-24-AM. Efforts of the pharmacist intervention to the hospitalization support center in our hospital
中原萌子1, 塚田寛子1, 山下典子1, 山脇一浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2018.
Japanese Article P0120-24-AM. Change of prescription ... before the hospitalization by the in front of securing of safety - pharmacist technique outpatient department of the perioperative medical therapy utilizing the uniform management system of a side effect, the allergic information
荒木良介1, 三田恭平1, 宇野崇之1, 加藤加奈恵1, 長谷康史1, 小幡薫1, 菱沼隆一1, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2018.
Japanese Article P0122-24-AM. Effect of the pharmacist intervention that we gave to the obstetrics and gynecology department surgery cancellation number
古賀祥子1, 村上翔一1, 畑瀬圭佐1, 高倉栄治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2018.
Japanese Article P0124-24-AM. Is going to perform operations in the middle scale hospital; is intervention to stopping medicine confirmation during the preoperation of the outpatient
譲原千広1, 小川紗知1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2018.
Japanese Article P0126-24-AM. Investigation of the discontinuation evaluation enforcement situation before operation of the orthopedics ward and the discontinuation compliance
石井有紀1, 水谷妙子1, 池田大地1, 田中文1, 登内盛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2018.
Japanese Article P0128-24-AM. Examination about the order change case in the foreign cancer chemotherapy on that day
平池美香子1, 川俣洋生1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2018.
Japanese Article P0130-24-AM. Establishment of the pharmacist outpatient department for patients with cancer depending on the ambulatory practice system
村上賢次1, 水本恵梨花1, 早坂大1, 宅和真由美1, 平田敦宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2018.
Japanese Article P0113-23-PM. "Efforts (the third report) for grasp and the improvement of the use of inhalant situation in our hospital in inhalational adherence"
荒木寛也1, 久田明日香1, 福井愛1, 坂柳悦章1, 長谷康志1, 森井涼子1, 加藤裕隆1, 辻博幸1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2018.
Japanese Article P0115-23-PM. Construction of the pharmacist ambulatory service in the kidney internal medicine
小宅典子1, 井口恵美子1, 栗原佳奈子1, 男全昭紀1, 藤澤一2, 猪股克彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2018.
Japanese Article P0117-23-PM. Efforts of the pharmacist in the admitting department establishment
宮部泰輔1, 北野祐香1, 上田善美1, 十田達也1, 石野佑樹1, 田中奈桜1, 窪田彩花1, 藤井克至1, 生越由美1, 黒川拓也1, 東達也1, 田村憲昭1, 井上敦介1, 廣畑和弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2018.
Japanese Article P0119-23-PM. Intervention of the pharmacist in the admitting department
木村康人1, 廣原成1, 今井祐貴子1, 村田茉央1, 内藤久志1, 橋本友希1, 尾崎昌大1, 添田真司1, 渡邊昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2018.
Japanese Article P0121-23-PM. Review of pharmacist outpatient department establishment and allied duties
吉田崇志1, 板垣美保1, 遠藤清香1, 渋江泉1, 板垣有紀1, 羽太光範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2018.
Japanese Article P0123-23-PM. Foreign efforts before pharmacist technique for the urologic surgery patients
長島真洋1, 安村吉彦1, 澤村愼吾1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2018.
Japanese Article P0125-23-PM. Is going to be operated on; examination about the usefulness of by hospitalization front and the medicine medicine cooperation by the pharmacist to the patients
瀧祐介1, 山崎愛子1, 岩水陽子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2018.
Japanese Article P0127-23-PM. Is going to be operated on; the intervention after the encounter of the ward pharmacist for the patients
松岡未紗1, 後藤義之1, 角紀一郎1, 岡田久美1, 石崎真由美1, 茶野下貴恵1, 光井彩1, 青木理恵1, 島崎沙織1, 戸田翔子1, 森戸敏志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2018.
Japanese Article P0129-23-PM. The examination that how contributes to the surgery enforcement that a pharmacist interview in the support center before hospitalization is safe
野村勇太1, 上田覚1, 藤澤彰宏1, 高田知正1, 三井克巳1, 尾上雅英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2018.
Japanese Article P0131-23-PM. Trend of the medicine decreasing by it after the drug global assessment adjustment addition new establishment
菅井千尋1, 原島久美1, 箱崎かおり1, 飯山久美子1, 田上明子1, 関本聡子1,2, 屋宮由季1, 中舘朝未1, 安藤浩巳1, 水村恒雄1, 串田一樹2, 廣原正宜2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2018.
Japanese Article P0133-23-PM. Consideration about the need of confirmation of bringing medicine in consideration of renal function
甲元大樹1, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2018.
Japanese Article P0135-23-PM. Role of the pharmacist in the hospitalization and release adjustment room
高氏秀展1, 神谷武司1, 岡崎博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2018.
Japanese Article P0132-24-AM. We began Masuda Japan Red Cross, a polypharmacy measures project!
山崎祐子1, 俵早紀1, 山藤千晶1, 赤石憲俊1, 大谷崇仁1, 宅江孝修1, 吉田勝好1, 郷原学1, 安木恵一2, 桐田郁3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2018.
Japanese Article P0134-24-AM. Can you depend on prescription notebook (medicine feeling) for the medication information (bringing medicine report)?
小口正義1, 宮崎雄紀1, 水谷妙子1, 酒井美香1, 山崎夕貴1, 田中文1, 登内盛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2018.
Japanese Article P0136-24-AM. About the change of ward drug duties contents before and after the "confirmation of bringing medicine before hospitalization" duties introduction
宮井明日香1, 美濃佳代子1, 清水けいこ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2018.
Japanese Article P0137-23-PM. About the usefulness of duties by pharmaceutical products SPD out of the fixed form
関屋裕史1, 友宗直樹2, 緒方豊2, 梶原隆弘3, 福永洋子3, 森木豊栄3, 長友隆雄1, 保田和哉1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2018.
Japanese Article P0139-23-PM. Attempt ... to utilize analysis - Chinese medicine of the interview using "mind" of the Chinese medicine for health care
日置智津子1, 伊藤エミ2, 宇高一郎2, 中井賀世子2, 村重史子2, 椎名昌美1, 武田卓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2018.
Japanese Article P0141-23-PM. Result of the management that we continued a balun strike scorecard in the Yokohama General Hospital and used
廣瀬直樹1, 佐村優1, 小川寿子1, 倉田武徳1, 高田啓介1, 稲垣和幸1, 井上純樹1, 関根寿一1, 金田昌之2, 佐藤透3, 赤瀬朋秀4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2018.
Japanese Article P0143-23-PM. Consideration about the pharmacist duties in the small and medium size hospital judging from 2017 "current situation investigation of the hospital pharmacy gate"
樋島学1,2, 田中協1, 荒川隆之1, 荒木隆一1, 岩崎雅弘1, 兼重晋1, 佐村優1, 濱浦睦雄1, 久岡清子1, 渡邊学1, 賀勢泰子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2018.
Japanese Article P0145-23-PM. Objective evaluation of the duties system using job satisfaction measure JOBSS-HP27 for hospital pharmacist
永倉史子1, 陶山明日香1, 濃沼政美2, 大久保淑子1, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2018.
Japanese Article P0138-24-AM. Efforts of the prescription representation that was able to achieve the duties burden reduction of the physician and duties efficiency of the pharmacy at the same time
中村伸也1, 安山泰1, 寺前祐樹1, 二宮大樹1, 野村祥子1, 谷山康子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2018.
Japanese Article P0140-24-AM. Work-life balance and career plan of the female pharmacist in upper Goto
小徳由梨絵1,2, 大島聖也1, 湯川浩一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2018.
Japanese Article P0142-24-AM. Efforts and result twelfth report for the balun strike scorecard introduction for hospital pharmacist
藤田明宏1,2, 赤瀬朋秀2, 井口恵美子2, 上原君男2, 岡添進2, 小林岳2, 関口信香2, 大幸淳2, 中村葉月2, 小田切正美2, 吉田博史2, 金田昌之2, 金田光正2, 佐藤透2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2018.
Japanese Article P0144-24-AM. Literature examination of the job satisfaction study in the pharmacist
小串興平1, 濃沼政美2,3, 高木彰子3, 中村均2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2018.
Japanese Article P0146-24-AM. With an adverse event spontaneous report database and individual pharmaceutical products link; is ... using the ingredient dictionary including ... life science dictionary
寺内恭平1, 宮村信輝1, 酒井幸1, 阿部純子1, 杉平直子1, 金子周司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2018.
Japanese Article P0148-24-AM. Investigation about the way of the reporting about the driving using PMDA exhibition data
越野早紀1, 渡辺浩明1, 田村広志1, 和泉秀明1, 佐藤弘康1, 三本松泰孝1, 亀井浩二郎1, 金住麻子1, 福島麻里乃1, 菅大地1, 島津智行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2018.
Japanese Article P0150-24-AM. Fact-finding about the use of antiepileptic drug in women of the childbearing age based on administrative data
菊池大輔1,2, 小原拓2,3,4, 三浦良祐1, 宍戸可成子1, 城坂理紗1, 渡辺善照1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2018.
Japanese Article P0152-24-AM. The making of the system to extract the decreased renal function patients, and to show an optimal dose to and the evaluation
松本薫1, 佐藤篤郎1, 片山広美1, 伊藤昌美1, 深谷詩織1, 天野哲史1, 加藤奈美1, 八並ゆかり1, 鈴木厚志1, 板倉由縁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2018.
Japanese Article P0154-24-AM. About information on adverse drug reactions collection by the search by keyword in the electronic medical chart record
奈良美波1, 岩田あすか1, 橋口文乃1, 中石真由美1, 久野薫1, 下田寿子1, 林明子1, 橋井祐子1, 佐藤和生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2018.
Japanese Article P0156-24-AM. Examination about the drug repositioning of digoxin using the large-scale database
横山聡1, 杉本泰浩1, 細見光一1, 高田充隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2018.
Japanese Article P0158-24-AM. Examination of the adverse event expression of EGFR-TKI situation using adverse drug reaction database (JADER)
中山敏光1, 堤大輔1, 安部恵1, 渡邉文之1, 林宏行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2018.
Japanese Article P0160-24-AM. Usefulness examination of search database Lexicomp Online of the drug information resource in the Aichi Medical University Hospital
生田智宏1, 野々垣知行1, 宇野英理子1, 深谷さおり1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2018.
Japanese Article P0162-24-AM. Making and evaluation of the injection drug incompatibility search tool in the hospital basic for acute phase
小林晃子1, 仁熊宏樹1, 小倉志保1, 西村健二1, 有澤礼子1, 亀井健人1, 赤木晋介1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2018.
Japanese Article P0164-24-AM. Trial report of the side effect check list which we applied RMP to
杉尾由希子1, 宮下裕央1, 杉町代1, 大窪典子1, 津曲恭一1, 尾之江剛樹2, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2018.
Japanese Article P0166-24-AM. Inquired analysis about the incompatibility in infusion put to the infusion DI center
佐々木美由紀1, 堀越由里1, 竹林佑花1, 津田朋枝1, 松田直子1, 吉岡小都子1, 福田まゆみ1, 河野裕則1, 岩原良晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2018.
Japanese Article P0168-24-AM. Usefulness evaluation of the improved version ut for medication guides for patients
間宮愛子1, 西村春香1, 橋本梨紗1, 米田杏寿美1, 角山香織1, 中村敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2018.
Japanese Article P0170-24-AM. Inspection of the cancer onset protective efficacy with statin drugs for patients with dyslipidemia
西川寛来1, 高木将行1, 石川秀樹2, 武藤倫弘3, 真野泰成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2018.
Japanese Article P0172-24-AM. It is ... using analysis ... simple suspension advisability information sharing system data of simple suspension accumulation data
原田恭江1, 細川宜嗣1, 五郎丸剛2, 世良庄司3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2018.
Japanese Article P0147-23-PM. Estimate of the factor affecting the medical measures use or nonuse in database analysis - pharmaceutical products-related report of the business such as mishaps in medical practice intelligence, and the like
室高広1, 中川博雄1,2, 中村忠博1, 佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2018.
Japanese Article P0149-23-PM. Relative analysis with α 1 receptor blockade and the faint using the adverse drug reaction database and the previous faint symptom
大山勝宏1, 古本真也1, 杉浦宗敏1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2018.
Japanese Article P0151-23-PM. Of the quantity of magnesium oxide prescription for the person of decreased renal function based on medical examination, receipt data, actually
高橋愛1, 佐藤倫広2, 薄井健介1,3, 岡田浩司1,3, 村上任尚2, 目時弘仁2, 渡辺善照1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2018.
Japanese Article P0153-23-PM. Examination of the usefulness of the NCGM drug interactions search (hepatitis therapeutic drug) system
瀬戸恵介1, 赤沢翼1, 増田純一1, 近藤直樹1, 坂本治彦1, 小林明信1, 寺門浩之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2018.
Japanese Article P0155-23-PM. Construction of the drug information database in our hospital
渡邉美樹1, 谷口仁孝1, 山本彩佳1, 千葉恵美子1, 前川知子1, 坂井愛実1, 前田典子1, 水野稜子1, 小原祐子1, 徳村博子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2018.
Japanese Article P0157-23-PM. Examination - utilizing effect - large scale medical care information that nicorandil gives for the prognosis of patients with cardiopulmonary arrest
新村貴博1, 座間味義人1,2, 石澤有紀3, 今西正樹2, 武智研志4, 福島圭穣5, 堀ノ内裕也3, 池田康将3, 藤野裕道5, 土屋浩一郎6, 玉置俊晃3, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2018.
Japanese Article P0159-23-PM. Prediction of the side effect of machine learning using adverse drug reaction database (JADER)
小野田良1, 松井大樹2, 山下由依亜1, 中村武夫1, 伊藤栄次1, 大内秀一1, 和田哲幸1, 八軒浩子1, 大星直樹2, 松野純男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2018.
Japanese Article P0161-23-PM. The analysis of an inquiry, the inquiry example accumulated in our hospital pharmacy and examination of results
中島のぞみ1, 山田倭花1, 内山乃映1, 上田奈緒美1, 大窪真理絵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2018.
Japanese Article P0163-23-PM. Development ... of I-system which assumes construction - frequent use spreadsheet Excel of the contraindicated medicine prescription check system a base at renal failure utilizing the electronic medical chart search feature
元木貴大1, 井上達也1, 立道貴清1, 水岡大策1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2018.
Japanese Article P0165-23-PM. For the exhibition of the collection of information about the quality (blue book) and the inflection of the generic drug
阿部康弘1, 吉田寛幸1, 伊豆津健一1, 合田幸広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2018.
Japanese Article P0167-23-PM. Investigation for the inflection of the pharmaceutical products risk management plan
本郷知世1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2018.
Japanese Article P0169-23-PM. Construction of the questions and answers record portal site corresponding to the needs of the pharmacist
長尾由佳1, 赤木晋介1, 奥田敏勝1, 大熊沙代子1, 西田麻以1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2018.
Japanese Article P0171-23-PM. Comparison of herbal medicinal products "Kakkonto" which is medical use and a nonprescription drug
成橋和正1, 齋藤唯衣1, 藏所志穂1, 津江南瑠海1, 中村憲夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2018.
Japanese Article P0173-23-PM. Investigation about the apothecaries measure before and after the dissolution in the lyophilized products of the injectable antimicrobial, antifungal agent
杉田裕貴1, 細見健悟1, 小牧佐知子1, 稲田智子1, 増本憲生1, 高子優子2, 大槻裕朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2018.
Japanese Article P0176-24-AM. Fact-finding of the magnesium oxide administration depending on the renal function in elderly patients
藤崎正宏1, 山田邦夫1, 山田充宏1, 棚橋美里1, 和泉孝2, 鈴島仁3, 森岡淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2018.
Japanese Article P0178-24-AM. H. in our hospital The current situation of the pylori sanitization therapy
岩田佳菜子1, 栗崎貴啓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2018.
Japanese Article P0180-24-AM. Side effect fact-finding of five kinds of pain-killers in the Kumamoto function hospital
武藤崇1, 星野輝彦1, 下田賢一郎1, 塩津和則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2018.
Japanese Article P0182-24-AM. Questionary survey about taking OROS type controlled release control preparation Methylphenidate Concerta
中野歩美1, 杉山育美1, 遠山明宏2, 東透2, 佐塚泰之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2018.
Japanese Article P0184-24-AM. The use situation of the oral anticoagulant drug in elderly people in the triple heart center
松岡佳子1, 前田雄太郎1, 木本珠美1, 伊藤涼子1, 梶間勇樹1, 高井靖1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2018.
Japanese Article P0186-24-AM. Consideration from a viewpoint of running it of the DPC Hospital in the choice of the generic medicine
北岡晃1, 榎木瑞穂1, 西村理恵子1, 竹場和代1, 小倉敬史1, 藤井隆2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2018.
Japanese Article P0192-24-AM. Effect to bone density by the use of each osteoporosis therapeutic drug
酒井祐1, 永江朋子1, 秋元朝行1, 高橋泰久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2018.
Japanese Article P0194-24-AM. Hold attitude survey - Epinephrine autoinjector class for the adrenalin self injection drug; and ...
浅野志津1, 小原香那1, 日浦亜実1, 森英樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2018.
Japanese Article P0196-24-AM. Analysis of the factor to have an influence on the adherence of the agent for hyperlipidemia through "knob medicine bag motion"
川浪望恵1, 小林大介1, 窪田敏夫2, 川尻雄大1, 丸山真実1, 都築加奈1, 三井所尊正3, 瀬尾隆3, 小柳香織3, 高木淳一3, 木原太郎3, 田中泰三3, 島添隆雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2018.
Japanese Article P0198-24-AM. The review of the placement drug of the emergency cart and future problem
杉本恵理1, 堀部緑1, 柘植麻里奈1, 寺田雄亮2, 荒木朋浩3, 斎藤誉宏4, 木村匡男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2018.
Japanese Article P0175-23-PM. The prescription change of the antiepileptic drug
杉山尭紀1, 山本吉章1, 加藤浩充1, 矢嶋隆宏1, 菅寛史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2018.
Japanese Article P0177-23-PM. The prescription situation of the laxative in our center
淀川進也1, 黒崎由希子1, 冨岡謙二1, 古澤一成2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2018.
Japanese Article P0179-23-PM. The difference that it showed from fact-finding of hospitalized lansoprazole famotidine
竹澤唯1, 中川左理1,2, 粕谷香1, 波多野彩美1, 見田秋与志2, 岡本禎晃2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2018.
Japanese Article P0181-23-PM. The use actual situation of the sleeping drug in our hospital orthopedics ward
土元研史1, 安田礼子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2018.
Japanese Article P0183-23-PM. The use situation of the morphine note for the terminal heart failure in the Kasugai Municipal Hospital
伊東和真1, 大岩拓馬1, 田中伸明1, 鈴木大吾1, 前田剛司1, 坂田洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2018.
Japanese Article P0185-23-PM. Use investigation of the anticoagulant in the convalescent rehabilitation ward
小土井亮介1, 酒井照美1, 西塚亨1, 峯浦一喜2, 白川真3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2018.
Japanese Article P0187-23-PM. Research about the appropriateness doses of the direct action type oral anticoagulant drug
井上朋彦1, 相澤政明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2018.
Japanese Article P0189-23-PM. Questionary survey about the medication adherence for patients with cardiovascular disease and the chief physician
大津友紀1,2, 甲斐麻美子2, 清見文明3, 末松保憲4, 朔啓二郎4, 三浦伸一郎4, 神村英利1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2018.
Japanese Article P0193-23-PM. The use situation investigation for the purpose of the folinic acid preparation proper use
末延道太1, 佐藤史織1, 川元崇志1, 上田由貴1, 稲垣芙美佳1, 山代栄士1, 原尻学志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2018.
Japanese Article P0195-23-PM. Examination of the administration cancellation reason in the tolvaptan new introduction patients
千葉貴志1, 早坂美希1, 上村新吾1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2018.
Japanese Article P0197-23-PM. The current situation of the osteoporotic liaison service in the care mix hospital and future problem
森崎崇文1, 星野輝彦1, 塩津和則1, 清田克彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2018.
Japanese Article P0199-23-PM. Fact-finding of how to work on patients about the medication situation and the medication
天海祐紀1, 岩瀬利康1, 赤羽正之1, 渡邊紘子1, 丸山林土1, 吉成徹1, 半田淑子1, 石崎憲1, 鈴木隆寛1, 和貝益男2, 松田美和3, 田中浩太郎4, 安隆則5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2018.
Japanese Article P0200-24-AM. Effect to medical expenses reduction by the intervention of the pharmacist on medical treatment
四方公亮1, 篠原梨沙1, 桝早紀子1, 伊東充1, 佐藤香織1, 勝俣はるみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2018.
Japanese Article P0202-24-AM. Inspection of the medical expenses reduction effect by the Residual medicine return handling of hospitalization prescription
小野優紀恵1, 渡部寿康1, 大竹麻衣子1, 古賀彩織1, 菊地洋平1, 安齋英里1, 我妻禎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2018.
Japanese Article P0204-24-AM. The results of a doubt inquiry, the prescription suggestion in our hospital and the medical economic effect
芝琴奈1, 益子里美1, 岡田宜和1, 福山博務1, 山崎智世1, 飯嶋歩1, 鎭目晶子1, 安田陽子1, 藤谷竜磨1, 滝島さやか1, 高久聡子1, 目黒正明1, 真柴友紀1, 塩地園代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2018.
Japanese Article P0206-24-AM. Effect of thrombomodulin and the antithrombin III preparation combination on DIC patients derived from an infection
中野貴文1,2, 佐藤啓介1, 森脇典弘1, 仲村佳彦3, 兼重晋1, 緒方憲太郎1,2, 神村英利1,2, 江川孝1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2018.
Japanese Article P0208-24-AM. Fact-finding about the medical therapy of local elderly people: Examination - of the effect factor to give to Nakajimacho study - medication adherence
徳用百合奈1, 石田奈津子2, 菅幸生2, 松下良2, 石崎純子2, 篠原もえ子3, 駒井清暢4, 山田正仁3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2018.
Japanese Article P0201-23-PM. Drug costs reduction effect by the hospitalization prescription return medicine for pharmacist management
橋本磨里奈1, 村山綾那1, 高柳論也1, 小林恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2018.
Japanese Article P0203-23-PM. Examination about the disposal situation and the medical expenses reduction at anticancer agent preparation
鈴木敦詞1, 前田剛司1, 坂田洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2018.
Japanese Article P0205-23-PM. Examination of the need of the new preparation standard in consideration of a dose of the albumin suspension type paclitaxel
中井將人1, 北本真一2, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2018.
Japanese Article P0207-23-PM. Local population properties and the pharmacist distribution influence ethical drug sales; or analysis - of the medical economics using - Lorentz curve
安藤崇仁1, 井上和男2, 安原眞人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2018.
Japanese Article P0209-23-PM. Examination of the Similar effect medicine with the in-hospital adoption medicine
田所正年1, 東島幸道1, 鳥山純司1, 梅本啓史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2018.
Japanese Article P0210-24-AM. Questionary survey about the pharmaceutical products quality reporting for the generic drug company
大谷智也1, 浅山美穂1, 松井友希1, 笹原里美2, 木暮晃士2, 立木秀尚2, 恩田光子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2018.
Japanese Article P0212-24-AM. The current situation of the change to the generic medicine in the Soka Municipal Hospital outside Parliament prescription and the evaluation
源川良一1, 村社計寿1,2, 高橋雅弘2, 木村直也1, 越前宏俊2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2018.
Japanese Article P0211-23-PM. Pharmaceutical products interview form and company homepage publication information for the purpose of the quality intelligence of the generic drug
浅山美穂1, 大谷智也1, 松井友希1, 恩田光子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2018.
Japanese Article P0213-23-PM. Investigation about the use of drugstore situation in Japan of the visit to Japan foreigner and the own country and the purpose
吉田舞衣1, 村重勇輔1, スミス朋子2, 楠瀬健昭2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2018.
Japanese Article P0215-23-PM. Proposal to problems and the remedy in outer box information and the package insert of the general Bacillus natto-containing preparation with the high-risk medicine warfarin and interaction
大塚邦子1,2, 桑原諒1, 鈴木啓太郎1, 細野哲司1, 安原一3, 内田直樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2018.
Japanese Article P0214-24-AM. Study on comparisons such as regulation, and the like such as Sweden, Germany, the advisability, and the like of the pharmaceutical products online sale in Canada
赤川圭子1, 長谷川洋一2, 中尾裕之3, 今井博久4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2018.
Japanese Article P0216-24-AM. The use situation investigation of the biofollowing article of insulin glargine in our hospital
坂柳悦章1, 荒木寛也1, 西川隆一1, 澤柳直樹1, 藤井友一1, 辻博幸1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2018.
Japanese Article P0218-24-AM. We look at the rear about the safety of the rituximab Biosimilar and examine a mark
服部有希1, 坂本靖宜1, 太田一郎1, 渡邉美知子1, 鈴木絢子1, 山本幸二郎1, 若杉正1, 小池博文1, 佐橋幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2018.
Japanese Article P0217-23-PM. Investigation about the use situation and the infusion reaction expression of rituximab bio follower product in patients with malignant lymphoma
兼松哲史1, 中村英明1, 吉田均2, 伊藤貴彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2018.
Japanese Article P0219-23-PM. Reevaluation of the chemotherapy regimen accompanied with the electronic medical chart shift
大野梨絵1, 浦田修平1, 千阪智美1, 北畑恵理子1, 高橋沙季1, 竹迫明子1, 是枝秀彦1, 森山徳文1, 関屋裕史1, 平原康寿1, 岩切智美1, 奥村学1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2018.
Japanese Article P0221-23-PM. Efforts for the infusion set unionization in the regimen
西畑友尋1, 松岡葉子1, 稲見有1, 森正一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2018.
Japanese Article P0220-24-AM. Regimen management of blood hematopoiesis tumor using the literature evaluation sheet
坂本竜平1, 向井淳治1,2, 浦瀬文明3, 奥田広志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2018.
Japanese Article P0222-24-AM. Efforts for the medical security at cancer chemotherapy regimen re-registration accompanied with the electronic medical chart shift
浦田修平1, 大野梨絵1, 千阪智美1, 北畑恵理子1, 高橋沙季1, 竹迫明子1, 是枝秀彦1, 森山徳文1, 関屋裕史1, 平原康寿1, 岩切智美1, 奥村学1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2018.
Japanese Article P0223-23-PM. Efforts of our hospital by the multi-type of job cooperation aiming at proper use of S1
三島江津子1, 永松秀紹1, 榊原洋一1, 吉川直利1, 竹内由佳2, 村上照幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2018.
Japanese Article P0225-23-PM. Pharmacist duties in the treatment with immune checkpoint inhibitor support team
中野友寛1, 原田嵩大1, 大下守得1, 篠原由紀1, 玉井宏一1, 渡部早苗1, 久保さつき1, 奥津武志1, 田房恭子2, 山下広恵2, 武田千津2, 井上考司3, 中西徳彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2018.
Japanese Article P0227-23-PM. Efforts - second report - of the multi-type of job cooperation in the blood medical service
今井美沙1, 伊藤佳織1,2, 冨田章裕2, 稲熊容子2, 入山智沙子2, 柘植雅大1, 島戸茜1, 全並美穂1, 出羽薫3, 楠照香理3, 村木由加里3, 山田成樹1, 恵美宜彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2018.
Japanese Article P0229-23-PM. Examination of problems and measures to promote medicine medicine cooperation about the cancer chemotherapy in the Gunma Chumo district
千吉良幸子1,9, 西場弘美1,9, 松浦雅人2,9, 須藤弥生3,9, 真下晴菜3,9, 増野貴司4,9, 名坂輝子5,9, 中村浩規6,9, 矢島俊介7,9, 相川潤7,9, 鈴木達宙1, 大林恭子8,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2018.
Japanese Article P0224-24-AM. Efforts ... by the multi-type of job to ensure oral surgery consultation before safe administration - administration of zoledronic acid hydrate, the denosumab
森健太郎1, 内田将吾1, 西口浩明2, 北島聖晃3, 加藤有香4, 山関智恵1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2018.
Japanese Article P0226-24-AM. Role of the pharmacist in the making of the immune checkpoint inhibitor proper use manual
新玉紗理奈1, 山下典子1, 原田愛子1, 柳井美奈1, 木村健1, 今村美智子2, 三好康雄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2018.
Japanese Article P0228-24-AM. The case that was successful in the patients for staying out support and discharge support by the multi-type of job cooperation for cancer terminal phase
小林義典1, 川口洋実1, 勝又一雄1, 北村修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2018.
Japanese Article P0230-24-AM. Efforts about the cancer medical therapy training acceptance of the health insurance pharmacy pharmacist in the Sapporo east Tokushukai Hospital
徳留章1, 谷口亮央2, 西澤健太2, 秋山恵里佳1, ファジオ恵里3, 鈴木奈緒3, 新舎里絵3, 吉江昌代3, 佐藤仁昭1, 木明貴幸1, 武田契巳1, 南盛一3, 武田清孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2018.
Japanese Article P0233-23-PM. Fact-finding of the pharmaceutical intervention in the foreign cancer chemotherapy of the pharmacist
藤井友和1, 澤柳直樹1, 西川隆一1, 荒木寛也1, 坂柳悦章1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2018.
Japanese Article P0235-23-PM. Evaluation of the physician for a cancer medical therapy authorization pharmacist attending patients with cancer encounter
陸丸幹男1, 大塚愛美1, 福山薫子1, 原尻学志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2018.
Japanese Article P0237-23-PM. The current situation and factorial experiments of doubt inquiry of the cancer chemotherapy in our hospital
山崎将英1, 黒田千里1, 藤井怜史1, 山下亜友1, 吉岡薫1, 牧野新輝1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2018.
Japanese Article P0239-23-PM. Fact-finding of the emergency visit consultation in patients who received cancer chemotherapy
横山美里1, 榊原崇芳1, 間瀬悟1, 佐々木英雄1, 三宅芳男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2018.
Japanese Article P0241-23-PM. Importance of the medication counseling (Stop and Go) by the pharmacist outpatient department in the Everolimus exemestane combination therapy for progress, recurrent breast cancer
郷真貴子1, 川地志緒里1, 五十川万喜幸1, 宇佐美英績1, 木村美智男1, 亀井桂太郎2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2018.
Japanese Article P0243-23-PM. Example that we were able to lead to the discovery of MTX-LPD from an intraoral algetic suit at medication counseling
足立奈緒子1, 宮崎俊明1, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2018.
Japanese Article P0245-23-PM. Fact-finding about the dose of the foreign chemotherapy for the elderly aged 75 or over (75 years or older)
内藤舞1, 本多伸二1, 佐分利美帆子1, 三松史野1, 目黒裕史1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2018.
Japanese Article P0232-24-AM. The PBPM introduction to hepatitis B reactivation measures in the cancer chemotherapy and the effect
冨田敦和1, 種村繁人1, 惠谷里奈1, 今井邦行1, 小玉幸与1, 野田直樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2018.
Japanese Article P0234-24-AM. 1 case that a crown spastic angina contraction attack with irinotecan was suggested
岡野芳彦1, 吉田優1, 掛札聡美1, 宍倉啓介1, 篠崎亮介1, 石井紀子1, 寺山義泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2018.
Japanese Article P0236-24-AM. Advisory about the change of the pharmaceutical intervention for the foreign cancer chemotherapy
鈴木隆宏1, 草野元1, 渡部智文1, 佐藤かおり1, 池田友香1, 松田明宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2018.
Japanese Article P0238-24-AM. Efforts to the improvement of the drug reporting book in the foreign chemotherapy
今井陽子1, 寺岡綾1, 一色靖洋1, 生島五郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2018.
Japanese Article P0240-24-AM. Construction of the order substitution input procedure by efforts - pharmacist for the rise in HBV-DNA fixed-quantity examination rate of use and effect ...
山中義裕1, 臼井崇1, 小島愛1, 横山正人1, 朝日恵美2, 日比知志3, 田村圭浩4, 岡本好史5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2018.
Japanese Article P0242-24-AM. Efforts in our hospital in alerting it for the driving, and the like of foreign cancer chemotherapy patients
棚田訓彰1, 渡瀬美登里1, 高浪優紀1, 今村陽子1, 柏田匡広1, 大石貴裕1, 池田浩和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2018.
Japanese Article P0244-24-AM. About renal carcinoma, usefulness of by medical examination front for treated patients of the prostate cancer
堀晃代1, 田中和秀1, 板津直美1, 大澤友裕1, 安田昌宏1, 水井貴詞1, 米田尚生2, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2018.
Japanese Article P0246-24-AM. Gather, and is given a preparation an anticancer herbalist, for exposure measures until the disposal without interruption
坂田茂代1, 平野聡子1, 山口文子1, 名和亜利沙1, 佐藤透1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2018.
Japanese Article P0248-24-AM. Environmental pollution investigation of the anticancer agent exposure
杉村勇人1, 間瀬広樹1, 石嶋麗1, 中出恵里奈1, 本井悠子2, 嶽加奈子2, 坂倉喜代美2, 北俊之3, 秋山哲平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2018.
Japanese Article P0250-24-AM. Introduction ... of the cleaning method using consideration - ozone water from anticancer agent exposure findings in our hospital
八重樫允徳1, 高橋喜統1, 荒井涼子1, 山本康人1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2018.
Japanese Article P0252-24-AM. Efforts of the administration route introduction of the anticancer agent exposure measures closed system anesthesia system in the pediatric hospital
小川沙夕里1, 小森桂子1, 寺岡知香1, 浅原章裕1, 藤川郁世1, 大津由美子1, 藤田敬子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2018.
Japanese Article P0256-24-AM. Effect of the cost side by the introduction of the closed system anesthesia mixture adjustment appliance
清水浩幸1, 中野歩1, 前田祥花1, 廣岡賢輔1, 米田栄子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2018.
Japanese Article P0258-24-AM. The current situation and problem of the introduction of the closed system anesthesia drug transportation system chemosafe in our hospital
冨山成章1, 田實裕介1, 松ヶ野聡美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2018.
Japanese Article P0260-24-AM. Efforts of exposure measures by the closed system anesthesia appliance entire surface introduction at anticancer agent preparation
陣田剛志1, 岡田悠加1, 佐倉小百合1, 藤原康浩1, 國東ゆかり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2018.
Japanese Article P0262-24-AM. Attitude survey about an effective evaluation and the anticancer agent exposure for nurses to priming enforcement in the pharmacy
井口菜摘1, 鈴木毅1, 石井岳夫1, 難波有智1, 水野いず美2, 門田靜明2, 与那覇房子1, 外間惟夫1, 中村克徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2018.
Japanese Article P0264-24-AM. Pollution investigation by the cyclophosphamide exposure to restroom in being at home
加藤雅斗1, 宮澤憲治2, 早川裕二1, 溝神文博1, 平野隆司1, 關留美子3, 勝見章4, 小林智晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2018.
Japanese Article P0247-23-PM. Examination about the error of the quantity of preparation in the anticancer agent no bacteria preparation of the lyophilized products
北出紘規1, 宮永和美1, 示野哲也1, 西山郁雄1, 大田栄一1, 久保勝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2018.
Japanese Article P0249-23-PM. Follow-up ... of environmental monitoring - five years for the anticancer medicine exposure in the new hospital
三宅知宏1, 野口祥紀1, 服部公紀1, 中西由衣1, 小川晃宏1, 内田早弓1, 和田亜希1, 谷村学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2018.
Japanese Article P0251-23-PM. Participate in actual situation and problems - national hospital mechanism network collaborative investigation of the exposure situation obtained from the anticancer medicine exposure findings; and ...
玉木慎也1, 高田慎也1, 鈴木訓史1, 高橋由美2, 渡邊健一3, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2018.
Japanese Article P0253-23-PM. About the efforts of anticancer agent exposure measures in our hospital
太田哲徳1, 溝口由梨香1, 永田愛子2, 南雲里美2, 染谷美佐2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2018.
Japanese Article P0255-23-PM. Use fact-finding for the drug costs reduction by the Drug Vial Optimization introduction of the injection anticancer agent
目黒聡子1, 永倉史子1, 熊谷修一1, 佐々木裕花1, 糸井彩乃1, 渡辺京彦1, 大川真里奈1, 大久保淑子1, 田中統子2, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2018.
Japanese Article P0259-23-PM. Duties burden investigation to hang over the core ring incidence and product made in reshaping at anticancer agent preparation using the closed system anesthesia drug transportation system
矢野安樹子1, 濟川聡美1, 白石沙弥1, 中井昌紀1, 安永大輝1, 高田裕介1, 乗松真大1, 坂本宜俊2, 飛鷹範明1, 田中守1, 田中亮裕1, 薬師神芳洋3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2018.
Japanese Article P0261-23-PM. Attitude survey of the preparation staff by the anticancer medicine preparation inspection system introduction in our hospital
古林園子1, 小沼大祐1, 神長雅浩1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2018.
Japanese Article P0263-23-PM. Pollution fact-finding of the anticancer medicine in the chemotherapy room restroom
景秀典1, 井野川徹1, 河野友昭1, 高山慎司1, 後藤一美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2018.
Japanese Article P0265-23-PM. Fact-finding of the edematous expression in the docetaxel
鈴木博1, 後藤孝之1, 深谷一2, 樋口徹3, 有澤文夫3, 斎藤毅3, 佐竹清1, 興野克典1, 町田充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2018.
Japanese Article P0267-23-PM. The case that induced cancer treatment-related heart failure in our hospital
蓮尾憲作1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2018.
Japanese Article P0269-23-PM. One case with the heart failure attributable to the estracyt which we took for ten years
後藤健志1, 竹尾恵理子1, 酒井欣嗣2, 石川真平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2018.
Japanese Article P0271-23-PM. The effect that hypoalbuminemia at the paclitaxel + ramucirumab combination therapy gives to neutropenias Grade3 or more on gastric cancer
中澤佑介1, 影山明1, 原田大1, 北村正樹1, 三森教雄2, 川久保孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2018.
Japanese Article P0273-23-PM. It is an example with suspected cefepime encephalopathy during febrile neutropenia treatment after the cancer chemotherapy
小川智子1, 明石直子1, 萬浪綾乃1, 清水彩加1, 庄野裕志1, 大谷陽子2, 宮部貴識1, 佐光留美1, 増田慎三2, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2018.
Japanese Article P0275-23-PM. Examination for the effect of the paclitaxel nab-paclitaxel to give thrombocytopenia expression of Carboplatin
西部幸一1, 森本雅子1, 佐藤裕美1, 松村翔太1, 稲井邦宏1, 高橋奈々恵1, 小山絹子1, 福野和治1, 松川雅子1, 今井桂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2018.
Japanese Article P0277-23-PM. 2 case ... which was restored from denosumab administration ... dangerously ill low Ca blood symptom to the haemodialysis patients with metastases to bone
宿谷光則1, 小林俊博1, 中島敦美1, 坪谷綾子1, 松本浩1, 伊藤由香1, 相田紘一郎2, 吉岡まき2, 瀧康洋3, 冨永直人3, 坂下裕子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2018.
Japanese Article P0281-23-PM. One case that interstitial pneumonia and hypersensitivity complicated during the adjuvant chemotherapy CapeOX enforcement after the operation
菊地義明1, 高橋誠1, 藤林遼1, 庄崎沙耶1, 藤田果那1, 朝倉幹己1, 田中耕太1, 木下愛1, 山本翔太1, 山田将悟1, 前川英輝1, 鈴木直哉1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2018.
Japanese Article P0283-23-PM. Comparison of the onset of vascular pain situation in lyophilized products of the gemcitabine and the solution
橋本浩季1, 村上通康1, 宮崎実千芸1, 山口恭平1, 佐伯恵2, 福岡沙知2, 東千恵2, 玉井恭子2, 川口英俊3, 白石猛4, 西崎隆5, 仙波昌三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2018.
Japanese Article P0285-23-PM. Consumption investigation of Pregabalin for chemotherapy-induced peripheral neuropathy (CIPN) and examination of the cancellation influence factor
粟井明日香1, 山本智也1, 新谷拓也1, 麻那古信之1, 今中良1, 原伸輔1, 勝浦正人1, 門脇裕子1, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2018.
Japanese Article P0287-23-PM. The expression situation and the correspondence situation investigation of Oxaliplatin hypersensitivity
谷口潤1, 金澤絵莉1, 村上摩利2, 佐伯哲3, 橋本雅司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2018.
Japanese Article P0291-23-PM. Effect on endocytosis of the cisplatin by the Mg combination
安田恵1, 岸本修一2, 天野学1, 福島昭二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2018.
Japanese Article P0293-23-PM. Research of the treatment continuation factor of the gemcitabine cisplatin therapy for the elderly people urothelial carcinoma
八木聡美1, 藤野泰孝1, 福澤翔太1, 佐々直人2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2018.
Japanese Article P0295-23-PM. A GFR estimation type in the Carboplatin doses setting in the gynecologic cancer TC therapy of Japanese people and investigation about the side effect
吉川英里1, 田辺公一3, 水野加奈子1, 飯澤泉2, 藤堂由紀2, 麻生美佐子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2018.
Japanese Article P0297-23-PM. Use fact-finding of the Carboplatin desensitization
柴田直樹1, 川上和宜1, 中村匡志1, 平出誠1, 竹野伸洋1, 吉岡秀哲1, 鈴木賢一1, 温泉川真由2, 竹島信宏3, 濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2018.
Japanese Article P0299-23-PM. Examination about the effect that dysgeusia by adjuvant chemotherapy S-1 gives for treatment after the gastric cancer technique
石川寛1, 佐藤淳也1, 若林茜1, 宮口貴守1, 増島広幸1, 田中怜1, 金子美智子1, 鴨志田武1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2018.
Japanese Article P0301-23-PM. Attempt of the information storage every regimen for nourishment intervention of the effective cancer chemotherapy by the ward pharmacist
丸岡浩太1, 中島のぞみ1, 山田倭花1, 内山乃映1, 村松奈緒美1, 大窪真理絵1, 伊代田萌子1, 梅澤仁美1, 河村伸介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2018.
Japanese Article P0303-23-PM. Investigation about start doses and continuance of lenalidomide for the multiple myeloma and the dermatopathy
永田和美1, 正置耕一1, 高子優子1, 澁谷奈穂1, 近藤万友美1, 吉岡睦展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2018.
Japanese Article P0305-23-PM. Look at the rear about the usefulness of the antithrombotic therapy at the multiple myeloma therapeutic drug IMiDs treatment; mark investigation
隅田英幸1, 槙枝大貴1, 二宮洋子1, 佐野史典2, 近藤英生2, 和田秀穂2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2018.
Japanese Article P0307-23-PM. Examination of the risk factor of the immune-mediated adverse event expression with the immune checkpoint inhibitor
古田裕幸1, 今津邦智1, 中田恭子1, 長尾宣宏1, 大畑広貴1, 石川暢久2, 篠崎勝則3, 土井美帆子3, 林聖二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2018.
Japanese Article P0309-23-PM. Example that intervened pharmaceutical for the adrenal disorder that occurred by nivolumab administration
波々壁信也1, 須田智1, 望月真太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2018.
Japanese Article P0311-23-PM. Examination about allergic related conditions in the antiPD-1 antibody medicine
星田唯史1, 森本奈緒美1, 藤原大一朗1, 眞下惠次1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2018.
Japanese Article P0313-23-PM. Side effect case of the use of Pembrolizumab situation and the dermatopathy of our hospital
森脇典子1, 平良智1, 山本紗織1, 福大哉1, 稲嶺盛佳1, 長濱照美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2018.
Japanese Article P0315-23-PM. Investigation of the intervention situation of the pharmacist for the antihypertensive therapy accompanied with the use of neovascularisation inhibitor in our hospital
上杉章紀1, 羽田野翔太1, 木内貴章1, 水野奈穂子1, 加藤良治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2018.
Japanese Article P0317-23-PM. Examination of protein urine and the adverse event in bevacizumab ramucirumab treated patients
丸田基史1, 山科卓也1, 藤田強記2, 高武嘉道2, 中川義浩2, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2018.
Japanese Article P0319-23-PM. We read the side effect expression of patients with TAS-102 medication situation from liver function and renal function
古橋隆久1, 鈴木善貴1, 杉山みづほ1, 丸山昌広1, 中村希和子1, 加藤裕子1, 加藤愛実1, 伏見英晃1, 河内沙織1, 小林さやか1, 氷見敬嗣1, 鳥山琴美1, 加藤知加依1, 河西愛美1, 板垣千華1, 野中梨恵1, 門井実1, 定盛理純1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2018.
Japanese Article P0321-23-PM. Fact-finding about menstruation after the LH-RH agonist preparation administration in patients with premenopausal hormone acceptor-positive breast cancer and the side effect
冨田奈々1, 平野公美1, 宮本康敬1, 遠藤拓未1, 杤久保順平2, 細川優子2, 渡邉進士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2018.
Japanese Article P0323-23-PM. Chemical depression of the side effect of EGFR tyrosine kinase inhibitor
大森紀和1, 米澤穂波1, 上原至雅1, 西谷直之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2018.
Japanese Article P0266-24-AM. Search of the factor about the onset of neutropenia in the Ramucirumab + Paclitaxel therapy
鈴木弘文1, 千葉健史2, 柳生千代子3, 青木毅一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2018.
Japanese Article P0268-24-AM. The onset situation of FN by the fresh food intake in the solid carcinoma chemotherapy
渡部寿康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2018.
Japanese Article P0270-24-AM. About the blood toxicity in the breast cancer technique aftercare TC therapy
阿部多一1, 住谷達也1, 井口恵美子1, 清水大輔2, 猪股克彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2018.
Japanese Article P0272-24-AM. It is an example with suspected the HBV activation by nab-paclitaxel administration
井ノ口岳洋1, 輪湖哲也1, 田中弘人1, 中村博子1, 敦賀剛気1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2018.
Japanese Article P0274-24-AM. Investigation of the angular stomatitis development situation in the use of capecitabine patients
北澤美里1, 今野慶一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2018.
Japanese Article P0276-24-AM. Present with serious myelosuppression and mucous membrane disorder; one case with suspected capecitabine intolerance
小池彩子1, 出宮千聖1, 中尾なつみ1, 永原照也2, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2018.
Japanese Article P0278-24-AM. Starting pharmaceutical products of the oxaliplatin infusion liquid, comparison of the vascular pain frequency between the generic medicine
田中康弘1, 宮原強1, 松永尚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2018.
Japanese Article P0280-24-AM. Questionary survey about the current situation of the pharmacist intervention for CIPN
石嶋麗1, 中出恵里奈1, 間瀬広樹1, 杉村勇人1, 齋藤讓一1, 秋山哲平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2018.
Japanese Article P0282-24-AM. Search of the factor associated with the constipation aggravation after the palonosetron administration
木村早希子1, 細矢和久1, 緒方健二1, 古野龍也1, 祖川倫太郎1, 田崎正信1, 川口淳2, 柏田知美3, 荒金尚子1,4, 能城浩和5, 倉富勇一郎6, 横山正俊7, 野口満8, 安西慶三9, 山下佳雄10, 木村晋也2,3, 成澤寛1,11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2018.
Japanese Article P0284-24-AM. Examination about a relation and the safety of the pharmacist for the short hydration method introduction of the cisplatin
光家勉1, 久保緑1, 北村登喜生1, 米川恭史1, 渡部なおみ1, 富田国男1, 吉田友紀2, 塘賢二郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2018.
Japanese Article P0286-24-AM. The side effect expression situation investigation of the use of cisplatin regimen in elderly people
高田遼1, 山下亜友1, 吉岡薫1, 山崎将英1, 國本雄介1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2018.
Japanese Article P0288-24-AM. Polypharmacy measures in the chemotherapy including the cisplatin
山田千代子1, 米澤美和1, 久保杏奈1, 虎瀬和子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2018.
Japanese Article P0290-24-AM. One case that a hypersensitivity symptom by the doxorubicin developed during adjuvant chemotherapy after the breast cancer technique
井上徹雄1, 松高秀昭1, 稲角利彦1, 田中一穂2, 櫻井美由紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2018.
Japanese Article P0292-24-AM. Examination of Nedaplatin doses according to the renal function in the bladder cancer GN therapy
山本悠樹1, 稲野寛1, 米山大志1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2018.
Japanese Article P0296-24-AM. Investigation for the use situation of the Drd therapy in the Naha Municipal Hospital and the side effect expression
比嘉大輔1, 永井賢作1, 金城雄一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2018.
Japanese Article P0298-24-AM. Examination of the effect of the side effect expression situation investigation and the use of the immune checkpoint inhibitor in our hospital of steroid
永松秀紹1, 三島江津子1, 榊原洋一1, 中野里佳2, 竹内由佳2, 村上照幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2018.
Japanese Article P0300-24-AM. Examination of frequency and the clinical features of the immune-mediated side effect of nivolumab in the non-small cell lung cancer
金崎修平1, 中尾將彦2, 長底利恵1, 木村仁美1, 山崎直樹1, 吉田徹也1, 坪口裕子3, 津谷あす香3, 駄賀晴子3, 村田みどり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2018.
Japanese Article P0302-24-AM. Examination about the safety of the Osimertinib in the non-small cell lung cancer
中西大介1, 畑地治2, 柳川泰裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2018.
Japanese Article P0304-24-AM. About a change of blood pressure, proteinuria by the bevacizumab and a change of the renal function
長岡麻沙美1, 津曲恭一1, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2018.
Japanese Article P0306-24-AM. About the introduction of the protein urine/creatine ratio at use of antiVEGF antibody medicine in our hospital and examination of the usefulness
斎藤恭正1, 北川和男2, 淺利知1, 戸田裕太1, 宇井可奈枝1, 三橋平2, 山本秀巨3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2018.
Japanese Article P0308-24-AM. Use fact-finding about Lenvatinib proper use in patients with thyroid cancer
大野千尋1, 石橋麻衣2, 浜田幸宏1, 外賀裕次郎1, 川辺桂太郎1, 岡本高宏3, 木村利美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2018.
Japanese Article P0310-24-AM. The current situation investigation of the rasburicase administration in our hospital
石井一也1, 中村豪志1, 荻原好章1, 神原康佑1, 大塚識稔1, 原景子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2018.
Japanese Article P0312-24-AM. Examination about the difference in onset of infusion reaction by the dilution level of rituximab
松本浩明1, 益本周治1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2018.
Japanese Article P0314-24-AM. About the onset of adverse event situation by the rituximab Biosimilar
田中裕章1, 水岡大策1, 山口佳津騎1, 高橋功一1, 安宅希美子1, 本田由紀1, 元木貴大1, 加地雅人1, 朝倉正登1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2018.
Japanese Article P0316-24-AM. We look at the rear of the regorafenib for unresectable progress colon cancer and are examined the use situation and the medication method by the mark investigation
小谷野大地1, 高山俊輔1, 増田裕子1, 土肥大典1, 鍵山智樹1, 玉木秀子2, 真壁秀樹1, 濱口哲弥3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2018.
Japanese Article P0318-24-AM. Investigation about the Palbociclib administration in the Brest peer Miyazaki Hospital
永友由里子1, 三根明1, 駒木幹正2, 齋藤智和2, 船ケ山まゆみ2, 前田資雄2, 柴田伸弘3, 中原浩4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2018.
Japanese Article P0320-24-AM. Risk factor investigation of the onset of liver function abnormality by the Erlotinib
梅田道1, 大澤友裕1, 甲田明英1, 大野佑城1, 安田昌宏1, 水井貴詞1, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2018.
Japanese Article P0324-24-AM. It is examined fatigue, the lassitude improvement in the change in an Enzalutamide remedy timing
関永彩夏1, 吉川明良1, 村上礼隆1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2018.
Japanese Article P0327-23-PM. Economic evaluation of 5-HT3 receptor blocker palonosetron in the CHOP therapy
黒田真希1, 木村雄太2, 高田慎也1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2018.
Japanese Article P0329-23-PM. Evaluation of the effectiveness of olanzapine for retching, vomiting that cancer medical therapy causes
平野翔子1, 嶋田修治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2018.
Japanese Article P0331-23-PM. Use investigation before and after the well-known application of "the digestive organ symptom with the antineoplastic administration" of olanzapine
松本和樹1, 橋本早苗1, 廣畑秀記1, 酒井克紀1, 福田英克1, 南波勝栄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2018.
Japanese Article P0333-23-PM. Examination about the effectiveness of the antiemetic in the gemcitabine hydrochloride + nab-paclitaxel combination therapy (GEM + nab-PTX therapy)
深井靖大1, 楠本将裕2, 横田崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2018.
Japanese Article P0335-23-PM. The proper use promotion of the antiemetic drug in the chemotherapy of stomach and the cancer of the esophagus and improvement of the compliance
宇都宮奈々1, 沖田健太郎1, 長谷川将1, 安河内寿成1, 松永里香1, 中道亜依子1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2018.
Japanese Article P0326-24-AM. Effect on antiemesis effect by the presence or absence of aprepitant administration in the Carboplatin - albumin-binding paclitaxel therapy
西村亮1, 中西真也1, 吉野新太郎1, 原田卓弥1, 中浴伸二1, 濱宏仁1, 森本茂文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2018.
Japanese Article P0328-24-AM. Effect of the ramosetron as retching vomiting measures with the azacitidine administration on myelodysplastic syndrome
山田政典1, 田中彩2, 黒岩三佳3,4, 大徳真也3, 潟永安亘2, 安谷屋源2, 後藤隆2,4, 草葉一友2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2018.
Japanese Article P0330-24-AM. Antiemesis therapy investigation under the use of olanzapine in our hospital
鈴木俊一1, 根本昌彦1, 岩山竜大1, 阿部春果1, 原田悠介1, 小川竜徳1, 坂本莉紗1, 山元麻衣1, 佐藤渉1, 四十物由香1, 齋藤祥子1, 青山芳文1, 大河原悠2, 名和健2, 品川篤司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2018.
Japanese Article P0332-24-AM. Investigation about the use actual situation of non-fixed form antipsychotics (olanzapine) in the antiemesis treatment of cancer chemotherapy patients
坂倉智子1, 岩澤真紀子2, 柳澤優里2, 瀬戸良教1, 椎崇1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2018.
Japanese Article P0334-24-AM. Usefulness evaluation of the antiemesis supportive care using "a treatment diary" for the purpose of the symptom grasp of foreign cancer chemotherapy patients
福長豊己1, 森川記道1, 西倉教子1, 西原昌幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2018.
Japanese Article P0336-24-AM. About the CINV expression situation of a gynecologic cancer of our hospital and the Carboplatin-containing regimen in the lung cancer domain
岩村高弘1, 藤井秀一1, 森光保武1, 神原史織1, 尾高登美枝1, 福場夕起1, 岡本直樹1, 高田悠作1, 前原健司1, 池田敦1, 岩永崇志1, 杉原義彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2018.
Japanese Article P0337-23-PM. The effect that peg filgrastim gives to docetaxel therapy in castration-resistant prostate cancer treatment
高武嘉道1, 鶴崎泰史1, 藤田強記1, 花田聖典1, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2018.
Japanese Article P0339-23-PM. Examination of the peg filgrastim administration time for the R-CHOP therapy to elderly people
佐々木美織1, 櫻井淳二1, 野澤寿吉2, 佐藤伸輔1, 宮内康夫1, 阿部順1, 阿部正理3, 野村順3, 石澤文章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2018.
Japanese Article P0343-23-PM. About effect of the UGT1A1 genetic polymorphism giving it to the irinotecan administration in the digestive organ cancer case
高橋健太1, 浦田理華1, 浅野順治1, 太宰昌佳2, 関沢祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2018.
Japanese Article P0345-23-PM. One case that received FOLFOX therapy for patients with progress gastric cancer during haemodialysis
松尾尚美1, 鶴山萌子3, 横山知美1, 鶴田南奈子1, 三好孝法1, 丸田基史1, 田尻裕匡2, 江頭明典2, 川中博文2, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2018.
Japanese Article P0347-23-PM. Effect of the diabetes merger on prognosis of patients with nabPTX + GEM therapy enforcement pancreatic cancer
林明希1, 武智研志1,2, 中馬真幸1,2, 岡田直人1, 今西正樹1, 座間味義人1,3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2018.
Japanese Article P0349-23-PM. The use situation of antiPD-1 antibody Pembrolizumab in our hospital
石崎文子1, 相原敏彦1, 増尾昌則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2018.
Japanese Article P0351-23-PM. Development of clinical test value check system (LDCS) in the cancer chemotherapy and examination of the usefulness
本田由紀1, 井上達也1, 安宅希美子1, 高橋功一1, 山口佳津騎1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2018.
Japanese Article P0353-23-PM. Factor analysis to have an influence on the infusion reaction expression at the Rituximab administration
小川晃宏1, 野口祥紀1, 三宅知宏1, 谷村学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2018.
Japanese Article P0355-23-PM. We look at the effectiveness of Daratumumab in the Japanese recurrent or refractory multiple myeloma and the rear about the safety and examine a mark
小倉宏之1, 中川雄介1, 伊勢崎竜也1, 鈴木正論1, 安室修1, 小林宏紀2, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2018.
Japanese Article P0357-23-PM. Examination of the bevacizumab addition effect after the monotherapy PD judgment of the trifluridine Tipiracil hydrochloride
桝茂典1, 成廣哲史2, 岡田悠美1, 安藤尚美1, 中川隼一1, 櫻井彩乃1, 高橋苑子1, 高橋真一1, 蔭山博之1, 平島徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2018.
Japanese Article P0359-23-PM. 1 case that was treated effectively with a 1% alum water continuation perfusion therapy for hemorrhagic cystitis with cyclophosphamide in patients with acute severe renal failure
岡崎敏幸1, 吉井圭佑1, 春木祐人1, 江草太郎1, 山下真弘2, 杉山哲大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2018.
Japanese Article P0361-23-PM. The effectiveness of the Hangeshashinto gargle for stomatitis by the Everolimus
阿部圭輔1, 阪田安彦1, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2018.
Japanese Article P0363-23-PM. Examination about the safety of the PCC therapy for oral cancer
鈴木訓史1, 河村奈々美1, 田中寛之1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2018.
Japanese Article P0365-23-PM. Fact-finding of the antimicrobial prescription after the foreign chemotherapy enforcement
仁尾祐太1,2, 杉田栄樹1,2, 奥村和子3, 清水久範1,2, 佐々木忠徳1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2018.
Japanese Article P0367-23-PM. The current situation investigation, a cause and measures of the omission of calculation of the foreign chemotherapy addition in the Ina center Hospital
六波羅孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2018.
Japanese Article P0338-24-AM. The comparison that enforced peg filgrastim in the breast cancer dose dense AC therapy in day2 or day4
生田智基1, 亀岡春菜1, 筒井陽子1, 小暮友毅1, 槇恒雄1, 小池恭正1, 宇野摩耶2, 三好雄一郎2, 高橋三奈2, 原文堅2, 高嶋成輝2, 青儀健二郎2, 大住省三2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2018.
Japanese Article P0340-24-AM. Examination of the usefulness of the peg filgrastim in the amrubicin therapy for the small cell lung cancer
杉野善彦1, 浅野寿規1, 桜田宏明1, 山村益己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2018.
Japanese Article P0342-24-AM. Comparison every disease about the possibility of the interaction judging from the content of the use drug in patients with blood-forming organ tumor
武内偲乃1, 大里洋一1, 五味緩子1, 長山佳之1, 大塚健太郎1, 大橋養賢1, 谷地豊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2018.
Japanese Article P0344-24-AM. The effect that dose setting in consideration of age and degree of corpulence gives to the cancer chemotherapy of blood-forming organ tumor
白井雄大1, 槇枝大貴1, 植木春香1, 亀尾剛士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2018.
Japanese Article P0346-24-AM. Elucidation of the clinical significance of the cancer-restraining gene CYLD expression drop in the breast cancer medical therapy
西郷智香1, 平井ちか2, 桑野明香理2, 林光博3, 岩瀬弘敬4, 齋藤秀之1, 城野博史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2018.
Japanese Article P0348-24-AM. Effect of the renal function on RDI of the gemcitabine in the GC therapy
関口展貴1, 杉山昌秀1, 宮田智陽1, 篠原佳祐1, 岩水雅俊1, 渡邉将隆1, 関戸大司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2018.
Japanese Article P0350-24-AM. The effectiveness of pancreatic cancer chemotherapy GS therapy in our hospital, FOLFIRI-NOX therapy, the GEM + nabPTX therapy and safe examination
服部豊1, 齊藤麻衣子1, 安孫子瞳1, 山澤真之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2018.
Japanese Article P0352-24-AM. The use situation of antiPD-L1 antibody atezolizumab for the non-small cell lung cancer
成田綾香1, 米澤美和1, 山田千代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2018.
Japanese Article P0354-24-AM. Examination of the medication method of the daratumumab
松林麻里子1, 石原溶子1, 大橋一輝2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2018.
Japanese Article P0356-24-AM. Comparison of KRd therapy and the IRd therapy in the recurrent or refractory multiple myeloma
淺野肇1, 宮本大嗣1, 森嶋祥之1, 芦田隆司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2018.
Japanese Article P0360-24-AM. One case that we became in desensitization for etoposide hypersensitivity suspicion if treatment was possible continuously
松本友香理1, 多賀谷光2, 福嶋知樹1, 橋本晃樹1, 菊池良介1, 中澤一磨1, 橘田文彦1, 手塚春樹1, 河田圭司1, 鈴木正彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2018.
Japanese Article P0362-24-AM. Pharmacist attitude survey questionnaire before and after the educational program enforcement for oral mucositis of patients with cancer
吉田謙介1, 勝良剛詞2, 島田泉1, 田中雄介1, 鈴木直人1, 高木律男3, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2018.
Japanese Article P0364-24-AM. Examination about the use of opioid for oral mucositis with the head and neck cancer chemoradiotherapy
永谷明子1,2, 高橋典子1,2, 松井美月1,2, 須永登美子1,2, 渡邊徹1,2, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2018.
Japanese Article P0366-24-AM. Investigation of the onset of low Mg blood symptom situation and the Mg supply situation with the Cetuximab administration for head and neck cancer
田代紘士1, 平池美香子1, 牛島知実1, 坂口晋哉1, 堤国章1, 川俣洋生1, 林稔展2, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2018.
Japanese Article P0368-24-AM. Investigation, examination of doubt inquiry in anticancer agent preparation duties and prescription confirmation contents
山村真貴子1, 沖田健太郎1, 安河内寿成1, 上地純子1, 宗本佐知子1, 三村英恵1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2018.
Japanese Article P0369-23-PM. Attitude survey using the attitude scale (FATCOD-Form B-J) about the terminal care for a hospital, drugstore pharmacists
熊井正貴1, 加藤信太郎1, 小柳遼1, 久保田康生1, 古堅彩子2, 鳴海克哉2, 小林正紀1, 笠師久美子1, 土居由有子3, 郡修徳4, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2018.
Japanese Article P0371-23-PM. Search study of the factor influencing the necessity or not of the tight military ration of the fentanyl oral mucosa absorbent
藤本英哲1, 中村めぐみ1, 藤村昭太1, 大矢浩之1, 佐野元彦1, 近藤正巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2018.
Japanese Article P0377-23-PM. 1 case with suspected attenuation of serving mild sufferings from breathing of the opioid by combination of the naldemedine
小島正照1, 宇野崇之1, 荒木良介1, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2018.
Japanese Article P0379-23-PM. Examination about the effectiveness of the tapentadol for the metastases to bone-related pain
西村美馨子1,2, 奥苑朱加2, 高岡龍蔵2, 中村智絵2, 後藤健志1,2, 遠山幸男2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 石川真平1, 板倉由縁3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2018.
Japanese Article P0381-23-PM. The use situation of the drug for the medical care for the pain due to mucositis in the advanced head and neck cancer
村上郁1,2, 市倉大輔1,2, 縄田修一1,2, 峯村純子1,2, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2018.
Japanese Article P0383-23-PM. Efforts to the self-care operation of the drug for the medical care
西澤圭祐1, 山関智恵1,4, 飯田昭宏1,4, 岩本貴子3,4, 青木佐知子2,4, 田嶋学2, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2018.
Japanese Article P0385-23-PM. The current situation of bisphosphonate injection preparation and the onset of necrosis of the jaw bone
伊藤友一1, 今岡寛美1, 森住誠1, 石原美加1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2018.
Japanese Article P0387-23-PM. One case that a pharmacist intervened in the palliation of the colon cancer peritoneum dissemination patients, and was able to leave the hospital
勝又一雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2018.
Japanese Article P0389-23-PM. Role of the pharmacist attending the medical examination of the physician in the palliative care outpatient department
饗庭孝一1, 近藤結1, 小澤祐介1, 小池健太1, 岡平将志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2018.
Japanese Article P0391-23-PM. Contribution degree investigation of the current situation and the charge pharmacist about the palliative care in the national hospital mechanism (the fourth report)
中村孝佑1,2, 形部文寛2, 武智宣佳2, 小野友香2, 波多江崇3, 八本久仁子2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2018.
Japanese Article P0393-23-PM. We look back on the end-of-life approach for patients with heart failure who had colon cancer
隅田美紀1,4, 粥川真衣1, 小木曽正輝1, 亀山祐行2,4, 林和徳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2018.
Japanese Article P0370-24-AM. Comparison between betamethasone and dexamethasone about the lassitude improvement in patients with terminal cancer
水越千晶1, 高野尊行1, 倉井由香1, 柿沼博子1, 長尾結花1, 中丸朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2018.
Japanese Article P0372-24-AM. Examination of the usefulness for the analgesic effect of the fentanyl sublingual tablet for the cancer pain
和田紀子1,2, 半田智子2, 山本仁美2, 樋口比登実3, 佐々木忠徳1,4, 加藤裕久2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2018.
Japanese Article P0374-24-AM. About the use situation and usefulness of the naldemedine
南貴之1, 若月淳一郎1, 花輪和己1, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2018.
Japanese Article P0376-24-AM. Use fact-finding of the naldemedine for the opioid-induced constipation in patients with cancer
久枝真一郎1, 西明子1, 宗広樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2018.
Japanese Article P0378-24-AM. An example with suspected ileus by the naldemedine
高橋未來1, 宇田竜也1, 中田和宏1, 加藤知孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2018.
Japanese Article P0380-24-AM. 1 case that an elimination of pain effect and tolerability were shown in by pain control by the high-dose tapentadol
宇野崇之1, 小島正照1, 荒木良介1, 菱沼隆一1, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2018.
Japanese Article P0382-24-AM. Efforts of the pharmacist outpatient department for the use of drug patients for the medical care
郷治久美1,2, 深津昌弘1, 水元弥生2, 熊澤尚美2, 澤田憲朗2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2018.
Japanese Article P0384-24-AM. National survey about the actual situation of the internal use rescue medicine (drug) self-care of the inpatient for the cancer practice cooperation base Hospital, and the like
杉浦礼菜1, 中村和行2, 野田実希2, 黒野俊介1, 杉浦洋二2, 長谷川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2018.
Japanese Article P0386-24-AM. About difference in dose setting of the acetaminophen preparation in adults less than 50 kg in weight, we examine validity from the presence of the liver damage after the administration
高野陽平1, 上野英文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2018.
Japanese Article P0388-24-AM. An example of the young breast cancer that suffered from pain relief though we gave medical therapy in consideration of a lifework
前田晶美1, 柏木佑貴1, 足立恵子1, 前田翠1, 依藤健之介1, 松本章士1, 山神和彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2018.
Japanese Article P0390-24-AM. About a setup of the palliative care unit in the small and medium size special hospital and pharmacist duties
寺本拓哉1, 吉丸侑子1, 山本裕子1, 猿渡康宏1, 伊藤由希1, 赤坂綾1, 横山賢二1, 丸田佐知子1, 水本智子1, 平井裕子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2018.
Japanese Article P0392-24-AM. The preparations situation of the palliative care-related drug in the regional alliances institution
鈴木景就1, 村川麻里子1, 石渡明子2, 明石浩史3, 木村雅美4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2018.
Japanese Article P0394-24-AM. Two patients who responded to mexiletine hydrochloride internal use for rectal tenesmus
山下千草1, 川原裕1, 佐野雅昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2018.
Japanese Article P0395-23-PM. After the operation in the cardiovascular surgery efforts (the third report) for use of infection prophylaxis antimicrobial aptitude
吉川慧1,3, 鈴木ゆきえ1,3, 花房喜子1,3, 小森亮子1,3, 小椋大1,3, 渡部智文1, 松田明宏1, 吉川真一4, 吉田進4, 高木賢司3, 飯高祐子3, 林靖子3, 中山晴夫3, 入江嘉仁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2018.
Japanese Article P0397-23-PM. Investigation about the incidence of the use actual situation and SSI of the antimicrobial in the foreign normal tooth extraction
金子奨太1, 吉田謙介1, 磯辺浩和1, 鈴木直人1, 児玉泰光2, 高木律男2, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2018.
Japanese Article P0399-23-PM. Antimicrobial proper use evaluation before operation in the operation under laparoscopy of the uterine myoma
井上彩花1, 枦秀樹1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2018.
Japanese Article P0401-23-PM. It is the use situation investigation of the infection prophylaxis antimicrobial after the oral art in the cataract surgery
臼井和明1, 大石丸美1, 岩武幹乃1, 山村真貴子1, 安藤暢彦1, 森田佳博1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2018.
Japanese Article P0403-23-PM. The effect that a pharmacist-led antimicrobial proper use support activity gives to antibiotic exposure
林幹也1, 後藤志典1, 吉本和代1, 山元紀世子2, 白井雅美3, 伊藤美登里3, 赤崎淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2018.
Japanese Article P0405-23-PM. Relation of the pharmacist in the antimicrobial proper use support team
岡野翔1, 高橋詩織1, 岩崎正宏1, 清水勇基1, 重成大介1, 野田師正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2018.
Japanese Article P0407-23-PM. About AST activity in our hospital
小野寺潤1, 石井美千代2, 間地知子3, 武内悠里子4, 片山順平5, 中川基人6, 山田健一朗7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2018.
Japanese Article P0409-23-PM. About the activity of the antimicrobial proper use support team and the result
山本圭城1, 安井友佳子1, 大谷典子1, 中野剛志1, 飯田大貴1, 石坂敏彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2018.
Japanese Article P0411-23-PM. Antimicrobial Stewardship (AS) activity in our hospital using the antimicrobial proper use support sheet that linked an electronic medical chart and the evaluation
長谷川恭子1, 末永拓也1, 岩尾恭寛1, 工藤真裕1, 大庭奈未代2, 新島奈津子3, 高橋康一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2018.
Japanese Article P0413-23-PM. Intervention to antimicrobial proper use support of the small and medium size hospital pharmacist
緒方雅章1, 山本諒子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2018.
Japanese Article P0415-23-PM. Satisfaction investigation about the antimicrobial proper use support (AS) activity in the pharmacy
西本辰徳1, 山崎恵子1, 中村康彦1, 清水裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2018.
Japanese Article P0417-23-PM. Investigation of the use of oral antimicrobial situation in the ambulatory practice
田沼道也1, 田中昌代1, 田澤庸子2, 入口慎史1, 加藤敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2018.
Japanese Article P0419-23-PM. Adoption rearranging of the third generation oral cephalosporin
佐々木康弘1, 金丸亜佑美2, 山口明子3, 高安博史4, 矢野雅隆5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2018.
Japanese Article P0421-23-PM. Examination about the adoption situation of the carbapenem-based antimicrobial in the medical institution in Niigata
佐藤智功1, 三星知2, 継田雅美3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2018.
Japanese Article P0423-23-PM. Effect by the intervention point change to the use of carbapenem-based antimicrobial patients
徳山ことみ1, 馬生良則2, 横山恵三2, 二階堂弘美3, 安藤由香4, 矢野朋文5, 竹田克明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2018.
Japanese Article P0425-23-PM. Change of the rate of use of the appropriate culture test by the revision of the use of meropenem report vote
根本将徳1, 瀧澤幸三1, 黒金悦子1, 氣賀澤郁1, 加藤愛1, 山本航大1, 横田伸幸1, 濱野圭子1, 吉永芽以1, 山下創平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2018.
Japanese Article P0427-23-PM. Examination about a background factor and the vital prognosis associated with the renal function recovery after the onset of renal failure with vancomycin
植木哲也1,2,5, 實松絵美子1, 古谷頼和1, 篠原義剛1, 村上由花2, 宮崎晶2, 坂本佳子2, 眞柴晃一3, 中嶋弥穂子4, 中嶋幹郎5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2018.
Japanese Article P0429-23-PM. Comparison of the impaired renal function in injectable vancomycin and the injectable antimicrobial combination
萩原大樹1, 佐藤啓介1, 森脇典弘1, 兼重晋1, 神村英利1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2018.
Japanese Article P0431-23-PM. 1 case that infective endocarditis due to the MRSA was able to be treated with combination of vancomycin and daptomycin conservatively
天野哲史1,2, 生田幸江1,3, 山崎均1,4, 稲塚信郎1,5, 八並ゆかり2, 船戸優佑6, 服部晃左6, 杉浦厚司6, 板倉由縁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2018.
Japanese Article P0433-23-PM. Thrombocytopenia by the linezolid, examination of the serum Na level drop
森村春菜1, 秋場孝則1, 貝塚朋恵1, 小野田弘崇1, 塚本宏夢1, 中野一男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2018.
Japanese Article P0435-23-PM. The effect that an adoption standard change of the antimicrobial gives to medication method and drug costs
山崎洋平1, 山田彩加1, 新沼芳文1, 本郷文教1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2018.
Japanese Article P0437-23-PM. The effect that anti-VAIO gram and antimicrobial administration support using the critical path give to antimicrobial proper use
松木祥彦1, 石毛宏治1, 石田雅也1, 金井絵美1, 西沢大樹1, 富田千尋1, 大島香1, 杉田恵1, 長谷川雄介1, 米井万紀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2018.
Japanese Article P0439-23-PM. Presence and prognosis of the antibiotic exposure in the patients with non-serious case 10 case that is higher than C-reactive protein 40 mg/dL
福田哲也1, 伊東伶子1, 水越寛2, 山下知子2, 蓮見章太2, 八代智子1, 吉田誠也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2018.
Japanese Article P0441-23-PM. The onset of hepatic dysfunction situation investigation with voriconazole
吉原涼子1, 溝田繁治1, 松竹紀子1, 谷口潤1, 橋本雅司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2018.
Japanese Article P0443-23-PM. It is one patient using the colistin for the MDRP bacteremia of patients with congenital solitary kidney
井田真仁1,2, 鈴木伸志1,2, 岡村彰子2, 小林義正2, 飯草正実2, 本田なつ絵2, 松田直人2, 春木宏介2, 松本富夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2018.
Japanese Article P0445-23-PM. Evaluation of the effectiveness of the antimicrobial for the pyelonephritis case
池本雅章1, 岡村和彦1, 佐々木雄啓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2018.
Japanese Article P0447-23-PM. The case that took a ciprofloxacin high dose for purulent spondylitis
小澤拓1,2, 若松雄太1,2, 石津智司1,2, 小林敦子2, 高子優子1, 小川佳美1, 正置耕一1, 吉岡睦展1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2018.
Japanese Article P0449-23-PM. 1 case that suffered from negative pressure closed treatment and antibiotic exposure for MRSA mediastinitis that occurred after the coronary arteries bypass operation
山西彩香1, 城尾晃太1, 植田実佐1, 長橋かよ子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2018.
Japanese Article P0451-23-PM. Administration case ... by the simple suspension method that administration experience - exposure and the disposal loss of the valganciclovir to neonates in the municipal hospital were considered
寺崎玲香1, 後藤敏也1, 鈴木宏明2, 遠藤彰3, 正木銀三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2018.
Japanese Article P0396-24-AM. The postoperative infection event occurrence situation in the cardiovascular surgery surgery of our hospital
三橋未帆1, 杉尾和昭1, 小野田稔久1, 宮本康平1, 藺藤佑哉2, 齋藤綾2, 本村昇2, 増田雅行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2018.
Japanese Article P0398-24-AM. The perioperative glycemic control and surgical-site infections (Surgical site infection, SSI) prevention
森美奈子1, 日下部華子1, 中島みゆき1, 金内幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2018.
Japanese Article P0400-24-AM. It is efforts of the infection prophylaxis antimicrobial proper use after the operation in the child surgery
中山澄香1, 枦秀樹1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2018.
Japanese Article P0402-24-AM. It is effect of the infection prophylaxis antimicrobial cancellation after the onset situation of the infection and the oral art after the operation in the percutaneous transluminal coronary angioplasty
白石貴寿1, 臼井和明1, 栗原江未1, 宇都宮奈々1, 吉田悦朗1, 近藤真由1, 羽山千尋1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2018.
Japanese Article P0404-24-AM. Pharmacist-led antimicrobial proper use support team
古川大樹1, 伊藤嘉英1, 林房江2, 菱田志乃3, 長谷川雅哉1, 中尾彰宏4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2018.
Japanese Article P0406-24-AM. Efforts ... for antimicrobial proper use support activity - specific antimicrobial consumption decrease by the infection measures team
倍味亜矢子1, 中川典子1, 佐武喜美子1, 高岸ひろみ1, 岩田亜里1, 足立哲也1, 川口祐司1, 若林亜希子1, 桝屋根佳子1, 辻本吉広2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2018.
Japanese Article P0408-24-AM. Report of the Antimicrobial Steward ship Team activity in the Tomigusuku center Hospital
小杉卓大1, 新垣里奈1, 新垣淑大1, 長嶺結奈2, 安里彩子2, 島添亜依子3, 大嵩昌子3, 石川美根子3, 村山知生4, 橋本孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2018.
Japanese Article P0410-24-AM. About an activity of antimicrobial proper use support team (AST) of our hospital and the effect
平野典子1, 杉浦龍也1, 川瀬将紀1, 伊藤広樹1, 守田覚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2018.
Japanese Article P0412-24-AM. Practice and evaluation of the infection related to antimicrobial proper use support team early monitoring
中谷亮介1, 満田正樹1, 石川裕大1, 太田かおり2, 奥野千晶3, 松本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2018.
Japanese Article P0414-24-AM. Use turn of eventss of PIPC/TAZ by the AST intervention
平賀八重子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2018.
Japanese Article P0416-24-AM. Questionary survey ... for attitude survey - hospital pharmacist and the health insurance pharmacy pharmacists of the pharmacist about the drug-resistant (AMR) action plan
加藤渓1,6, 満田正樹2,6, 久保健児3,6, 阪口勝彦5,6, 稲葉眞也4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2018.
Japanese Article P0418-24-AM. The use of oral antimicrobial situation investigation in our hospital
甲斐達夫1, 川俣洋生1, 福石和久1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2018.
Japanese Article P0420-24-AM. Fact-finding of the coagulation disorder by the cefmetazole in our hospital
百瀬公博1, 荒木真2, 秋月茂樹1, 伏見幸浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2018.
Japanese Article P0422-24-AM. The use situation of the carbapenem-based antimicrobial of our hospital guessed by a report of use of designated antimicrobial
檜山瑠美1, 阿部佳史1, 門間貴大1, 向平亨1, 齋藤裕輝1, 青木裕香1, 作田重人1, 関沢祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2018.
Japanese Article P0424-24-AM. Carbapenem-based antimicrobial prescription pulse-taking after the Antimicrobial Stewardship Team activity reinforcement in the Iizuka Hospital
内田守次1,2, 梅田勇一1,2, 長崎皓光1, 的野多加志2,3, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2018.
Japanese Article P0426-24-AM. Gram-negative bacilli, validity evaluation of the early period of meropenem doses for patients with bacteremia
河本和1, 川崎仁央1, 半田愛1, 藤井哲英1, 北川誠子1, 勝村登美子1, 二宮洋子1, 河口豊2, 桑原篤憲3, 大石智洋4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2018.
Japanese Article P0428-24-AM. Search of the factor accompanied with the protraction of the drug-related impaired renal function with vancomycin
綺田尚久1, 藤原信二1, 伊藤美咲1, 西嶋長1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2018.
Japanese Article P0430-24-AM. Examination of vancomycin doses in patients with blood tumor of the decreased renal function case
島田泉1, 森紗世子1, 小林将文1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2018.
Japanese Article P0432-24-AM. 1 case of the purulent spondylitis due to the MRSA that a therapy with vancomycin and fosfomycin was effective
吉野秀紀1, 森田直1, 堤良祐2, 畔柳弥生1, 木下里紗1, 紙谷公彦1, 坂本武志2, 小林政彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2018.
Japanese Article P0434-24-AM. One patient who evaded thrombocytopenia by weight loss administration of the linezolid
亀田圭輔1, 北村友乃1, 渡来和宏3, 小森功夫2, 生島五郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2018.
Japanese Article P0436-24-AM. Difficulty of deleting the adoption antimicrobial
福本康之1, 森下和美1, 川上典子1, 佐野克典2, 白井保子3, 飯岡義教4, 吉田康秀4, 近藤昌子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2018.
Japanese Article P0438-24-AM. About the diachronic correlation of antimicrobial consumption and the chemosensitive rate
藤島哲大1, 佐藤家恒1, 高橋幸1, 小川信二1, 佐藤博樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2018.
Japanese Article P0440-24-AM. The current situation investigation of the antimicrobial administration for the animal bite for the medical institutions in the catchment area
吉田悦朗1, 白石貴寿1, 臼井和明1, 宇都宮奈々1, 栗原江未1, 長谷川将1, 中島信能1, 岩本幸英1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2018.
Japanese Article P0442-24-AM. To beta-lactam derivative antimicrobial beta lactam agent readministration - fact-finding - to the patients with allergy
井澤香1, 土井啓員1, 増田雅行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2018.
Japanese Article P0444-24-AM. About the use situation of the multidrug-resistant antiphthisic drug Delamanid in our hospital
小迫晶寛1, 加茂章弘1, 江原正博1, 植村隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2018.
Japanese Article P0446-24-AM. Intervention effect to medical treatment on Clostridium difficile-related loose bowels (CDAD)
久田瑛吉1, 加藤洋介1, 牧野勇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2018.
Japanese Article P0448-24-AM. One case of the acute suppurative thyroiditis with the cyst of thyroid infection by Staphylococcus epidermidis
竹内祐介1, 小泉祐一1, 王恩2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2018.
Japanese Article P0450-24-AM. One case that intervened immediately from the intervention mass spectrography of the AST pharmacist to the bacteremia in the decreased renal function patients
更谷和真1, 中澤明日香1, 徳濱潤一1, 奥村愉美子1, 原田晴司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2018.
Japanese Article P0452-24-AM. Look at the blood poison-related rear with ganciclovir; mark investigation
保田和哉1, 平原康寿1, 吉川直樹1, 外山智章1, 浦田修平1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2018.
Japanese Article P0453-23-PM. Introduction and problems of the report of use of specific antimicrobial system
小澤章裕1, 中山菜実1, 鈴木美帆1, 石毛佑樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2018.
Japanese Article P0455-23-PM. A report and evaluation of the antimicrobial proper use promotion activity in our hospital with several clinical departments
豊福泰代1, 岡田隆文2, 松原始朗3, 仙波靖士1, 立花広志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2018.
Japanese Article P0457-23-PM. Relative examination with use of antimicrobial density AUD and the MRSA separation rate
溝田繁治1, 吉原涼子1, 谷口潤1, 大野直義1, 中村みさ1, 江島遥1, 藤岡ひかる1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2018.
Japanese Article P0459-23-PM. Including the consumption comparison of attitude survey - hand disinfectants of the pharmacist for the hand hygiene -
伊賀正典1, 高野温志1, 亀井陽子1, 齋藤彩子1, 井上朋子1, 町田充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2018.
Japanese Article P0461-23-PM. Fact-finding of the blood culture follow-up in the bacteremia case of our hospital
成島俊輔1, 鯉沼縁1, 岡田絵梨子1, 青山美恵子2, 井坂彰一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2018.
Japanese Article P0463-23-PM. Quinolone-resistant E. Examination of pulse-taking and measures of coli
加藤一雲1, 近藤晃史1, 坂野昌志1, 寺井文廣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2018.
Japanese Article P0465-23-PM. Investigation of the HBV reactivation screening test for the immunosuppressive drug in the orthopedics domain
廣岡賢輔1, 木村和幸2, 満田朱理3, 清水浩幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2018.
Japanese Article P0467-23-PM. Examination about the association between antimicrobial administration, nutritional status and PT-INR change
野口悠高1, 南木伸基2, 西尾貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2018.
Japanese Article P0469-23-PM. Use pulse-taking of the antifungal agent in Japan from 2006 through 2015
河邊絢子1, 石井沙季1, 胡井愛1, 後藤良太1, 村木優一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2018.
Japanese Article P0471-23-PM. Use trend of the antiMRSA medicine based on the volume in Japan from 2006 through 2015
後藤良太1, 石井沙季1, 胡井愛1, 河邊絢子1, 村木優一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2018.
Japanese Article P0454-24-AM. Efforts to report of use of specific antimicrobial submission rate improvement using an electronic medical chart system
森下和美1, 福本康之1, 長山晃1, 平野雄一1, 川上典子1, 近藤昌子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2018.
Japanese Article P0456-24-AM. The effect that the antimicrobial proper use round in the infection specialist absence institution gives in outcome index
大戸祐治1,4,5, 新井祐司2,4, 岡田壮令3,4, 田中克巳1,5, 佐々木忠徳5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2018.
Japanese Article P0458-24-AM. Efforts of the ICU person in charge of hand hygiene index pharmacist for the improvement
明石岩雄1, 須田奈美1, 山本律子1, 影山明1, 北村正樹1, 北村好申1,2, 川久保孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2018.
Japanese Article P0460-24-AM. Pollution status investigation ... formulations apparatus of the formulations apparatus by an examination of bacteria and the ATP analysis is really beautiful; or ...
植松卓也1, 松浦亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2018.
Japanese Article P0462-24-AM. Examination of the initial antimicrobial and mortality in patients with blood culture-positive rheumatic disease
川上智久1, 吉田三矢1, 南翔大1, 三浦菜々子1, 山口崇臣1, 畝佳子1, 政道修二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2018.
Japanese Article P0464-24-AM. Examination of the background that affected the number of the Klebsiella oxytoca detection increase
木村順平1, 武田龍馬1, 池田大騎1, 山田和範3, 山澤裕司3, 本間和加子1, 中村博彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2018.
Japanese Article P0466-24-AM. Appropriate management of the endoscope based on culture results by the ICT
青木康二1,5, 中嶋里佳1,5, 森章哉1,5, 小林百合2,5, 別所裕二3,5, 村田哲也4,5, 河村雅人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2018.
Japanese Article P0468-24-AM. Examination of the incompatibility based on the pH change of the antibiotic
平野剛1, 滝川裕基1, 高村茂生1, 櫻田渉1, 中山章1, 吉田栄一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2018.
Japanese Article P0470-24-AM. Use trend (2006-2015) of the antimicrobial with the antiPseudomonas aeruginosa effect in Japan
胡井愛1, 石井沙季1, 河邉絢子1, 後藤良太1, 村木優一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2018.
Japanese Article P0472-24-AM. A use trend of the antimicrobial to use for Clostridium difficile infection in Japan and effect of the treatment guideline
石井沙季1, 胡井愛1, 河邊絢子1, 後藤良太1, 村木優一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2018.
Japanese Article P0473-23-PM. Idea to make use of the presence of the pharmacist in the medical care of patients with mental disorder [the first report] - Mental disease zone -
梅田賢太1, 父田智子1, 松本伊都子1, 荒木博陽2, 園部漢太郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2018.
Japanese Article P0475-23-PM. The current situation and tendency of the drug global assessment adjustment addition calculation in the psychopathic ward
黒川拓也1, 生越由美1, 宮部泰輔1, 井上敦介1, 廣畑和弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2018.
Japanese Article P0477-23-PM. Prescription fact-finding (compare 2017 with 2013) of the medical therapy about patients with schizophrenia in the university hospital
松崎遥菜1, 波多野正和1,2, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2018.
Japanese Article P0479-23-PM. Examination of the effect on quantity of olanzapine prescription by the smoking
赤瀬川豊1, 有村洋平2, 井上雅文3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2018.
Japanese Article P0481-23-PM. 1 case that developed hyponatremia during S citalopram internal use
矢野真弓1, 木村由紀子1,2, 大礒宏昭1, 下地晶1, 池田郁子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2018.
Japanese Article P0483-23-PM. Investigation about the background of conveyed patients emergency for acute drug intoxication
藤田強記1, 高武嘉道1, 鶴崎泰史1, 丸田基史2, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2018.
Japanese Article P0485-23-PM. Evaluation of the medication adherence in DAI-10 in the psychology educational program enforcement patients
岡本和之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2018.
Japanese Article P0487-23-PM. Evaluation of the treatment flowchart introduction effect in the delirium
吹谷真紀子1, 齊藤伸1, 工藤和彦1, 仙葉悠紀1, 木元健寛1, 一関美江子1, 金美紀1, 篠田和人1, 山崎恵葉1, 鈴木ひとみ1, 八代佳子1, 水沢重則1, 後藤敏晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2018.
Japanese Article P0474-24-AM. About the activity of the pharmacist in the mental hospital outpatient department D care
正井淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2018.
Japanese Article P0476-24-AM. Efforts to the psychotropic drug adjustment cooperation addition
南憲一1, 下川千賀子1, 竹中克之1, 中川里弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2018.
Japanese Article P0480-24-AM. Patients satisfaction investigation in the Asenapine sublingual tablet
福山雄卯介1, 江崎肇2, 宮崎敦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2018.
Japanese Article P0482-24-AM. One patient who was treated effectively with a sublingual tablet for the symptom control of patients of the traumatic perforation of small intestine
松下隆行1, 佐野彩女1, 兼松友紀1, 長谷部千夏1, 塚原民夫1, 堀内正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2018.
Japanese Article P0484-24-AM. The side effect situation investigation of the Perampanel hydrate and examination of the associated factor
松竹紀子1, 高田正温1, 橋本雅司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2018.
Japanese Article P0486-24-AM. The effect that DELTA program introduction gives in the prescription trend of the delirium analogous drug
清水善仁1, 西田祥啓1, 高瀬文超1, 高橋喜統1, 宮東剛文2, 中井有里3, 橋本玲子4, 新田佑輔4, 川崎康弘4, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2018.
Japanese Article P0488-24-AM. Examination about the risk factor that a remedy drug affects the fall in the psychopathic ward
宮本亜季1, 日笠真一2, 岡本ちはる2, 島袋翔多2, 田中邦佳2, 柳井美奈2, 三上ひとみ3, 清野仁美4, 松永寿人4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2018.
Japanese Article P0489-23-PM. Examination about a dose of the genetically-modified thrombomodulin in the decreased renal function patients and the prognosis
角真太郎1, 南智香子1, 宮本由貴1, 緒方健二1, 西順也1, 祖川倫太郎1, 江本晶子1, 田崎正信1, 阪本雄一郎3, 成澤寛1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2018.
Japanese Article P0491-23-PM. The effect that the cinacalcet administration in maintenance patients on dialysis gives to a serum P concentration
石田翔1, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2018.
Japanese Article P0493-23-PM. The current situation investigation of the central venous hyperalimentation for haemodialysis patients in our hospital and future problem
先崎貴洋1, 田原温1, 野口周作1, 宮田広樹1, 笠原英城1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2018.
Japanese Article P0495-23-PM. Investigation of the effect on serum phosphorus concentration by the dosage form change of the lanthanum carbonate hydrate
久松大介1, 木村繁和1, 林貴子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2018.
Japanese Article P0490-24-AM. Consciousness reform of the member for drug doses doubt inquiry in the decreased renal function patients
二上佳世子1, 高野由美子1, 松森智士1, 前田志帆1, 大越美根子1, 小堀勝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2018.
Japanese Article P0492-24-AM. Improvement of the polypharmacy by the CKD education hospitalization
小澤慶祐1, 國津佑貴1, 磯野哲一郎1, 藪田直希1, 増田恭子1, 平大樹2, 大澤紀之3, 荒木信一3, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2018.
Japanese Article P0494-24-AM. Effective and safe evaluation with calcium-containing preparation and Seve Lamar for the high phosphorus blood symptom merged with patients on dialysis
石田理絵子1, 嶋田修治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2018.
Japanese Article P0496-24-AM. Examination of the renal function improvement in the agate Pross ton remedy
廣瀬浩一1, 松井健一1, 高橋理寛1, 齋田正和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2018.
Japanese Article P0497-23-PM. Sugar, a serum lipid metabolism change and medication counseling effect on patients with DPP-4 inhibitor administration diabetes
玉井祐馬1, 江月優1, 瀧田優樹1, 中村由香2, 行宗千裕2, 泉京江2, 武田未佳2, 大橋綾子3, 三浦剛4, 佐々木英久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2018.
Japanese Article P0501-23-PM. The use situation of the ipragliflozin in our hospital
石橋真実1, 大森麻江1, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2018.
Japanese Article P0503-23-PM. Inspection of the usefulness of the diabetes therapeutic drug Dulaglutide through the self-injection introduction instruction by the pharmacist
石田詞子1, 小野達也1, 西田英之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2018.
Japanese Article P0505-23-PM. Significance of the pharmacist intervention in the changes, and the like to the SAP (Sensor Augmented Pump) with a hypoglycemia prediction, the interruption function in the insulin pump therapy
米元治朗1, 白川葉子1, 片山知子1, 毛利有美子1, 田中祐希2, 宮前至博2, 玉城成雄2, 笠原督2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2018.
Japanese Article P0509-23-PM. Association between diabetes image and medication adherence of patients with type 2 diabetes
浦田航希1, 吉田綾乃1, 玉田実花1, 堀内礼子2, 山秋直人3, 八木邦公4, 橋本昌子1, 荒井國三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2018.
Japanese Article P0511-23-PM. The effect that hospitalization of the convalescent rehabilitation gives to diabetes treatment
佐々木麻里1, 辻倫子1, 内薗令子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2018.
Japanese Article P0513-23-PM. About the perioperative blood sugar control situation of the diabetes education inpatient
伊東崇仁1, 川井龍美1, 祝田靖2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2018.
Japanese Article P0515-23-PM. Investigation about Miyagi diabetes medical treatment instruction, a pharmacy workshop start and the diabetes medical treatment instruction in the pharmacist
鈴木さとみ1,7, 佐藤伸輔2,7, 本田弘3,7, 堤栄二4,7, 渥美久義5,7, 松本健司6,7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2018.
Japanese Article P0498-24-AM. Significance of the change of prescription to the allogeneic medicine for patients with DPP-4 inhibitor administration diabetes
瀧田優樹1, 玉井祐馬1, 江月優1, 中村由香2, 行宗千裕2, 泉京江2, 武田未佳2, 大橋綾子3, 三浦剛1, 佐々木英久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2018.
Japanese Article P0500-24-AM. Extraction of the important factor affecting the change and the treatment result of HbA1c of the SGLT2 inhibitor Empagliflozin remedy patients
宮田絵莉加1, 黒川彰太1, 岡村和彦1, 藤本孝則1, 池本雅章1, 佐々木雄啓1, 長廣由美佳2, 小河潮美2, 木村幸司2, 佐和章弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2018.
Japanese Article P0502-24-AM. The effectiveness of the GLP-1 receptor agonist Dulaglutide 0.75 mg once a week preparation in patients with type 2 diabetes and safe examination
玉城由実加1,2, 宇都宮励子1, 結城由恵2, 廣田憲威1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2018.
Japanese Article P0504-24-AM. The effectiveness of the glinide medicine in patients with type 2 diabetes and safe examination
鈴木喬也1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 牧和歌子2, 増田富2, 鈴木敦詞2, 山田成樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2018.
Japanese Article P0506-24-AM. Efforts of the pharmacist in the pump therapy (SAP) introduction with the sensor in patients with type I diabetes mellitus and the data analysis
毛利有美子1, 片山知子1, 白川葉子1, 米元治朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2018.
Japanese Article P0510-24-AM. It is ... about taking pharmaceutical products needing attention for ... renal function about the combination drug of patients with diabetes in our hospital
平岡陽一1, 橋本隆信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2018.
Japanese Article P0512-24-AM. Investigation about the blood sugar change every dexamethasone doses in patients with diabetes during cancer chemotherapy
室伏孔樹1, 秋本純矢1, 好川瑛美子1, 大久保紀宏1, 内藤淳嗣1, 馬島碧子1, 中川隼一1, 蔭山博之1, 平島徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2018.
Japanese Article P0514-24-AM. About patients questionary survey in the class for diabetics of our hospital
立花慧千1, 小林薫1, 伊藤宏彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2018.
Japanese Article P0516-24-AM. Example that a drug administration design succeeded for patients with type 2 diabetes that fixed its eyes on being at home
平島麻由美1, 佐藤晃1, 池田舞1, 中野里美1, 持田知志1, 堀竜2, 堀裕貴也3, 齊藤幹夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2018.
Japanese Article P0517-23-PM. Tentative plan of use of psychotropic drug guidelines for a pregnant woman, the nursing mother in our hospital
藤尾容子1, 佐藤岳春1, 安部裕美1, 中島理絵1, 國原将洋1, 八本聖秀1, 神垣伸2, 長島信行2, 朝倉岳彦2, 大盛航2, 板垣圭2, 竹林実2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2018.
Japanese Article P0519-23-PM. To the intervention to mother of the baby-friendly hospital authorization institution mental disorder
宮井絢美1, 別府博仁1, 関本裕美1, 木下かすみ2, 吉田愛3, 小林明子4, 武内享介3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2018.
Japanese Article P0521-23-PM. Examination of the zinc transitivity to the whole first milk in the Wilson disease merger mother's body during high-dose zinc acetate remedy
松田紘子1, 杉本浩子1, 鳥谷部邦明2, 田中博明2, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2018.
Japanese Article P0523-23-PM. Case report about the fetal transitivity of amiodarone
西中川遥1, 生駒歌織1, 池田麗1, 越智純子1, 中北和樹1, 橋詰宏美1, 寺川伸江1, 川端一功1, 老田章1, 月永理恵2, 神谷千津子2, 岩永直子2, 吉松淳2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2018.
Japanese Article P0525-23-PM. Examination about the puerperium rubella vaccine inoculation in our hospital
木藤一美1, 橋本隆信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2018.
Japanese Article P0527-23-PM. The current situation of rubella antibody titers in early pregnancy and the postpartum vaccination
松下久美1, 瀧祐介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2018.
Japanese Article P0529-23-PM. The effect that magnesium-containing preparation combination gives for retching vomiting expression in the early or threatened labour pregnant woman
柿沼博子1, 高野尊行1, 倉井由香1, 柿沼貴広1, 水越千晶1, 長尾結花1, 中丸朗1, 白石悟2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2018.
Japanese Article P0531-23-PM. Importance of the pharmaceutical management of the blood clotting factor IX preparation in the hemophilia B carrier pregnant woman
森田靖代1, 森田聡美2, 榎本麻里子1, 東香歩1, 八木祐助1, 常風興平1, 松島幸生2, 池上信夫2, 前田長正2, 宮村充彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2018.
Japanese Article P0533-23-PM. It is unified the doubt correspondence of the OTC medicine for a pregnant woman, the nursing mother in our hospital
三原瑞貴1, 芦澤穂波1, 富永紗菜恵1, 北村悠里子1, 石田あい1, 木村真策1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2018.
Japanese Article P0535-23-PM. An attitude survey about the pregnant woman prescription of the resident in the night, the holiday and making of the pregnant woman prescription support tool
鈴木秀明1, 佐藤寛子1, 伊藤有美1, 滝本典夫1, 足立守1, 梅津朋和2, 小山勝志3, 山本真一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2018.
Japanese Article P0518-24-AM. Relation of the actual situation and the pharmacist of the medical treatment of the puerperant complicated with a mental disorder
桐林美緒1, 佐藤千比呂1, 金田美咲緒1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2018.
Japanese Article P0520-24-AM. Reporting about the mother's milk transitivity of the remedy drug of expectant mothers and the effect
春名柚佳1, 木村佳代子1, 都築仁美1, 谷香苗1, 小野尚志1, 山下恭範1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2018.
Japanese Article P0522-24-AM. 2 cases that was given mother's milk childcare during cyclosporine internal use
山川恵1, 三島唯1, 北島美有1, 藤原尚子1, 橋本真梨1, 松本久美子1, 大本暢子1, 久米学1, 森實真由美2, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2018.
Japanese Article P0524-24-AM. Change - of the risk recognition to investigation - teratogenesis and fetuses about the counseling in the medical therapy of the pregnant woman and the pregnancy continuation intention
今岡美紀子1, 布野優子1, 横手克樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2018.
Japanese Article P0526-24-AM. Become the meningitis suspicion for second pregnancy trimester; a case using vancomycin
門倉史枝1, 大庫百代1, 本上ほなみ1, 二星知紗1, 永井浩章1, 大谷美奈子1, 廣瀬晃子1, 井上智恵1, 見上千昭1, 本間久美子1, 西尾孝1, 辻本勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2018.
Japanese Article P0528-24-AM. Study on pregnancy outcome of the ST medical mixture remedy pregnant woman
三井由加子1, 加藤沙織1, 堀亜也子1, 亀田谷和将1, 小澤明香1, 長山直実1, 齋藤健一1, 谷島春江2, 小野義久3, 側島久典4, 近藤正巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2018.
Japanese Article P0530-24-AM. Effect of the corpus luteum hormone on ritodrine doses in the impending premature birth treatment
日野光記枝1, 大橋健吾1, 吉田真也1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2018.
Japanese Article P0532-24-AM. Study on pregnancy outcome of the dyslipidemia therapeutic drug remedy pregnant woman
長谷川まゆみ1, 加藤沙織1, 和智りべか1, 宮原菜生1, 鈴木千明1, 小澤明香1, 長山直実1, 齋藤健一1, 谷島春江2, 小野義久3, 側島久典4, 近藤正巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2018.
Japanese Article P0534-24-AM. Questionary survey of the proper use of the pharmaceutical products to a nursing mother
磯崎遥1, 岡部愛子4, 門馬恵1,2, 越塚宏美1,2, 阿部久瑠美1,2, 小林麻美2,3, 柏原由佳1,2, 田中克巳1,2, 佐々木忠徳2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2018.
Japanese Article P0536-24-AM. The taking psychotropic drug situation to see from a consultation example of "the pregnancy and the medicine outpatient department" of our hospital
渡邊真理恵1,2, 川邉桂1,2, 勝亦秀樹1, 栗城紘子2, 浜之上はるか2, 小池博文1, 平原史樹4, 伊藤秀一2,3, 佐橋幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2018.
Japanese Article P0537-23-PM. Efforts (the second report) for the elderly people multiple drug prescription adequacy by pharmacist - physician collaboration
稲垣芙美佳1, 上田由貴1, 山代栄士1, 川元崇志1, 鴛海太郎2, 塩田星児2, 高倉健2, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2018.
Japanese Article P0539-23-PM. It is ... about the operation of the drug adjustment report at a discharge at the polypharmacy Team activity report - adjustment in the elderly people special hospital
小原朋也1, 羽田慶子1, 瀧川美和1, 島崎良知1, 森淑子1, 石川譲治2, 岩切理歌3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2018.
Japanese Article P0541-23-PM. About the medical treatment intervention example of the pharmacist in the dementia support team (DST)
濱邊秋芳1, 嶋田聖子1, 納富貴子1, 有川菜木沙1, 永田真二郎2, 豊里悦子2, 大平康智3, 田渕真理子4, 徳安清昭5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2018.
Japanese Article P0543-23-PM. About the efforts for the drug becoming the precipitants of the delirium in dementia care rounds
曽我弘道1, 前田朱香1, 富田敏章1, 清水誉志1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2018.
Japanese Article P0545-23-PM. Preventive measures against elderly people polypharmacy and follow-up in the cerebral surgery acute phase hospital
曽和鮎美1,2, 山崎みどり1, 山田佳奈1, 山田愛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2018.
Japanese Article P0547-23-PM. The use actual situation of the active form vitamin D3 medicine in elderly people and current situation investigation about the measurement frequency of serum calcium concentrations
伴具也1, 尾浜直子1, 大森清孝1, 三浦誠1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2018.
Japanese Article P0538-24-AM. An evaluation of the drug consumption of the elderly people in the medical treatment ward and pharmaceutical intervention
竹下秀司1, 佐野一也1, 久保田倫代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2018.
Japanese Article P0540-24-AM. Use fact-finding of sedative hypnotic, the antianxiety drug in the care health center for the elderly attached to our hospital
佐藤裕美1, 柴田麻里子1, 高橋奈々恵1, 林みさ1, 松村翔太1, 福野和治1, 森本雅子1, 松川雅子1, 西部幸一1, 今井桂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2018.
Japanese Article P0542-24-AM. Efforts of the drugstore in dementia support Committee
安田美奈子1, 秋元凌1, 栃原龍宏1, 五藤里奈1, 白川舞1, 熊田克幸1, 小川嘉久1, 荒井圭二2, 東佐恵子2, 三輪嘉明3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2018.
Japanese Article P0544-24-AM. Factor search of the polypharmacy in the elderly aged 75 or over
宮前文明1, 福田和希1, 竹山知志1, 小川喜通1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2018.
Japanese Article P0546-24-AM. The use situation of magnesium oxide in our hospital care department and serum magnesium level
森光恵1, 中川貴史1, 新田千恵1, 西出直人2, 臼倉幹哉3, 鈴木邦彦4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2018.
Japanese Article P0548-24-AM. Evaluation about the detection of drug (PIMs) inappropriate potentially using the medical therapy guidelines in elderly people
亀田敬子1, 佐古渚1, 高橋えりか1, 木本信介1, 山田周平1, 西田直史1, 福澤祐幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2018.
Japanese Article P0549-23-PM. Onset of combination situation of the antiulcer agent in the aspirin Enteric tablet taking our hospital patients and upper gastrointestinal bleeding situation investigation
関奈緒子1, 和田淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2018.
Japanese Article P0551-23-PM. Factor investigation of the drug induced hepatic injury by the clexane
佐々木優1, 曽根麻里奈1, 湯本哲郎2, 稲葉健二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2018.
Japanese Article P0553-23-PM. The dose course investigation between the side effect expression of pregabalin group for the neuropathic pain
小田剛史1, 山本諭1, 岩本佳代子1, 柴田千保1, 浅井茂夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2018.
Japanese Article P0555-23-PM. 1 case of the mixed connective tissue disease that developed an AV block during hydroxychloroquine sulfate remedy
濱走優人1, 小野友加里1, 安高勇気1,2, 兼重晋1, 緒方憲太郎1,2, 氷室尚子3, 三宅勝久3, 中島衡3, 神村英利1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2018.
Japanese Article P0557-23-PM. The effect that administration before operation of the dexamethasone in the gynecologic operation under laparoscopy gives for nausea post-operative vomiting
伊藤千裕1,2, 大島葵1, 井上岳1,2, 上野哲生3, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2018.
Japanese Article P0559-23-PM. Analysis of the use situation and the onset of vascular disorder situation of the nicardipine injection in patients with cerebral hemorrhage
綿貫陽一1, 和田麻季子1, 木村麗砂1, 日浦寿美子1, 小林秀樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2018.
Japanese Article P0561-23-PM. 2 cases that was called off by hypernatremia after the tolvaptan administration, and was given it during the hospitalization again
谷口仁孝1, 小原祐子1, 山本彩佳1, 前川知子1, 千葉恵美子1, 渡邉美樹1, 坂井愛実1, 前田典子1, 水野稜子1, 徳村博子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2018.
Japanese Article P0563-23-PM. One case with suspected induction of Guillain-Barre syndrome by the etanercept
山本飛翔1, 殿岡久美子2, 前田幹広1, 有木宏宗1, 坂上逸孝1, 高桑由希子2, 川畑仁人2, 田中恒明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2018.
Japanese Article P0565-23-PM. A false high level case of the blood sugar accepted by pralidoxime iodide (PAM) administration and the consideration
小林由里愛1, 遠藤愛樹1, 花輪和己1, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2018.
Japanese Article P0567-23-PM. For the appropriate enforcement of the thyroid function tests in patients receiving amiodarone
井上大樹1, 山口優子1, 上田賢太郎1, 高橋憲二1, 生島五郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2018.
Japanese Article P0569-23-PM. Efforts for the photo-allergy prevention with the aminolevulinic acid hydrochloride granule in the urology department
高嶋祥匡1, 高橋弘泰1, 大谷寧次郎1, 窪田裕樹2, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2018.
Japanese Article P0550-24-AM. Investigation of the discontinuation situation and the adverse event of anticoagulation, the antithrombocytic agent in the proximal thighbone bone fracture
宇佐美伶奈1, 伊藤匡伸1, 米山英二1, 鈴木真子1, 松下義弘1, 小林恵果1, 岩瀬由枝1, 井野裕美1, 木村友美1, 小口武2, 杉浦洋二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2018.
Japanese Article P0552-24-AM. Drug causation evaluation of 1 case that sinus bradycardia was induced by the use of carteolol hydrochloride/latanoprost combination eye drops
飯田慎也1, 山本譲1, 大滝康一1,2, 山下恭範1, 小野尚志1, 三嶋一登1, 福土将秀1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2018.
Japanese Article P0554-24-AM. Example that produced skin necrosis with the blistering during vasopressin a very small amount of sustained intravenous administration for the central diabetes insipidus that occurred by a brain tumor
森永光1, 中川祐紀子1, 坪内清貴1, 中出順也1, 板井進悟1, 加納美優2, 宮下勝吉3, 嶋田努1, 崔吉道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2018.
Japanese Article P0556-24-AM. An example of orthostatic hypotension in the use of cyclophosphamide
立花京香1, 後藤健志1, 竹尾恵理子1, 石川真平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2018.
Japanese Article P0558-24-AM. Preoperative renin-angiotensin system inhibitor remedy and perioperative hypotensive relative examination
芦田郁実1, 柏宗伸1, 田中玖実1, 増地淳1, 西橋正芳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2018.
Japanese Article P0560-24-AM. Examination of the onset of hypokalemia time at the amphotericin B administration in children
長谷川彩薫1, 歌野智之1, 文靖子1, 大隅朋生2, 加藤元博2, 富澤大輔2, 松本公一2, 山谷明正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2018.
Japanese Article P0562-24-AM. Example that accepted free air in abdominal cavity by chronic administration of the tolvaptan
金子睦志1, 渡辺一也1, 篭島正浩1, 高橋祥史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2018.
Japanese Article P0564-24-AM. Investigation about the onset of hepatic dysfunction by the high-dose prescription of acetaminophen
小笠原綾香1, 足立智洋1, 真井雄規1, 村上智香1, 石田陽美1, 門脇督1, 土井佳子1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2018.
Japanese Article P0566-24-AM. Example that the diarrhea symptom that occurred with colchicine of the familial mediterranean fever therapeutic drug improved by the intervention of the pharmacist
内山乃映1, 上田奈緒美1, 山田倭花1, 大窪真理絵1, 中島のぞみ1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2018.
Japanese Article P0568-24-AM. Exhaustive analysis of our hospital phlebitis development factor with the periphery drip to be able to put
遠山泰崇1, 井上真1, 福島祐子1, 堀光愛子1, 柴田麻美1, 幸沙和1, 末延裕海1, 新宮裕美1, 福田智哉1, 武石優哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2018.
Japanese Article P0570-24-AM. Evaluation of the Adverse Drug Event detection method using Adverse drug event trigger tool
土肥大典1,2, 平山美津江1, 坂本優介1, 杉本直樹1, 小関信吾1, 川井信孝1, 鍵山智樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2018.
Japanese Article P0571-23-PM. Investigation about the blood hypercoagulability time in Warfarin and the S-1 combination patients
遠藤晋吾1,2, 小竹武2, 石渡俊二2, 井上知美2, 村田彩純2, 小川直希1, 鶴島克将1, 安井友佳子1, 石坂敏彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2018.
Japanese Article P0573-23-PM. Examination about the concomitant drug which affected the warfarin doses during our hospital hospitalization
千葉里菜1, 佐藤陽介1, 小笠原蓉子1, 西館俊介1, 佐藤圭吾1, 追木正人1, 西和哉1, 佐賀利英1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2018.
Japanese Article P0575-23-PM. One case that blood level of voriconazole increased under the miconazole gel combination
福田正悟1, 中田英夫1, 石川春樹1, 池谷修1, 木村元範1, 宇賀村文3, ちょ柏松3, 村松博1, 望月眞弓1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2018.
Japanese Article P0577-23-PM. Blood itraconazole in the lung transplantation patients and tacrolimus levels management under the rifabutin combination
福井彩香1, 中川俊作1, 片田佳希1, 糸原光太郎1, 杉本充弘1, 山本由貴1, 石橋直哉1, 傳田将也1, 深津祥央1, 米澤淳1, 中川貴之1, 長尾美紀2, 野口実紗3, 濱路政嗣3, 青山晃博3, 陳豊史3, 伊達洋至3, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2018.
Japanese Article P0579-23-PM. The effect of antacids to give LDL-C drop effect of the rosuvastatin: Rearward medical record investigation second report
立沢正臣1, 小川竜一2, 金素安1, 金城直樹1, 大久保淳史1, 小山内美樹1, 土屋美香1, 住吉正孝1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2018.
Japanese Article P0581-23-PM. Effect of esomeprazole giving it to metabolism of proguanil and the vonoprazan
中内佳奈1, 中林勇1, 合田ひとみ1, 舟越亮寛2, 山岸喜彰1, 工藤敏之1, 伊藤清美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2018.
Japanese Article P0583-23-PM. One case with suspected hypothyroid coma onset by the combination of LT4 preparation and calcium polystyrene sulfonate
甲斐知美1, 梶原洋文1, 玉井文洋2, 生山祥一郎3, 山田雅也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2018.
Japanese Article P0572-24-AM. The effect that the end of the combination of warfarin and rifampicin gives to PT-INR
安部圭紀1, 五十嵐文1, 山本郁生1, 高橋賢成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2018.
Japanese Article P0574-24-AM. The case that showed a rise, subcutaneous haemorrhage of the INR by combination of capecitabine and warfarin
池崎友明1, 坂東翔1, 坂井晴香1, 武内仁美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2018.
Japanese Article P0576-24-AM. One case that CYP3A4 conduction with rifampicin had a long-term influence on the internal change of voriconazole
和地徹1, 佐々木崇1, 齋藤はるか1, 菅野和1, 小笠原蓉子1, 鈴木雄太1, 小原拓2, 石田雅嗣3, 小林誠一3, 矢内勝3, 佐賀利英1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2018.
Japanese Article P0578-24-AM. Examination for the adverse event associated with drug interactions of vincristine and the itraconazole private business liquid
野崎千暁1, 田村賢士1, 金子誠1, 寺田伊知郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2018.
Japanese Article P0580-24-AM. Example that a neutrophil count decrease in imatinib and clarithromycin by the drug interaction was found in
宮田智陽1, 和佐本諭2, 杉山昌秀1, 篠原佳祐1, 関口展貴1, 渡邊将隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2018.
Japanese Article P0582-24-AM. Effect of the vitamin D3 preparation giving it to solubility of celecoxib
高見陽一郎1,2, 武田有紀2, 福島由貴2, 島田倫栄2, 小松原早織2, 浦上知香2, 笹原莉子2, 小川壮寛1, 安倉央1, 江川孝3, 島田憲一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2018.
Japanese Article P0584-24-AM. 1 case that intervened by ward pharmacist duties and TDM for the interaction of antiepileptic drug and the MAC therapeutic drug
吉川直樹1, 田崎智也1, 畑中真理1, 関屋裕史1, 平原康寿1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2018.
Japanese Article P0585-23-PM. Examination of the effect that carvedilol after acute myocardial infarction gives to a left ventricular ejection fraction
齋藤晶仁1, 石田耕太1, 池ノ内浩2, 鈴木憲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2018.
Japanese Article P0587-23-PM. Examination of the renal function at the DOAC change of patients with fault valve-related atrial fibrillation in our hospital outpatient department
早坂美希1, 千葉貴志1, 上村新吾1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2018.
Japanese Article P0589-23-PM. Fact-finding about the apixaban initial dosage in patients with venous thromboembolism
滝田美紀子1, 小林加寿子1, 日浦寿美子1, 小林秀樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2018.
Japanese Article P0591-23-PM. A use case of the Eppikajutsuto and the effect on herpes zoster treatment
嶋田聖子1, 濱邊秋芳1, 納富貴子1, 有川菜木沙1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2018.
Japanese Article P0593-23-PM. A use actual situation evaluation in the inhalant and examination of the future evaluation method
西正浩1, 三角ひかる1, 萩原里美1, 東久美子1, 羽田野あゆみ1, 松本健吾1, 坂本一貴1, 畑加奈子1, 向井光一朗1, 松井法子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2018.
Japanese Article P0595-23-PM. Effective evaluation of the carnitine preparation for the hyperammonemia associated with the cirrhosis
田杭直哉1, 黒田香織1, 近藤匡慶1, 菅谷量俊1, 津久井拓2, 高瀬久光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2018.
Japanese Article P0597-23-PM. It is examination about the effectiveness of the pain-killer commuter pass internal use of the fixed quantity in patients after the operation of the knee anterior cruciate ligament reconstruction
恒川朋子1, 土屋篤志1, 長谷川一行1, 武藤達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2018.
Japanese Article P0599-23-PM. Examination of the risk factor about retching, vomiting that occurred after the surgery of the orthopedics domain in the Kokura medical center
堀勇太1, 趙成三2, 松尾待池3, 山口泰弘3, 山下愛登4, 坂本峰代3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2018.
Japanese Article P0601-23-PM. Relation of the pharmacist for the Nusinersen Na intraspinal injection enforcement in our hospital
川谷梨紗1, 徳井志野1, 山口泰弘1, 赤崎大恭1, 中村敦士1, 浦本邦弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2018.
Japanese Article P0586-24-AM. The effectiveness in the long-term use of the drug elution stent for patients who received percutaneous coronary intervention and safe evaluation
廣田佳美1, 嶋田修治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2018.
Japanese Article P0588-24-AM. Comparison of the bleeding risk by the clopidogrel start time in patients receiving argatroban
長尾結花1, 高野尊行1, 倉井由香1, 柿沼博子1, 中丸朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2018.
Japanese Article P0590-24-AM. Examination of the DIC secession rate in the use of antithrombin gamma case that used recombinant thrombomodulin together
井上大奨1, 濱崎翔平1, 水町純一1, 花田聖典1, 鶴崎泰史1, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2018.
Japanese Article P0592-24-AM. The case that drainage decreased by inhibition of the intestinal tract peristalsis, and an artificial anus trouble improved
古川和弘1, 中山真紀2, 緒方優子2, 唐原和秀3, 鈴田浩孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2018.
Japanese Article P0594-24-AM. The effectiveness of the colchicine administration in the treatment of postpericardiotomy syndrome (PPS) of children
高藤由紀子1, 齋藤裕里奈1, 長井美樹1, 赤羽三貴1, 真船亮2, 小野博2, 賀藤均2, 山谷明正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2018.
Japanese Article P0596-24-AM. Study on microRNA associated with a non-alcoholic lipid liver disease
柴山良彦1, 久保儀忠1, 中川勉1, 長野正信2, 藤井暁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2018.
Japanese Article P0598-24-AM. Example that conducted pharmaceutical intervention for patients with copper deficiency anemia, and was improved
宮明佑輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2018.
Japanese Article P0600-24-AM. Examination of the effect that the number of the remedy drugs gives in rehabilitation after cerebrovascular disease treatment
高本光次郎1,2, 和田陽介3, 上田昌宏1, 近藤純1, 坂本淳一2, 志方敏幸1, 辻野健2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2018.
Japanese Article P0602-24-AM. Intervention to selenium lack, the excretion control in neonates with intestinal tract imperfection
瀬戸口誠1,2, 指宿卓也1,2, 野妻俊也1,2, 武藤充2,3, 大橋宏史2,3, 鈴木恵美子2,4, 久保美佐子2,4, 真方美紀2,5, 福岡龍一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2018.
Japanese Article P0604-24-AM. Correspondence of our hospital pharmacy for intravenous alimentation-related liver damage (PNALD)
樋口眞宏1,2, 中村優3, 瀬川恵1, 八田理絵2, 山本佳奈子2, 小原史織2, 仁田美由希2, 宇野敦子1, 野村一之1,2, 荒金英樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2018.
Japanese Article P0608-24-AM. Making and operation of the central venous hyperalimentation check sheet
市原航1, 福井宗憲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2018.
Japanese Article P0603-23-PM. Rearward observational study to examine appetite enhancement effect of olanzapine and the Rikkunshito in our hospital
宮森彩香1, 柳澤京子1, 阿部宏美2, 嶋田健3, 豊田康義4, 森嶋友一4, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2018.
Japanese Article P0605-23-PM. Examination of the risk factor about the onset of hypophosphatemia after the hyperalimentation preparation introduction for the renal failure
兼平暖1, 田邉直人1, 村山暢子1, 入口慎史1, 市橋孟1, 高野浩彦1, 加藤敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2018.
Japanese Article P0607-23-PM. Effect to give to the glycemic control of patients with stroke that sugar adjustment liquid food is complicated with diabetes
茂木孝裕1,2, 鈴木慶介1,2, 木村直也1, 源川良一1, 高橋暁3, 副島誠4, 高橋雅弘5, 越前宏俊5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2018.
Japanese Article P0609-23-PM. Construction of the simultaneous assay of plasma voriconazole using the column switching LC-MS/MS method and voriconazole N- oxide
山本達郎1, 森木邦明1, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2018.
Japanese Article P0611-23-PM. Examination about the pharmacokinetics of mycophenolic acid in liver-transplant recipients
杉本充弘1, 木全柾典1, 佐藤裕紀1, 糸原光太郎1, 佐藤夕紀1, 中川俊作1, 米澤淳1, 中川貴之1, 穴澤貴行2, 伊藤孝司2, 岡島英明2, 海道利実2, 上本伸二2, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2018.
Japanese Article P0613-23-PM. Rearward investigation about the effect on renal function of the early period of vancomycin doses
田端志帆1, 吉村真理1, 平野陽子1, 前田彩菜1, 末廣陽子1, 新谷智則1, 東高士1, 渡辺享平1,2, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2018.
Japanese Article P0615-23-PM. Factor investigation to have an influence on the initial blood level of the vancomycin hydrochloride
鈴木絢子1,2, 田中広紀3, 柳原麻里1, 池田裕一2,4, 渡邊徹3, 佐々木忠徳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2018.
Japanese Article P0617-23-PM. It is evaluated the proper use as a pharmacist intervenes in TDM analysis of vancomycin for patients with blood tumor
原田好子1, 立沢正臣1, 森本景子1, 土屋美香1, 小山内美樹1, 住吉正孝1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2018.
Japanese Article P0619-23-PM. Efforts to improvement in blood level measurement rate of antiMRSA medicine (vancomycin, Teicoplanin) treated patients and TDM analysis rate
福石和久1, 甲斐達夫1, 坂口晋哉1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2018.
Japanese Article P0621-23-PM. Examination of the Teicoplanin loading dose in patients with blood tumor
後藤総太郎1, 赤瀬麻希1, 木下理恵1, 石原溶子1, 関谷紀貴2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2018.
Japanese Article P0610-24-AM. Development of the simple and easy serum mitotane levels assay with the HPLC
若井恵里1,2, 池村健治1, 小田都紀子1, 岩本卓也1,2, 奥田真弘1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2018.
Japanese Article P0612-24-AM. Report of 1 case that a blood level drop of the sudden Everolimus was found in by taking clotrimazole cancellation
宇野貴哉1,4, 和田恭一3, 松田紗知1, 西野料司1, 竹中裕美1, 寺川伸江1, 老田章1, 高田充隆4, 渡邉琢也2, 熊井優人2, 黒田健輔2, 中島誠子2, 瀬口理2, 簗瀬正伸2, 福嶌教偉2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2018.
Japanese Article P0614-24-AM. Examination of the vancomycin maintenance doses for the renal function normalcy patients
今西嘉生里1, 中藏伊知郎1, 宮部貴識1, 佐光留美1, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2018.
Japanese Article P0616-24-AM. Examination about the parameter at the vancomycin administration in patients with burn
小濱弥眞斗1, 坂本修1, 宇野洋司1, 椙山聡一郎1, 橋本真也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2018.
Japanese Article P0618-24-AM. Correlation of eGFR and vancomycin clearance (CLVCM) in the cancer-carrying patient
森岡悠紀1, 田中寛之1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2018.
Japanese Article P0620-24-AM. Comparison of the blood level in the use of Teicoplanin high dose regimen case
青木洋平1, 恒川朋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2018.
Japanese Article P0622-24-AM. A change of the Teicoplanin doses by the guidelines revision in the Kariya Toyota General Hospital and the blood level and future problem
小野沙百合1, 小嶋俊輝1, 柴田大地1, 滝本典夫1, 足立守1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2018.
Japanese Article P0623-23-PM. Participation of the uptake transporter in cytotoxicity of the ipragliflozin in human keratinocytes HaCaT cells
白土恵理1, 辻本雅之1, 折方琴音1, 辻本美菜1, 松本彩夏1, 田中慎子1, 松下望1, 河渕真治2, 栄田敏之2, 峯垣哲也1, 西口工司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2018.
Japanese Article P0625-23-PM. Effect of various CYP2D6 inhibitors including the antidepressant on dopamine generation activity by human cytochrome P450 (CYP) 2D6
杉本静也1, 柳井檀1, 山野花織1, 雫真里菜1, 丹羽俊朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2018.
Japanese Article P0627-23-PM. Effect by the active testosterone 6 β - hydroxylation by the human cytochrome P450 3A subfamily and endogenous steroid hormone
岡本綾香1, 小林恭子1, 丹羽俊朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2018.
Japanese Article P0629-23-PM. Effect of periphery tissue inflammation to give to anesthetic action of the central nervous system depressant
鈴木啓一郎1, 岡田淳芳1, 原啓介2, 松本和也1, 神志那萌子1, 合葉哲也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2018.
Japanese Article P0624-24-AM. A non-linear internal change of lithium in the rat: Does saturation of the renal tubular reabsorption with the phosphate transporter cause it?
上井優一1, 川嵜達也1, 鍋倉智裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2018.
Japanese Article P0626-24-AM. Effect of the endogenous steroid hormone on tolbutamide hydroxylation activity by human cytochrome P450 (CYP) 2C9 and CYP2C19
田内和寛1, 安田沙希1, 丹羽俊朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2018.
Japanese Article P0628-24-AM. Internal change and efficacy analysis of the diabetes therapeutic drug nateglinide in the acute tissue inflammation condition of a patient
神志那萌子1, 西脇あかね1, 鈴木啓一郎1, 藤本和貴1, 合葉哲也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2018.
Japanese Article P0630-24-AM. Predictive precision criteria using the population average parameter of the daptomycin
山科卓也1, 入江健司1, 鶴山萌子2, 丸田基史1, 西尾公志1, 尾上知佳3, 辻泰弘3, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2018.
Japanese Article P0632-24-AM. The effect that a plasma exchange gives to blood level of fosphenytoin
西田承平1, 林祐一2, 平井啓太3, 小林亮1, 丹羽隆1, 林秀樹1,3,4, 杉山正4, 下畑享良2, 鈴木昭夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2018.
Japanese Article P0631-23-PM. teceleukin, ch14. for the intractable neuroblastoma Pharmacokinetic study of teceleukin in 18 combination
深谷寛1, 浜田幸宏1, 丸山拓実1, 木村利美1, 伏見咲子2, 仁谷千賀3, 吉村健一4, 河本博5, 原純一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2018.
Japanese Article P0633-23-PM. nivolumab exposure evaluation of patients with non-small cell lung cancer in the true clinical practice
岡田章1, 入江慶2,3, 岡田裕2, 秦明登4, 加地玲子4, 鈴木浩史1, 福島昭二3, 永井尚美1, 片上信之4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2018.
Japanese Article P0635-23-PM. One case receiving the warfarin after the small intestine total excision
栗島彬1, 林基高2, 飯島明2, 小山洋伸3, 山形誠一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2018.
Japanese Article P0636-24-AM. Efforts to improvement in inhalational maneuver utilizing regional alliances
山本圭祐1, 石塚友一1, 河野雅人2, 宮下晃一2, 廣瀬勝也1, 鈴木理恵1, 笹野知海1, 澤昇平1, 三木良浩2, 橋本大2, 中村秀範2, 矢部勝茂1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2018.
Japanese Article P0638-24-AM. Report about the regional alliances activity that Kurashiki center hospital pharmacy works on
阿曽沼和代1, 徳田衡紀1, 赤木晋介1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2018.
Japanese Article P0640-24-AM. Role of the discharge support by the ward pharmacist in our hospital
持田知志1, 佐藤晃1, 池田舞1, 中野里美1, 平島麻由美1, 堀竜2, 堀裕貴也3, 齊藤幹夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2018.
Japanese Article P0642-24-AM. Parenteral injection administration case for the home care patient in our drugstore
秋元義幸1, 玉井典子2, 尾崎裕一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2018.
Japanese Article P0644-24-AM. Intervention to patients with dementia in the treatment at home
宗岡美紗1, 浅野陽子1, 日高良昌1, 岡敦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2018.
Japanese Article P0646-24-AM. In attitude survey - at-home medicine about the vital sign collection by the pharmacist and the effect on medical therapy of the examination for dip stick -
柳本ひとみ1, 櫻井秀彦2, 古田精一1, 黒澤菜穂子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2018.
Japanese Article P0648-24-AM. Factor to have an influence on the test result report submission to the drugstore by patients
清水紗弥香1, 佐藤秀昭1, 富岡佳久2, 中村哲也3, 小田慎3, 大木稔也1, 今井博久4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2018.
Japanese Article P0650-24-AM. About the situation of hospital pharmacist duties before and after the drugstore opening of an office in the site and a future problem
郷原学1, 山藤千晶1, 俵早紀1, 山崎祐子1, 赤石憲俊1, 大谷崇仁1, 村上裕葵1, 大霜玲子1, 脇浦勇樹1, 宅江孝修1, 吉田勝好1, 田原明子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2018.
Japanese Article P0637-23-PM. Construction - of the interactive information sharing system using regional alliances - medication reporting about the inhalational instruction
松元芽久美1, 山本圭城1, 面谷幸子5, 河村亜美1, 柳澤有子1, 大谷典子1, 宇高歩1, 宮川道英4, 石坂敏彦2, 郷間厳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2018.
Japanese Article P0639-23-PM. Improvement effect of the doubt introduction duties with the efforts (the sixth report) for joint medical treatment (CDTM) in the community medical care positive list
小川壮寛1, 松下明2, 守安洋子1, 山崎桃子1, 懸山啓太1, 河南真依1, 田中綾1, 中尾直1, 江川孝3, 島田憲一4, 高見陽一郎1, 高橋正志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2018.
Japanese Article P0641-23-PM. At-home support and information sharing ... in connection with practice and evaluation - pharmacy service under health insurance drugstore of the conference before discharge that aimed at the seamless medical therapy
満田正樹1, 尾崎加織1, 松本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2018.
Japanese Article P0643-23-PM. Protect patients making use joining information of the hospitalized medicine together; is reporting book ... between 2 ... institutions
川村大輔1, 久岡清子1, 増田博也1, 澤口友紀1, 亀岡喬1, 鹿沼奈央1, 大荒政志1, 吉川真央1, 松浦亜梨紗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2018.
Japanese Article P0645-23-PM. Shift to being at home of the cancer terminally ill patients
吉川三保子1, 玉田太志1, 平木精一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2018.
Japanese Article P0647-23-PM. About the diachronic intervention contents of the drugstore pharmacist in the treatment at home
杉浦聡1,2, 北村佳久1, 高橋正志2, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2018.
Japanese Article P0649-23-PM. Competitive review about the collection situation of the drug information in Hokkaido District and drugstore pharmacists of the whole country
梅田純代1, 柳本ひとみ2, 古田精一2, 黒澤菜穂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2018.
Japanese Article P0651-23-PM. About promotion of the medicine medicine cooperation in our hospital
河原香織1, 太田あづさ1, 西窪奈津子1, 塩田恵1, 吉田直恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2018.
Japanese Article P0653-23-PM. Efforts and questionnaire evaluation of the medicine medicine cooperation in the Ichinomiya City municipal hospital
染原渉1, 浅野祥子1, 亀重貴弘1, 三浦愛美1, 杉野善彦1, 川瀬洋次1, 吉田昌子1, 堀田敏之1, 桜田宏明1, 山村益己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2018.
Japanese Article P0655-23-PM. Is the protocol utilization effective for a hospital and the cooperation of the health insurance pharmacy?
高橋友里1, 金子実央1, 津田尚始1, 夏目義明1, 伊藤由美2,8, 高橋雄大3,8, 杉浦早紀4,8, 高木健司5,8, 市川浩6,8, 坂本悟7,8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2018.
Japanese Article P0657-23-PM. Introduction and the multi-type of job cooperation of the heart failure community medical care cooperation pass in our hospital
廣田あゆ子1, 藤江郁1, 新城唯1, 藤茂登希2, 加藤礼子2, 東郷和美3, 松川彰4, 橘大輔5, 福家聡一郎6, 齋藤博則6,7, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2018.
Japanese Article P0659-23-PM. Examine illness in making and whole city operation - Takarazuka-shi of the glaucoma seal; medicine scrum -
石居美和1, 辻隆志1, 笹岡幸夫2,3, 柴田哲夫3,4, 松井眞理子1, 尾形公子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2018.
Japanese Article P0661-23-PM. Efforts aiming at qualification of the cancer treatment authorization pharmacist foreign by regional alliances
袰岩靖子1, 熊谷史由1, 高松謙1, 羽川典江1, 伊藤美子2, 新谷裕子2, 岩倉大介2, 菅野和彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2018.
Japanese Article P0663-23-PM. About the instruction to patient cooperation with the health insurance pharmacy including the XELOX therapy
安藤志帆1, 豊田真史1, 若林千草1, 川島千夏1, 夏目真美2, 益子里美3, 松本啓一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2018.
Japanese Article P0665-23-PM. About the use situation of the electronic edition prescription notebook in the Himeji Branch
田中美早1, 櫛田宏幸1, 森保貴典2, 藤田佳典2, 浦上文男2, 砂金秀美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2018.
Japanese Article P0667-23-PM. An evaluation and problem of the tracing report utilization situation in our hospital
近藤智彦1, 粟野萌1, 上林愛1, 木村匡男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2018.
Japanese Article P0669-23-PM. About a method of the reporting to the health insurance pharmacy
清水けいこ1, 細川朋弘1, 美濃佳代子1, 三輪あゆみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2018.
Japanese Article P0671-23-PM. Doubt inquiry contents analysis from the pharmacy service under health insurance drugstore for the outside Parliament prescription
守内匡1, 守内典子1, 田中治1, 冨岡美悠1, 松井ひろみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2018.
Japanese Article P0673-23-PM. Efforts of the doubt inquiry simplification protocol based on the agreement of a health insurance pharmacy and the hospital
木下隆市1, 山崎友里絵1, 廣田等1, 染谷光洋1, 谷口亮央1, 中島史雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2018.
Japanese Article P0677-23-PM. Efforts for the discharge instruction reinforcement in our hospital
馬場啓貴1, 馬場親紀1, 中村一成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2018.
Japanese Article P0679-23-PM. The current situation investigation after the clinical test value mention start to outside Parliament prescription
村田諭1, 夘月博和1, 平野享1, 大木孝夫1, 秋山明美2, 中村祐大3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2018.
Japanese Article P0681-23-PM. Unification and evaluation ... of the efforts - kidney, liver function test value-related inquiry standard for the inflection of the outside Parliament prescription with the test value by the collaboration with the neighborhood drugstore
中村健一1, 寺谷俊昭1, 辻本高志1, 末永美由紀1, 大下直宏1, 加納宏樹1, 高橋強1, 上田晃1, 川本由加里1, 後藤仁和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2018.
Japanese Article P0652-24-AM. Efforts of the medicine medicine cooperation that aimed at the seamless relaxation medical care from a hospital to being at home from a hospital
八本久仁子1,2, 大棚貴史3,4, 永田博幸3,5, 吉田弘太郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2018.
Japanese Article P0654-24-AM. Efforts to medicine medicine cooperation by the patients follow-up system construction
高島伸也1, 牧陽介1, 村田雅子2, 鈴山直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2018.
Japanese Article P0656-24-AM. Dermatopathy management utilizing the medicine medicine cooperation
浦川龍太1,2, 橋本早苗3, 廣畑秀記3, 酒井克紀3, 松浦佳代4, 福田英克3, 南波勝栄3, 上島悦子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2018.
Japanese Article P0658-24-AM. Efforts of the authorized system aiming at standardization of the pediatric inhalational instruction
大野愛1, 桑村彩加1, 井上智喜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2018.
Japanese Article P0660-24-AM. About the study operation of the internal use anticancer medicine check seat
牧陽介1, 村田雅子2, 末長芽以1, 緒方康之3, 宇土隆4, 鈴山直人1, 高島伸也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2018.
Japanese Article P0662-24-AM. Attitude survey about the division formulations of the long-term prescription of patients receiving cancer chemotherapy
鈴木洋子1, 小田慎2, 大木稔也1, 神隆浩1, 阿蘇拡樹1, 今井博久3, 佐藤秀昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2018.
Japanese Article P0664-24-AM. It is telephone hearing ... by ... insurance pharmacist about side effect of medicine medicine cooperation monitoring of the oral anticancer medicine
菱沼隆一1, 三田恭平1, 長谷康史1, 荒木良介1, 井上邦彦2, 岡本大介3, 土井瑛博4, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2018.
Japanese Article P0666-24-AM. Comparison in the operation of the medication reporting book with EHR and the FAX
小川充恵1, 植田真理1, 井上麻衣1, 山崎肇1, 小枝伸行2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2018.
Japanese Article P0668-24-AM. Inflection case study of the tracing report in our center
岩西雄大1, 角川幸男1, 川田知加1, 濱谷佳名子1, 下辻恒久1, 高木麻里1, 金銅葉子1, 坂上嘉浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2018.
Japanese Article P0670-24-AM. Efforts for the "pharmacy management summary" for patients information sharing operation
大内友季江1, 安達寛成1, 佐藤千穂1, 番匠理絵1, 遠藤武弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2018.
Japanese Article P0672-24-AM. Doubt inquiry from the health insurance pharmacy and inquired efficiency and the effect
山口美樹1, 渡嘉敷俊介1, 山内拓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2018.
Japanese Article P0674-24-AM. Examination of an effect and the problem of the Residual medicine adjustment in the doubt inquiry simplification protocol
齋田正和1, 廣瀬浩一1, 松井健一1, 下村真野1, 高橋理寛1, 岡本智枝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2018.
Japanese Article P0676-24-AM. Holding and the current situation investigation of the pharmaceutical cooperation combination study session for polypharmacy measures by the questionnaire
秋山恵里1, 木村丈司1, 山本和宏1, 飯田真之1, 藤田弥佐1, 清水倫子1, 久保萌子1, 住吉霞美1, 番匠咲帆1, 三島唯1, 戸田飛鳥1, 宇田篤史1, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2018.
Japanese Article P0678-24-AM. The current situation investigation about mention contents of the prescription notebook in the discharge instruction
塚田寛子1, 塚田正之2, 山下典子1, 山脇一浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2018.
Japanese Article P0680-24-AM. New approach not to put test value on a prescription
設樂誉1, 設樂美紗子1, 千葉光1, 阿部優1, 鈴木康弘1, 佐藤真凡1, 熊谷智惠子1, 佐藤昌博1, 齋藤利彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2018.
Japanese Article P0682-24-AM. Problem of our hospital for the revision model core curriculum introduction in the pharmacy business training
山下花南恵1, 鎌田里紗1, 松岡勇作1, 池末裕明1, 奥貞智1, 室井延之1, 橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2018.
Japanese Article P0684-24-AM. Fix the eyes on hospital business training in conformity with revision core Cali; and evaluation - of making and the trial training of the - lube Rick evaluation list
國津侑貴1, 上田智弘1, 増田恭子1, 平大樹1,2, 森田真也1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2018.
Japanese Article P0686-24-AM. Current situation investigation - of the super acute phase ward training using upbringing 17th report - text mining of the pharmacist carrying the next generation
平松未智瑠1, 大川恭昌1, 川端崇義1, 田坂健1, 大月理恵子1, 井上知美1, 井上誠子1, 川西秀明1, 久保和子1, 猪田宏美1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2018.
Japanese Article P0683-23-PM. Base construction of the pharmacy education system for the revision model core curriculum accomplishment
菊地未由1, 大友眞菜1, 星野祐太1, 渡邊卓嗣1, 菅野和彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2018.
Japanese Article P0685-23-PM. Analysis - from medical therapy for 8 representative disease experience situation in upbringing 16th report - drugstore, the hospital business training of the pharmacist carrying the next generation
久保和子1, 猪田宏美1, 小川瑶子1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2018.
Japanese Article P0687-23-PM. Efforts ... of the training introduction about upbringing 18th report - postoperative pain management of the pharmacist carrying the next generation
槇田崇志1, 森下陽介1, 晴田佑介1, 浅澤大樹1, 国富泰介1, 川島理沙1, 猪田宏美1, 久保和子1, 岡崎昌利1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2018.
Japanese Article P0689-23-PM. ... that we do it exaggeratedly if making (the third report) - oneself of the lube Rick evaluation in the checking prescription thinks about the approximate age, and praising it is just good
渡邉正教1, 日比徹1, 中沢修司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2018.
Japanese Article P0690-24-AM. Consciousness change of the pharmacy student for the medical care in remote area by the on-site training
吉岡三郎1, 岡祥太郎1, 瀬川正昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2018.
Japanese Article P0692-24-AM. Practice of the multi-type of job cooperation education in the pharmacy school that does not have a medical system department: Stage, continuous educational program
野田幸裕1,6, 半谷眞七子2,6, 末松三奈3,6, 岡崎研太郎3,6, 高橋徳幸3,6, 福井愛子2, 亀井浩行2, 渕田英津子4,6, 阿部恵子5,6, 吉見陽1,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2018.
Japanese Article P0694-24-AM. The effect that the distribution continuation of the information paper for student, protectors and the holding of the business trip conference give to the pharmaceutical products education supplement, and the like to a junior high student
仲田里穂1, 喜友名侑舞1, 岡本晃典1, 大柳賀津夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2018.
Japanese Article P0696-24-AM. Because is sports fur better strike "; an activity and the future with" meaning to conduct
杉山育美1, 佐塚泰之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2018.
Japanese Article P0691-23-PM. Usefulness of the training about a prior learning "evaluation of the medical treatment based on the case" for the hospital business training
飛田夕紀1, 平山武司2, 川野千尋2, 厚田幸一郎2, 黒山政一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2018.
Japanese Article P0693-23-PM. Current situation - of the study on basic social skill -4 annual student sought by a new face pharmacist
中尾幸代1,2, 村田明子1,3, 松田裕子1, 南恵理子1,4, 山中智香1,5, 沼田千賀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2018.
Japanese Article P0695-23-PM. A study on non-language communication: Examination of distance, the angle between optimal patients - pharmacists using the autonomic nerve usability test
立松紗枝1, 仲山千佳1, 宮地佑佳1, 大嶋耐之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2018.
Japanese Article P0697-23-PM. Efforts of the sports fur better strike through the anti-doping lecture for the high school student athlete
遠藤進一1, 中村健志1, 玉木宏樹1, 西村信弘1, 直良浩司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2018.
Japanese Article P0698-24-AM. Progress and package insert comparison of the genome biomarker study on severe drug eruption in the laboratory of national keep
斎藤嘉朗1,2, 今任拓也1, 佐井君江1, Research Group Jsar2, 中村亮介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2018.
Japanese Article P0699-23-PM. Effect on temperament, character that Synaptic Vesicle Protein 2A genetic polymorphism gives
守屋友加1, 白井麻奈1, 杉浦礼菜1, 森理乃1, 平川菜実2, 齋藤邦明2, 鍋島俊隆2, 毛利彰宏2, 今西宏之3, 伊東亜紀雄1, 黒野俊介1, 松本修一1, 長谷川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2018.
Japanese Article P0700-24-AM. 1 case that worked on the delivery of the HIV infection pregnant woman who became pregnant by freeze thaw embryo transplantation by the multi-type of job
住吉健太1, 冨田淳子1, 加地雅人1, 田中裕章1, 元木貴大1, 小坂信二1, 窪田良次2, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2018.
Japanese Article P0701-23-PM. It is ... mainly on an example about analysis - HIV infection of the exposure accident in our hospital
大道淳二1, 石橋真実1, 横田幸子1, 佐久川亮2, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2018.
Japanese Article P0703-24-PM. An investigation and inspection of the incident report before and after the simple suspension method manual revision
山本理香子1, 湯浅周1, 壁谷めぐみ1, 近藤奈央子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2018.
Japanese Article P0705-24-PM. We effectively utilize it with the current situation of the dead stock psychotropic drug
中村武夫1, 蒲谷亘2, 増田信也2, 佐藤優子2, 木村えり2, 近澤生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2018.
Japanese Article P0707-24-PM. Effect accompanied with the trend of the use of selected patients drug in our hospital and the change of the application method
藤田謙1, 大竹満博1, 鐘司光貴1, 菅原克也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2018.
Japanese Article P0709-24-PM. Examination of the modi operandi in the cool place medicine inventory control system introduction using an IC tag
堀尾秀明1, 立田愛実1, 林宏樹1, 櫻井愛菜1, 福岡麻実1, 平野茂樹1, 戸田康裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2018.
Japanese Article P0704-25-AM. Intervention to fact-finding and quality control of the pharmaceutical products management in inside the hospital
笠井翼1, 榊原伸1, 佐藤大輔1, 安田知弘1, 水谷麻希子1, 天野杏南1, 木全司1, 木下元一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2018.
Japanese Article P0706-25-AM. Consideration about fact-finding and adequacy measures of pharmaceutical products management, the giving and receiving in the drugstore
長谷川洋一1, 赤川圭子2, 中尾裕之3, 今井博久4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2018.
Japanese Article P0708-25-AM. Evaluation of the operability of the new packing container (medication support container) of the tablet
永井晶大1, 内田信也1, 柏倉康治1, 石坂優佳1, 田中紫茉子1, 鈴木寛2, 山内克哉2, 伊藤譲3, 並木徳之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2018.
Japanese Article P0710-25-AM. Duties improvement investigation by the storage of designated medicine injection ordering management system introduction
朝岡裕樹1, 笹尾武史1, 神谷洋子1, 川澄清孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2018.
Japanese Article P0715-24-PM. Evaluation of the analysis of the incident about the drug for the medical care and the measures
戸田陽香1, 井門敬子1, 乗松真大1, 飛鷹範明1, 田中守1, 田中亮裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2018.
Japanese Article P0717-24-PM. Efforts of our hospital for the potentially serious medical errors and future problem
近藤健太1, 近藤倫成1, 杉本恵理1, 青孝明1, 寺田雄亮2, 木村匡男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2018.
Japanese Article P0719-24-PM. Inspection of drug duties based on JCI certification update
三浦篤史1, 鬼窪利英1, 中野和佳1, 中村久美1, 上條泰弘1, 伊藤隆哉1, 高木洋明1, 細川理博1, 荻無里千史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2018.
Japanese Article P0721-24-PM. Association of a fall, a fall and the use drug in the inpatient
友寄旬1, 松木有莉1, 荒川桃子1, 八幡弘子1, 中村裕一1, 田中悠季1, 飛澤国広1, 小原秀治1, 伊藤香苗2, 小原郁司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2018.
Japanese Article P0723-24-PM. Fall rate investigation in the classification of the sleeping drug
八木遥1, 山本義貴1, 臼窪一平1, 中村友香1, 下山あさ子1, 東修司1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2018.
Japanese Article P0725-24-PM. Suvorexant for the purpose of the reduced risk of a fall, the fall, introduction effect of S zopiclone
野村洋恵1, 塚本裕貴1, 川崎千尋1, 大田典正1, 後藤紅音1, 園田佳保里1, 福田浩之2, 二神咲子1, 山田正紀1, 由井薗陽一1, 槇林智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2018.
Japanese Article P0727-24-PM. Participation in planning to efforts - medical care security to tube self withdrawal, delirium-related risk reduction: ... which tests medical therapy from the viewpoint of the pharmacist
柴田博子1, 横田聖子1, 兵頭純子1, 永井佳代2, 西田真由美3, 西脇正美3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2018.
Japanese Article P0729-24-PM. Efforts for the proper use of the sedative in the Fujita Health University Hospital
加藤さや香1, 榊原有季子1, 加藤滉基1, 守作美咲1, 福永綾奈1, 桑原碧1, 大島晴佳1, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2018.
Japanese Article P0731-24-PM. Effect of pharmaceutical products safety measures in the medical safety management center placement of the manager for pharmaceutical products safety management
澤野純子1,2, 井上美樹1, 藤井一美1, 植田忠一1, 塩賀朋子2,3, 安井友佳子1, 石坂敏彦4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2018.
Japanese Article P0733-24-PM. Report of the pharmaceutical intervention in the decreased renal function patients
松石裕也1, 宮下裕央1, 津曲恭一1, 大津貴寛2, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2018.
Japanese Article P0735-24-PM. Do-it-yourself importing and health hazard of the ethical drug for the purpose of the disease therapeutic drug
岸本桂子1, 福本真理子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2018.
Japanese Article P0714-25-AM. Efforts to prevention of incident occurrence about the hospitalized self-care medicine by the collaboration with the nurse
鵜飼茜1, 松村若菜1, 新海大智1, 粟田浩文1, 土井裕一1, 澤田和久1, 奥平正美1, 鈴木鏡穂2, 鈴木真由美2, 杉浦洋二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2018.
Japanese Article P0716-25-AM. Count and analysis about the formulations incident of level 0
和田芙由子1, 吉田和子2, 篠原裕1, 矢作紘子1, 則武隆佑1, 山本明璃1, 蒲原範子1, 水沼知彦1, 米本佳代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2018.
Japanese Article P0718-25-AM. About securing of risk accompanied with the once quantity input change and appropriate prescription order
室井政子1, 柴田昌彦1, 橋本佑香1, 岩本明日香1, 綛谷哲也1, 岩田浩幸1, 的場美香1, 山東真寿美1, 吉田智江1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2018.
Japanese Article P0722-25-AM. Fact-finding of a fall example and the use drug in our hospital
永松美穂1, 松原美紀1, 長内佐斗子2, 石田耕太1, 加藤啓一3, 鈴木憲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2018.
Japanese Article P0724-25-AM. The fall prophylaxis of the inpatient by the proper use promotion of the sleeping drug and the evaluation
大谷道輝1, 稲川覚子1, 信澤弘美1, 松元美香1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2018.
Japanese Article P0726-25-AM. Examination about the usefulness of the suvorexant judging from a fall rate
伊藤夕貴1, 高岡龍蔵1, 藤井智美1, 伊藤裕美子1, 杉村聡1, 遠山幸男1, 久田達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2018.
Japanese Article P0728-25-AM. Can you use the companies prefilled syringe with a terfusion small size syringe pump? - Second report -
荒川昌史1, 高倉祐希1, 羽金智彦1, 小林亮1, 須藤俊明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2018.
Japanese Article P0730-25-AM. Epidemiologic study about the taking inpatient factor to affect it to be wrong
小久保友美1, 杉本崇1, 中村安孝1, 永山勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2018.
Japanese Article P0732-25-AM. It is Hospital Evaluation of function general hospital 1 <3rd G from a viewpoint of the medical security: Ver. Efforts of 2.0> auditee
田原雅子1, 平昭圭介1, 花田徳子1, 新谷茂之1, 熊本拓也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2018.
Japanese Article P0734-25-AM. The current situation of the proper use in the outside Parliament prescription of the drug requiring a renal function evaluation
小川実華1, 金城俊之介1, 坂本拓也1, 土佐直子1, 小川洋司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2018.
Japanese Article P0736-25-AM. Effect of the dispensing error reduction by the analysis of the medical accident to occur in pharmacy and the introduction of the bar code authentication system
木村洸1, 北村智哉1, 村山慶2, 益本周治1, 亀井健人1, 徳田衡紀1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2018.
Japanese Article P0738-25-AM. The example that formulations recorder was useful in the formulations act
上田紘子1, 戸田史恵1, 山中佑合子1, 高安敏子1, 浦川龍太1, 上田幹子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2018.
Japanese Article P0740-25-AM. Design of the aluminum pillow packing product for the purpose of the improvement in workability at formulations
溝江拓人1, 西田雅也1, 荻野哲也2, 大村朋幸1, 鈴木徹也1, 杉本昌陽1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2018.
Japanese Article P0742-25-AM. Research for the usability of the new tablet packing ESOP (easy seal open pack) and the improvement
佐藤夕紀1, 梨本俊亮2, 武隈洋2, 平野卓哉3, 野田敏宏3, 須田範行4, 井関健4, 盛本修司5, 菅原満2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2018.
Japanese Article P0744-25-AM. Correlative evaluation of taste bitter and the properties of matter of the list of essential drugs publication drug for children in WHO
原口珠実1, 小島穂菜美1, 村上絢香1, 堀恵里加1, 西川知花1, 井上穂南1, 吉田都1, 内田享弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2018.
Japanese Article P0746-25-AM. Making of a dissolution conversion table and the injection instructions book template for the preparation wrong prevention of the injection antimicrobial in the pediatric ward
古庄弘和1, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2018.
Japanese Article P0748-25-AM. Analysis of the reuse, disposal of return of goods medicine situation and future efforts
岩田真子1, 貝瀬眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2018.
Japanese Article P0737-24-PM. The study on factor to give it to malpractice: About picking work
大西正文1, 竹内正幸1, 長芝計代1, 島田博之1, 木下功1, 水野まい2, 宮地佑佳2, 仲山千佳2, 斎藤寛子1, 大嶋耐之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2018.
Japanese Article P0739-24-PM. Compounding of medicines duties efficiency by the powdered medicine formulations robot DimeRo introduction
船田茜1, 石塚仁保1, 尾形朱史鈴1, 坂本和央1, 北川裕也1, 樋浦一哉1, 飛澤国広1, 小原秀治1, 小原郁司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2018.
Japanese Article P0741-24-PM. Questionary survey for the development of the oral solution single remedy container for children
渡邉穣1, 成光大紀1, 岩田梨江1, 三輪朋也1, 濱田光宏1, 三田村しのぶ1, 菊田真穂1, 高田雅弘1, 首藤誠1, 垣野由佳理2, 菱川慶裕2, 山下伸二3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2018.
Japanese Article P0743-24-PM. Examination of the usefulness of the simple suspension method using the vortex
野口智宏1, 山内浩子1, 馬見新ちとせ2, 八木秀明1, 小杉雅史3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2018.
Japanese Article P0745-24-PM. Usefulness evaluation of the flavor enhancing peptide as the taste bitter inhibitor of the drug
内田享弘1, 森本栞1, 春名麻美1, 小島穂菜美1, 原口珠実1, 吉田都1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2018.
Japanese Article P0747-24-PM. Fact-finding of the germfree mixed preparation duties of the injection drug by the pharmacist
榎本英明1, 大森崇行1, 阿部猛1, 川名賢一郎1, 後藤一美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2018.
Japanese Article P0749-24-PM. About the fact-finding of doubt inquiry aiming at the safety improvement of patients
加藤佑治1, 田中昌代1, 上田文子1, 河野真由1, 高野浩彦1, 加藤敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2018.
Japanese Article P0750-25-AM. Properties of matter of the methylcellulose solution which made a drug suspended
下山哲哉1, 田辺将1, 伊藤邦彦1, 小林道也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2018.
Japanese Article P0752-25-AM. An example of the salivary hypersecretion in the seriously disabled child treated effectively with scopolamine ointment
下村香菜1, 田村賢士1, 藤村裕司1, 菊池健樹1, 木口智之2, 寺田伊知郎1, 下平雅之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2018.
Japanese Article P0754-25-AM. Use fact-finding of the Yokukansan bougie
横田睦美1, 高橋直也1, 阿部千秋1, 岩堀真弓1, 及川華代1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2018.
Japanese Article P0756-25-AM. Clinical preparation (hospital preparation) - based on suggestion - PDCA cycle from the Academy of Pharmaceutical Science and Technology, Japan clinical preparation focus group
花輪剛久1,9, 山内仁史2,9, 米持悦生3,9, 河野弥生1,9, 百賢二4,9, 宮嵜靖則5,9, 中島孝則6,9, 小林賢滋7,9, 笹津備尚3,9, 河田圭司8,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2018.
Japanese Article P0751-24-PM. Usefulness and safety of the ulinastatin vagina bougie for the early or threatened labour
佐竹清1,2, 岩田政則2, 中島孝則2, 宮本純孝3, 中村学3, 安藤昭彦3, 町田充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2018.
Japanese Article P0753-24-PM. Evaluation of preservation stability of the 8% hydroquinone ointment and properties of matter
大野修司1, 山内理恵1, 金子加奈1, 斉藤和花1, 久保元1, 竹場和代2, 小林稔2, 川崎智子2, 北岡晃2, 浅井和範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2018.
Japanese Article P0755-24-PM. Examination of the use of incompetent water effectiveness to be able to put of the persimmon to the intractable hiccups patients
五井はるか1, 鷲見実咲1, 川田彰彦1, 藤井梨沙1, 佐々木崇1, 西和哉1, 及川崇紀2, 成川孝一2, 加藤量広2, 佐賀利英1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2018.
Japanese Article P0757-24-PM. About bacteria pollution after dividing it of ω 3 system fatty acid preparation (Omegaven)
洲脇薫1, 下村祥子1, 中家清隆2, 中村安孝1, 大西聡3, 濱崎孝史3, 掛屋弘2, 永山勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2018.
Japanese Article P0758-25-AM. The establishment of the enforcement system of ward drug duties and the evaluation
小川紗知1, 譲原千広1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2018.
Japanese Article P0760-25-AM. It is ... for the visualization of ... ultimate about efforts and the result of ward drug duties of the municipal Otsu Municipal Hospital
神原諒1, 山中理1, 中山英夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2018.
Japanese Article P0762-25-AM. The system construction and effect for the improvement of pharmaceutical instruction
佐多照正1, 堀之内志織1, 中松穂菜美1, 鶴永大貴1, 中村有莉恵1, 堀内智裕1, 赤星真広1, 上原友美1, 池増鮎美1, 吉井美保2, 徳重浩一3, 西島浩雄2,3, 前之原茂穂3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2018.
Japanese Article P0764-25-AM. About effect to give patients satisfaction and medication adherence by the medication counseling
大登剛1, 土屋裕伴1, 諸橋賢人1, 日野亜莉沙1, 塩野このみ1, 師藤成美1, 齋藤由貴1, 青島彩香1, 中村友真1, 梁瀬加寿子1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2018.
Japanese Article P0766-25-AM. Medical treatment management (PBPM) introduction and evaluation based on the protocol in the division of cardiovascular disease ablation treatment
村木佑子1, 澤海健作1, 金高悠哉1, 山口春奈1, 長谷川芳裕1, 佐々木豪貴1, 増田宏章1, 佐藤康弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2018.
Japanese Article P0768-25-AM. Efforts for the reporting of the QT prolonged patients for physicians, and the like
石原裕介1, 伊藤太一1, 陶山裕平1, 原妃紗子1, 原直之1, 安食健一1, 横手克樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2018.
Japanese Article P0770-25-AM. Fact-finding of the discontinuation management before operation for antithrombotic drugs
三崎桃子1, 宮崎元康1, 松尾宏一1, 内山将伸1, 中島章雄1, 高瀬友美1, 今給黎修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2018.
Japanese Article P0772-25-AM. The effect second report that the involved site of patients with cerebrovascular disorder gives for medication self-discipline
藤原久登1,2, 後藤慧也3, 田中絵里子1, 高木桂子1, 泉真由美1, 東野真弓2, 中村彰子2, 須永登美子2, 川手信行4, 川添和義3, 渡邊徹2, 佐々木忠徳2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2018.
Japanese Article P0774-25-AM. The need of one and the pharmacist in the medical treatment ward successful by the pharmacist intervention for the medical treatment ward patients who detected a sleep disorder
篠原裕1, 小滝和代2, 田畑美海2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2018.
Japanese Article P0776-25-AM. About a comparison with examination of the periarticular cocktail for the Total Knee Arthroplasty in our hospital and the continuous epidural analgesia
栗崎貴啓1, 相方靖史2, 井上雅文3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2018.
Japanese Article P0778-25-AM. Efforts for the general electrolyte abnormality in the middle scale hospital
清水忠洋1, 浅川真由美1, 浅川杏子1, 城綾香1, 齊藤安昌1, 曾根原亘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2018.
Japanese Article P0780-25-AM. It is examination of becoming it assessment improvement of high-risk medicine
池田理沙1, 中田一孝1, 山本美沙1, 森住誠1, 坂井建樹1, 橋本佑樹1, 須原良海1, 本間暢1, 白石祐子1, 石原美加1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2018.
Japanese Article P0782-25-AM. Establishment of efforts and duties to polypharmacy in our hospital
木下照常1, 柴田大地1, 菅原さやか1, 伊藤有美1, 宮田知世1, 木村優里1, 本間崇正1, 足立守1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2018.
Japanese Article P0784-25-AM. Efforts for the drug global assessment adjustment addition calculation in the existence floor medical office
渡部直樹1, 宮田恵里子1, 布谷直美1, 三道悦子1, 小島千裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2018.
Japanese Article P0786-25-AM. Efforts to the injection drug mixed preparation by the ward placement pharmacist
吉澤雅恵1, 渡辺孔明1, 長澤宏之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2018.
Japanese Article P0788-25-AM. Result of importance and the activity of the pharmacist in the urination care team
林剛史1, 古川大樹1, 長谷川雅哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2018.
Japanese Article P0790-25-AM. Relation of the pharmacist in the osteoporotic liaison service using "a re-bone fracture prevention notebook"
打矢貴子1, 垣越咲穂1, 鈴木亮平1, 中村あゆみ1, 金子真理子2, 長岡宏一1, 深津哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2018.
Japanese Article P0759-24-PM. Role of the pharmacist of the local inclusion care ward in the extensive acute phase hospital
早瀬友和1, 吉川依里1, 新木智映子1, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2018.
Japanese Article P0763-24-PM. With expectation to real - future of the ward exclusive duty pharmacist -
竹野孝慶1, 阿部剛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2018.
Japanese Article P0765-24-PM. It is comparison between prescription intervention and doubt inquiry ... by ... ward pharmacist about prescription intervention utilized the specialty of the pharmacist by ward drug duties
尾内陽香1, 青孝明1, 川口奈緒美1, 堀部緑1, 上林愛1, 木村匡男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2018.
Japanese Article P0767-24-PM. The intervention situation investigation about the drug at discharge in patients admitted to the circulatory organ internal medicine
石山由香1, 寺島純一1, 山田哲也1, 中村直人1, 鷹見繁宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2018.
Japanese Article P0769-24-PM. Participation in medical therapy ... in prescription suggestion - circulatory organ ward of the diuretic in consideration of results of the echocardiography
塗木勇介1, 橘淳1, 原竜太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2018.
Japanese Article P0771-24-PM. The use results and proper use of the thrombomodulin alfa preparation for the disseminated intravascular coagulation syndrome
山田峻史1, 丹保亜希仁4, 眞鍋貴行2, 櫻庭好祐1, 小野尚志1, 田原克寿3, 粟屋敏雄3, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2018.
Japanese Article P0773-24-PM. For improvement in quality of the pharmaceutical participation associated with stroke complications in our hospital
水谷彩伽1, 眞野加奈子1, 高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2018.
Japanese Article P0775-24-PM. One case of the rheumatoid arthritis with suspected drug-related pancytopenia by the levetiracetam
山村亮太1, 藤井一憲1, 中村祐太2, 永野俊玲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2018.
Japanese Article P0777-24-PM. Efforts to the standardization of the sleeplessness dose of medicine by the choice method construction of the ward drug for household delivery to use at sleeplessness
西川直也1, 豊田貴美子1, 渡邊正規1, 清永智子1, 高砂美和子1, 幸田恭治1, 北原隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2018.
Japanese Article P0779-24-PM. Rearward investigation about the pharmaceutical intervention of the ward pharmacist for patients with multiple myeloma admitted to the blood internal medicine
門村将太1, 下口谷貴1, 川本康太郎1, 藤井達郎1, 鈴木智子1, 福田由布子1, 井藤達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2018.
Japanese Article P0781-24-PM. Inhalational support by the inhalational device choice using PBPM
安積奈々美1, 夏目義明1, 黒須智博1, 伊藤聖子1, 恩田愛子1, 朝日晶子1, 柳澤友希1, 金子実央1, 太野垣陽子1, 渡辺未紗子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2018.
Japanese Article P0783-24-PM. For the material making about the administration method to children
伊藤泰代1, 加藤結1, 後藤祥子1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2018.
Japanese Article P0785-24-PM. Fact-finding of the multiple drug prescription based on the operational situation of the ward drug duties enforcement addition
今井一輝1,2, 二村昭彦1, 伊東知美1, 上葛義浩1, 前川ゆか1, 吉岡京子1, 岩佐雅子1, 山田成樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2018.
Japanese Article P0787-24-PM. It is efforts to adequacy and medical expenses reduction of the infection prophylaxis antimicrobial after the ward pharmacist-led operation
木村純子1, 高木祥子1, 吉田弘樹1, 田宮真一1, 木下元一1, 加藤紀子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2018.
Japanese Article P0789-24-PM. A fact of the pharmacist intervention in the breathing care team activity and future problem
海老井佳織1, 野口周作1, 宮田広樹1, 笠原英城1, 大川陽平2, 高柳佳津紗2, 加藤和久2, 中村康一3, 小林和陽4, 唐木文江5, 齋藤佳輔5, 上野訓子5, 齋藤浩子5, 山口貴子5, 月岡悦子5, 高木聡5, 板倉潮人6, 吾妻安良太6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2018.
Japanese Article P0791-24-PM. Fact-finding about the bringing medicine for ward pharmacist confirmation duties for the direct hospital admission of emergency case in the cancer special hospital
原田まなみ1, 鈴木真也1, 太田貴洋1, 久松大祐1, 菊地寛隆1, 五十嵐隆志1, 岩本義弘1, 末永亘1, 石原淑子1, 瀬戸裕美子1, 金子明日美1, 川崎敏克1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2018.
Japanese Article P0792-25-AM. Investigation of drug-related incident contents before and after the ward drug duties start in NICU/GCU ward
瑞慶山にいな1, 砂川由佳1, 伊差川サヤカ1, 大田久美子1, 与那覇房子1, 外間惟夫1, 中村克徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2018.
Japanese Article P0794-25-AM. Doubt contents investigation about the proper use of the perioperative drug in HCU
森理保1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2018.
Japanese Article P0796-25-AM. Ward drug duties in the intensive care unit and evaluation of drug information offer contents
山口晃司1, 徳丸隼平1, 川上佳那子1, 坂本修1, 小杉三弥子1, 大塚将秀2, 橋本真也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2018.
Japanese Article P0798-25-AM. Making and operation of the dry concentration person prothrombin complex (Kay Saint lah) dosage manual
河村聡志1, 佐脇久美1, 薬師寺寿世1, 陸丸幹男1, 平松眞澄2, 稲垣伸洋3, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2018.
Japanese Article P0800-25-AM. Examination of the conversion ratio accompanied with the switching from an orchid geo-roll continuous intravenous infusion to a bisoprolol patch
昆貴志1, 小椋玲奈1, 森雅之1, 栃窪克行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2018.
Japanese Article P0802-25-AM. 2 cases that produced drug-related sinus arrest or cardiopulmonary arrest though blood pilsicainide levels were slight high level
種田靖久1, 松村知洋1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2018.
Japanese Article P0804-25-AM. The effect that the introduction of the corresponding flowchart gives to treatment on status epilepticus in the Anjo rebirth hospital critical care center
森理乃1, 山本恭平2, 鶴田昌吾2, 岩瀬由枝2, 奥明美2, 伊藤友恵2, 大野愛2, 久保田敏行2, 杉浦洋二2, 長谷川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2018.
Japanese Article P0793-24-PM. Efforts about the proper use of the injection drug in the pediatric intensive care unit
小野寺みさき1, 小川隆弘1, 花島玲子1, 本間雅士1, 小林昌宏1,2, 坂倉智子1, 近藤留美子1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2018.
Japanese Article P0795-24-PM. The current situation and problem of ward drug duties in SCU of our hospital and the pharmaceutical intervention to patients with stroke
中村和美1, 山之上真央1, 坂井恵理子1, 中村純平1, 松下裕子1, 中島誠2, 河野隆幸3, 安東由喜雄2, 武笠晃丈3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2018.
Japanese Article P0797-24-PM. Development of drug control, the evaluation system based on the evaluation according to the organ system which pointed to standardization, the efficiency of the duties in drug control, the evaluation of ICU patients
内田淳1, 米山早紀1, 寺田芳弘1, 内藤沙紀1, 須田沙也加1, 橘田文彦1, 河田圭司1, 鈴木正彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2018.
Japanese Article P0799-24-PM. The case that inhalant was given than the tracheotomy tube of patients during the respirator wearing, and helped the ventilator weaning
佐藤琢磨1, 二神諒子1, 中村敏史1, 山岡貴花1, 山田真史2, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2018.
Japanese Article P0801-24-PM. The blood pressure management situation using the vasopressor drug for the low blood pressure during the operation of the angiotensin II receptor antagonist continuation patients
西千恵子1, 宇夛裕基1, 加畑千春2, 河原昌美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2018.
Japanese Article P0803-24-PM. 1 case that evaluated amikacin blood pleural effusion during the CART enforcement and filtration concentrate levels
西川嘉広1, 小出哲朗1, 鷲見香織2, 今西義紀1, 川崎好人1, 橋本陽1, 芳川史嗣3, 大村崇3, 伊藤久美子1, 登内仁1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2018.
Japanese Article P0805-24-PM. It is ... for examination ... people about the usefulness in I-System in the critical care center and the hybrid duties of the machine
立道貴清1, 井上達也1, 元木貴大1, 山口佳津騎1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2018.
Japanese Article P0806-25-AM. About the usefulness of the duties that the encounter of the pharmacist in the digestive organ internal medicine sits
齋藤由貴1, 大登剛1, 土屋裕伴1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2018.
Japanese Article P0808-25-AM. Comparison ... with usefulness - other types of job of the pharmacist duties in the admitting department
小倉弥生1, 吉田千秋1, 若月秀明1, 大木孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2018.
Japanese Article P0810-25-AM. Examination of the pharmacist duties improvement accompanied with the hospitalization and release support center new establishment
男全昭紀1, 小宅典子1, 平田周祐1, 井口恵美子1, 猪股克彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2018.
Japanese Article P0812-25-AM. Consideration - that we maintain role - outpatient department bringing medicine for pharmacist differentiation in the support before hospitalization
内山幸子1, 伊原明宏1, 永江隆二1, 佐田竜尚1, 西田和代2, 福山貴子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2018.
Japanese Article P0814-25-AM. Examination of the pharmacist intervention effect on patients with invasive maneuver (surgery and biopsy, endoscopic treatment, and the like to be carried out by local anesthesia) plan in the hospitalization and release support center
鈴木誠麗1, 安田寛1, 横山智子1, 吾月遥1, 清水皓一1, 西澤広介1, 坂本真紀1, 西澤健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2018.
Japanese Article P0816-25-AM. Efforts for the discontinuation management before operation in the loanword before pharmacist technique
山中洋1, 杉山健二郎1, 錦織良平1, 河相景子1, 倉本成一郎1, 土井克史2, 八本久仁子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2018.
Japanese Article P0818-25-AM. Examination about the factor of the observance situation and discontinuation mistake of the discontinuation before operation in the existence floor medical office
宮田恵里子1, 布谷直美1, 渡部直樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2018.
Japanese Article P0820-25-AM. Intervention effect before operation of the pharmacist in the surgery preparations outpatient department
阿部正人1, 下野智美1, 今浦将治1, 西村瑞紀1, 武田康平1, 永瀬怜司1, 澤柳ユカリ2, 谷口英喜2, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2018.
Japanese Article P0822-25-AM. Effect to physician burden reduction by the pharmacist intervention using the pharmaceutical products management tool in the perioperative period
田中里奈1, 石田俊介1, 今西正樹1, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2018.
Japanese Article P0824-25-AM. Pharmacist intervention in the treatment with specific drug management charges 2 calculation
阿部一仁1, 藤井常宏2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2018.
Japanese Article P0826-25-AM. The expression situation of nausea post-operative, vomiting in the female surgery patients and future problem
下野智美1, 阿部正人1, 今浦将治1, 西村瑞紀1, 武田康平1, 永瀬怜司1, 澤柳ユカリ2, 谷口英喜2, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2018.
Japanese Article P0828-25-AM. Association with the participation in medical treatment consciousness of the communication frequency between patients - pharmacists through the prescription notebook and contents and patients
北潟和也1,2,3, 庄司雅紀2, 荒川行生3, 恩田光子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2018.
Japanese Article P0807-24-PM. Analysis about cost and the medical service fees of pharmacist duties for asthmatic treatment management charges 2
田辺就子1, 藤岡貴光1, 柴田壮一1, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2018.
Japanese Article P0809-24-PM. Examination about the effect that the information sharing in the hospitalization and release control center gives to the quality of the pharmacist interview
吉武由華1, 梶田志保1, 小倉功1, 横井尋和1, 河合俊樹1, 坪井千明1, 巽昭代1, 小野田奈々1, 坪井美知恵1, 松山哲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2018.
Japanese Article P0811-24-PM. Examination of the usefulness of the pharmacist intervention in the hospitalization support task
伊藤有美1, 高木早紀1, 小早川佳子1, 木下照常1, 鈴木優里1, 北川加寿子1, 小嶋俊輝1, 矢部知子1, 宮田知世1, 佐原祥子1, 柴田大地1, 滝本典夫1, 足立守1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2018.
Japanese Article P0813-24-PM. Examination about the usefulness of confirmation of common use medicine before hospitalization by the pharmacist
梅田将光1, 藤村由梨香1, 矢島領1, 渡邉裕次1, 稲毛俊介1, 林太祐1, 伊勢雄也1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2018.
Japanese Article P0815-24-PM. Making (including ARB, hormone drug, the immunosuppressive drug, and the like) of the drug report in the perioperative period
渡部智子1, 中川貴史1, 森光恵1, 中川浩子2, 坪川雅子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2018.
Japanese Article P0817-24-PM. New role of the foreign pharmacist in front of the art
青木洸英1, 鍵山智樹1, 土肥大典1, 吉田悟史1, 真壁秀樹1, 佐伯俊昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2018.
Japanese Article P0819-24-PM. Inspection of the effect that the intervention by the preoperative pharmacist outpatient gives to management of the stopping medicine during preoperation
米澤龍1, 横山桃子2, 伊東亜莉紗2, 宮坂善之3, 杉沢諭1, 上嶋浩順4, 刑部月5, 石川恵美子6, 川上由香子6, 柴田由美5, 栗原竜也1, 向後麻里2, 大嶽浩司4, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2018.
Japanese Article P0821-24-PM. Efforts of the pharmacist in the loanword before PFM (Patient Flow Management) and anesthesiology technique
稲村澄子1, 山田美映子1, 西村恵里子1, 本多秀俊1, 林由紀子1, 並木路広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2018.
Japanese Article P0823-24-PM. Intervention of the pharmacist for the stop medicine in front of the art of the perioperative patients
井無田優1, 江良円佳1, 渡部善博1, 吉原郁夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2018.
Japanese Article P0825-24-PM. Consideration about a fact and the cancer instruction to patient management charges 3 calculation of the number of oral anticancer agent intervention in the ambulant treatment
橋本直弥1, 立松三千子1,2, 稲熊一英1, 梶田正樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2018.
Japanese Article P0829-24-PM. The rebuilding of the bringing medicine bag issuance system and the evaluation
伊賀久美1, 安永大輝1, 檜垣宏美1, 飛鷹範明1, 田中守1, 田中亮裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2018.
Japanese Article P0831-24-PM. Evaluation in introduction and the operation of the bringing medicine differentiation system in connection with an electronic medical chart
小松めぐみ1, 乾朱里1, 西内祥子1, 木村美保子1, 田島千愛1, 市川麻美1, 田所美和1, 吉岡りえ1, 市吉真貴子1, 八木亜紀子1, 田中照夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2018.
Japanese Article P0833-24-PM. Efforts in the prehospital common use medicine intelligence and bringing medicine management
佐藤涼子1, 渡辺克明1, 鈴木さとみ1, 田村淳1, 吉田昌弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2018.
Japanese Article P0830-25-AM. About the nurse satisfaction investigation in the bringing medicine differentiation book change and the change of the false medicine incidence
田村悟1, 宇都直哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2018.
Japanese Article P0832-25-AM. Relation to operational start and other types of job, medicine medicine cooperation of the bringing medicine for planned inpatient confirmation duties in the outpatient department
後藤敏也1, 高屋敷奈々1, 松原大祐1, 正木銀三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2018.
Japanese Article P0834-25-AM. Relation ... of the pharmacist judging from "convalescent rehabilitation hospital" - prescription content
島児佳孝1, 中西祥子2, 津波古晶子1, 佐藤晴彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2018.
Japanese Article P0835-24-PM. Construction of the pharmaceutical support system in the RI private business therapy using the radium chloride (<SUP> 223 </SUP> Ra) injection
鈴木恵子1, 佐藤淳也1, 宮口貴守1, 田中怜1, 池ヶ谷優美2, 中村昌史3, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2018.
Japanese Article P0837-24-PM. Koto hospital pharmacy growth strategy of 2018 using the balun strike scorecard
黒田健吾1, 佐藤大輔1, 寺山和利1, 岡田侑子1, 若木麻由1, 田中美都子1, 加藤菊郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2018.
Japanese Article P0839-24-PM. The cascade to the drug section of the hospital balun strike scorecard and consideration about the congruity of the balun strike scorecard for hospital pharmacist
金田昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2018.
Japanese Article P0836-25-AM. For the expansion of preparation, quality control duties of the radioactive medicines by the pharmacist
山本孝幸1, 藤森博1, 今井綾乃1, 高澤佳江3, 小手康博4, 明星智洋2, 大澤浩2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2018.
Japanese Article P0838-25-AM. Examination - current situation survey ... of BSC (balun strike scorecard) utilization characteristics by job satisfaction measure (JOBSS-HP27) for hospital pharmacist
陶山明日香1, 永倉史子1, 濃沼政美2, 大久保淑子1, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2018.
Japanese Article P0840-25-AM. Consideration about the usefulness of the balun strike scorecard in the duties construction of the drug section
稲葉健二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2018.
Japanese Article P0841-24-PM. Analysis about the amiodarone-induced thyroid function abnormality using the adverse event spontaneous report database
木下佐昌子1, 細見光一2, 横山聡2, 高田充隆2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2018.
Japanese Article P0843-24-PM. Upper respiratory infection risk review of the DPP-4 inhibitor using the medical database (receipt, spontaneous report)
多門啓子1, 五島誠1, 吉井利郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2018.
Japanese Article P0845-24-PM. About the usefulness of the medical information cooperation system (Fukui medical net)
平賀貴志1,2, 木村嘉明1, 坂谷英亨1, 嶋田千穂1, 有田奈美1, 山口洋枝1, 服部はるか1, 篠田秀幸2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2018.
Japanese Article P0847-24-PM. Development of the use and application ~ side effect accumulation database of the information on adverse drug reactions in the foreign cancer chemotherapy and applied ~
鈴木直哉1, 山田将悟1, 杉山豪2, 藤林遼1, 菊地義明1, 前川英輝1, 高橋誠1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2018.
Japanese Article P0849-24-PM. Introduction to development and the pharmacist duties of the drug information offer support tool using the artificial intelligence (AI)
西原茂樹1, 神崎浩孝1, 堤絵利子2, 瀧下哲也2, 西広規2, 佐藤晶子1, 田中雄太1, 村川公央1, 北村佳久1, 木村隆夫2, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2018.
Japanese Article P0851-24-PM. Adverse event analysis of the neuropathic pain therapeutic drug using FDA adverse event report system (FAERS)
槇田潤1, 地嵜悠吾1, 松村千佳子1, 矢野義孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2018.
Japanese Article P0853-24-PM. It is ... about a side effect of examination - NSAIDs of the side effect risk in elderly people using NDB opening data and JADER
伊東岳1, 箕輪篤志1, 武田大将1, 中野渡恵1, 齊藤啓熙1, 杉山奈津子1, 加藤芳徳1, 前澤佳代子1, 倉本敬二1, 百瀬泰行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2018.
Japanese Article P0855-24-PM. Examination - of the structure which is available in - simpleness and easiness to utilize drug information by electronic prescription notebook
折井孝男1, 田代朋子2, 本田卓也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2018.
Japanese Article P0857-24-PM. Development of the database supporting proper use of the antimicrobial medicine
雨宮理1, 大野逸子1, 杉平直子1, 尾関理恵2, 小茂田昌代2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2018.
Japanese Article P0859-24-PM. The pharmaceutical products safety information report utilizing the severity classification standard of the side effects such as pharmaceutical products, and the like and the evaluation
関谷泰明1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2018.
Japanese Article P0861-24-PM. Construction of the web system aiming at the effective detection of the polypharmacy and the cooperation with the health insurance pharmacy
野崎晃1, 山本和宏1, 木村丈司1, 松田美玖1, 高橋知子1, 小倉史愛1, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2018.
Japanese Article P0863-24-PM. Consideration about the cause of the heavy stomach with the Rehmannia Root from literatures
柏崎友紀江1, 稲葉健二郎2, 岩本淳平2, 定村洋士1, 赤瀬朋秀3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2018.
Japanese Article P0865-24-PM. Comparison of the adverse event expression of non-benzodiazepine system sleeping drug and benzodiazepine system sleeping drug tendency
野口義紘1, 大坪愛実1, 古山愛紗1, 上野杏莉1, 松山卓矢1, 戸田有美1, 勝野隼人1, 杉岡まゆ子1, 村山あずさ1, 舘知也1, 土屋照雄2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2018.
Japanese Article P0867-24-PM. Efforts of the problem solving about intermittent administration medicine in our hospital
池田光1, 松田一駿1, 武田和也1, 眞木秀子1, 伊藤正昭1, 羽太光範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2018.
Japanese Article P0869-24-PM. The report that was involved in the medical therapy of the athlete
緒方有記1, 黒崎文広1, 木下礼児1, 松木俊明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2018.
Japanese Article P0842-25-AM. Examination of the seasonal variation of the contrast media side effect occurrence situation using the in-hospital side effect report data set
本多立1, 北村麻理愛1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2018.
Japanese Article P0844-25-AM. The drug interactions onset actual situation (the second report) of the oral molecular target medicine using receipt data
小林秋景1, 百賢二1, 安武夫1, 伊倉由夏2, 濃沼政美2, 黒田誠一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2018.
Japanese Article P0846-25-AM. Significance of the magnesium administration for the cisplatin-induced renal failure by the meta-analysis
山崎智司1, 浜田幸宏1, 山田真由美2, 丸山拓実1, 木村利美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2018.
Japanese Article P0848-25-AM. Development of the database using a documentation function (Excel) and the joint ownership folder of the electronic medical chart
入江健司1, 山科卓也1, 鶴田南奈子1, 鶴山萌子3, 小田原真希1, 松本紗織1, 松尾尚美1, 金原沙織2, 川俣洋生3, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2018.
Japanese Article P0850-25-AM. Examination of the safety measures using the mishaps in medical practice database accompanied with the clinical department new establishment
小竹優希1, 向井淳治1,2, 奥田広志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2018.
Japanese Article P0852-25-AM. Fact-finding of eye disorders with the anticancer medicine using adverse drug reaction database (JADER)
北見紀明1, 川澄賢司1, 川崎敏克1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2018.
Japanese Article P0854-25-AM. Analysis ... of the inquiry database to put on development and clinical application - system of the drug information offer support tool using the artificial intelligence (AI)
神崎浩孝1, 西原茂樹1, 瀧下哲也2, 堤絵利子2, 西広規2, 黒田智1, 田中雄太1, 佐藤晶子1, 村川公央1, 北村佳久1, 木村隆夫2, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2018.
Japanese Article P0856-25-AM. Efforts to the efficiency of DI duties associated with the collection of pharmaceutical products making
濱口翔太1, 岸川悦子1, 清水佐良子1, 平綿洋子1, 矢野忠1, 市川訓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2018.
Japanese Article P0858-25-AM. Fact-finding such as possession, the offer, and the like of the drug information about the simple suspension method in the pharmaceutical company and the tablet crush
新井克明1, 秋山滋男2, 輿石徹3, 石田志朗4, 倉田なおみ5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2018.
Japanese Article P0860-25-AM. International comparison of the pharmaceutical products safety information report for medical persons
門田佳子1,2, 幕田里奈1, 仲谷玲亜1, 植田かれん1, 加藤友希1, 平田絵里子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2018.
Japanese Article P0864-25-AM. Platinum system anticancer agent and impaired renal function
島田和代1, 長沼美紗1, 元岡佑美1, 笹岡沙也加1, 畠平春奈1, 長谷川栞1, 福田昌穂1, 中尾智史1, 平出耕石2, 森卓之3, 吉村知哲3, 加藤武司2, 中村光浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2018.
Japanese Article P0866-25-AM. About association of Dipeptidyl Peptidase-4 inhibitor and the autoimmune disease
戸田有美1, 野口義紘1, 勝野隼人1, 江崎宏樹1,2, 松山卓矢1, 上野杏莉1, 大坪愛実1, 古山愛紗1, 杉岡まゆ子1, 村山あずさ1, 舘知也1, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2018.
Japanese Article P0868-25-AM. The doping inquiry system in the health insurance pharmacy and correspondence example
川島大希1, 高橋祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2018.
Japanese Article P0872-25-AM. Adequacy of the prescription of the PPI using the PPI decrease medicine algorithm
長橋かよ子1, 段昭江1, 中川尚1, 浅澤友希1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2018.
Japanese Article P0874-25-AM. Prescription change of the sleep inducer in our hospital
岡林真由1, 宮崎俊明1, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2018.
Japanese Article P0876-25-AM. Efforts to use of acetaminophen promotion for the purpose of the pain-killer proper use
長澤欣弘1, 財津孝希1, 瀧内瑛輔1, 羽生智宏1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2018.
Japanese Article P0878-25-AM. The use of mild cathartic in the use of drug patients for the medical care, bowel movement situation investigation
佐々木美理1, 坂田茂代1, 山口文子1, 鈴木澪1, 佐藤透1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2018.
Japanese Article P0880-25-AM. Is it used as use comparison - second prevention of the anticoagulant appropriately? ...
中井聖子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2018.
Japanese Article P0882-25-AM. About the use situation of the Kay Saint lah in our hospital
濱端綾太1, 橋本貴史1, 礒元啓吾1, 大谷美奈子1, 前原大輔1, 見上千昭1, 本間久美子1, 西尾孝1, 辻本勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2018.
Japanese Article P0886-25-AM. Use fact-finding of the Sucroferric oxyhydroxide
大橋史嵩1, 田中壮周1, 越智裕太1, 丸山卓哉1, 後藤悠1, 嘉屋則子1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2018.
Japanese Article P0888-25-AM. The use situation of the tolvaptan in patients with our hospital cirrhosis
内田和孝1,2, 山田邦夫1, 山田聖浩1, 束野奈津己2, 宮瀬志保2, 藤山重俊2, 森岡淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2018.
Japanese Article P0890-25-AM. Through efforts - health Festival for the improvement in recognition of the hospital pharmacist duties for local inhabitants -
長谷川雅紀1, 福本康之1, 川上典子1, 近藤昌子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2018.
Japanese Article P0892-25-AM. Is RMP utilized in the healthcare setting? Suggestion of the utilization situation of RMP and the further use and application method
飯塚啓人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2018.
Japanese Article P0894-25-AM. Prescription fact-finding of the drug with the pharmaceutical products risk management plan
千田泰健1, 元木孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2018.
Japanese Article P0871-24-PM. About use fact-finding of gentamicin in our hospital
沢仁美1, 中島才博1, 近藤智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2018.
Japanese Article P0873-24-PM. The use situation investigation of the agate Pross ton in the ambulatory practice of the Iizuka Hospital
長崎皓光1, 内田守次1, 梅田勇一1, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2018.
Japanese Article P0875-24-PM. About the situation investigation of the long-term prescription of the benzodiazepine (BZ) receptor agonist in our hospital and measures
本多明香里1, 中嶋友代1, 齋藤暢人1, 武下恭子1, 日高博司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2018.
Japanese Article P0877-24-PM. Standardization of the use of in-hospital sedative and investigation of the observance situation
森谷康志1, 益本周治1, 亀井健人1, 徳田衡紀1, 中山克洋3, 山下茂樹2, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2018.
Japanese Article P0879-24-PM. The use situation investigation of the naldemedine and usefulness, safe examination
木村桃子1, 長尾由佳1, 岡野和真1, 亀井健人1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2018.
Japanese Article P0881-24-PM. It is an investigation about the proper use of the oral anticoagulant drug directly
猿川麻希子1, 瀬尾達朗1, 池上幸子1, 福本由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2018.
Japanese Article P0883-24-PM. For patients with cardioembolic is an investigation about the efforts of the proper use by renal function mention of the use situation and the prescription of the oral anticoagulant drug directly
山本涼子1, 中村友哉1, 枦秀樹1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2018.
Japanese Article P0885-24-PM. Glecaprevir, an effect of the Pibrentasvir and safe investigation
如田真貴1, 後藤渉1, 森田祐輔2, 大江真里2, 大穂有恒2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2018.
Japanese Article P0887-24-PM. About contribution to improvement of the ADL with the erythropoietin preparation administration
川瀬準也1, 尾田健志1, 里村恭子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2018.
Japanese Article P0889-24-PM. Efforts for the use situation investigation of the oral hepatitis C virus therapeutic drug to kick in our hospital and the intervention of the hospital pharmacist
筒井景子1, 山内浩子1, 八木秀明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2018.
Japanese Article P0891-24-PM. The effect that an attitude survey of the antibiotic exposure and an in-hospital workshop give on cold syndrome on our hospital staff
浅尾直哉1, 岩本遼1, 山田晃義1, 藤村裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2018.
Japanese Article P0893-24-PM. Situation ... of the pharmacist participation in the reinforcement of 2017 Kanagawa hospital pharmacist party duties survey - polypharmacy, antimicrobial proper use, the pharmaceutical products management
芦塚拓也1,2, 濃沼政美3, 稲葉健二郎1, 飯田純一1, 瀧本淳1, 河原英子1, 江島慎太郎1, 小串興平1, 柏崎友紀江1, 佐々木寿子1, 白鳥千穂1, 古川大輔1, 渡邊美智留1, 菅野浩1, 金田光正1, 佐藤透1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2018.
Japanese Article P0895-24-PM. Use case report of the direct action type antiviral drug in our hospital
長谷川豊則1, 小野翔太郎1, 水谷加代子1, 金澤克洋1, 柴田紗希1, 鈴木彩美1, 中川由紀子1, 加賀香織1, 籾山智美1, 兼子結衣1, 山田実咲1, 板倉充沙1, 長谷川瑛美1, 竹内詩乃1, 小田切英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2018.
Japanese Article P0896-25-AM. Examination of the drug costs reduction effect by the pharmaceutical intervention of the pharmacist
瀧浪靖子1, 三宅美有紀1, 細直子1, 大本奈緒子1, 野際俊希1, 奥下梨賀1, 中谷亮介1, 稲葉静香1, 藤井美紀1, 本郷志帆1, 石川裕大1, 石本昌裕2, 松本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2018.
Japanese Article P0898-25-AM. Economical effect by the use of division of a biological drug in our hospital and the anticancer agent
山下貴史1, 脇由香里1, 江原亜沙子1, 野田晋司1, 相松伸哉1, 藤戸淳夫1, 片山歳也1, 松田浩明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2018.
Japanese Article P0900-25-AM. Investigation of the new pharmaceutical products medicine charge calculation situation using the Central Social Insurance Medical Council exhibition material (about the medicine charge publication of pharmaceutical products)
向井梨々香1, 長谷川栞1, 加藤大和1, 松井利亘1, 畠平春奈1, 笹岡沙也加1, 元岡佑美1, 中尾智史1, 島田和代1, 上田夏実1, 中村光浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2018.
Japanese Article P0902-25-AM. Risk review with the use situation and the combination drug of the laxative in our hospital at admission
河村紳介1, 中島のぞみ1, 山田倭花1, 内山乃映1, 村松奈緒美1, 大窪真理恵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2018.
Japanese Article P0904-25-AM. About approach of the polypharmacy in the Care health center for the elderly
安部一秀1,2, 阿部真弓1, 渡部雄哉1, 柳田慎一1, 佐藤昌克1, 渡辺実2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2018.
Japanese Article P0897-24-PM. Examination for the medical expenses reduction by economic loss by the Residual medicine disposal of anticancer agent and the Drug Vial Optimization (DVO) introduction
櫻田啓介1, 佐藤加菜1, 中野裕介1, 棚谷貢1, 飛澤国広1, 小原秀治1, 小原郁司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2018.
Japanese Article P0899-24-PM. Possibility and problem of current situation and drug vial adequacy (DVO) of the quantity of disposal of injectable anticancer agent in the small and medium size hospital
高橋久樹1, 古川佳奈子1, 今野武志1, 柿崎貴昭1, 菅野絢子1, 小野寺佑実1, 佐藤浩保1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2018.
Japanese Article P0901-24-PM. Does it become in the red in cancer chemotherapy regimen and what kind of relative - case with the amount of DPC medical service fees? -
堀川佳津美1, 吉田直樹1, 菅谷量俊1, 高瀬久光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2018.
Japanese Article P0903-24-PM. Effect of the Residual medicine in the drug control of foreign maintenance haemodialysis patients
上野雅代1, 上本慶子1, 斉藤喬雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2018.
Japanese Article P0905-24-PM. Efforts of the duties improvement using KPI
高橋俊明1, 高橋恵2, 廣原正宜3, 串田一樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2018.
Japanese Article P0906-25-AM. Comparison between starting pharmaceutical products and generic medicine between the preparation in sedative antiinflammatory tapes
金丸達哉1, 北風日向1, 河地勇樹1, 内田昌希1, 八巻努1, 夏目秀視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2018.
Japanese Article P0908-25-AM. Comparison about rheology properties in the forerunner of the infusion ointment and the generic medicine
谷健太郎1,2, 小川千晶1, 畑山賢輔1, 矢田部恵1, 井上元基2, 谷地豊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2018.
Japanese Article P0907-24-PM. Policy for the current situation and promotion of the use of generic medicine in Iwate
藤村哲雄1,3, 田村剛1,3, 佐塚泰之2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2018.
Japanese Article P0909-24-PM. Safe investigation accompanied with the change to generic medicine of the tazobactam sodium/piperacillin sodium preparation
島井沙貴子1, 高野秀仁1, 鈴木正論1, 清田憲吾1, 石塚寛和1, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2018.
Japanese Article P0910-25-AM. Examination about the quality evaluation of the trophicity food containing zinc
村上雅裕1, 吉田敦哉1, 寺内真理1, 安田恵1, 天野学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2018.
Japanese Article P0912-25-AM. Effect on doxorubicin-induced cytotoxicity analysis with the chromophyll anthocyanin
竹林裕美子1, 數原由理恵1, 山崎智加1, 永井純也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2018.
Japanese Article P0911-24-PM. Dietary fiber and examination - using blood change in interaction - rat of metformin and Caco-2 cells
岩崎綾乃1, 喜多雄飛1, 山本賀奈栄1, 金子侑史1, 猿渡隆信1, 大西優斗1, 今井公江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2018.
Japanese Article P0913-24-PM. Introduction of a "peg filgrastim" regimen registration system and the use consent system
松田圭一郎1, 延川正雄1, 齋藤順1, 菅原拓也1, 荒井浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2018.
Japanese Article P0915-24-PM. Making, operation of the protocol for the methotrexate therapy for central nervous system origin malignant lymphoma and the evaluation
福井圭亮1, 澤井陽1, 山下恵梨香1, 田中こずえ1, 鈴鹿隆晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2018.
Japanese Article P0917-24-PM. The observance situation investigation after the use of denosumab guideline revision in our hospital and the evaluation
高原悠子1, 吉田弘樹1, 鈴木雅人1, 三上沙織1, 牧原明秀1, 木全司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2018.
Japanese Article P0914-25-PM. Efforts about the reduction of the cancer chemotherapy regimen that the use results have few
野田実希1, 杉山惠亮1, 川井正光1, 濱石華乃子1, 志賀有雅1, 森巧一1, 若原美沙紀1, 竹澤茜1, 杉浦洋二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2018.
Japanese Article P0916-25-AM. Making of the unification, administration manual of the anticancer agent administration procedure
佐藤友昭1, 富田浩史1, 筒井道彰1, 堀大1, 渡明美2, 岩永一郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2018.
Japanese Article P0918-25-AM. Relation of the pharmacist in team establishment and the activity for the proper use of the immune checkpoint inhibitor in our hospital
伊藤幸男1, 波多野聡子1, 中根論士1, 山岸利隆1, 五十嵐弘幸1, 中川敦子2, 藤田弘子2, 白崎浩樹3, 中山俊3, 高嶋孝次郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2018.
Japanese Article P0920-25-AM. Examination about the effect of the chemo support by a pharmacist, the nurse cooperation
遠藤征裕1, 鈴木円花3, 齋藤雅隆2, 平泉達哉2, 国安美和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2018.
Japanese Article P0922-25-AM. Inspection of the usefulness of the administration management of the stomach cancer SP therapy utilizing a medicine medicine cooperation tool and the Hand-off sheet
小笠原信敬1, 三浦宏真1, 高橋慎太郎1, 城戸直人2, 及川淳2, 福山真希子1, 三浦清彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2018.
Japanese Article P0919-24-PM. Efforts to immune-mediated adverse event expression situation in our hospital and clinical department cross-sectional cooperation
三谷泰広1, 原口久義1, 國領俊之1, 江上優1, 山川雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2018.
Japanese Article P0921-24-PM. Establishment of the cancer chemotherapy that is certain by security by the other types of job combination
堀友美1,2, 吉村恵子2, 友末和子2, 河上卓弥1, 松谷洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2018.
Japanese Article P0925-24-PM. The frequency investigation of the cholinergic symptom with the irinotecan administration and usefulness evaluation of CDTM about the supportive care
青木万穂1, 宮崎俊明1, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2018.
Japanese Article P0927-24-PM. Is the pre-medication of onset of Colin symptom situation investigation - anticholinergic drug with irinotecan necessary? ...
伊藤慎二1, 山田純子1, 加藤千里1, 勝村佳代1, 村瀬貴子1, 小林沙矢香1, 磯貝潤一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2018.
Japanese Article P0929-24-PM. Efficiency and current situation ... in the intervention - cancer instruction to patient management charges 3 calculation of the pharmacist in foreign chemotherapy patients
上原友美1, 堀ノ内志織1, 中松穂菜美1, 鶴永大貴1, 須賀理恵1, 中村有莉恵1, 堀内智裕1, 赤星真広1, 石神誠子1, 池増鮎美1, 佐多照正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2018.
Japanese Article P0931-24-PM. Efforts of the foreign cancer chemotherapy instruction to patient in our hospital and future problem
又吉里佳1, 川上博瀬1, 浜元善仁1, 翁長真一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2018.
Japanese Article P0933-24-PM. Improvement in rate of use by the relation of the pharmacist to HBV screening during cancer chemotherapy
岩下佳敬1, 高田侑那1, 薗田晃弘1, 中尾承司1, 兒玉麻代1, 浜園龍1, 宝来留美1, 久永あゆみ1, 森永知沙1, 石田和久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2018.
Japanese Article P0935-24-PM. About the disaster brochure manufacture for patients receiving cancer chemotherapy, palliative care
水木麻里1, 塩江さつき1, 後藤康平1, 石井大志1, 長江萌菜美1, 河野大嗣1, 中條恭孝1, 森吉雅代1, 大村ふみ1, 中川博之1, 福井伸也1, 中川朱美1, 野田好典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2018.
Japanese Article P0937-24-PM. Investigation of intervention contents to the cancer chemotherapy of the pharmacist in the surgery ward
木村佳弘1, 木元慎一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2018.
Japanese Article P0926-25-AM. Usefulness of the prescription support system by the medical examination attendance in the foreign cancer chemotherapy
吉田真人1, 深尾彰平1, 淡路健作1, 村野萌美1, 近藤匡慶1, 青木利恵2, 高瀬久光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2018.
Japanese Article P0928-25-AM. Investigation of the cancer instruction to patient management charges 3 calculation situation in the Red Cross hospitals of the whole country
村上通康1,11, 伊賀正典2,11, 小林政彦3,11, 大川浩子4,11, 堀大5,11, 佐賀利英6,11, 千田泰建7,11, 森一博8,11, 森英樹9,11, 谷村学10,11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2018.
Japanese Article P0930-25-AM. Efforts to the antineoplastic prescription management addition in our hospital
長芝計代1, 黒瀬優輔1, 江尻将之1, 佐久間晶基1, 木下功1, 大西正文1, 斉藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2018.
Japanese Article P0932-25-AM. Relation of the pharmacist for the hepatitis B screening enforcement situation and the improvement in rate of use
流石智恵子1, 小暮宗介1, 石橋正祥2, 梅谷直享3, 折井孝男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2018.
Japanese Article P0934-25-AM. It is the significance of the pharmacist interview in the adjuvant chemotherapy after the gastric cancer technique containing oxaliplatin
鈴木貴之1, 猪野達也1, 松本涼子1, 堀部聖1, 関根貴之1, 長谷川匡史1, 小針美佳1, 池上幸子1, 福本由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2018.
Japanese Article P0936-25-AM. Evaluation of the pharmaceutical intervention example about the cancer chemotherapy by the ward pharmacist
檀和貴1, 樋本繭子1, 荻原沙知1, 日原章詔1, 川上辰三1, 田中智也1, 新免徹1, 高瀬尚武1, 三木育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2018.
Japanese Article P0938-25-AM. Fact-finding of the medication adherence in the treatment with oral anticancer agent of patients with old cancer
市田泰彦1, 五十嵐隆志2, 山口正和3, 小川朝生4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2018.
Japanese Article P0939-24-PM. Participate in findings of the anticancer medicine preparation environment in our hospital and consideration - national hospital mechanism network collaborative investigation; and -
新島大輔1, 矢田部恵1, 小川千晶1, 軍司剛宏1, 松井哲2, 青儀健二郎3, 谷地豊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2018.
Japanese Article P0943-24-PM. The drug resolution removal test with the ozone water of the anticancer medicine pollution injection label surface
古田祐美子1, 土手賢史1, 岩根裕紀1,2, 小林由佳1,2, 成橋和正2, 杉浦伸一2, 中西弘和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2018.
Japanese Article P0945-24-PM. The anticancer agent using the closed system anesthesia drug transportation system pre-; the promotion of exposure measures by the making to prepare it
若林茜1, 永田菜美子1, 片山宏章1, 榊原辰弥1, 後藤真実1, 宮口貴守1, 伊藤雅子1, 佐藤淳也1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2018.
Japanese Article P0949-24-PM. Efforts for the full-scale introduction of the closed system anesthesia preparation appliance by the anticancer medicine preparation
西村雅次1, 板垣美保1, 石垣俊樹1, 羽太光範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2018.
Japanese Article P0951-24-PM. Inspection about the preparation cost cut of fluorouracil and cyclophosphamide using closed system anesthesia drug transportation system (CSTD)
加藤淳平1, 立田真也1, 石田耕太1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2018.
Japanese Article P0953-24-PM. Efforts to the use expansion of the obstruction-type drug transportation system in the anticancer agent adjustment and the evaluation
山崎博子1, 林幹也1, 赤崎淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2018.
Japanese Article P0955-24-PM. Introduction effect of the anticancer agent preparation training evaluation table
田辺真里1, 坂田茂代1, 山口文子1, 佐藤透1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2018.
Japanese Article P0957-24-PM. Examination of the cleaning method for the environmental exposure after the crush formulations of methotrexate tablets
青木学一1,2, 今野友貴2, 大和田真未2, 小田さつき1, 久保田聡2, 横田訓男2, 柴崎淳2, 渋谷清1,2, 尾鳥勝也1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2018.
Japanese Article P0959-24-PM. Examination of the usefulness of the simple suspension method of sirolimus tablets in the umbrella Bach merit syndrome of infants
津本有梨1, 小森桂子1, 寺岡知香1, 浅原章裕1, 大津由美子1, 藤田敬子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2018.
Japanese Article P0940-25-AM. Transfer the mitomycin C preparation duties in efforts - surgery center of the occupational exposure reduction with the anticancer agent to the drug department; and ...
大村花菜1, 横山正人1, 山中義裕1, 朝日恵美2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2018.
Japanese Article P0942-25-AM. Anticancer agent pollution investigation and measures in our hospital
田村淳1, 高橋明子2, 森屋智美3, 高木宏和1, 蒲生真紀夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2018.
Japanese Article P0944-25-AM. Evaluation of the pollution area zoning in anticancer agent exposure measures
田頭尚士1, 松本拓真1, 串田康弘1, 吉田昭昌1, 山本宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2018.
Japanese Article P0946-25-AM. Vascular pain onset frequency investigation of the gemcitabine hydrochloride accompanied with the powdery preparation prior dissolution after the closed system anesthesia drug transportation system introduction
永田菜美子1, 片山宏章1, 榊原辰弥1, 若林茜1, 後藤真実1, 宮口貴守1, 伊藤雅子1, 佐藤淳也1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2018.
Japanese Article P0948-25-AM. Abacterial examination in the vial under the preparation environment for the development of the DVO country enforcement standard
小野尚志1, 新田悠一朗1, 木村周古1, 相馬亮太1, 川田悠貴1, 仲谷彰規1, 三嶋一登1, 福土将秀1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2018.
Japanese Article P0952-25-AM. Closed system anesthesia drug transportation system (CSTD) introduction, the current situation report of northeastern Rousaibyoin
菅野和彦1, 高松謙1, 袰岩靖子1, 羽川典江1, 熊谷史由1, 片谷憲子2, 濱中直美2, 穂積史朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2018.
Japanese Article P0954-25-AM. Efforts before and after the closed system anesthesia preparation appliance introduction to all antineoplastic and the future prospects
大森義朗1, 藤井佑実1, 越智達郎1, 萩山博史1, 佐藤真也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2018.
Japanese Article P0956-25-AM. Usefulness of an attitude survey and the prevention of anticancer agent exposure enlightenment to the excretion of the person of patients, family, medical care about cancer chemotherapy at the home
齊藤直美1, 佐藤順子2, 阿部悟3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2018.
Japanese Article P0958-25-AM. It is the application to a note for an anticancer agent by note device (UG-XAD1) for radium chloride
大瀧翔太1, 継田雅美2, 古川智康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2018.
Japanese Article P0960-25-AM. Examination about the associated factor of an AUC estimate and the febrile neutropenia of the etoposide
山中礼子1, 槙原克也1, 内山ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2018.
Japanese Article P0962-25-AM. 1 case that was able to accomplish BEP therapy by desensitization of the etoposide
深沢健一1, 久保田豊1, 古川卓也1, 西澤千津恵2, 勝山善彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2018.
Japanese Article P0964-25-AM. Usefulness of the neutrophilic/lymphocytes ratio as the side effect expression predictor in nivolumab treated patients, the lymphocytes/monocyte ratio, the platelet/lymphocytes ratio
服部公紀1, 三宅知宏1, 野口祥紀1, 和田亜希1, 中西由衣1, 小川晃宏1, 内田早弓1, 谷村学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2018.
Japanese Article P0966-25-AM. The current situation investigation about intensity of treatment and the blood toxicity of patients with old lung cancer
伊佐治麻里子1, 桑山果織1, 白井博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2018.
Japanese Article P0968-25-AM. Efforts to the HBV reactivation measures of the internal use anticancer agent remedy patients utilizing the hepatitis B monitoring paper
與田賢作1, 松浦徹1, 桑名寿幸1, 内山有理香1, 奥野美和1, 田原裕希乃1, 山下大貴1, 立石裕樹1, 安部由起子1, 市川美佳1, 後藤貴央1, 大汐欣輝1, 日高美緒1, 村田智弘1, 重松由加1, 宮津大輔1, 田中博和1, 井上幸子1, 平川雅章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2018.
Japanese Article P0970-25-AM. Investigation about the onset of vascular pain risk at the gemcitabine administration
伊藤健史1, 眞野翔太1, 足立牧子1, 井上壽江1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2018.
Japanese Article P0972-25-AM. The Ergo thionein relieves peripheral neuropathy by inhibiting accumulation of oxaliplatin in the rat dorsal root ganglia
長澤一樹1, 大石晃弘1, 西田健太朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2018.
Japanese Article P0974-25-AM. Examination of the objective evaluation using Trace test and the grip measurement for oxaliplatin-induced peripheral neuropathy
原口久義1, 三谷泰広1, 國領俊之1, 江上優1, 山川雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2018.
Japanese Article P0976-25-AM. Investigation about the case that the use situation and interstitial pneumonia of the Pembrolizumab in our hospital developed
田中裕子1, 古林園子1, 神長雅浩1, 加藤一郎1, 安田直史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2018.
Japanese Article P0978-25-AM. Inspection of the effectiveness of the fenofibrate for the cisplatin-induced renal failure
斉家和仁1, 合田光寛2, 伊勢諒3, 新村貴博1, 石澤有紀3, 座間味義人1,2, 中馬真幸4, 濱野裕章2, 岡田直人2, 武智研志4, 今西正樹1,2, 堀ノ内裕也3, 池田康将3, 土屋浩一郎5, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2018.
Japanese Article P0980-25-AM. Fact-finding of the side effect of the liver arterial infusion chemotherapy, low-dose 5-FU+ cisplatin therapy in the unresectable progress hepatocellular carcinoma
道家雄太郎1, 藪田直希1, 上田智弘1, 長谷川千晶1, 野田哲史1, 平大樹1, 飯田洋也2, 谷眞至2, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2018.
Japanese Article P0982-25-AM. Side effect expression of FOLFIRINOX investigation for the unresectable progress pancreatic cancer in our hospital
中ノ内唯可1, 板倉祥嗣1, 土谷有美1, 津田正博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2018.
Japanese Article P0984-25-AM. Effect of the amino acid derivative on 5-fluorouracil-induced liver damage
福野修平1, 吉田咲紀1, 長井克仁1, 小西廣己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2018.
Japanese Article P0986-25-AM. Adverse event investigation of the GC therapy in the urologic domain
西山裕也1, 網代真史1, 谷口由理1, 窪田奈津子1, 敦見真由美1, 中谷孝史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2018.
Japanese Article P0988-25-AM. Examination of a risk factor and the preventive preparation of the thromboembolism in patients with Japanese multiple myeloma using lenalidomide
坂本健一1, 村瀬哲也2, 上野千奈美1, 西垣内亮2, 木村優美2, 櫻下弘志2, 泉谷悟2, 佐伯康之2, 松尾裕彰2, 谷口雅敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2018.
Japanese Article P0990-25-AM. Effect by the irAE check list introduction in the side effect monitoring of the immune checkpoint inhibitor
井上加菜子1, 近藤博紀1, 木下千恵美2, 上田潤哉1, 横幕香織1, 大野勝則1, 三露久生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2018.
Japanese Article P0992-25-AM. Look at the rear of the onset of interstitial pneumonia risk factor of nivolumab/Pembrolizumab for patients with lung cancer; trial ... in mark examination ... single institution
橋本貴尚1, 高橋克史1, 丸山香代子1, 本明孝広1, 飯島秀弥2, 栃窪克行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2018.
Japanese Article P0994-25-AM. Examination of the cancellation reason of the immune checkpoint inhibitor in the University of Occupational and Environmental Health Hospital
竹村知1, 長原功騎1, 久保田政二郎1, 徳丸一郎1, 麻生忠弘1, 横山雄一2, 蒲池英博2, 篠原義剛2, 西原豊1, 植木哲也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2018.
Japanese Article P0996-25-AM. Protein urine by the ramucirumab, fact-finding about the onset of high blood pressure situation
澤柳直樹1, 荒木寛也1, 坂柳悦章1, 西川隆一1, 藤井友和1, 辻博幸1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2018.
Japanese Article P0998-25-AM. 4 cases receiving the daratumumab for the recurrent or refractory multiple myeloma
宮本大嗣1, 芦田隆司2, 森嶋祥之1, 淺野肇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2018.
Japanese Article P1000-25-AM. Side effect measures and evaluation for the daratumumab administration
安宅希美子1, 水岡大策1, 田中裕章1, 山口佳津騎1, 元木貴大1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2018.
Japanese Article P1002-25-AM. Side effect expression of sorafenib investigation in our hospital
寺尾勇紀1, 内田将吾1, 大谷寧次郎1, 高橋弘康1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2018.
Japanese Article P1004-25-AM. Factor analysis of the onset of low Mg blood symptom with the antiEGFR monoclonal antibody medicine in patients with metastasis, recurrent colon cancer
深井雄太1, 高田慎也1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2018.
Japanese Article P1006-25-AM. The side effect of breast cancer therapeutic drug Palbociclib expression situation investigation
木村美甫1, 角川幸男1, 川田知加1, 高木麻里1, 金銅葉子1, 坂上嘉浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2018.
Japanese Article P1008-25-AM. Relation of the pharmacist in the onset of use actual situation and side effect of the Palbociclib in our hospital
山崎富士子1, 長島由紀子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2018.
Japanese Article P1012-25-AM. Effect of the febuxostat combination on side effect expression at the a large quantity of methotrexate therapy
篠木優里1, 池村健治1, 俵功2, 岩本卓也1, 片山直之2, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2018.
Japanese Article P1014-25-AM. Usefulness of myelosuppression frequency and the CARG score of patients who received elderly people chemotherapy in our hospital
畠山智明1, 篠原一宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2018.
Japanese Article P1016-25-AM. Inspection of the usefulness of the CTCAE test value grading tool using eXChart
阿部史誉1, 山中理1, 中山英夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2018.
Japanese Article P0963-24-PM. A neutropenia with the GC therapy in patients with progressive urothelium cancer and the neutrophilic/lymphocytes ratio and related examination with the survival period
笹野知海1, 山本圭祐1, 辻大樹2, 石塚友一1, 都甲海1, 中道秀徳1, 米田達明3, 矢部勝茂1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2018.
Japanese Article P0965-24-PM. Blood poison-related evaluation of the unresectable ramucirumab in progress, patients with recurrent stomach cancer
岩井美奈1, 伊藤大輔1, 浅野裕紀1, 安達志乃1, 岡田和智1, 宇佐美英績1, 木村美智男1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2018.
Japanese Article P0967-24-PM. Efforts of hepatitis B revival measures with the chemotherapy
結城正幸1, 村山恵智子2, 稲葉行男3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2018.
Japanese Article P0969-24-PM. Example that caused phlebitis, induration by Carfilzomib administration
木瀬大輔1, 大垣孝文1, 中永かおり1, 霜倉智子1, 上坂一行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2018.
Japanese Article P0971-24-PM. Examination of the onset of vascular pain by changes from the one for gem Saar injection to gemcitabine infusion liquid "NK"
鶴永大貴1, 上原友美1, 堀内智裕1, 中松穂菜美1, 須賀理恵1, 堀ノ内志織1, 中村有莉恵1, 赤星真広1, 石神誠子1, 池増鮎美1, 佐多照正1, 奥村浩2, 前之原茂穂2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2018.
Japanese Article P0973-24-PM. Association with the quantity of oxaliplatin per body-surface area during the early onset oxaliplatin-induced peripheral neuropathy and chemotherapy regimen
加藤芳徳1, 清水加奈子2,3, 中村裕義2,3, 山田治美1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2018.
Japanese Article P0975-24-PM. About the bullous pemphigoid onset of patients who received gemcitabine
杉町代1, 津曲恭一1, 西村尚芳1, 北島久義1, 尾之江剛樹2, 中山文子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2018.
Japanese Article P0977-24-PM. Analysis of the risk factor of the impaired renal function at the cisplatin (CDDP) administration
津曲恭一1, 三好孝法2, 魚井みゆき3, 大村芙佑希4, 田川幸5, 横田千明6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2018.
Japanese Article P0979-24-PM. 2 cases that developed ischemic enteritis during the adjuvant chemotherapy cisplatin + vinorelbine enforcement after the operation
高取裕司1, 牛膓沙織1, 吉村拓也1, 新井孝文1, 山本雅史2, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2018.
Japanese Article P0981-24-PM. Analysis of the exacerbation factor for the sensory nerve disorder of vincristine in patients who received R-CHOP/R-THP-COP therapy
松谷直樹1, 豊田倫之1, 岡安伸晃1, 麻生一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2018.
Japanese Article P0983-24-PM. Relative dose intensity and side effect investigation of the gemcitabine + albumin suspension type paclitaxel combination therapy in the pancreatic cancer
植松俊成1, 幸田恭治1, 北原隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1424, 2018.
Japanese Article P0985-24-PM. Investigation about the hiccups expression during the FP therapy in patients with cancer of the esophagus
平岡佳子1, 熊澤里美1, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1424, 2018.
Japanese Article P0987-24-PM. 1 case that a steroid rotation was effective for hiccups by the dexamethasone during S-1+CDDP therapy
細川浩輝1, 霜田英明1, 石井貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2018.
Japanese Article P0989-24-PM. Factor to have an influence on the blood sugar control after the goserelin administration in patients with prostate cancer
有松冴1, 桐生浩子1, 伊藤朱里1, 原美由紀1, 佐宗智之1, 小松由佳1, 加藤義章1, 出口賀奈子1, 西川嘉広1, 近藤加奈子1, 橋本陽1, 今西義紀1, 小出哲朗1, 須川由理子1, 堀田康広2, 木瀬英明3, 伊藤久美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2018.
Japanese Article P0991-24-PM. Examination of the backward field about the elevated blood pressure with the ramucirumab administration
中川雅史1, 泉本裕美1, 毛利萌1, 喜多由紀1, 宮内実奈絵1, 狩谷佳寛1, 樫葉利人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2018.
Japanese Article P0993-24-PM. Side effect investigation of the high blood pressure in ramucirumab treated patients
入江良之1, 廻千晴1, 光川由佳子1, 波多野真弓1, 江口善美1, 石井茂1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2018.
Japanese Article P0995-24-PM. Investigation about the use situation and the side effect expression of immune checkpoint inhibitor
長能優子1, 浜屋正志1, 米山栄司1, 河岸由紀夫2, 佐々木良子3, 本元浩和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2018.
Japanese Article P0997-24-PM. About the use actual situation of the immune checkpoint inhibitor in our hospital respiratory division domain
榊間絢子1, 水谷妙子1, 田中文1, 横山征史1, 濱至寛1, 登内盛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2018.
Japanese Article P0999-24-PM. Comparison between examination of proteinuria qualitative analysis and protein urine creatinine ratio (UPC) measurement
安藤純子1, 小松順子1, 建持岳史2, 足立茂樹3, 國枝克行4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2018.
Japanese Article P1001-24-PM. Fact-finding of protein urine measures at use of bevacizumab in our hospital
川原裕1, 山下千草1, 佐野雅昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2018.
Japanese Article P1003-24-PM. Examination about proteinuria with the neovascularisation inhibitor
宮本拓人1, 鈴木大介2, 大山英明2, 川澄清孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2018.
Japanese Article P1005-24-PM. About anemia with trifluridine Tipiracil hydrochloride combination tablets
柿本智広1, 三浦ひとみ2, 尾積時敬子1, 武田恵視1, 川床優子1, 岩元富有子1, 前田加奈子1, 枚田明1, 中島誠2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2018.
Japanese Article P1007-24-PM. The administration situation and side effect investigation of four multiple myeloma receiving the daratumumab
中嶋紘文1, 村永諒1, 外山裕晃1, 有賀久晃1, 坂田幸雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2018.
Japanese Article P1009-24-PM. One patient whom the acute necrotic esophagitis that Afatinib introduction was serious early developed in
荒井早穂1, 真砂聖1, 藏本裕信1, 足立恵子1, 前田翠1, 依藤健之介1, 井上明香2, 門田和也2, 松本章士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2018.
Japanese Article P1013-24-PM. Strength of an onset of tumor part and the dermatopathy in patients with colon cancer receiving cetuximab, examination about the association of the survival period
田初夏苗1, 高田慎也1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1431-1431, 2018.
Japanese Article P1015-24-PM. One case that resulted in heart failure during Cmab + mFOLFOX6 therapy
浦川美採1, 倉橋基尚1, 藤本冬佳1, 片桐茜1, 山岡真由美1, 松本涼1, 門田友貴1, 卜部和美1, 澤崎高志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2018.
Japanese Article P1017-24-PM. Comparison with the 5-FU note for the blood vessel-related adverse event of fluorouracil note "Towa"
原かをり1, 前田章光1, 尾瀬功2, 稲熊一英1, 梶田正樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2018.
Japanese Article P1018-25-AM. The current situation investigation about the effectiveness of palonosetron in the Carboplatin combination therapy for the lung cancer
吉村拓也1, 高取裕司1, 牛膓沙織1, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1433-1433, 2018.
Japanese Article P1020-25-AM. An antiemesis effect and safety by granisetron for retching, vomiting in the ABVD therapy or palonosetron alone and the corticosteroid combination
内田まやこ1,2, 中村任2, 秦晃二郎1, 渡邊裕之1, 森康雄3, 加藤光次3, 宮本敏浩3, 細畑圭子2, 増田智先1, 赤司浩一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2018.
Japanese Article P1022-25-AM. The use situation investigation of olanzapine for the digestive organ symptom (retching, vomiting) with the antineoplastic administration
猪股浩介1, 片山瑞補1, 陣田剛志1, 岡田悠加1, 佐倉小百合1, 藤原康浩1, 國東ゆかり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2018.
Japanese Article P1024-25-AM. It is association with onset of retching and the surgery in the adjuvant chemotherapy after the S-1 technique
川地志緒里1, 郷真貴子1, 木村美智男1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2018.
Japanese Article P1026-25-AM. About a drug costs reduction effect obtained by the antiemesis therapy review of the chemotherapy regimen
永石浩貴1, 松尾圭祐1, 林淳一郎1, 尾之江剛樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2018.
Japanese Article P1019-24-PM. Investigation about the effectiveness of the antiemesis therapy with aprepitant in the low-dose cisplatin divided doses for the testicular germ cell carcinoma
蛯江裕美1, 城間由奈1, 吉見陽1,2, 宮崎雅之2, 山田清文2, 野田幸裕1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2018.
Japanese Article P1021-24-PM. Dose comparison of granisetron for patients with lung cancer
宮川貴行1, 田中翔一1, 水口敦子1, 梶井孝洋1, 西澤修一1, 西川正直1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2018.
Japanese Article P1023-24-PM. The use situation of olanzapine for retching, vomiting with the cancer chemotherapy
山本英晶1, 原一樹1, 渡邉浩人1, 草谷朋子1, 藤森浩美1, 川上恭弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2018.
Japanese Article P1025-24-PM. Of the steroid supportive care in the highly emetic risk regimen single; and is weighed divided doses
大柿滋1, 牛島智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2018.
Japanese Article P1027-24-PM. Make use of a - national hospital mechanism Kyushu block multicenter study about efforts for the antiemesis therapy standardization for LEC of our hospital; and -
松尾圭祐1, 永石浩貴1, 林淳一郎1, 尾之江剛樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2018.
Japanese Article P1028-25-AM. About usefulness of the sustained G-CSF preparation peg filgrastim for the breast cancer AC therapy
谷口賢二1, 和田祐一1, 鈴木美世利1, 福永浩也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2018.
Japanese Article P1030-25-AM. Investigation of the effect to give the use situation of the sustained G-CSF preparation peg filgrastim in our hospital and intensity of treatment
磯貝潤一1, 伊藤慎二1, 村瀬貴子1, 小林沙矢香1, 大橋武司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2018.
Japanese Article P1032-25-AM. One case of patients with ALL that blood catharsis was useful for the extensive excretion delay after the Methotrexate massive dose therapy and acute renal failure
森紗世子1, 難波亜矢子2, 後藤千尋2, 柴崎康彦2,3, 増子正義3, 曽根博仁2, 後藤佐和子4, 細島康宏4, 山本卓4, 成田一衛4, 島田泉1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2018.
Japanese Article P1034-25-AM. Consideration after the Carboplatin + etoposide therapy for haemodialysis patients
牛膓沙織1, 高取裕司1, 野村翔1, 浅井美穂1, 山本雅史2, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2018.
Japanese Article P1036-25-AM. Investigation of progress, the factor that eribulin therapy gives to extension for patients with recurrent breast cancer liver metastases for a survival period
小倉千奈1, 生田智基2, 武良卓哉3, 槇恒雄2, 橋本修1, 小川喜通4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2018.
Japanese Article P1038-25-AM. Examination about the triple-drug therapy in the cancer of the esophagus preoperative chemotherapy of our hospital
曽根千晶1, 淺野肇1, 佐々侑寿香1, 藤原季美子1, 家田正子1, 月岡康行1, 森嶋祥之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2018.
Japanese Article P1040-25-AM. Comparison after the second treatment of the nivolumab for the non-small cell lung cancer and the third treatment
大野裕之1, 田中佳子1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2018.
Japanese Article P1042-25-AM. About pre-medication examination and an evaluation for infusion reaction prevention in the Daratumumab administration
網野一真1, 赤坂知香1, 柏原佑香1, 江口彩香1, 登内盛治1, 内山倫宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2018.
Japanese Article P1044-25-AM. One case that a transmistake came to have good by prescribing it, and supporting VRd therapy for the multiple myeloma to be complicated with impaired renal function
宮下裕央1, 津曲恭一1, 大津貴寛2, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2018.
Japanese Article P1046-25-AM. Research about the maintenance therapy of the pemetrexed in our hospital respiratory division
安田将樹1, 野洌孝二1, 大岡千寿子1, 高山直樹1, 中村俊之1, 神田雄史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2018.
Japanese Article P1048-25-AM. Usefulness of the Hangeshashinto for oral mucositis in the head and neck cancer TPF therapy
出町拓也1, 北山秀則1, 城ケ崎怜奈1, 千葉里織1, 和田由美1, 芦崎雅之1, 平田力1, 早坂州生1, 竹内公美1, 渡邉昭仁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2018.
Japanese Article P1050-25-AM. It is an example using the indometacin gargle for oral mucositis with the cancer chemotherapy
堀井麻衣1, 百賢二1, 安武夫1, 黒田誠一郎1, 横山和明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2018.
Japanese Article P1052-25-AM. It is examined the protective efficacy of low-dose oral aciclovir for the herpes zoster after the hematopoietic stem cell transplantation enforcement of children
建部泰尚1, 江角悟1, 真鍋洋平1, 牛尾聡一郎1, 小川敦1, 村川公央1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2018.
Japanese Article P1054-25-AM. Evaluation about the usability of the constant infusion pump for exclusive use of the anticancer medicine and the accuracy of the 5-FU discharge completion time
横山雄一1, 篠原義剛1, 植木哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2018.
Japanese Article P1029-24-PM. Examination of the clinical response of the G-CSF primary prophylaxis in the ramucirumab + docetaxel treatment
小山田聡1, 久松直樹1, 小島純子1, 野村明広2, 井坂彰一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2018.
Japanese Article P1031-24-PM. About usefulness of the pegfilgrastim administration in the relief chemotherapy for the malignant lymphoma
島田惇司1, 伊藤やす江1, 五十嵐貴之1, 岡田和博1, 泉澤友宏1, 島崎博士1, 鈴木一史2, 西脇嘉一2, 長谷川英雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2018.
Japanese Article P1033-24-PM. Examination about the association between serum zinc levels and peripheral blood lymphocyte counts in patients with first malignant lymphoma
守作美咲1, 伊藤佳織1,2, 岡本昌隆2, 今井美沙1, 全並美穂1, 柘植雅大1, 稲熊容子2, 徳田倍将2, 恵美宜彦2, 加藤さや香1, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2018.
Japanese Article P1035-24-PM. 1 case that was given paclitaxel/Carboplatin combination therapy for patients with lung adenocarcinoma during the haemodialysis enforcement
松本拓真1, 田頭尚士1, 竹原基晴1, 吉田昭昌1, 山本宏1, 尾関太一2, 南大輔2, 柴山卓夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2018.
Japanese Article P1037-24-PM. Change analysis of the serum hepcidin concentrations in cisplatin treated patients
中村任1, 新潟里歩2, 山下和彦3, 久米学4, 安井裕之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2018.
Japanese Article P1039-24-PM. We look at the rear of patients with progress, recurrence colon cancer which is impossible of curative resection in the single institution chemotherapy center and analyze a mark
里見眞知子1, 河野透2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2018.
Japanese Article P1041-24-PM. Efforts for the use situation investigation and the proper use of the immune checkpoint inhibitor
三好孝法1, 吉村幸永2, 高野由香里2, 鶴田南奈子1, 上野拓也3, 福山誠一4, 深田陽子5, 甲斐宜貴6, 清崎邦洋7, 鶴田悟8, 光尾邦彦9, 矢野篤次郎4, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2018.
Japanese Article P1043-24-PM. Investigation about the Infusion Reaction expression at the Daratumumab administration
安森奈緒子1, 川俣洋生1, 福石和久1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2018.
Japanese Article P1045-24-PM. A treatment result of the KRd therapy for a recurrence, the intractable multiple myeloma in the JCHO Kyushu Hospital and examination of the side effect
西村直朗1, 桑村恒夫1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2018.
Japanese Article P1047-24-PM. The use situation investigation of the ramucirumab combination regimen in our hospital
小西史子1, 濱武清範1, 美和孝之1, 松本弘誠1, 中西輝1, 酒井ちひろ1, 野間敏也1, 足立那々緒1, 後藤仁美1, 仲忠士1, 小島一晃1, 神田直樹2, 恒松一郎3, 北英夫4, 菅理晴5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2018.
Japanese Article P1049-24-PM. An example of ovarian cancer successful in Carboplatin desensitization by examination of the pre-medication
松山千容1, 馬見新佳那子1, 松井礼子1, 原野謙一2, 川崎敏克1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2018.
Japanese Article P1051-24-PM. Effect of the pre-treatment to give it to onset of oral mucositis at the allogeneic hematopoietic stem cell transplantation and disease severity
吉越静香1, 北澤文章1, 村山和子1, 森本拓也1, 上田久美1, 中山優子3, 高良恒史3, 佐原敏之1, 淵田真一2, 島崎千尋2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2018.
Japanese Article P1053-24-PM. Protective efficacy of the dexamethasone ointment for stomatitis by the Everolimus
下川福子1, 小山拓弥2, 林洋平2, 澤田奈津子2, 清水裕行2, 原田沙枝子2, 船越幸代3, 柄川千代美4, 川嵜英二2, 前田頼伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2018.
Japanese Article P1055-24-PM. Effect of the oral Mg agent giving it to onset of low Mg blood symptom by the cisplatin
賀茂佳子1, 佐藤淳也1, 田中怜1, 石川寛1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1454-1454, 2018.
Japanese Article P1057-24-PM. Fact-finding about the proper use of the fentanyl citrate sublingual tablet after the protocol introduction
藤岡貴光1, 斎藤太寿1, 小林義和1, 齋藤雅俊1, 柴田壮一1, 松原肇1,2, 中山莊平3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2018.
Japanese Article P1059-24-PM. Use stocktaking of the naldemedine in our hospital
松藤敬佑1, 原茉梨絵1, 築田晃直1, 仲田浩成1, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2018.
Japanese Article P1061-24-PM. The investigation for the change of the laxative in the null Medellin administration and analysis of the factor
中島隆良1, 植松卓也1, 菅尾高裕1, 玄田拓哉1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2018.
Japanese Article P1063-24-PM. It is ... using the examination - palliative care self-assessment vote of the risk factor of opioid-induced retching, vomiting (OINV) and an emetic risk factor evaluation
三浦愛美1, 吉田昌子1, 山中規明1, 桜田宏明1, 山村益己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2018.
Japanese Article P1065-24-PM. Examination of the use situation of hydromorphone in our hospital and examination of the use situation of the once a day oral morphine slow-release preparation
原圭子1, 山下秀之1, 山口伸二1, 田畑貴康1, 中村徹志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2018.
Japanese Article P1067-24-PM. Quality of life change of patients with cancer by the intervention of the health insurance pharmacy pharmacist
佐藤由美1,2, 粂和彦1, 大澤匡弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2018.
Japanese Article P1069-24-PM. Use actual situation evaluation of duloxetine in patients not to deceive
辻茉莉香1, 五十嵐文1, 佐藤弘子1, 市田千佳1, 澤村公志1, 山本郁生1, 高橋賢成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2018.
Japanese Article P1071-24-PM. 1 case that pain and the bad smell of the cancerous skin ulcer due to the breast cancer were improved by use of the metronidazole gel, and became available for weight loss of the opioid
村上幸恵1, 山本修也1, 金井紀江2, 伊達和俊3, 藤田亘浩3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2018.
Japanese Article P1073-24-PM. One case that we were able to connect with palliative care patients from foreign going to hospital, inpatient care to home care by the intervention of the pharmacist smoothly
元木孝1, 菊池謙宏1, 泉谷理恵2, 高柳昌宏1, 千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2018.
Japanese Article P1075-24-PM. The current situation and problem of the palliative care team which we saw from request time
礒貝明彦1,2, 小川智恵子1,2, 藤原俊輔1,2, 吉田玲1, 小松弘尚2, 橋本佳浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2018.
Japanese Article P1077-24-PM. Making of the mild medical therapy manual for pharmacists
中永かおり1, 大垣孝文1, 木瀬大輔1, 霜倉智子1, 上坂一行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2018.
Japanese Article P1079-24-PM. Investigation of the use of psychotropic drug situation after the initial cancer medical therapy start of patients with breast cancer
波多野優希1, 波多野正和1,2, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2018.
Japanese Article P1081-24-PM. For a feeling of dyspnea of patients with terminal heart failure, it is one case that continuously administering it was effective of the morphine hydrochloride from a hospitalization early stage
前田朱香1, 曽我弘道1, 福島将友1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2018.
Japanese Article P1058-25-AM. One case with suspected hyperalgesia with the fentanyl tape
今野耕英1,4, 倉繁愛1,4, 大竹隆晴1,4, 大江奈美子2,4, 佐藤彩2,4, 阿部立也3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2018.
Japanese Article P1060-25-AM. Attitude survey to the current situation and a physician of the fentanyl patch prescription to opioid-free patients
世古口拓也1, 濱口容子1, 三宅知宏1, 谷村学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2018.
Japanese Article P1062-25-AM. Investigation about the use situation of the naldemedine and the side effect expression situation
田島紳介1, 関礼輔1, 篠原高雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2018.
Japanese Article P1064-25-AM. Use fact-finding of the naldemedine tosyl acid salt for the opioid-induced constipation and examination about the usefulness
北野祐香1, 東達也1, 井上敦介1, 岡本明子2, 廣畑和弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2018.
Japanese Article P1066-25-AM. Investigation about the role of the palliative care team at introduction of naldemedine tosyl acid salt tablets of our hospital and the use situation and the effect
高木茂実1,2, 宮本幸雄2,3, 野村朋子2,4, 土田真樹子2,4, 米田杏子2,5, 吉田絵美2,5, 林みどり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2018.
Japanese Article P1068-25-AM. One patient who was treated effectively with neurodestruction by the intrathecal phenol block for the cancerous pain to suffer from
赤石憲俊1, 吉田勝好1,3, 郷原学1, 片桐浩2, 土佐めぐみ3, 斉藤操3, 服部晋司3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2018.
Japanese Article P1070-25-AM. In-hospital instructions examination in the use of opioid preparation half a dose
北村修1, 勝又一雄1, 川口洋実1, 小林義典1, 小林豊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2018.
Japanese Article P1072-25-AM. Relation to the patients who cannot express pain well
堀敦雄1, 久保寺祐季1, 川嵜真太郎1, 西嶋長1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2018.
Japanese Article P1074-25-AM. The preparation of the duloxetine bougie and evaluation of the bioavailability
山田龍之介1, 大門拓実2, 清水翔太1, 滕真由美1, 村田勇1, 井上裕1, 金本郁男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2018.
Japanese Article P1076-25-AM. One patient who was treated effectively with Mohs paste for a breast cancer disintegration wound
渡部智文1, 根本紀子2, 吉川慧1, 吉川真一3, 吉田進3, 松田明宏1, 川口信哉2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2018.
Japanese Article P1078-25-AM. Consideration about the factor becoming the wall of the active pharmacy management instruction for the cancerous pain relief therapy case
畝佳子1, 覚野律2, 政道修二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2018.
Japanese Article P1080-25-AM. Contribution degree investigation of the current situation and the charge pharmacist about the palliative care of the national hospital mechanism (the fifth report)
形部文寛1, 中村孝祐2, 林俊吾3, 山崎富士子3, 八本聖秀4, 波多江崇5, 八本久仁子6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1468-1468, 2018.
Japanese Article P1082-25-AM. Relations of a dose and the SSI incidence per weight of prophylactic antimicrobial in the elective lower digestive tract surgery
入口慎史1, 田中昌代1, 加藤敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1469-1469, 2018.
Japanese Article P1084-25-AM. Efforts and results to proper use of the prophylactic antimicrobial based on results of the surveillance of the perioperative infection
小関崇文1, 日向早苗3, 大貫敏明1, 安田麻美1, 笠井洋輝1, 西關由梨子1, 芦澤由佳1, 加藤由紀1, 伊藤早紀1, 大場雄一4, 湊栄治2, 小舛修三2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2018.
Japanese Article P1086-25-AM. Examination of the effect by having unified infection prophylaxis antimicrobial after the operation of our hospital orthopedics surgery in CEZ
梅木拡嵩1, 森伸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2018.
Japanese Article P1088-25-AM. Examination of the usefulness of the administration before kanamycin in the colon cancer surgery and metronidazole technique
馬島務1, 浅井茂夫1, 稲村勝志1, 深海広平1, 高田宏文1, 小田剛史1, 山下剛史郎1, 山本諭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2018.
Japanese Article P1090-25-AM. Approach ... from the pharmacist using the use of efforts - identification antimicrobial questionnaire to the antimicrobial proper use with the medical institution which cannot organize AST
白川哲1, 松尾明子1, 四元華奈1, 佐藤肇1, 松尾啓1, 中村忠之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2018.
Japanese Article P1092-25-AM. Invention of the hospital infection measures education in the small and medium size hospital obtained from the staff questionnaire and problem of the pharmacist
浅井憲和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2018.
Japanese Article P1094-25-AM. Effect by the pharmacist round start for the blood culture submission patients
岡平将志1, 北村卓麿1, 近藤結1, 播磨里美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2018.
Japanese Article P1096-25-AM. Efforts of our hospital in the drug-resistant measures action plan
並木孝哉1, 枦秀樹1, 太田哲徳1, 織田錬太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2018.
Japanese Article P1098-25-AM. Examination about efforts and the education effect to the antimicrobial proper use by the antibacterial chemotherapy workshop (Osaka ABC) for young pharmacists
安井友佳子1, 上田覚2, 行本拓史3, 眞継賢一4, 山田智之5, 伊藤千恵6, 吉野秀紀7, 石坂敏彦8, 関雅文9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2018.
Japanese Article P1100-25-AM. Efforts and enforcement results of Antimi-crobial Stewardship Program for antimicrobial proper use in our hospital
須山由佳子1, 神戸宏憲2, 神田藍1, 杉山恭平1, 鈴木清美2, 大石和伸3, 袴田康弘2, 木村緑1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2018.
Japanese Article P1102-25-AM. About intervention of Antimicrobial stewardship team for the purpose of the antibacterial chemotherapy adequacy
梅坪翔太1, 望月敬浩1, 櫻井美満1, 押田幸恵2, 杉山知代2, 市川美香2, 山本泰正3, 明貝路子3, 伊東直哉3, 堤直之3, 倉井華子3, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2018.
Japanese Article P1104-25-AM. Effect ... by the intervention of attitude survey - antimicrobial proper use support team about the antimicrobial proper use support for ward pharmacists
弓長藤佳1, 渡部智貴1, 加藤一郎1, 金田暁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2018.
Japanese Article P1106-25-AM. Use fact-finding of the antimicrobial in the emergency pediatric service outpatient department
吉田真也1, 松岡知子1, 大橋健吾1, 日野光記枝1, 安田茉緒1, 森万希子1, 黒田彩夏1, 宇佐美英績1, 鹿野博明2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2018.
Japanese Article P1108-25-AM. Prescription investigation of the oral antimicrobial in the outpatient department and future problem
松島菜々1,2, 鈴木千博1, 村山将也1,2, 關直子1, 辻晋也2, 藤井奨2, 吉見猛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2018.
Japanese Article P1110-25-AM. The prescription situation investigation of levofloxacin for the internal use in the Iizuka Hospital
梅田勇一1, 内田守次1, 長崎皓光1, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2018.
Japanese Article P1112-25-AM. Consumption evaluation of the carbapenem-based antimicrobial using Days of therapy (DOT)
長尾柚香1, 近藤晃史1, 坂野昌志1, 寺井文廣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2018.
Japanese Article P1114-25-AM. Evaluation of the meropenem proper use judging from PK/PD parameter
松崎玲奈1, 近藤晃史1, 坂野昌志1, 寺井文廣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2018.
Japanese Article P1116-25-AM. Comparison about the safety between meropenem hydrate generic medicine two drugs
中蔵伊知郎1,2, 今西嘉生里1,2, 宮部貴識1, 佐光留美1, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1478-1478, 2018.
Japanese Article P1118-25-AM. Factorial experiments of the acute renal failure onset by the combination of vancomycin and tazobactam/piperacillin
上瀧喬仁1, 酒井義朗1, 樋口恭子1, 三輪涼子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1478-1478, 2018.
Japanese Article P1120-25-AM. Fact-finding about the vancomycin administration situation under the peritoneal dialysis
中川裕介1, 島田泉1, 小林将文1, 袖山健吾1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2018.
Japanese Article P1122-25-AM. Correlation of thrombocytopenia expression and dose in the linezolid administration
石井奈津季1, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 仲村亮太1, 森智子1, 駒井勇太1, 人見百合子1, 石井英之1, 田仲祐子1, 府川祥子1, 村雲智久1, 近藤理美1, 坂口結斗1, 白木萌1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 中村麗紗1, 山中愛美1, 吉村美菜1, 岸本実優1, 北池祥子1, 小久保綾乃1, 又吉樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2018.
Japanese Article P1124-25-AM. An example of the seriously ill burn patients who were able to be treated with linezolid and ST medical mixture combination therapy for daptomycin-resistant MRSA bacteremia
神戸宏憲1, 宮川赳平2, 三宅章公2, 春田浩一2, 吉岡良造2, 成田知大2, 牧信行2, 吉田裕2, 大石和伸3, 木村緑1, 登坂直規2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2018.
Japanese Article P1126-25-AM. Relation of the pharmacist in the clinical path making of the aspiration pneumonia
伊藤隆哉1, 青木静恵2, 手島憲一3, 吉池昭一4, 小田切範晃5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2018.
Japanese Article P1128-25-AM. Stocktaking of the Bundle compliance for the MRSA bacteremia in the Tsushima Municipal Hospital
清水智也1, 伊藤嘉英2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2018.
Japanese Article P1130-25-AM. Fact-finding of the liver damage of the antimicrobial in the Kumamoto function hospital
塚本康代1, 星野輝彦1, 下田賢一郎1, 塩津和則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2018.
Japanese Article P1132-25-AM. Comparison - with examination - Pseudomonas aeruginosa case of the two-drug resistant Pseudomonas aeruginosa case
鈴木美華1, 平岩歳久1, 寺澤宏紀1, 鈴木竜太1, 山田茂樹1, 石井潤一3, 石川清仁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2018.
Japanese Article P1134-25-AM. The current situation of the antimicrobial administration for the acute respiratory tract infection in our hospital
唐芳浩太1, 菅原秀悦1, 吉田和美1, 阿部憲介1, 後藤達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2018.
Japanese Article P1136-25-AM. A bacterial brain abscess by the pharmacist participation is ... using one - injection antimicrobial which we healed and internal use antimicrobial
杉田尚子1, 遠藤愛樹1, 花輪和己1, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2018.
Japanese Article P1138-25-AM. The case that infection treatment was provided by local gentamicin sustained administration from intra-Sectional Antibiotics Perfusion (iSAP)
松尾麻美1, 中島一1, 今村陽子1, 柏田匡広1, 大石貴裕1, 池田浩和1, 福田文雄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2018.
Japanese Article P1083-24-PM. Analysis of the perioperative infection risk factor in the cardiovascular surgery surgery of our hospital
河村真歩1, 門口直仁1, 橋田真佐1, 三宅陽一郎2, 田中聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2018.
Japanese Article P1085-24-PM. Examination of the appropriate antimicrobial usage of the perioperative infection prophylaxis
今井雅之1, 石崎均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2018.
Japanese Article P1087-24-PM. It is examined the infection prophylaxis antimicrobial proper use after the operation in our hospital otolaryngology
有延早弥香1, 吉岡睦展1,2, 岡秀樹3, 小澤拓1,2, 山本真由美1, 細見真世1, 若松雄太1,2, 石津智司1,2, 森田聡子1, 西山祐美1, 小林敦子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2018.
Japanese Article P1089-24-PM. The oral antimicrobial administration cancellation having been appropriate after examination ... operation about the usefulness of AMR measures in the central part Rousaibyoin obstetrics and gynecology department or ...
丹村亜梨朱1, 山口智江1,4, 中根茂喜2, 宮原兼二1,4, 平松久典1,4, 兼子詩布1, 片野貴大1, 荒川正悟1, 菅もも3, 藤原多子3, 石川真弓4, 福原順子4, 町田和彦4, 伊藤功治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2018.
Japanese Article P1091-24-PM. Analysis of the factor affecting the evaluation and the suggestion acceptance rate of the antimicrobial proper use support (AS) activity by the pharmacist
齊藤伸1, 木元健寛1, 仙葉悠紀1, 工藤和彦1, 吹谷真紀子1, 一関美江子1, 金美紀1, 篠田和人1, 山崎恵葉1, 鈴木ひとみ1, 八代佳子1, 水沢重則1, 後藤敏晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2018.
Japanese Article P1093-24-PM. Efforts of the antimicrobial proper use support team conference in our hospital
佐藤圭吾1,2, 佐藤陽介1, 伊藤貴亮1, 菅野和1, 茄子川智子2, 永沼結花3, 尾池泰典2,3, 松本亜紀2, 井上顕治2,4, 篠崎滋5, 小林誠一6, 矢内勝2,6, 佐賀利英1,7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2018.
Japanese Article P1095-24-PM. The change of the antimicrobial proper use promotion activity in the public west Chita General Hospital: Comparison of antimicrobial proper use team activity three years
小林義和1,2, 川崎祥平1, 吉岡祐貴1, 長谷川万里子1, 新美太祐1,2, 伊藤靖2, 生田宏次2, 浅野昌彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2018.
Japanese Article P1097-24-PM. An antimicrobial proper use support activity in our hospital and the evaluation
北村好申1, 大川華代2, 篠崎陽一2, 北村正樹2, 中澤靖1, 川久保孝2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2018.
Japanese Article P1099-24-PM. Construction of AST duties using the specific drug monitoring system
伊藤新司1, 坂井孝行1, 六波羅孝1, 内木義泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2018.
Japanese Article P1101-24-PM. AST activity in our hospital and effect on use of CDI therapeutic drug actual situation
松本芳樹1, 三木芳晃1, 塚本啓介1, 梅林良英1, 山口みなみ1, 渡邉優子1, 西垣玲奈1, 山下加珠美1, 川口尚子2, 萱野勇一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2018.
Japanese Article P1103-24-PM. Antimicrobial medicine proper use investigation in the night emergency visit
田中一平1, 加籐智之1, 中村友香1, 浜田吉昭1, 日野斉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2018.
Japanese Article P1105-24-PM. Investigation by the monitoring system construction of the quantity of oral antimicrobial prescription in the respect and affection society
玉城哲子1, 浦崎清美1, 城間盛彦1, 仲吉亜依美1, 武富美貴子1, 長濱照美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2018.
Japanese Article P1107-24-PM. The use situation of the internal use antibiotic in the seriously disabled child (person)
川原茉莉1, 脇田恵里1, 伊藤洋貴1, 佐藤賛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2018.
Japanese Article P1109-24-PM. Examination about the use situation of the wide area antimicrobial by carbapenem-based antimicrobial proper use measures
河村茉衣1, 花房伸幸1, 小池彩子1, 廣田あゆ子1, 奥格2, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2018.
Japanese Article P1111-24-PM. The reporting by the antimicrobial proper use support team for the purpose of the meropenem proper use support and use turn of eventss with it
浅野嘉之1, 伊東和真1, 大岩拓馬1, 加藤麻理乃1, 水草博希1, 前田剛司1, 坂田洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2018.
Japanese Article P1113-24-PM. Grasp and comparison between public west Chita General Hospital and use of meropenem (MEPM) situation between the regional alliances institution of the Chita Peninsula demographic division of medical services
川崎祥平1, 野澤正徳2, 外山昌伸3, 吉岡祐貴1, 小林義和1, 生田宏次1, 浅野昌彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2018.
Japanese Article P1115-24-PM. Examination of the impaired renal function that vancomycin and tazobactam/piperacillin combination cause
袖山健吾1, 島田泉1, 小林将文1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2018.
Japanese Article P1117-24-PM. Suggestion of the alternative agent in consideration of the cross reactivity for the patients who presented with neutropenia during vancomycin administration
勝綾香1, 中薗健一1, 末永桂子1, 横山美恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2018.
Japanese Article P1119-24-PM. Inspection of the causation of the vomiting expression in linezolid treated patients
堤竹蔵1, 今井俊吾1, 堤佳那1, 山田武宏1, 笠師久美子1, 小林正紀1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2018.
Japanese Article P1121-24-PM. We look at the rear of the factor affecting the thrombocytopenia with the linezolid administration and examine a mark
向山直樹1, 向山麻衣子1, 成瀬徳彦1, 黒野康正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2018.
Japanese Article P1123-24-PM. About the making of the aspiration pneumonia pass for the purpose of the antimicrobial proper use and the usefulness
山田富美子1, 滝雪歩1, 安原昌宏1, 原田靖子1, 大成洋二郎2, 西原昌幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2018.
Japanese Article P1125-24-PM. Can you plan the proper use of the antimicrobial by antimicrobial proper use bundle?
井出和男1, 寶福誠1, 小井土啓一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1496-1496, 2018.
Japanese Article P1127-24-PM. The intervention example that we conducted a certain grounds suggestion according to a principle for patients with animal bite, and a transmistake became good
西村尚芳1, 津曲恭一1, 尾之江剛樹2, 古郷修一郎3, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1496-1496, 2018.
Japanese Article P1129-24-PM. One patient who they presented with febrile neutropenia and meningitis due to multidrug-resistant Pseudomonas aeruginosa after the chemotherapy, and obtained recovery
浅川杏子1, 清水忠洋1, 齊藤安昌1, 曾根原亘1, 太田光2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1497-1497, 2018.
Japanese Article P1131-24-PM. Look at the rear of the treatment case of multidrug-resistant tuberculosis in our hospital; mark investigation
柴田有希子1, 内藤靖雄1, 赤沢翼1, 増田純一1, 近藤直樹1, 坂本治彦1, 小林明信1, 寺門浩之1, 高崎仁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1497-1497, 2018.
Japanese Article P1133-24-PM. The case that suggested appropriate antimicrobial for a brain abscess
安冨佑思1, 津曲恭一1, 尾ノ江剛樹2, 北島久義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1498-1498, 2018.
Japanese Article P1135-24-PM. Bacillus sp. which developed in patients with myelodysplastic syndrome during azacitidine therapy One case of the bacteremia to depend on this
大島千佳1, 奥田拓也1, 伊東克郎2, 新井成俊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1498-1498, 2018.
Japanese Article P1137-24-PM. One patient who was able to connect to the interaction evasion of VRCZ for the purulent omarthritis that presented βD glucan high level
千葉博暁1, 富樫ふみ2, 古田島聡3, 村上衛4, 狩野太郎5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1499-1499, 2018.
Japanese Article P1139-24-PM. One case that we resumed warfarin during use of miconazole gel, and a PT-INR level caused abnormal high level
永松翔1, 岩下龍史2, 寺師守彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1499-1499, 2018.
Japanese Article P1141-24-PM. Evaluation of the antimicrobial consumption of the Saiseikai Futsukaichi Hospital using the use of antimicrobial pulse-taking system (the JACS)
秀島久美子1, 中野祐樹1, 大竹野久雄1, 猪口陽子1, 蓮輪博嗣1, 横尾賢乗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1500-1500, 2018.
Japanese Article P1143-24-PM. Efforts to antimicrobial proper use support addition calculation in the Hashima Municipal Hospital
伊藤真也1, 山本英治1, 鈴木俊敬1, 濱田陽子1, 丹羽伊紀詠1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1501-1501, 2018.
Japanese Article P1145-24-PM. Comparison of the MRSA detection situation and the use of hand disinfectants situation in the Niigata public welfare consecutive 15 institution, comparison of skin disinfectant at blood culture and the blood culture-positive rate
霍間尚樹1,2, 細川浩輝2, 渡辺一也2, 丸山弘朗2, 山田加代子2, 江口裕子2, 岩田昌英2, 山岸綾子2, 笹原一裕2, 石川光教2, 庭野旬子2, 結城杏子2, 相田有美子2, 石川昭子2, 赤塚孝宏2, 本間絵美2, 佐藤宏2, 山本修也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1501-1501, 2018.
Japanese Article P1147-24-PM. Infection measures class of the practice pattern for the drugstore desk work that aimed at the alteration of consciousness
石原義久1, 竹内正幸2, 里山雅子1, 永田梨奈1, 柏木宏仁1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1502-1502, 2018.
Japanese Article P1149-24-PM. Examination about the onset of de-escalation and infection lifesaving rate of the antimicrobial in blood culture-positive patients and antimicrobial-related loose bowels situation
岡崎萌水1, 柳澤成佳1, 八木祐助1, 森田靖代1, 宮村充彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1502-1502, 2018.
Japanese Article P1151-24-PM. Epidemiologic studies about the drug resistance of the Haemophilus influenzae derived from the children in the single teaching hospital of Japan
原直己1,2, 田中愛海2, 落合翔子2, 瀬山翔史3, 輪島丈明2, 野口雅久2, 夏目義明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1503-1503, 2018.
Japanese Article P1153-24-PM. Evaluation about the infection prevention effect of peroxymonosulfuric acid hydrogen potassium combination sanitization, the cleaner to Clostridioides difficile infection
今井清隆1, 一幡結1, 上坂一行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1503-1503, 2018.
Japanese Article P1155-24-PM. Attitude survey of the healthcare worker for the antimicrobial prescription to cold syndrome
川島渉1,2, 詫間章俊2, 市村丈典1,2, 高田昂輔1,2, 市倉大輔1,2, 縄田修一1,2, 峯村純子1,2, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1504-1504, 2018.
Japanese Article P1157-24-PM. Local joint surveillance about antimicrobial consumption and the resistant bacteria separation rate in the Toyama prefecture 26 institution
細野美幸1, 飯尾志帆1, 高野雄介1, 高橋慎太郎1, 脇田真之1, 守内匡1, 加藤貴子1, 窪田佳代子1, 杉田真理子1, 船本哲生1, 辻泰弘2, 山本善裕3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1504-1504, 2018.
Japanese Article P1142-25-AM. Efforts of an investigation and the pharmacist of the use of antimicrobial situation for the AMR measures promotion
中市里実1, 澤田美穂2, 善積司行1, 岩佐沙希子1, 楠本民彌1, 三浦絢1, 前田智佳子1, 長野有沙1, 台野佳代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1505-1505, 2018.
Japanese Article P1144-25-AM. Participate in AMR measures - infection measures network in the psychiatry single department hospital; and -
津倉由里1, 上中敦1, 大尾充剛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1506-1506, 2018.
Japanese Article P1146-25-AM. Fact-finding about the maneuver of the hand hygiene in Japanese Foundation for Cancer Research Ariake hospital pharmacy duties
川村舞雪1, 山田玲子1, 庄司大悟1, 鈴木強志1, 濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1506-1506, 2018.
Japanese Article P1148-25-AM. An example and the hospital infection measures that were treated for meningococcus meningitis by the ICT
森章哉1,5, 中嶋里佳1,5, 青木康二1,5, 小林百合2,5, 別所裕二3,5, 村田哲也4,5, 河村雅人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1507-1507, 2018.
Japanese Article P1150-25-AM. Inflection of the bloodstream infections management bundle aiming at standardization of the bloodstream infections prevention
奥平正美1,2, 犬塚和久1,3, 大曲貴夫1,4, 笠井正志1,5, 日馬由貴1,4, 松島由実1,6, 村木優一1,7, 村松有紀1,8, 八木哲也1,9, 三鴨廣繁1,10
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1507-1507, 2018.
Japanese Article P1152-25-AM. Study on risk factor of the Respiratory Syncytial Virus infection patients of the 2017 season
丹代恭太1, 工藤晋1, 鈴木弘文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1508-1508, 2018.
Japanese Article P1154-25-AM. Stocktaking of the Bundle compliance for the Candida bacteremia in our hospital
伊藤嘉英1, 清水智也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1508-1508, 2018.
Japanese Article P1156-25-AM. Use of antimicrobial density (AUD) under Okinawa and use days (DOT) surveillance - Okinawa hospital pharmacist meeting infection subcommittee multicenter study ...
座間味丈人1,2, 潮平英郎1,2, 上地幸平2,3, 小杉卓大4, 新垣淑大4, 喜舎場知香5, 伊波寛史5, 喜友名朝史5, 入月健6, 與那原希6, 島袋友香子7, 小橋川健枝7, 高良秀史8, 吉本尚志9, 新崎さや乃9, 宜保潤10, 浜元善仁11, 平田やよい11, 戸北浩志12, 玉城哲子13, 城間盛彦13, 金城亜衣美13, 川平浩子5, 外間惟夫1, 藤田次郎2,14
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1509-1509, 2018.
Japanese Article P1158-25-AM. Chronic kidney disease and renal function evaluation in rheumatic disease methotrexate chronic administration patients
大津貴寛1, 松石裕也2, 宮下裕央2, 津曲恭一2, 橋本雅司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1510-1510, 2018.
Japanese Article P1160-25-AM. Problems of the pharmaceutical products proper use of patients in CKD in the health insurance pharmacy
長谷川浩三1, 西竜二郎1, 門脇大介2, 宮村重幸3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2018.
Japanese Article P1162-25-AM. Effect examination to the iron-deficiency anemia of the dialysis introduction patients in the ferric citrate hydrate
藤崎来夢1, 枦秀樹1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2018.
Japanese Article P1164-25-AM. Examination about the combined effect of a lipid dysbolism therapeutic drug and the high phosphorus blood symptom therapeutic drug using the high fat diet rat
小田雅子1, 佐々木環凪1, 角能佑樹1, 染木拓也1, 市村祐一1, 齊藤浩司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1512-1512, 2018.
Japanese Article P1159-24-PM. About safety of the eplerenone administration for the decreased renal function patients
西尾洋平1, 藤吉里紗1, 奥村浩樹1, 渡部実咲1, 田中佳子1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1513, 2018.
Japanese Article P1161-24-PM. For problems extraction and the solution to drug proper use program - current situation for patients in CKD which an insurance pharmacist founds
島祐子1, 有山知代1, 山森直子1, 梅野明子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2018.
Japanese Article P1163-24-PM. Effect on anemia-related index with the ferric citrate hydrate administration in haemodialysis patients
西崎文祥1, 増田展利1, 杉山哲大2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2018.
Japanese Article P1165-24-PM. About the combined effect of DPP-4 inhibitor and the SGLT-2 inhibitor
田仲祐子1, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 仲村亮太1, 森智子1, 駒井勇太1, 人見百合子1, 府川祥子1, 村雲智久1, 近藤理美1, 坂口結斗1, 石井英之1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 水野康平1, 山中愛美1, 吉村美菜1, 岸本実優1, 北池祥子1, 小久保綾乃1, 白木萌1, 中村麗紗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1515-1515, 2018.
Japanese Article P1167-24-PM. Sugar, a serum lipid metabolism change and medication counseling effect on patients with SGLT2 inhibitor ipragliflozin administration diabetes
江月優1, 玉井祐馬1, 瀧田優樹1, 中村由香2, 行宗千裕2, 泉京江2, 武田未佳2, 三浦剛3, 佐々木英久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2018.
Japanese Article P1169-24-PM. Investigation of the change of the blood glucose level accompanied with Dulaglutide and the liraglutide introduction of the GLP-1 receptor agonist
鳥居葵1, 村瀬瑞希1, 和田祐一郎1, 坂井裕美1, 穂積廣1, 加藤香奈1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2018.
Japanese Article P1171-24-PM. Comparison between precedent biomedicine and effect of the Biosimilar of insulin glargine
中山潤美1, 加藤まゆ1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2018.
Japanese Article P1179-24-PM. Usefulness evaluation as the biomarker of the plasma kiss peptin concentration in the diabetes diagnosis
片桐文彦1, 小谷仁人2, 木村耕二1, 高柳理早1, 山田安彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2018.
Japanese Article P1181-24-PM. Ophthalmology consultation encouragement for the diabetic retinopathy prevention by the drugstore pharmacist
夏山絢子1, 小西秀平1, 吉田恭子1, 河島大介1, 木下大輔1, 石橋正次1, 兼重晋1, 山村伸也1, 古賀友一郎1, 高木淳一1, 鷲山厚司1, 虎石顕一1, 田中泰三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2018.
Japanese Article P1168-25-AM. Effect and examination of the risk factor to give HbA1c of the SGLT2 inhibitor kana glyph rosin remedy patients
亀田美保1, 水永耀子1, 横田智美1, 町田加純1, 黒川彰太1, 岡村和彦1, 佐々木雄啓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2018.
Japanese Article P1170-25-AM. Usefulness of the Dulaglutide in patients with type 2 diabetes and safe examination
橋本公貴1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 吉野寧維2, 岡本慧子2, 鈴木敦詞2, 山田成樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2018.
Japanese Article P1172-25-AM. It is versatility and effect ... of the administration extended ... insulin Degludec of the treatment with insulin choice to elderly people three times a week
安部絵里1, 中島啓二1, 臼井一将1, 多賀小枝子1, 新井かおり1, 伊藤加代1, 蜜田哲也1, 宇佐美英績1, 柴田大河2, 傍島裕司2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2018.
Japanese Article P1174-25-AM. Examination about the diabetes self injection drug in elderly people
糸川貴之1, 斉藤芳敬1, 西村栄一1, 近藤智幸1, 村上達也1, 鈴木正樹1, 簑島弓未子1, 橋本光生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2018.
Japanese Article P1176-25-AM. About carrying of the sugar at the hypoglycemia
木元慎一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1523-1523, 2018.
Japanese Article P1178-25-AM. 1 case that developed heart failure during pioglitazone remedy
村瀬瑞季1, 鳥居葵1, 和田祐一郎1, 坂井裕美1, 穂積廣1, 加藤香奈1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1523-1523, 2018.
Japanese Article P1180-25-AM. Relationship of serum Zn and HbA1c
森田啓嗣1, 川上恭弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1524-1524, 2018.
Japanese Article P1182-25-AM. It is ... about the inflection of current situation - diabetes conversation map (TM) of the use of antidiabetic drug situation investigation and the diabetes medical treatment instruction of the Kanagawa Saiseikai young grass hospital
宮永幸実1, 小杉満孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1524-1524, 2018.
Japanese Article P1183-24-PM. Intervention of a pregnant woman, the nursing mother medical therapy authorization pharmacist for the mental disorder merger pregnant woman
松本侑季1, 星裕也1, 石井紀子1, 寺山義泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1525-1525, 2018.
Japanese Article P1185-24-PM. Blood level measurement ... of case - pregnant woman of the breast-fed infant of the zonisamide remedy patients and neonates
三上有希1, 澤井麻記1, 野崎歩1, 前田万里紗2, 澤田彩李4, 澤田眞智子3, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1526-1526, 2018.
Japanese Article P1187-24-PM. Counseling contents until the drug blood level change of mother children in the case given the pregnancy, the nursing after the tacrolimus internal use and the nursing start
伊差川サヤカ1, 大田久美子1, 瑞慶山にいな1, 潮平英郎1, 与那覇房子1, 外間惟夫1, 中村克徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1526-1526, 2018.
Japanese Article P1189-24-PM. The pregnancy outcome by the presence or absence of influenza immunization of the pregnant woman and effect on fetuses
星野裕子1, 関澤真人1, 高津戸敬1, 渡辺尚2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1527-1527, 2018.
Japanese Article P1191-24-PM. 1 case of the initial infection pregnant woman who needed the enforcement situation investigation of the cytomegalovirus antibody screening and treatment
遠藤千夏1, 國本雄介1, 伊藤彩子1, 景山ますみ1, 北川学1, 木明智子1, 中田浩雅1, 水内将人2, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1527-1527, 2018.
Japanese Article P1193-24-PM. Examination about the presence or absence of effect accompanied with the abolition of postpartum prophylactic methylergometrine and the antimicrobial internal use administration
森本めぐみ1, 中浴伸二1, 濱宏仁1, 森本茂文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1528-1528, 2018.
Japanese Article P1195-24-PM. The effect that ritodrine hydrochloride doses give to a rise in serum creatine kinase value
出口賀奈子1, 伊藤朱里1, 桐生浩子1, 原美由紀1, 西川嘉広1, 橋本陽1, 今西義紀1, 小出哲朗1, 須川由理子1, 本橋卓2, 伊藤久美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1528-1528, 2018.
Japanese Article P1197-24-PM. Efforts for pharmacist intervention in the obstetrics and gynecology department ward of the Sapporo Tokushukai Hospital
山岡幸1, 宮腰恵生1, 藤澤春香1, 宮越貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1529-1529, 2018.
Japanese Article P1199-24-PM. Efforts of the current situation and our hospital of questions and answers about the medical therapy of a pregnant woman, the nursing mother
伊藤緑1, 佐藤直子1, 土井啓員1, 増田雅行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1529-1529, 2018.
Japanese Article P1201-24-PM. The gestation period, lactational medicine consultation foreign current situation in our hospital
前田早織1, 小林映子1, 藤岡泉2, 笠井靖代2, 石田耕太1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1530-1530, 2018.
Japanese Article P1184-25-AM. Attempt - of the pharmacist by instruction management - multi-type of job cooperation to the expectant mothers who had the mental disorder
伏見友里1, 榎澤彩1, 春岡美姫1, 古川ゆかり1, 松永理恵1, 大澤優里1, 神下大佑1, 藤本和利1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1531-1531, 2018.
Japanese Article P1186-25-AM. Mother's milk childcare case by the blood level monitoring in a mother's body and neonates during lamotrigine remedy
早川朋子1, 大橋拓人1, 藤井尚子1, 君野沙紀1, 須田奈美1, 加藤潤一郎1, 生駒直寛2, 田辺行敏2, 上出泰山3, 川久保孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1532-1532, 2018.
Japanese Article P1188-25-AM. Caffeine concentration out of consciousness and the mother's milk for the caffeine intake of mother at one month medical examination
香西祥子1,2, 加藤育子2, 田中彩2, 白澤彩香2, 河西邦浩1, 岡田仁2, 日下隆2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1532-1532, 2018.
Japanese Article P1190-25-AM. For drug evaluation - Drugs in Pregnancy and Lactation (G.G.Briggs et al.) revision for taking Amoxicillin at pregnancy -
増田寛樹1, 中野志乃1, 前田恵里2, 岡田裕子2, 溝口優1, 山口友明3, 鷲見正宏4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1533-1533, 2018.
Japanese Article P1192-25-AM. Efforts for right knowledge enlightenment about the vaccination of the gestation period
佐藤寛子1, 伊藤有美1, 鈴木秀明1, 滝本典夫1, 足立守1, 今井夏子2, 長船綾子3, 梅津朋和3, 山本真一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1533-1533, 2018.
Japanese Article P1194-25-AM. IgA nephropathy merger pregnant example that evaded dialysis introduction by the intervention of the pharmacist
加藤沙織1, 長谷川まゆみ1, 三井由加子1, 小野義久2, 長谷川元3, 近藤正巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1534-1534, 2018.
Japanese Article P1196-25-AM. One patient whom the myotonica dystrophia of mother children was diagnosed in with the rhabdomyolysis onset after the ritodrine hydrochloride oral administration
豊田容子1, 関谷泰明1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1534-1534, 2018.
Japanese Article P1198-25-AM. Analysis of pharmaceutical management intervention contents in the use of supplement for hospitalized pregnant women
安達真紀子1, 高橋亜樹子1, 孝田佳子1, 井上和子1, 高根浩1, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1535-1535, 2018.
Japanese Article P1200-25-AM. Investigation using the questionnaire targeted for a physician about the effect by the electronic medical chart publication of a pregnant woman, the nursing mother medical therapy material
大野愛1, 伊藤友恵1, 伊藤孝子1, 山本恭平1, 岩瀬由枝1, 鶴田昌吾1, 石上仁美1, 猪岡真己1, 久保田敏行1, 杉浦洋二1, 勝見章男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1535-1535, 2018.
Japanese Article P1202-25-AM. Attitude survey to the medication of the nursing mother
足立易子1, 杉本芙美1, 浜田凌介1, 神谷量子1, 銭瑶子1, 澤井健太1, 多賀野正嗣1, 堀哲史1, 伊藤公博1, 竹田和也1, 藤村保夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1536-1536, 2018.
Japanese Article P1203-24-PM. Proper use investigation of the psychotropic drug for BPSD in the medical treatment ward
渡辺智康1, 難波良平1, 山崎恵1, 高取孝一1, 安藤哲信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1537-1537, 2018.
Japanese Article P1205-24-PM. Association of the physical factor, therapeutic drug of the fall fall in the middle scale hospital 80 years or older inpatient
今井芳1, 福田哲也1, 大越千紘1, 加藤由起子1, 藤田詩織1, 大熊玲子1, 伊藤祥子1, 野本友妃子2, 八代智子1, 吉田誠也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1538-1538, 2018.
Japanese Article P1207-24-PM. Fact-finding of the medical therapy in the delirium patients whom a dementia care team intervened in
薄雅人1,9, 市川竜太郎1,9, 塩川幸子2,9, 高野直人3,9, 内田美子4,9, 小嶋紀子5,9, 豊島遼太郎6,9, 滝久司1, 高木亮1, 黒田勝宏7,9, 溝口功一8,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1538-1538, 2018.
Japanese Article P1209-24-PM. The results of the pharmacist for the polypharmacy in the care ward
矢倉尚幸1, 佐々木優1, 大森那美1, 渡辺智之1, 湯本哲郎2, 稲葉健二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1539-1539, 2018.
Japanese Article P1211-24-PM. Pharmaceutical management of DOAC depending on the renal function in the convalescent rehabilitation ward
山本清子1, 門脇大介2, 森伸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1539-1539, 2018.
Japanese Article P1213-24-PM. We examine our hospital screening tabulation for PIMs
田畑寛明1, 若林厚史1, 辻依利1, 里見彩1, 猿谷淳1, 向一美1, 地野幹子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1540-1540, 2018.
Japanese Article P1204-25-AM. Inspection of the clinical usefulness and economic effect of the prescription suggestion that a pharmacist makes at the Care health center for the elderly rounds of the physician
須藤寛1, 新井克明2, 青木洋平3, 大庭建三4, 倉田なおみ5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1541-1541, 2018.
Japanese Article P1206-25-AM. Efforts for fall risk assessment and the proper use of benzodiazepine drugs
森伸子1, 森直樹2, 猿渡淳二3, 門脇大介4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1542-1542, 2018.
Japanese Article P1208-25-AM. Role of the pharmacist in the dementia care team
佐賀嘉英1, 梅原祐奈1, 大西真由1, 生井太基1, 四方純子1, 上羽沙綾1, 門脇隼也1, 奥村智晴1, 塩見明日香1, 谷田有花1, 芦田理沙1, 村上由樹1, 足立圭司1, 川見里奈1, 堀雅博1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1542-1542, 2018.
Japanese Article P1210-25-AM. About the current situation and a problem in the polypharmacy of the inpatient, the intervention effect of the dementia delirium support team (DST)
市川大介1, 藤野優菜1, 小田真澄1, 中田早苗1, 齋藤文佳1, 古谷佳美1, 安江佳南1, 河本紫帆1, 涌谷洋介2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1543-1543, 2018.
Japanese Article P1212-25-AM. Current situation investigation (1) of the medical therapy to have an influence on the aspiration pneumonia of elderly people
渡邊梓1, 西川満則1, 勝浦正人1, 三輪芳弘1, 大石雅子1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1543-1543, 2018.
Japanese Article P1214-25-AM. The effect that an ad usum externum basis (macrogol, water absorption cream) gives to STZ rat healing of wound process
大竹裕子1, 出口粧央里1, 上田純也1, 坂本竜祐1, 野田康弘2, 長井紀章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1544-1544, 2018.
Japanese Article P1216-25-AM. Need - pharmacists involved in a drug and the prevention that can become the "skin-tear" origin, please know "the skin-tear"; ...
益成宏1, 原田清美2, 秋元夕希2, 松永美明2, 弘中真紀2, 柳澤知子2, 佐古純子3, 寺尾隆4, 竹本朱美5, 中野純二5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1545-1545, 2018.
Japanese Article P1215-24-PM. Examination about the usefulness of the material for in-hospital reading in pressure sore treatment and the refinement
篠原梨沙1, 中野由希子1, 岩本剛志1, 中川はる奈1, 四方公亮1, 井上由紀1, 佐藤香織1, 勝俣はるみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1546-1546, 2018.
Japanese Article P1219-24-PM. About effect to give to the test value that the number of the taking antiepileptic drug agents before and after the hospitalization brings
矢嶋隆宏1, 山本吉章1, 加藤浩充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1548-1548, 2018.
Japanese Article P1221-24-PM. It is a 1 case with suspected cholinergic crisis onset with distigmine bromide under the fast instructions
花房伸幸1, 甲元大樹1, 松井美紗子1, 河村茉衣1, 竹中皇2, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1548-1548, 2018.
Japanese Article P1223-24-PM. Intervention to the bone fracture risk in the outside patients targeted for efforts FRAX to the bone fracture risk in patients with steroidal osteoporosis
細沼万衣1, 高澤麻美1, 木立美奈子1, 丹羽直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1549-1549, 2018.
Japanese Article P1225-24-PM. It is investigated the end reason of the epidural anaesthesia after the operation in our hospital
五十嵐詠美1, 貝瀬眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1549-1549, 2018.
Japanese Article P1227-24-PM. Change of the serum potassium level by the Shakuyakukanzoto remedy
服部真奈1, 杉浦龍也1, 川瀬将紀1, 伊藤広樹1, 守田覚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1550-1550, 2018.
Japanese Article P1229-24-PM. An example of the young woman whom hypercalcemia developed in by eldecalcitol
佐藤誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1550-1550, 2018.
Japanese Article P1231-24-PM. About a pemphigoid case by the DPP-4 inhibitor internal use in elderly people
高木彩菜1, 溝神文博1, 真野澪1, 天白宗和1, 加藤雅斗1, 高嶋理穂1, 安部匡生1, 戸上博昭1, 平島学1, 早川裕二1, 森下瑞穂1, 木ノ下智康1, 平野隆司1, 磯貝善蔵1, 小林智晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1551-1551, 2018.
Japanese Article P1233-24-PM. Report of the adverse event by the Ustekinumab administration by IV drip
久保靖憲1, 大滝康一1,2, 三嶋一登1, 小野尚志1, 山下恭範1, 福土将秀1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1551-1551, 2018.
Japanese Article P1235-24-PM. One case of the allergic contact dermatitis with aminocaproic acid included in OTC eye drops
川本英子1, 小池彩子1, 石橋真実1, 山口麻里2, 妹尾明美2, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1552-1552, 2018.
Japanese Article P1237-24-PM. Search of the cells which are optimal for High-Sensitive Allergy Test (HiSAT)
安高勇気1,2, 芝口浩智2,3, 神村英利1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1552-1552, 2018.
Japanese Article P1218-25-AM. Examination about the postoperative PT-INR rise in the warfarin remedy patients
森下友紀1, 徳山ことみ1, 井上結夏1, 藤里駿1, 猪股英幸1, 竹田克明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1553-1553, 2018.
Japanese Article P1220-25-AM. An example in the children whom acute renal failure with gabapentin was suspected in
在本麻由加1, 伊藤俊和1, 三宅麻文1, 尾上雅英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1554-1554, 2018.
Japanese Article P1222-25-AM. About 2 cases suggestive of the amantadine poisoning
福田裕子1, 田中裕貴子1, 森田貴子1, 道下佳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1554-1554, 2018.
Japanese Article P1224-25-AM. One case that presented an anaphylactic symptom by a methylprednisolone succinic acid ester sodium 40 mg IV infusion
山中祐美1, 加賀正基1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1555-1555, 2018.
Japanese Article P1226-25-AM. An example of the brain abscess that presented metronidazole-induced encephalopathy by a high dose for a long term
小西喜昭1, 九鬼大作1, 河村雅人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1555-1555, 2018.
Japanese Article P1228-25-AM. Examination of the factor influencing the serum magnesium level of the magnesium oxide preparation internal use patients
兼石誠1, 岡村智文1, 柴田茂貴1, 松岡佳歩1, 松永愛1, 柴田文規1, 田口みどり1, 船越幸代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1556-1556, 2018.
Japanese Article P1230-25-AM. It is an example with suspected onset of Collagenous Colitis with lansoprazole after the regular hospital change ridge from the ICU
武田佳子1, 土倉史香1, 大木伸泰1, 中野貴文1, 兼重晋1, 緒方憲太郎1, 神村英利1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1556-1556, 2018.
Japanese Article P1232-25-AM. About effect on blood glucose level of fixed-quantity and the KK-Ay mouse of the saccharide of the study on crude drug ingredient (11) - Daikenchuto of Chinese medicine -
椎崇1,2, 米倉萌笑1, 松尾侑希子1, 黒田明平1, 稲葉二朗1, 三巻祥浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1557-1557, 2018.
Japanese Article P1234-25-AM. About safety of the vonoprazan administration for the stress ulcer prevention
高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1557-1557, 2018.
Japanese Article P1238-25-AM. Examination - of the screening not to limit introduction of the HBV screening system and effect - subject drug to chemotherapy
初鹿野達也1, 沖田直美1, 菅原早織1, 原愛1, 山本康仁2, 舩津久美3, 城田幹生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1558-1558, 2018.
Japanese Article P1239-24-PM. Effect to give to antimicrobial activity and warfarin of the etoposide on Bacteroides fragilis group
吉田宣政1, 白土亮子2, 福原佐知1, 檜山智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1559-1559, 2018.
Japanese Article P1241-24-PM. 1 case that caused PT-INR extension by a complex factor
田中裕貴子1, 福田裕子1, 森田貴子1, 道下佳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1560-1560, 2018.
Japanese Article P1243-24-PM. An administration change of voriconazole and α-GI is one case with suspected induction of the liver damage by drug interaction
佐藤晃1, 池田舞1, 中野里美1, 平島麻由美1, 堀竜2, 堀裕貴也3, 齊藤幹夫4, 持田知志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1560-1560, 2018.
Japanese Article P1245-24-PM. One case of the purulent spondylitis that showed hypernatremia, polyuria during tolvaptan, fosfluconazole combination
佐脇久美1, 山代栄士1, 原尻学志1, 中島竜太2, 稲垣伸洋2, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1561-1561, 2018.
Japanese Article P1247-24-PM. Effect on Pemetrexed treated patients investigation of the non-steroidal anti-inflammatory drug combination
西和哉1, 川田彰彦1, 鈴木雄太1, 佐々木崇1, 佐藤ひかり2, 石田雅嗣2, 小野学2, 花釜正和2, 小林誠一2, 矢内勝2, 佐賀利英1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1561-1561, 2018.
Japanese Article P1249-24-PM. Effect on active ingredient Aripiprazole dosage by the incompatibility with the drinking water of 0.1% of prawns rephi private business liquid
石田志朗1, 浜田茂明2, 森本真仁2, 田中成枝1,3, 鈴江朋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1562-1562, 2018.
Japanese Article P1251-24-PM. 1 case that produced the hypoglycemia which combined repaglinide with the cyclosporin A remedy patients, and was prolonged
河村美弥子1, 田代将貴1, 松原大祐1, 上甲佳奈1, 佐藤潤2, 妹川史朗2, 正木銀三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1562-1562, 2018.
Japanese Article P1240-25-AM. Analysis of the PT-INR rise factor during the antimicrobial administration in the warfarin remedy patients
武田龍馬1, 半澤里佳1, 木村順平1, 山田和範2, 本間和加子1, 上山憲司3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1563-1563, 2018.
Japanese Article P1242-25-AM. Examination of the thrombotic event occurrence situation by the interaction of an antithrombocytic agent and the proton pump inhibitor in patients with peripheral arterial disease
松田璃沙1, 小原直紘1, 池上洋平2, 田路章博3, 山口崇臣1, 畝佳子1, 政道修二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1564-1564, 2018.
Japanese Article P1244-25-AM. Examination about drug interactions with tacrolimus and voriconazole after the hematopoietic stem cell transplantation
太田涼介1, 平田敦士1, 能登啓介1, 福井愛子1, 横山聡2, 細見光一2, 高田充隆2, 松岡寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1564-1564, 2018.
Japanese Article P1246-25-AM. Examination of the serum potassium rise factor of patients receiving sulfamethoxazole/trimethoprim
館内謙太郎1, 元木孝1, 高柳昌宏1, 千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1565-1565, 2018.
Japanese Article P1248-25-AM. Examination of frequencies and the risk factor of the hypokalemia at the aminophylline injection administration
小寺聖1, 田中佳子1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1565-1565, 2018.
Japanese Article P1250-25-AM. Magnesium preparation and PPI, examination of the bowel movement effect by the combination of H2bloker
新保一1, 浅見友美子1, 勝俣寛成1, 関川敬1, 伊東秀幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1566-1566, 2018.
Japanese Article P1252-25-AM. Construction of the quantitative drug interactions calculation tool using the CR-IR method
福田祥子1, 黒崎一博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1566-1566, 2018.
Japanese Article P1253-24-PM. Effect by safety and the decreased renal function of transdermal absorbing form bisoprolol in the acute heart disease
奥川寛1, 馬橋美由季1, 野崎歩1, 小林由佳1, 小林智子2, 中村茂2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1567-1567, 2018.
Japanese Article P1255-24-PM. About examination of the THA/TKA postoperative edoxaban start time
野中葉月1, 岡村央1, 若杉正1, 小池博文1, 佐橋幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1568-1568, 2018.
Japanese Article P1257-24-PM. Efforts including pharmacist intervention to anagrelide medication continuation for the essential thrombocythaemia
磯知輝1, 小柴聖史2, 小池道明3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1568-1568, 2018.
Japanese Article P1259-24-PM. An example of the levodopa carbidopa hydrate combination drug therapy intervention for the jejunum administration in our hospital
垣沼智之1, 木下史一1, 野田貴義1, 菅尾高裕1, 玄田拓哉1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1569-1569, 2018.
Japanese Article P1261-24-PM. Effective and safe examination of caffeine for patients with apnea of prematurity within week number 28 weeks for gestational ages
長郷あかね1,2, 中村公紀3, 神村英利1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1569-1569, 2018.
Japanese Article P1263-24-PM. add-on effect of the Rifaximin in hepatic encephalopathy treatment
加藤愛梨1, 大谷綾1, 西條由夏1, 笹瀬典子1, 中尾啓子1, 上田愛梨1, 塙久瑠実1, 白井ゆりか1, 金秀基2, 金守良2, 井本勉2, 金啓二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1570-1570, 2018.
Japanese Article P1265-24-PM. Intervention ... for promotion - pregabalin duloxetine of the drug proper use based on a renal function evaluation
貝塚朋恵1, 秋場孝則1, 小野田弘崇1, 森村春菜1, 中野一男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1570-1570, 2018.
Japanese Article P1267-24-PM. Investigation about the use actual situation and the adverse event of the prophylactic ST medical mixture for patients with collagenosis
西尾公志1, 三好孝法1, 山科卓也1, 小林宇太郎1, 山下克也1, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1571-1571, 2018.
Japanese Article P1269-24-PM. HbA1c change in the direct action type antivirus combination therapy and relations of the patients background
友野絵里加1, 平井利典1, 舩木文子1, 伊東俊雅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1571-1571, 2018.
Japanese Article P1254-25-AM. Search of the factor to control real introduction advisability for the heart failure exacerbation patients meeting a tolvaptan introduction standard
白井麻奈1, 澤田和久2, 鵜飼茜2, 新海大智2, 粟田浩文2, 伊東亜紀雄1, 杉浦洋二2, 長谷川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1572-1572, 2018.
Japanese Article P1256-25-AM. Effective and safe examination of the Edoxaban tosilate acid salt hydrate weight loss administration in patients who underwent lower limbs orthopedics surgery
栗城政子1, 鶴崎大1, 川畑舞佐子1, 深滝利也1, 菊池憲和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1573-1573, 2018.
Japanese Article P1258-25-AM. Examination about the skin irritation reduction effect by the pasting method of the hot compress
近藤綾子1,4, 山本泰大1,4, 出口裕子1,4, 平野茂樹1,4, 櫻井愛菜1,4, 奥村佳美2,4, 公文章子2,4, 浅井泰行3,4, 小田切拓也3,4, 渡邊紘章3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1573-1573, 2018.
Japanese Article P1260-25-AM. Efforts for the unification of inhalational instruction contents
中西有璃1, 堀本智香1, 渡邉稜子1, 齋藤あゆみ1, 乗松耕平1, 野田有貴子1, 研真梨子1, 尾向紗由理1, 愛甲佳未1, 由良沙央理1, 坂本有里恵1, 山田真人1, 三輪祐太朗1, 藤永仁美1, 大前隆広1, 石田達彦1, 上田里恵1, 福井由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1574-1574, 2018.
Japanese Article P1262-25-AM. The administration of zinc acetate hydrate preparation (Novell gin) results to the serum zinc level drop patients in cirrhosis and the gastric cancer
山本文哉1, 金田知詞1, 鈴木麻里子1, 横手信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1574-1574, 2018.
Japanese Article P1264-25-AM. Use fact-finding of the zinc acetate hydrate for the hypozincaemia of patients with cirrhosis
若松遼介1, 飯田美紅1, 道貝優太1, 須藤大雄1, 村中一大1, 飛澤国広1, 小原秀治1, 小関至2, 小原郁司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1575-1575, 2018.
Japanese Article P1266-25-AM. About the use actual situation and the effectiveness of the pain-killer in patients with rheumatoid arthritis and the sedative adjuvant
金澤沙衣1, 渡辺浩明1, 田村広志1, 和泉秀明1, 佐藤弘康1, 三本松泰孝1, 晴山知拓1, 能登数馬1, 蝦名勇樹1, 門野冴美1, 池田龍一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1575-1575, 2018.
Japanese Article P1268-25-AM. About a mucous membrane lesion and the revival predictor of the 5-ASA preparation internal use UC patients
藤林遼1, 鈴木直哉1, 朝倉幹己1, 藤田果那1, 木下愛1, 庄崎沙耶1, 田中耕太1, 山本翔太1, 前川英輝1, 山田将悟1, 菊地義明1, 高橋誠1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1576-1576, 2018.
Japanese Article P1270-25-AM. The need of the NST intervention in treated patients of the chemoradiotherapy to head and neck cancer
山本明日香1, 岡見英里香1, 辻本高志1, 寺谷俊昭1, 山田純一1, 上田晃1, 川本由加里1, 後藤仁和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1577-1577, 2018.
Japanese Article P1272-25-AM. Efforts for the rate of application adequacy of the lipid microsphere
田村健1,2, 川口友理1,2, 鎗田陽子1,3, 飯島顕子1,2, 長嶋亜希子1,4, 島村圭二2, 高石聡1,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1578-1578, 2018.
Japanese Article P1274-25-AM. Evaluation about the onset of impaired renal function by the use of amino acid addition sugar electrolyte infusion
矢野愛理1, 深水知英1, 柴田由香里1, 寺薗英之1, 武田泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1578-1578, 2018.
Japanese Article P1276-25-AM. The current situation and problem of the glycemic control at TPN enforcement in the Tomigusuku center hospital surgery department ward
上原千晶1, 赤嶺千秋1, 國分千代1, 洲鎌陽子2, 橋本孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1579-1579, 2018.
Japanese Article P1271-24-PM. It is examined the role of the ward pharmacist in the nourishment management than the pharmaceutical intervention example to the patients targeted for NST
片岡聡1, 吉本孝1, 岩崎要人1, 林基世1, 三宅佑美1, 奥村智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1580-1580, 2018.
Japanese Article P1273-24-PM. One consideration and examination for the transluminal tube occlude evasion of the nutrient for intestinal administration with the drug
田井達也1, 山口佳津騎1, 山本高成1, 香西真衣1, 本田由紀1, 元木貴大1, 田中裕章1, 加地雅人1, 森照茂2, 星川広史2, 大北仁裕3, 奥山浩之3, 辻晃仁3, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1581-1581, 2018.
Japanese Article P1275-24-PM. Clinical examination of the alimentation by the preoperative oral nutrient for intestinal administration of immunity
鈴木彰人1, 白尾一定2, 本吉佳世3, 武田朋子3, 花牟禮富美雄4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1581-1581, 2018.
Japanese Article P1277-24-PM. Comparison ... with evaluation - ampicillin-sulbactam of the administration method according to the renal function based on the human prostatic glandular tissue-specific PK/PD analysis of Piperacillin-tazobactam
松山侑未1, 猪川和朗1, 黒田明1, 小田川周平1, 山田和奈1, 中村小源太2, 西川源也2, 小林郁生2, 住友誠2, 森川則文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1582-1582, 2018.
Japanese Article P1279-24-PM. An example of the childhood epilepsy syndrome associated with the administration plan of the potassium bromide
片桐光1, 平良木由布1, 波多野亘1, 島田祐子1, 堀寧1, 山田徹1, 眞柄慎一2, 川島英志3, 塚野真也3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1583-1583, 2018.
Japanese Article P1281-24-PM. The effect that a high trough value in the treatment with initial vancomycin gives for onset of impaired renal function
春木祐人1, 広本篤2, 毎熊隆誉2, 手嶋大輔2, 春木麻衣1, 杉山哲大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1583-1583, 2018.
Japanese Article P1283-24-PM. Rearward inspection of the vancomycin administration plan in patients with obesity
猪口陽子1, 中野祐樹1, 大竹野久雄1, 秀島久美子1, 蓮輪博嗣1, 横尾賢乗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1584-1584, 2018.
Japanese Article P1285-24-PM. Vancomycin administration plan in patients with febrile neutropenia
倉重靖子1, 山本彩雅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1584-1584, 2018.
Japanese Article P1287-24-PM. Exhaustive preliminary examination of the estrangement factor from the population mean of the Teicoplanin blood trough level
小林亮1, 荒川昌史1, 須藤俊明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1585-1585, 2018.
Japanese Article P1289-24-PM. The use situation investigation of the antiMRSA medicine in our hospital for the antimicrobial proper use support team activity start
北山秀則1, 坪内孝敏1, 出町拓也1, 田中宏尚1, 村紗苗1, 芦崎雅之1, 平田力1, 岩本浩史1, 早坂州生1, 竹内公美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1585-1585, 2018.
Japanese Article P1278-25-AM. One case that suffered from blood tacrolimus levels management after the hematopoietic cells transplant by the interaction of the concomitant drug
黒岩勇人1, 伊藤武志1, 眞継賢一1, 塚本泰彦1, 濱口良彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1586-1586, 2018.
Japanese Article P1280-25-AM. The current situation of our hospital in the TDM duties of the antiarrhythmic drug
秋場孝則1, 森村春菜1, 小野田弘崇1, 菅原翼1, 塚本宏夢1, 中野一男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1587-1587, 2018.
Japanese Article P1282-25-AM. Examination about the inflection of TDM guidelines in the initial administration plan on vancomycin
中川恭宏1, 丸山久美子1, 奥美和1, 谷口一成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1587-1587, 2018.
Japanese Article P1284-25-AM. It is ... through construction and the evaluation - MRSA bacteremia case of the TDM enforcement system of vancomycin by the ward pharmacist
牧田亮1, 関谷泰明1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1588-1588, 2018.
Japanese Article P1286-25-AM. Examination of the neonates case that VCM blood level became the high level than predicted value
杉理江1, 佐野良輔1, 松浦優里1, 仙波靖士1, 久保井徹2, 立花広志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1588-1588, 2018.
Japanese Article P1288-25-AM. Examination about the effectiveness and the safety of the high-dose regimen in the Teicoplanin initial administration plan
山嶋仁実1, 片田佳希1, 中川俊作1, 杉本充弘1, 木全柾典1, 都築徹教1, 福井彩香1, 今井哲司1, 米澤淳1,2, 深津祥央1, 中川貴之1, 長尾美紀3, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1589-1589, 2018.
Japanese Article P1290-25-AM. Evaluation of the validity of antimicrobial TDM duties of our hospital
杉本誠1, 安泰成1, 安道代1, 梅澤貴志1, 笠原千草1, 金子憲太郎1, 川村僚一朗1, 島田雅人1, 竹永文子1, 松永佳誉子1, 茂木まどか1, 森井理貴1, 吉川明彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1589-1589, 2018.
English Article P1291-24-PM. Minor contribution of cytochrome P450 3A5 to the metabolism of hepatitis C NS5B inhibitor beclabuvir in vitro
Su Nwe San1, 松本准2, 斎藤祐実4, 小池雅子4, 坂上弘明3, 加藤芳徳4, 藤吉正哉2, 有吉範高2, 山田治美1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1590-1590, 2018.
Japanese Article P1293-24-PM. Effect of aldehyde oxidase giving it to Nicotine metabolism and CYP2A6
田山剛崇1, 西村さとみ1, 前田志津子1, 杉原数美1, 北村繁幸2, 佐和章弘1, 三宅勝志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1591-1591, 2018.
Japanese Article P1295-24-PM. Examination of the microemulsion preparation for the purpose of the bioavailability improvement of cannabidiol
中野裕佳子1,2, 森田まみ1, 冨田みさと1, 田島正教1, 杉山恵理花1, 佐々木忠徳2, 佐藤均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1591-1591, 2018.
Japanese Article P1292-25-AM. Effect of melatonin giving it to Xanthine oxidase activity
西村さとみ1, 田山剛崇1, 喜多智夫1, 大松秀明1, 覚前美希1, 前田志津子1, 佐和章弘1, 三宅勝志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1592-1592, 2018.
Japanese Article P1294-25-AM. An internal change of the morphine in the rat inflammatory model and examination of the analgesia
玉田実花1, 木村嘉明1, 柴田実香1, 浦田航希1, 橋本昌子1, 尾崎紀之2, 荒井國三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1593-1593, 2018.
Japanese Article P1296-25-AM. Relations with an Afatinib blood level trough value and the renal function test value
高橋毅行1,2, 寺薗英之1, 菅原英輝1, 新田美奈1, 中嶋洋生1, 水野圭子2, 井上博雅2, 武田泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1594-1594, 2018.
Japanese Article P1298-25-AM. Anticipatory evaluation of the interaction by the FDA drug interaction guidance model using clinical study data at grapefruit juice drinking
高橋雅弘1, 越前宏俊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1595-1595, 2018.
Japanese Article P1297-24-PM. Predictive - based on effect - physics chemical property of the diet to give to pharmacokinetics of the oral antitumor agents
大町蕗子1, 金子昌樹1, 飯島亮介1, 板垣文雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1596-1596, 2018.
Japanese Article P1299-24-PM. Example that the maintenance of the therapeutic range was thought to be necessary for a defibrillation effect of bepridil
藤本明子1, 戸田純司1, 大谷拓也1, 室岡邦彦1, 中里祐二1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1597-1597, 2018.
Japanese Article P1300-25-AM. Examination (the second report) for the cooperation of a ward pharmacist and the nursing facility using cooperation support tool "pharmacist summary"
田中成枝1, 合田貴史1, 白石剛一1, 越智大輔1, 毎熊隆誉3, 広本篤3, 手嶋大輔3, 大西順子1, 山地教代2, 近藤祥代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1598-1598, 2018.
Japanese Article P1302-25-AM. Intervention of the pharmacist in the hemophilic harmful effect case that we worked on by the multi-type of job community medical care cooperation system
田上直美1, 高林学1, 永居えい子2, 高木雅敏3, 原田薫4, 中田浩智5, 内場光浩6, 松下修三7, 齋藤秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1599-1599, 2018.
Japanese Article P1304-25-AM. Protect patients making use joining information of the hospitalized medicine together; is 1 ... prescription notebook ...
久岡清子1, 増田博也1, 合田さやか1, 佐々木健志1, 澤口友紀1, 間千晴1, 川村大輔1, 平野真衣1, 井上萌1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1599-1599, 2018.
Japanese Article P1306-25-AM. Investigation about the cooperation with medical facilities, the nursing facility, and the like in the drugstore
伊野陽子1, 舘知也2, 島内あかり1, 野口義紘2, 堺千紘1, 加納亜紀3, 寺町ひとみ2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1600-1600, 2018.
Japanese Article P1308-25-AM. Difference with efforts and the hospital pharmacist to the at-home duties as the insurance pharmacist
岡部真季1, 浅野陽子1, 宗岡美紗1, 日高良昌1, 岡敦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1600-1600, 2018.
Japanese Article P1310-25-AM. Effect to give to a self-care continuance rate after the rehabilitation ward discharge convalescent a change of the number of the internal use drugs and the number of medication
山田潤也1, 吉川舞1, 清水岳広1, 宮川哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1601-1601, 2018.
Japanese Article P1312-25-AM. Fact-finding in the health insurance pharmacy for foreigner
高橋恵美利1, 高橋良徳2, 佐藤ひろみ3, 大林恭子1, 武智洋一郎4, 高橋謙造5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1601-1601, 2018.
Japanese Article P1301-24-PM. Operational investigation of the medical cooperation system "blue bank link"
金子郁子1,3, 山口真衣子1, 田淵沙織1, 中村真理1,3, 西川浩子1,3, 吉田薫1,3, 岩城久弥1,3, 山本景一2, 稲葉眞也3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1602-1602, 2018.
Japanese Article P1303-24-PM. We saw it in the making of efforts - citizen health meet to the community medical care in the Chiba medical center
畑下真希1, 田中裕子1, 新藤学2, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1603-1603, 2018.
Japanese Article P1305-24-PM. Efforts of the tuberculosis patient discharge conference in our hospital
脇田恵里1, 山田英理1, 伊藤洋貴1, 佐藤賛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1603-1603, 2018.
Japanese Article P1307-24-PM. Analysis of the enforcement factor of the cooperation with medical facilities, the nursing facility, and the like in the drugstore
島内あかり1, 舘知也2, 伊野陽子1, 野口義紘2, 堺千紘1, 加納亜紀3, 寺町ひとみ2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1604-1604, 2018.
Japanese Article P1309-24-PM. Type of the drug in the home care patient visit drug control instruction, change of the number of the agents
滝澤康志1, 西澤さとみ1, 久保田令枝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1604-1604, 2018.
Japanese Article P1311-24-PM. Examination about the role of the pharmacist in the treatment at home to be able to see from the change of medical service fees
村瀬惇1, 松野純男1, 幸松健二1,2, 大鳥徹1, 北小路学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1605-1605, 2018.
Japanese Article P1313-24-PM. We work on enlightenment of "the medicine" to local inhabitants that we turn on a "home delivery of cooked foods lecture" "health Meister training cram school"
野田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1605-1605, 2018.
Japanese Article P1314-25-AM. Efforts of the medicine medicine cooperation promotion in the Takaoka demographic division of medical services
北澤英徳1, 脇田真之2, 麻生美佐子3, 小堀勝4, 山本一郎5, 永野康巳6, 浜野邦彦7, 藤森毅至8, 鈴木博幸9, 飴谷伸貴10
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1606-1606, 2018.
Japanese Article P1318-25-AM. Good use of pharmaceutical cooperation monitoring seat in hepatitis C treatment
横田千明1, 吉本辰暁1, 四郎園巧2, 本村奈津子3, 鶴崎泰史1, 中川義浩1, 杉和洋4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1607-1607, 2018.
Japanese Article P1320-25-AM. Efforts for the improvement in dentistry consultation in the bisphosphonate system medicine remedy patients
渡邉真一1,2, 渡部覚氏3, 込山武弘1, 宮内芳郎3, 田中亮裕2,4, 山口巧1,2, 田中守2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1608-1608, 2018.
Japanese Article P1322-25-AM. Attitude survey for the medicine medicine cooperation of cancer practice cooperation base Hospital and the meeting a demand drugstore
伊東佳美1, 山口俊司2, 林昌広3, 坂東勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1608-1608, 2018.
Japanese Article P1324-25-AM. Efforts to booklet making for patients who received anticancer agent which fixed its eyes on medicine medicine cooperation
今井陽介1, 石川星1, 齋藤良子1, 土橋俊文1, 松林和幸1, 佐伯潤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1609-1609, 2018.
Japanese Article P1326-25-AM. Evaluation - by making and the pharmacist of the standardization (1) - "medication counseling tool" of the medication counseling to patients with dementia by the medicine medicine cooperation
小松原雄士1, 宮田広樹2, 清海杏奈1, 入澤将人3, 奥田裕子4, 片山直子5, 杉浦宗敏1, 笠原英城2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1609-1609, 2018.
Japanese Article P1328-25-AM. Evaluation of the cooperation with the medical institution using the tracing report
高倉夕季1, 内藤聡1, 緒形富雄2, 栗山建志2, 前田守3, 長谷川佳孝3, 月岡良太3, 森澤あずさ3, 大石美也3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1610-1610, 2018.
Japanese Article P1330-25-AM. Examine illness using the contact paper between pharmaceutical products institutions; efforts (the second report) to medicine cooperation
新関みどり1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 田村和彦1, 近藤和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1610-1610, 2018.
Japanese Article P1332-25-AM. Inspection about doubt inquiry duties by the use of FAX with the pharmacy service under health insurance drugstore in the local basic hospital
岩崎珠実1, 田中敏1, 佐藤志帆1, 武藤健史1, 根本詩織1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1611-1611, 2018.
Japanese Article P1334-25-AM. Evaluation for the effect of the prior agreement protocol operation about the doubt in the outside Parliament prescription
吉本辰暁1, 鶴崎泰史1, 山形真一2, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1611-1611, 2018.
Japanese Article P1336-25-AM. Investigation ... from role - medical service fees calculation item of the pharmacist in the local inclusion care system
大久保淑子1,4, 大塚昌孝2,5, 勝俣はるみ3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1612-1612, 2018.
Japanese Article P1338-25-AM. For the proper use of evaluation - seamless drug from the ethical pharmacy about the discharge drug reporting book -
浜田凌介1, 伊藤公博1, 竹田和也1, 堀哲史1, 多賀野正嗣1, 足立易子1, 澤井健太1, 銭瑶子1, 神谷量子1, 杉本芙美1, 藤村保夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1612-1612, 2018.
Japanese Article P1340-25-AM. Efforts of our hospital for the clinical test value notation to outside Parliament prescription
溝口百合香1, 古川卓也1, 久保田豊1, 木賀田亮介1, 勝山善彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1613-1613, 2018.
Japanese Article P1342-25-AM. Efforts of the medicine medicine cooperation for the inflection of the clinical test value and the effect
設樂美紗子1, 設樂誉1, 千葉光1, 阿部優1, 鈴木康弘1, 佐藤真凡1, 熊谷智惠子1, 佐藤昌博1, 齋藤利彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1613-1613, 2018.
Japanese Article P1315-24-PM. Construction of the medicine medicine cooperation system in consideration of man power
岡崎正彦1, 森真人1, 松岡克俊1, 土居友紀1, 石村明子1, 松原栄治1, 白石太朗1, 星川仁美1, 矢野勝之1, 藤井玲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1614-1614, 2018.
Japanese Article P1317-24-PM. Approach of medicine, the medicine medicine cooperation for CKD, renal-transplant recipients
太田あづさ1, 大島沙紀1, 河原香織1, 西窪奈津子1, 塩田恵1, 吉田直恵1, 福田清人2, 山下雅代2, 佐伯みずほ3, 藤井直彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1615-1615, 2018.
Japanese Article P1319-24-PM. Attitude survey about the cooperation of rheumatoid arthritis treatment for hospital pharmacist and drugstore pharmacists
亀山俊1, 本間丈士1,2, 飯塚敏美1, 堀口雅巳1, 杉山健太郎2, 平野俊彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1615-1615, 2018.
Japanese Article P1321-24-PM. Effect by the inhalational introduction not to contact as the pharmaceutical cooperation tool
宮崎俊明1, 石田正之2, 片岡大輔3, 上田真弓4, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1616-1616, 2018.
Japanese Article P1323-24-PM. Making of the tool which we unified in an area for the treatment with breast cancer hormone
鬼窪利英1, 中村久美1, 松原重征2, 野村香織3, 馬場麻里子3, 村田稔弥4, 西瀬直美4, 三浦篤史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1616-1616, 2018.
Japanese Article P1325-24-PM. Attitude survey about the use of medicine notebook in the cancer medical therapy
大川真里奈1, 永倉史子1, 熊谷修一1, 目黒聡子1, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1617-1617, 2018.
Japanese Article P1327-24-PM. Inspection - of the utilization situation grasp of questionary survey - information sharing tool about the medicine medicine cooperation in the foreign cancer chemotherapy and the usefulness
川畑舞佐子1, 鶴崎大1, 深滝利也1, 菊池憲和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1617-1617, 2018.
Japanese Article P1329-24-PM. Examination of the usefulness by the illness medicine cooperation using the medication information report (tracing report)
伊藤聡一郎1, 寺島純一1, 伊藤晴也1, 勝野晋哉1, 山田哲也1, 水野草平2, 鷹見繁宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1618-1618, 2018.
Japanese Article P1331-24-PM. Doubt inquiry simplification and operational report of the tracing report
上田昌宏1, 貴田聡史2, 高本光次郎1, 近藤純1, 志方敏幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1618-1618, 2018.
Japanese Article P1333-24-PM. An evaluation and problem after the outside Parliament prescription doubt inquiry simplification protocol introduction
後藤義之1, 角紀一郎1, 岡田久美1, 石崎真由美1, 松岡未紗1, 茶野下貴恵1, 光井彩1, 島崎沙織1, 青木理恵1, 戸田翔子1, 森戸敏志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1619-1619, 2018.
Japanese Article P1335-24-PM. The doubt inquiry simplification protocol introduction of the outside Parliament prescription and the evaluation
田中奈桜1, 十田達也1, 石野佑樹1, 藤井克至1, 北野祐香1, 窪田彩花1, 生越由美1, 黒川拓也1, 宮部泰輔1, 東達也1, 上田善美1, 田村憲昭1, 井上敦介1, 廣畑和弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1619-1619, 2018.
Japanese Article P1337-24-PM. About a job evaluation in the outside Parliament prescription doubt inquiry simplification protocol introduction
内藤睦1, 小寺由香1, 中野静香1, 辻俊美1, 足立充司1, 野村浩英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1620-1620, 2018.
Japanese Article P1339-24-PM. The case that the reporting at discharge to the family drugstore led to the proper use of the drug
根上朋子1, 杉生雅和1, 高子優子1, 大嶋浩一2, 小川佳美1, 吉岡睦展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1620-1620, 2018.
Japanese Article P1341-24-PM. Examination of the efforts of the discharge drug control reporting book grant to the family drugstore and the problems
佐々木佳世子1, 佐藤弘1, 金内幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1621-1621, 2018.
Japanese Article P1343-24-PM. Efforts to the outside Parliament prescription introduction that displayed clinical test value
潟永安亘1, 後藤隆1, 草葉一友1, 山口善久2, 馬場渉3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1621-1621, 2018.
Japanese Article P1344-25-AM. About training schedule construction and the participation that fixed their eyes on a revision core curriculum in 8 representative diseases
山中俊哉1, 井上壽江1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1622-1622, 2018.
Japanese Article P1346-25-AM. Questionary survey analysis about the enforcement situation of 8 representative diseases in the long-term business training
吉田都1, 内田享弘1, 桑原晶子1, 豊原朋子1, 片岡和三郎1, 原口珠実1, 小島穂菜美1, 福田侑梨子1, 綿本有希子1, 藤原由梨1, 波多江崇2, 三木知博1, 中林利克1, 篠塚和正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1623-1623, 2018.
Japanese Article P1348-25-AM. Attempt of the multiple hospital cooperation business training with a university hospital and the municipal hospital
日比陽子1,2,4, 西出景子1,3,4, 江崎哲夫4, 森下修行3, 中村康夫2, 木村和哲4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1623-1623, 2018.
Japanese Article P1350-25-AM. Recognition for the need of the participation in nutrition therapy of the pharmacist of the current situation and the pharmacy student of the nutrition therapy education in the business training
石橋正祥1,2, 早川沙樹2, 石井正和1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1624-1624, 2018.
Japanese Article P1345-24-PM. Efforts for the patients intervention of "the representative disease" in the revision model core curriculum and the evaluation
染谷洋和1, 大久保淑子1, 小串興平3, 木村健次郎4, 岩上健司2, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1625-1625, 2018.
Japanese Article P1347-24-PM. A response to long-term business training "F pharmacy clinical practice" in the angel Hospital and future problem
相馬まゆ子1, 今田愛也2, 平野剛3, 佐々木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1626-1626, 2018.
Japanese Article P1349-24-PM. Change of the recognition for the simple suspension method of the pharmacy student before and after the business training
蓮元憲祐1, 横井正之1,2, 平大樹1, 角本幹夫1, 岡野友信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1626-1626, 2018.
Japanese Article P1351-24-PM. Effect of the adverse event (AE) training that we introduced into pharmacy business training
奥村伊代1, 矢野裕士1, 飯塚敏美2, 外川陽子2, 木下大輔3, 鈴木優司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1627-1627, 2018.
Japanese Article P1352-25-AM. Education effect of the training program of the pharmacy student which adopted long-term physician-driven clinical study support duties
福井愛子1, 半谷眞七子1, 津川透1,2, 林高弘3, 山田成樹2, 亀井浩行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1628-1628, 2018.
Japanese Article P1354-25-AM. Practice and evaluation of the specialist job cooperation education aiming at upbringing of the specialist job that could contribute to the field of local health medical care welfare
内海美保1, 奥井順子1, 山原弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1629-1629, 2018.
Japanese Article P1356-25-AM. From comparison - entrance to school of the Japan-Korea pharmacist from an economic viewpoint to employment -
矢嶋幸一1, 犬伏彩夏1, 光家早紀1, 宮本凪美1, 吉岡三郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1629-1629, 2018.
Japanese Article P1353-24-PM. Change of the pharmacy student by the internship system enforcement in the hospital
大森清孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1630-1630, 2018.
Japanese Article P1355-24-PM. Comparison between study - settings pharmacist and student - about the basic social skill sought by a new face pharmacist
村田明子1,2, 中尾幸代1,3, 松田裕子1, 南恵理子1,4, 山中智香1,5, 沼田千賀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1631-1631, 2018.
Japanese Article P1357-24-PM. Can the business trip conference that school pharmacist conducts in a health room become the environment that a high school student is easy to talk about with a pharmacist?
喜友名侑舞1, 仲田里穂1, 岡本晃典1, 大柳賀津夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1631-1631, 2018.
Japanese Article P1358-25-AM. Efforts and problem to the duties improvement by "the young pharmacist meeting" led by the 6-year course pharmacist
岩津慎次郎1, 梅村拓巳1, 水野貴仁1, 寺本真弓1, 渡邊絵里1, 中村直人1, 鷹見繁宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1632-1632, 2018.
Japanese Article P1360-25-AM. Efforts to ward duties training curriculum revision for the Shinnyu staff who focused on work experience
宮下博幸1, 小林義和1, 齋藤雅俊1, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1633-1633, 2018.
Japanese Article P1362-25-AM. It is ... about new face educational program in our hospital in reference to ... NHOPAD
谷口智美1, 岡本明日香2, 形部文寛1, 橋本修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1633-1633, 2018.
Japanese Article P1364-25-AM. The present situation report of the medical therapy workshop by University of Shizuoka, hospital, the community pharmacy cooperation of 2017
内野智信1,2, 谷澤康玄1,2, 伊藤邦彦2, 井上達秀2, 河西きよみ2, 北村修2, 木村緑2, 黒川絢子2, 柴山芳之2, 名倉基雄2, 並木徳之2, 平野桂子2, 松山耐至2, 森本達也2, 山田静雄2, 山田浩2, 賀川義之1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1634-1634, 2018.
Japanese Article P1366-25-AM. Efforts - for activity report - HIV infection medical therapy authorized specialized pharmacist upbringing of the specialized pharmacist Board of Education HIV sectional meeting in the Aichi hospital pharmacist society
平野淳1,2, 奥平正美2,3, 塩田有史2,4, 加藤善章2,5, 戸上博昭2,6, 板倉由縁7,9, 山田清文5,9, 木村和哲8,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1634-1634, 2018.
Japanese Article P1368-25-AM. Efforts about the improvement in workplace communication by the training using Myers-Briggs Type Indicator
大里洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1635-1635, 2018.
Japanese Article P1361-24-PM. The new face pharmacist education that pointed to team approach in medical care
垣内祥宏1, 緑川拓也1, 渥美弘美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1637-1637, 2018.
Japanese Article P1363-24-PM. An evaluation and problem of the roof tile type new face education system in the Kanazawa Medical University hospital pharmacy
田紗永子1, 西田祥啓1, 宮東利恵1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1637-1637, 2018.
Japanese Article P1365-24-PM. Efforts (the second report) to postgraduate education for the purpose of the acquisition of the basic clinical medicine knowledge
山田雅也1, 力武隆浩2, 森一生3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1638-1638, 2018.
Japanese Article P1367-24-PM. Approach ... antimicrobial TDM analysis software experience type learning ... of the Saitama hospital pharmacist society area training sectional meeting
鍵山智樹1,12, 新井成俊2,12, 荒木淳一3,12, 古高裕子4,12, 唐澤匠太5,12, 黒下龍二6,12, 加藤剛7,12, 木村好伸8,12, 長谷部忠史9,12, 岩崎充10,12, 濱浦睦雄11,12, 北澤貴樹13
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1638-1638, 2018.
Japanese Article P1369-24-PM. Outcome evaluation by the electronic terminal introduction in the institutional review board
蜜田哲也1, 中島啓二1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1639-1639, 2018.
Japanese Article P1371-24-PM. Efforts to quick intelligence at Serious Adverse Event occurrence in the trial
川端奈緒美1,2, 三浦佳江1,2, 村上正樹1,2, 宇越郁子1, 渡部真紀1, 小谷麻衣子1, 小村晃子1, 佐藤恵美1, 野畑亜希子1, 西村信弘2, 直良浩司1,2, 田島義証1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1640-1640, 2018.
Japanese Article P1373-24-PM. The current situation investigation of the IRB in the medical association joint use institution
薬師寺寿世1, 加藤博和1, 末延道太1, 川元崇志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1640-1640, 2018.
Japanese Article P1375-24-PM. Examination of the clinical experimental medicine storage temperature en bloc management in the pediatric trial site
宮部祐子1,2, 松原侑紀1, 山崎美智子2, 平野慎也2, 藤田敬子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1641-1641, 2018.
Japanese Article P1377-24-PM. Duties improvement by the trial concomitant drug check system introduction using the YJ cord
村瀬哲也1,2, 小林真理1,2, 深川恵美子1,2, 永田剛志1, 田中惇子1,2, 藤井健司1,2, 木村優美1,2, 角山政之1,2, 松尾裕彰2, 梅本誠治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1641-1641, 2018.
Japanese Article P1379-24-PM. Efforts for the self-check in "the ethic guideline about the medical system study for people"
久米学1,2, 山崎純子2, 石田裕紀1,2, 村上冴2, 筧康正2, 永井洋士2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1642-1642, 2018.
Japanese Article P1381-24-PM. Examination of the need of the explanation to the subjects of survey patients in the use results investigation support task by the ward pharmacist
有馬秀樹1, 豊田貴美子1, 吉本久子1, 矢賀和子1, 越智文也1, 西川直也1, 谷澤香名子1, 幸田恭治1, 北原隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1642-1642, 2018.
Japanese Article P1370-25-AM. About the inquiry response to adverse event report in the trial
斉田翌美1,2, 筒井和美1,3, 吉野裕統1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1643-1643, 2018.
Japanese Article P1372-25-AM. About the cooperation with the CRC duties in the infection trial and other departments
川野智美1, 佐藤暁子1, 阿部亜貴子1, 川瀬佳織1, 赤井真侑子1, 山下愛登1, 平木洋一1, 久保徳彦2, 川中博文3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1644-1644, 2018.
Japanese Article P1374-25-AM. Efforts to the system construction about the clinical experimental medicine temperature management in the JCHO Kyushu Hospital
大西利彦1,2, 川久保充章1,2, 有吉美幸1,2, 古田彰1,3, 末松文博1,2, 山本英雄1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1644-1644, 2018.
Japanese Article P1376-25-AM. About correspondence at clinical experimental medicine temperature deviation
田島実弥1,2, 高崎紘臣2, 衛藤智章2, 笹川玲奈2, 松元俊博1, 三角紳博1, 瀬戸貴司2, 江崎泰斗2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1645-1645, 2018.
Japanese Article P1378-25-AM. Analysis of mention of the clinical positioning of the report by a deliberative committee
渡邊伸一1, 大泉麗子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1645-1645, 2018.
Japanese Article P1380-25-AM. The actual situation and attitude survey of trial, clinical studies duties in the hospital pharmacist
鶴丸雅子1,2, 近藤直樹1,3, 黒田智1,4, 寺元剛1,5, 酒井隆浩1,6, 水井貴詞1,7, 石塚良子1,8, 渡部一宏1,9, 武田泰生1,10, 田崎嘉一1,11, 松原和夫1,8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1646-1646, 2018.
Japanese Article P1382-25-AM. Health monitoring of the stricken area inhabitants utilizing outside Parliament prescription data
松浦誠1, 中村桃子1, 栗山あかな1, 谷川夏紀1, 中田義仁2, 金野良則3, 湊谷寿邦4, 高橋寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1647-1647, 2018.
Japanese Article P1384-25-AM. The establishment of the temporary drugstore in the in-hospital disaster training and activity report of the pharmacist
小武和正1, 則武有美1, 田窪和樹1, 池田佳織1, 川上恭弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1648-1648, 2018.
Japanese Article P1386-25-AM. Evaluation of the training about the pharmacist duties at large-scale disaster
五十嵐崇1, 齋藤謙治1, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1648-1648, 2018.
Japanese Article P1383-24-PM. Enforcement and evaluation of the training using the disaster action card according to the department in the pharmacy
岡田雅弥1, 満田正樹1, 中谷亮介1, 松本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1649-1649, 2018.
Japanese Article P1385-24-PM. Introduction and evaluation of the disaster support drugstore vehicle mobile pharmacy in university
林秀樹1,2, 羽山希2, 福田純久2, 生木庸寛2, 山下修司1, 小原道子2, 杉山正1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1650-1650, 2018.
English Article IP01. Safety re-evaluation on the concomitant use of the contraindicated chloral hydrate-furosemide combination in pediatric patients
Seung Hyun Lee1, Bilee Chwi Seo1, Ae Hee Jung1, Sun Hoi Jung1, Yoon Sook Cho1, Yun Jung Choi2, Dong In Suh2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1652-1652, 2018.
English Article IP02. Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions
Bomi Kim1, Sunwha Zara Kim1, Jin Lee1, Ae Hee Jung1, Sun-Hoi Jung1, Hyeon-Joo Hahn1, Hye RyunKang1, Dong In Suh1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1653-1653, 2018.
English Article IP04. Clinical Use of Delamanid in patients with Multidrug-resistant Pulmonary Tuberculosis
M. Kim1, S. Bae1, J. Mok2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1654-1654, 2018.
English Article IP05. Evaluation of the Adequacy of the Dosage Conversion Ratio in Switching from Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus
Jeong Yi Yoon1, Hye Young Kim1, So Yeon Park1, Mi Ran Oh1, Sung Min Lee1, Soon Joo Kim1, Shin Yi Hwangbo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1655-1655, 2018.
English Article IP06. Safe information use of Electronic medical record
Saki Kimura1, Takao Orii1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1656-1656, 2018.
English Article IP07. Retrospective Study of Risk Factors Associated with Hepatic Dysfunction Induced by Daclatasvir / Asunaprevir
Naoki Yoshikawa1, Kazuhiro Kitahata1, Manabu Okumura1, Tomomi Iwakiri1, Hiroshi Sekiya1, Kazuhiko Arimori1, Yuko Yonezawa2, Yasuji Arimura2, Ryuji Ikeda1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1656-1656, 2018.
English Article IP08. A novel method to identify proliferative cells in heterogenetic cell population
Hideyuki Terazono1, Yukiko Kobae1, Takayuki Takahashi1, Yasuo Takeda1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1657-1657, 2018.
English Article IP09. Linking Hospital and Community Pharmacy : The value of laboratory values stored in QR code prescription
Kazuto Mishima1, Tomoki Adachi1, Hirokazu Terakawa1, Sachiko Kasamo2, Ko-Ichi Ohtaki1,3, Takashi Ono1, Masahide Fukudo1, Toshio Awaya1,4, Yoshikazu Tasaki1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1657-1658, 2018.
English Article IP10. Application of Journal Club Trainings for Pharmacy Students and Hospital Pharmacists in Japan
Naoto Nakagawa1, Yuriko Murai2, Taku Obara3,4, Hiroshi Ohara1, Sachiyo Kurita5, Makiko Yoshida3, Hiroyuki Suzuki2, Yuta Ishii6, Yuji Sato3, Hisaki Suzuki3, Leanne Lai7, Nariyasu Mano3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1658-1659, 2018.
English Article IP11. The stability evaluation of hospital prepared eye drops
Ayumu Nagamine1,2, Hideaki Yashima1,2, Kana Ebisawa1, Tadashige Abe1, Takuya Araki1,2, Koujirou Yamamoto1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1659-1659, 2018.
English Article IP12. Consideration of appropriate anticancer drug mixing on the anticancer drug mixing time analysis
Sohei Ohshima1, Hideaki Yashima1,2, Tadashige Abe1, Takuya Araki1,2, Kohjiro Yamamoto1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1660-1660, 2018.
English Article IP13. Magnesium Oxide may Reduce Antidepressant-like Effects of Duloxetine via interactions in absorption
Satoru Esumi1, Yoshihisa Kitamura1, Hitomi Yokota-Kumasaki1, Soichiro Ushio1, Akane Yamada-Takemoto1, Ryo Nagai1, Atsushi Ogawa1, Yoichi Kawasaki1, Toshiaki Sendo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1661-1661, 2018.
English Article IP14. Effects of benzodiazepine medications on the pentobarbital-induced sleep behavior after the inflammatory reaction in mice
Yoshihisa Kitamura1, Ayumi Okada1, Shiho Hongo1, Kanami Otsuki1, Akihisa Miki1, Toshiaki Sendo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1661-1661, 2018.
English Article IP15. Analysis of current situation of antibiotics use in obstetrics and gynecology in China and suggestions for rational application
Zhou Boya1, Yue Wang1, Xin Feng1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1662-1663, 2018.
English Article IP16. Efflux pump transfer : a novel mechanism of tigecycline resistance
Xue Zhong1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1663-1663, 2018.
English Article IP17. Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia : A meta-analysis
Yu Bai1, Hai-Wei Wu1, Yan-Hua Zhang1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1664-1665, 2018.
English Article IP18. The role of clinical pharmacist in pharmaceutical care in the treatment team of Department of neurosurgery
Liu Xianjun1, Shiqi Zheng2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1665-1666, 2018.
▲